
<html lang="en"     class="pb-page"  data-request-id="756e8124-5aa1-458a-9e4f-fe8e6bb568d7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2014.57.issue-3;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm401635n;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of 7-Tetrahydropyran-2-yl Chromans: β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors That Reduce Amyloid β-Protein (Aβ) in the Central Nervous System" /></meta><meta name="dc.Creator" content="Allen A.  Thomas" /></meta><meta name="dc.Creator" content="Kevin W.  Hunt" /></meta><meta name="dc.Creator" content="Matthew  Volgraf" /></meta><meta name="dc.Creator" content="Ryan J.  Watts" /></meta><meta name="dc.Creator" content="Xingrong  Liu" /></meta><meta name="dc.Creator" content="Guy  Vigers" /></meta><meta name="dc.Creator" content="Darin  Smith" /></meta><meta name="dc.Creator" content="Douglas  Sammond" /></meta><meta name="dc.Creator" content="Tony P.  Tang" /></meta><meta name="dc.Creator" content="Susan P.  Rhodes" /></meta><meta name="dc.Creator" content="Andrew T.  Metcalf" /></meta><meta name="dc.Creator" content="Karin D.  Brown" /></meta><meta name="dc.Creator" content="Jennifer N.  Otten" /></meta><meta name="dc.Creator" content="Michael  Burkard" /></meta><meta name="dc.Creator" content="April A.  Cox" /></meta><meta name="dc.Creator" content="Mary K. Geck  Do" /></meta><meta name="dc.Creator" content="Darrin  Dutcher" /></meta><meta name="dc.Creator" content="Sumeet  Rana" /></meta><meta name="dc.Creator" content="Robert K.  DeLisle" /></meta><meta name="dc.Creator" content="Kelly  Regal" /></meta><meta name="dc.Creator" content="Albion D.  Wright" /></meta><meta name="dc.Creator" content="Robert  Groneberg" /></meta><meta name="dc.Creator" content="Kimberly  Scearce-Levie" /></meta><meta name="dc.Creator" content="Michael  Siu" /></meta><meta name="dc.Creator" content="Hans E.  Purkey" /></meta><meta name="dc.Creator" content="Joseph P.  Lyssikatos" /></meta><meta name="dc.Creator" content="Indrani W.  Gunawardana" /></meta><meta name="dc.Description" content="In an attempt to increase selectivity vs Cathepsin D (CatD) in our BACE1 program, a series of 1,3,4,4a,10,10a-hexahydropyrano[4,3-b]chromene analogues was developed. Three different Asp-binding moi..." /></meta><meta name="Description" content="In an attempt to increase selectivity vs Cathepsin D (CatD) in our BACE1 program, a series of 1,3,4,4a,10,10a-hexahydropyrano[4,3-b]chromene analogues was developed. Three different Asp-binding moi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 22, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401635n" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401635n" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401635n" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401635n" /></link>
        
    
    

<title>Discovery of 7-Tetrahydropyran-2-yl Chromans: β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors That Reduce Amyloid β-Protein (Aβ) in the Central Nervous System | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401635n" /></meta><meta property="og:title" content="Discovery of 7-Tetrahydropyran-2-yl Chromans: β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors That Reduce Amyloid β-Protein (Aβ) in the Central Nervous System" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0019.jpeg" /></meta><meta property="og:description" content="In an attempt to increase selectivity vs Cathepsin D (CatD) in our BACE1 program, a series of 1,3,4,4a,10,10a-hexahydropyrano[4,3-b]chromene analogues was developed. Three different Asp-binding moieties were examined: spirocyclic acyl guanidines, aminooxazolines, and aminothiazolines in order to modulate potency, selectivity, efflux, and permeability. Using structure-based design, substitutions to improve binding to both the S3 and S2′ sites of BACE1 were explored. An acyl guanidine moiety provided the most potent analogues. These compounds demonstrated 10–420 fold selectivity for BACE1 vs CatD, and were highly potent in a cell assay measuring Aβ1–40 production (5–99 nM). They also suffered from high efflux. Despite this undesirable property, two of the acyl guanidines achieved free brain concentrations (Cfree,brain) in a guinea pig PD model sufficient to cover their cell IC50s. Moreover, a significant reduction of Aβ1–40 in guinea pig, rat, and cyno CSF (58%, 53%, and 63%, respectively) was observed for compound 62." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401635n"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401635n">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401635n&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401635n&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401635n&amp;href=/doi/10.1021/jm401635n" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 878-902</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401622k" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm401642q" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 7-Tetrahydropyran-2-yl Chromans: β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors That Reduce Amyloid β-Protein (Aβ) in the Central Nervous System</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allen+A.++Thomas">Allen A. Thomas</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+W.++Hunt">Kevin W. Hunt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew++Volgraf">Matthew Volgraf</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ryan+J.++Watts">Ryan J. Watts</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xingrong++Liu">Xingrong Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guy++Vigers">Guy Vigers</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Darin++Smith">Darin Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Douglas++Sammond">Douglas Sammond</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tony+P.++Tang">Tony P. Tang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan+P.++Rhodes">Susan P. Rhodes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+T.++Metcalf">Andrew T. Metcalf</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karin+D.++Brown">Karin D. Brown</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer+N.++Otten">Jennifer N. Otten</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Burkard">Michael Burkard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=April+A.++Cox">April A. Cox</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary+K.+Geck++Do">Mary K. Geck Do</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Darrin++Dutcher">Darrin Dutcher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sumeet++Rana">Sumeet Rana</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+K.++DeLisle">Robert K. DeLisle</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kelly++Regal">Kelly Regal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Albion+D.++Wright">Albion D. Wright</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Groneberg">Robert Groneberg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kimberly++Scearce-Levie">Kimberly Scearce-Levie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Siu">Michael Siu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hans+E.++Purkey">Hans E. Purkey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+P.++Lyssikatos">Joseph P. Lyssikatos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Indrani+W.++Gunawardana">Indrani W. Gunawardana</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Array BioPharma, 3200 Walnut Street, Boulder, Colorado 80301, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div><div class="corresp-info"><strong>*</strong>(A.A.T.) Phone: 970-214-0574. E-mail: <a href="/cdn-cgi/l/email-protection#46272a2a232827322e292b27350625292b2527353268282332"><span class="__cf_email__" data-cfemail="8aebe6e6efe4ebfee2e5e7ebf9cae9e5e7e9ebf9fea4e4effe">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401635n&amp;href=/doi/10.1021%2Fjm401635n" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 878–902</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 7, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 October 2013</li><li><span class="item_label"><b>Published</b> online</span>22 January 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 February 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401635n" title="DOI URL">https://doi.org/10.1021/jm401635n</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D878%26pageCount%3D25%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAllen%2BA.%2BThomas%252C%2BKevin%2BW.%2BHunt%252C%2BMatthew%2BVolgraf%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D3%26contentID%3Djm401635n%26title%3DDiscovery%2Bof%2B7-Tetrahydropyran-2-yl%2BChromans%253A%2B%25CE%25B2-Site%2BAmyloid%2BPrecursor%2BProtein%2BCleaving%2BEnzyme%2B1%2B%2528BACE1%2529%2BInhibitors%2BThat%2BReduce%2BAmyloid%2B%25CE%25B2-Protein%2B%2528A%25CE%25B2%2529%2Bin%2Bthe%2BCentral%2BNervous%2BSystem%26numPages%3D25%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D902%26publicationDate%3DFebruary%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401635n"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2455</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">29</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401635n" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 7-Tetrahydropyran-2-yl Chromans: β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors That Reduce Amyloid β-Protein (Aβ) in the Central Nervous System&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Allen&quot;,&quot;last_name&quot;:&quot;A. Thomas&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;W. Hunt&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;Volgraf&quot;},{&quot;first_name&quot;:&quot;Ryan&quot;,&quot;last_name&quot;:&quot;J. Watts&quot;},{&quot;first_name&quot;:&quot;Xingrong&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Guy&quot;,&quot;last_name&quot;:&quot;Vigers&quot;},{&quot;first_name&quot;:&quot;Darin&quot;,&quot;last_name&quot;:&quot;Smith&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;Sammond&quot;},{&quot;first_name&quot;:&quot;Tony&quot;,&quot;last_name&quot;:&quot;P. Tang&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;P. Rhodes&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;T. Metcalf&quot;},{&quot;first_name&quot;:&quot;Karin&quot;,&quot;last_name&quot;:&quot;D. Brown&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;N. Otten&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Burkard&quot;},{&quot;first_name&quot;:&quot;April&quot;,&quot;last_name&quot;:&quot;A. Cox&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;K. Geck Do&quot;},{&quot;first_name&quot;:&quot;Darrin&quot;,&quot;last_name&quot;:&quot;Dutcher&quot;},{&quot;first_name&quot;:&quot;Sumeet&quot;,&quot;last_name&quot;:&quot;Rana&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;K. DeLisle&quot;},{&quot;first_name&quot;:&quot;Kelly&quot;,&quot;last_name&quot;:&quot;Regal&quot;},{&quot;first_name&quot;:&quot;Albion&quot;,&quot;last_name&quot;:&quot;D. Wright&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Groneberg&quot;},{&quot;first_name&quot;:&quot;Kimberly&quot;,&quot;last_name&quot;:&quot;Scearce-Levie&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Siu&quot;},{&quot;first_name&quot;:&quot;Hans&quot;,&quot;last_name&quot;:&quot;E. Purkey&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;P. Lyssikatos&quot;},{&quot;first_name&quot;:&quot;Indrani&quot;,&quot;last_name&quot;:&quot;W. Gunawardana&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;878-902&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401635n&quot;},&quot;abstract&quot;:&quot;In an attempt to increase selectivity vs Cathepsin D (CatD) in our BACE1 program, a series of 1,3,4,4a,10,10a-hexahydropyrano[4,3-b]chromene analogues was developed. Three different Asp-binding moieties were examined: spirocyclic acyl guanidines, aminooxazolines, and aminothiazolines in order to modulate potency, selectivity, efflux, and permeability. Using structure-based design, substitutions to improve binding to both the S3 and S2′ sites of BACE1 were explored. An acyl guanidine moiety provided the most potent analogues. These compounds demonstrated 10–420 fold selectivity for BACE1 vs CatD, and were highly potent in a cell assay measuring Aβ1–40 production (5–99 nM). They also suffered from high efflux. Despite this undesirable property, two of the acyl guanidines achieved free brain concentrations (Cfree,brain) in a guinea pig PD model sufficient to cover their cell IC50s. Moreover, a significant reduction of Aβ1–40 in guinea pig, rat, and cyno CSF (58%, 53%, and 63%, respectively) was observed for comp&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401635n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401635n" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401635n&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401635n" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401635n&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401635n" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401635n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401635n&amp;href=/doi/10.1021/jm401635n" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401635n" /></input><a href="/doi/pdf/10.1021/jm401635n" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401635n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401635n%26sid%3Dliteratum%253Aachs%26pmid%3D24397738%26genre%3Darticle%26aulast%3DThomas%26date%3D2014%26atitle%3DDiscovery%2Bof%2B7-Tetrahydropyran-2-yl%2BChromans%253A%2B%25CE%25B2-Site%2BAmyloid%2BPrecursor%2BProtein%2BCleaving%2BEnzyme%2B1%2B%2528BACE1%2529%2BInhibitors%2BThat%2BReduce%2BAmyloid%2B%25CE%25B2-Protein%2B%2528A%25CE%25B2%2529%2Bin%2Bthe%2BCentral%2BNervous%2BSystem%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D3%26spage%3D878%26epage%3D902%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292610" title="Antibiotic resistance">Antibiotic resistance</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jmcmar.2014.57.issue-3/production/jmcmar.2014.57.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In an attempt to increase selectivity vs Cathepsin D (CatD) in our BACE1 program, a series of 1,3,4,4a,10,10a-hexahydropyrano[4,3-b]chromene analogues was developed. Three different Asp-binding moieties were examined: spirocyclic acyl guanidines, aminooxazolines, and aminothiazolines in order to modulate potency, selectivity, efflux, and permeability. Using structure-based design, substitutions to improve binding to both the S3 and S2′ sites of BACE1 were explored. An acyl guanidine moiety provided the most potent analogues. These compounds demonstrated 10–420 fold selectivity for BACE1 vs CatD, and were highly potent in a cell assay measuring Aβ<sub>1–40</sub> production (5–99 nM). They also suffered from high efflux. Despite this undesirable property, two of the acyl guanidines achieved free brain concentrations (C<sub>free,brain</sub>) in a guinea pig PD model sufficient to cover their cell IC<sub>50</sub>s. Moreover, a significant reduction of Aβ<sub>1–40</sub> in guinea pig, rat, and cyno CSF (58%, 53%, and 63%, respectively) was observed for compound <b>62</b>.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62061" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62061" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">During the last few decades, breakthroughs in medicine have resulted in a decline of deaths associated with many major diseases. In contrast, deaths due to Alzheimer’s disease have steadily increased, in part due to a growing elderly population.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The worldwide prevalence of dementia-related diseases, of which Alzheimer’s is the most common, was estimated to be 36 million people in 2010, and this number is expected to almost double every 20 years.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Currently there is a great need for disease-modifying treatments, as the current standards of care (acetylcholinesterase inhibitors and NMDA antagonists) do not delay disease progression.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">Targeting the formation of the amyloid peptide (Aβ) has received considerable attention as a strategy for treating Alzheimer’s disease.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Much research has revolved around inhibiting the two major proteases responsible for processing the amyloid-β precursor protein (APP), γ and β-site APP cleaving enzyme 1 (BACE1).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> We chose to pursue BACE1 inhibitors because of the preclinical<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and genetic<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> evidence supporting its role in production of Aβ in the brain. More recently, it was demonstrated that a rare mutation in the APP, which reduces the efficiency of BACE1 cleavage, correlated with a dramatic improvement in cognition among elderly Scandinavians.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Compelling evidence for targeting BACE1 comes from clinical trial results from Eli Lilly<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and Merck<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> in which significant decreases in CSF Aβ were observed after dosing with BACE1 inhibitors. In addition to APP, BACE1 processes other substrates that may limit its usefulness as a therapeutic target.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Nonetheless, Merck’s BACE1 inhibitor MK-8931 has been well tolerated<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and is currently undergoing evaluation in phase II/III trials.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><div class="NLM_p">One of the greatest challenges in developing BACE1 inhibitors for Alzheimer’s disease is the need to cross the blood–brain barrier. In our discovery program, efforts were focused on compounds with physicochemical properties<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> that might give adequate brain levels to elicit a pharmacodynamic response. In conflict with this goal, our most potent BACE1 inhibitors<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> contained either an acyl guanidine (<b>1</b>) or aminooxazoline/aminothiazoline (<b>2</b> and <b>3</b>, respectively) warhead (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), which was necessary for potent interactions with the catalytic Asps in the active site (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). These warheads added two hydrogen bond donors and increased the total polar surface area (tPSA) of our compounds, both of which increased efflux liability and made obtaining brain penetrant molecules more challenging.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In addition to potency and brain penetration, we also desired compounds with >100-fold selectivity against another aspartyl protease, Cathepsin D (CatD), which has been implicated in multiple physiologically important roles.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> In an effort to overcome these challenges, we hypothesized that modification of our previously described BACE1 inhibitors<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> by incorporation of a 7-THP A-ring would generate 1,3,4,4a,10,10a-hexahydropyrano[4,3-b]chromenes (<b>1</b>–<b>3</b>; hereafter referred to as “7-THP chromans”), which might be highly potent vs BACE1 and >100-fold selective against CatD, due to differences in their active sites (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). The SAR and PK for these 7-THP chromans, which culminated with advancement of <b>62</b> to PD studies and its effect on lowering Aβ in the CSF will be the main focus of this article.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Numbering system and ring designation to be used for 1,3,4,4a,10,10a-hexahydropyrano[4,3-b]chromene analogues (“7-THP chromans”) discussed in this article. Spirocyclic warheads (WH): acyl guanidine (<b>1</b>), aminooxazoline (<b>2</b>), and aminothiazoline (<b>3</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray cocrystal structure of BACE1 and <b>62</b>. The two key active site aspartic acids, Asp32 and Asp228, are labeled. The distances between water oxygens (depicted as red spheres) and <b>62</b> are given in angstroms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24204" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24204" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> describes the synthesis of spirocyclic acyl guanidines of Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. Enamine <b>5</b> was prepared via the condensation of morpholine and pyranone <b>4</b>. Subsequent addition of <b>5</b> to aldehyde <b>6</b> followed by intramolecular aminal formation provided compound <b>7</b>. Swern oxidation of <b>7</b>, followed by in situ elimination afforded chromene-one <b>8</b>. <span class="smallcaps smallerCapital">l</span>-Selectride mediated reduction then gave chromanone <b>9</b>, which was isolated as the pure trans diastereomer after trituration with hexanes. Compound <b>9</b> was then subjected to the Bucherer–Bergs reaction, which gave diastereomer <b>10</b> as the major isomer, which was enriched to >80% diastereomeric purity by trituration with hot <i>i</i>-PrOH. Methylation of hydantoin <b>10</b> provided compound <b>11</b>, which was subsequently converted to the thiohydantoin <b>12</b> with Lawesson’s reagent. Oxidation/aminolysis of thiohydantion <b>12</b> afforded intermediate <b>13</b>. Analogues in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> (<b>56</b>–<b>68</b>) were prepared via Suzuki couplings with <b>13</b>. Racemic compounds <b>13</b> and <b>61</b> were resolved by chiral SFC to provide compounds <b>55</b>, <b>62</b>, and <b>63</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Compound <b>59</b> was prepared from enantiopure intermediate <b>55</b>. A cocrystal structure of <b>62</b> with BACE1 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) was obtained, and by analogy, the stereochemistries for compounds of Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> (<b>55</b>–<b>68</b>) were assigned.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) morpholine, toluene, reflux, Dean–Stark trap; (b) toluene, rt; (c) oxalyl chloride, DMSO, Et<sub>3</sub>N, DCM, −78 °C; (d) HOAc, rt; (e) <span class="smallcaps smallerCapital">l</span>-selectride, THF, −78 °C; (f) KCN, (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, NaHSO<sub>3</sub>, EtOH, 130 °C; (g) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (h) Lawesson’s reagent, toluene, 90 °C; (i) <i>t</i>-BuOOH, aq. NH<sub>4</sub>OH, MeOH, 50 °C; (j) RB(OH)<sub>2</sub>, Pd[P(Ph)<sub>3</sub>]<sub>4</sub>, aq. Na<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C. All chiral compounds depicted above were racemic, except for compounds <b>59</b>, <b>62</b>, and <b>63</b> as discussed below.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of 7-THP Chromans Containing a Spirocyclic Acyl Guanidine<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0013.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">BACE1<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">CatD<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">CatD/BACE1</th><th class="colsep0 rowsep0" align="center">cell IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">efflux ratio<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center"><i>P</i><sub>app</sub> AB<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b><a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">670</td><td class="colsep0 rowsep0" align="left">24000</td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">1200</td><td class="colsep0 rowsep0" align="left">3.4</td><td class="colsep0 rowsep0" align="left">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="left">3-methoxyphenyl</td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">1800</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">47</td><td class="colsep0 rowsep0" align="left">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="left">3-(difluoromethoxy)phenyl</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">780</td><td class="colsep0 rowsep0" align="left">34</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">49</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="left">3-cyanophenyl</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">2700</td><td class="colsep0 rowsep0" align="left">87</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">37</td><td class="colsep0 rowsep0" align="left">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b><a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">3-cyanophenyl</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">960</td><td class="colsep0 rowsep0" align="left">51</td><td class="colsep0 rowsep0" align="left">7.3</td><td class="colsep0 rowsep0" align="left">69</td><td class="colsep0 rowsep0" align="left">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="left">3-chloro-5-fluorophenyl</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">2300<a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">74</td><td class="colsep0 rowsep0" align="left">44</td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="left">2-fluoropyridin-3-yl</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">1100</td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">9.9</td><td class="colsep0 rowsep0" align="left">91</td><td class="colsep0 rowsep0" align="left">9.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b><a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">2-fluoropyridin-3-yl</td><td class="colsep0 rowsep0" align="left">9.5</td><td class="colsep0 rowsep0" align="left">840</td><td class="colsep0 rowsep0" align="left">88</td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">67</td><td class="colsep0 rowsep0" align="left">9.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">2-fluoropyridin-3-yl</td><td class="colsep0 rowsep0" align="left">490</td><td class="colsep0 rowsep0" align="left">14000</td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left">550</td><td class="colsep0 rowsep0" align="left">140</td><td class="colsep0 rowsep0" align="left">8.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="left">5-fluoropyridin-3-yl</td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">6200</td><td class="colsep0 rowsep0" align="left">190</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">56</td><td class="colsep0 rowsep0" align="left">6.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="left">5-chloropyridin-3-yl</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">3200</td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">170</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>66</b></td><td class="colsep0 rowsep0" align="left">5-methoxypyridin-3-yl</td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">5400</td><td class="colsep0 rowsep0" align="left">190</td><td class="colsep0 rowsep0" align="left">8.3</td><td class="colsep0 rowsep0" align="left">61</td><td class="colsep0 rowsep0" align="left">3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>67</b></td><td class="colsep0 rowsep0" align="left">5-cyanopyridin-3-yl</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">6300</td><td class="colsep0 rowsep0" align="left">260</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">61</td><td class="colsep0 rowsep0" align="left">2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="left">pyrimidin-5-yl</td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left">11000</td><td class="colsep0 rowsep0" align="left">280</td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">1.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Compounds were racemic, with relative stereochemistry as depicted, unless specified otherwise. All assay data was obtained at least in triplicate, and the values listed are the average from multiple experiments.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">BACE1 enzyme assay performed at 20 nM substrate concentration.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Cathepsin D enzyme assay was performed using enzyme derived from liver cells, unless specified otherwise.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">Cell assay measuring Aβ<sub>1–40</sub> production.</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last">Efflux ratio is the (B to A)/(A to B) value derived from LLC-PK1 cells transfected with human MDR1 (P-gp). Compounds were tested at 1 μM concentration. Control P-gp substrate, digoxin, had an average efflux ratio of 51 ± 30.</p></div><div class="footnote" id="t1fn6"><sup>f</sup><p class="last"><i>P</i><sub>app</sub> AB was determined using the LLC-PK1 parental cell line, in units of 10<sup>–6</sup> cm/s.</p></div><div class="footnote" id="t1fn7"><sup>g</sup><p class="last">Single enantiomer with <i>R</i> configuration at the spirocyclic center and <i>S</i>,<i>S</i> configuration at the ring fusion.</p></div><div class="footnote" id="t1fn8"><sup>h</sup><p class="last">Cathepsin D enzyme assay was performed using enzyme derived from spleen cells.</p></div><div class="footnote" id="t1fn9"><sup>i</sup><p class="last">Single enantiomer with <i>S</i> configuration at the spirocyclic center and <i>R</i>,<i>R</i> configuration at the ring fusion.</p></div></div></div><div class="NLM_p">Analogues in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, containing aminooxazoline or aminothiazoline warheads, were prepared according to Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Chromanone <b>9</b> (from Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) was reacted with Tebbe’s reagent to afford alkene <b>14</b>. Using published conditions,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> alkene <b>14</b> was converted to aminooxazoline <b>15</b> (X = O) or aminothiazoline <b>16</b> (X = S), obtained as a mixture of stereoisomers. Diastereomers of <b>15</b> (X = O) were separated by silica gel chromatography to provide <b>15a</b> and <b>15b</b> in nearly equivalent amounts. Diastereomers <b>16</b> were carried forward as a mixture and separated by silica chromatography at the final product stage. Analogous to compounds of Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, Suzuki coupling of intermediates <b>15</b> or <b>16</b> with various boronic acids provided compounds <b>69</b>–<b>76</b>. The stereochemical assignments for <b>15a</b> and <b>15b</b>, and by analogy, compounds <b>69</b>–<b>74</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) were made based on the cocrystal structure of compound <b>72</b> with BACE1.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The alternate diastereomers of aminothiazolines <b>75</b> and <b>76</b> were not isolated. The stereochemistries for compounds <b>75</b> and <b>76</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) were determined by cocrystal structure of compound <b>76</b> with BACE1.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of 7-THP Chromans Containing Spirocyclic Aminooxazolines or Aminothiazolines<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0014.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">diastereomer</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">BACE1<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">CatD<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">CatD/BACE1</th><th class="colsep0 rowsep0" align="center">cell IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">efflux ratio<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center"><i>P</i><sub>app</sub> AB<a class="ref internalNav" href="#t2fn6" aria-label="f">f</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">5-chloropyridin-3-yl</td><td class="colsep0 rowsep0" align="left">760</td><td class="colsep0 rowsep0" align="left">12000</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">230</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">5-chloropyridin-3-yl</td><td class="colsep0 rowsep0" align="left">440</td><td class="colsep0 rowsep0" align="left">120000</td><td class="colsep0 rowsep0" align="left">270</td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>71</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">2-fluoropyridin-3-yl</td><td class="colsep0 rowsep0" align="left">1300</td><td class="colsep0 rowsep0" align="left">15000<a class="ref internalNav" href="#t2fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">670</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>72</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">2-fluoropyridin-3-yl</td><td class="colsep0 rowsep0" align="left">830</td><td class="colsep0 rowsep0" align="left">170000<a class="ref internalNav" href="#t2fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">205</td><td class="colsep0 rowsep0" align="left">270</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>73</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">pyrimidin-5-yl</td><td class="colsep0 rowsep0" align="left">2500</td><td class="colsep0 rowsep0" align="left">76000<a class="ref internalNav" href="#t2fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">650</td><td class="colsep0 rowsep0" align="left">4.9</td><td class="colsep0 rowsep0" align="left">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">pyrimidin-5-yl</td><td class="colsep0 rowsep0" align="left">2000</td><td class="colsep0 rowsep0" align="left">>200000<a class="ref internalNav" href="#t2fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">940</td><td class="colsep0 rowsep0" align="left">5.5</td><td class="colsep0 rowsep0" align="left">9.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>75</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">5-chloropyridin-3-yl</td><td class="colsep0 rowsep0" align="left">220</td><td class="colsep0 rowsep0" align="left">57000</td><td class="colsep0 rowsep0" align="left">260</td><td class="colsep0 rowsep0" align="left">79</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>76</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">2-fluoropyridin-3-yl</td><td class="colsep0 rowsep0" align="left">330</td><td class="colsep0 rowsep0" align="left">96000</td><td class="colsep0 rowsep0" align="left">290</td><td class="colsep0 rowsep0" align="left">180</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">31</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Compounds were racemic, with relative stereochemistry as depicted, unless specified otherwise. All assay data was obtained at least in triplicate, and the values listed are the average from multiple experiments.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">BACE1 enzyme assay performed at 20 nM substrate concentration.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Cathepsin D enzyme assay was performed using enzyme derived from liver cells, unless specified otherwise.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Cell assay measuring Aβ<sub>1–40</sub> production.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">Efflux ratio is the (B to A)/(A to B) value derived from LLC-PK1 cells transfected with human MDR1 (P-gp). Compounds were tested at 1 μM concentration. Control P-gp substrate, digoxin, had an average efflux ratio of 51 ± 30.</p></div><div class="footnote" id="t2fn6"><sup>f</sup><p class="last"><i>P</i><sub>app</sub> AB was determined using the LLC-PK1 parental cell line, in units of 10<sup>–6</sup> cm/s.</p></div><div class="footnote" id="t2fn7"><sup>g</sup><p class="last">Cathepsin D assay was performed using enzyme derived from spleen cells.</p></div></div></div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Tebbe’s reagent, THF, rt; (b) I<sub>2</sub>, AgXCN (X = O or S), aq. NH<sub>4</sub>OH, CH<sub>3</sub>CN, THF, rt; for X = O, diastereomers were separated; (c) RB(OH)<sub>2</sub>, Pd[P(Ph)<sub>3</sub>]<sub>4</sub>, aq. Na<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C, for X = S, single diastereomers were isolated. All chiral compounds depicted above were racemic.</p></p></figure><div class="NLM_p">Aminooxazolines <b>77</b>–<b>82</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), substituted with a methyl group at the β-position, were synthesized according to Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Salicylaldehyde <b>18</b> was cyclized to hemiacetal <b>19</b> in the presence of Et<sub>3</sub>N and 3-methylbut-2-enal <b>17</b>. Diol <b>20</b> was formed upon treatment with NaBH<sub>4</sub> and could then be converted to ketone <b>21</b> in the presence of MnO<sub>2</sub>. Treatment with MOMCl provided MOM-protected ether <b>22</b>. Cyclic ether <b>24</b> was synthesized by deprotonation of <b>22</b> with LHMDS and trapping with TMSCl to provide intermediate <b>23</b> (not isolated), which was then treated with TiCl<sub>4</sub> to give <b>24</b> as the cis ring junction diastereomer. This cis ketone was then epimerized by deprotonation with LHMDS followed by kinetic reprotonation at −78 °C with ethyl salicylate to provide ketone <b>25</b> as a 5:1 mixture of trans/cis diastereomers. Olefin <b>26</b> was formed upon treatment with Tebbe’s reagent. The spirocyclic aminooxazolines <b>27</b> were then formed by treatment with I<sub>2</sub> and AgOCN followed by the addition of aq. NH<sub>4</sub>OH, in an analogous fashion to compounds <b>15</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). A mixture of diastereomers was obtained and carried forward to final product. Suzuki coupling then provided compounds <b>77</b>–<b>82</b>, which were isolated as pure diastereomers by silica gel chromatography or as single enantiomers after chiral SFC purification.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of 7-THP Chromans with Methyl Substitution at the α, β, and 8-Positions<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0015.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Compounds were racemic, with relative stereochemistry as depicted, unless specified otherwise. All assay data was obtained at least in triplicate, and the values listed are the average from multiple experiments.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">BACE1 enzyme assay performed at 20 nM substrate concentration.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Cathepsin D enzyme assay was performed using enzyme derived from liver cells.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">Cell assay measuring Aβ<sub>1–40</sub> production.</p></div><div class="footnote" id="t3fn5"><sup>Table e</sup><p class="last">Efflux ratio is the (B to A)/(A to B) value derived from LLC-PK1 cells transfected with human MDR1 (P-gp). Compounds were tested at 1 μM concentration. Control P-gp substrate, digoxin, had an average efflux ratio of 51 ± 30.</p></div><div class="footnote" id="t3fn6"><sup>Table f</sup><p class="last"><i>P</i><sub>app</sub> AB was determined using the LLC-PK1 parental cell line, in units of 10<sup>–6</sup> cm/s.</p></div><div class="footnote" id="t3fn7"><sup>Table g</sup><p class="last">Single enantiomer with <i>R</i> configuration at the spirocyclic center and <i>S</i>,<i>S</i> configuration at the ring fusion.</p></div></div><div></div></div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Et<sub>3</sub>N, dioxane, 55 °C; (b) NaBH<sub>4</sub>, MeOH, THF, 0 °C; (c) MnO<sub>2</sub>, DCM, rt; (d) MOMCl, i-Pr<sub>2</sub>EtN, DCM, rt; (e) LHMDS, TMSCl, THF, −70 °C; (f) TiCl<sub>4</sub>, DCM, −40 °C; (g) LHMDS, THF, −78 °C; (h) ethyl 2-hydroxybenzoate, THF, −78 °C; (i) Tebbe’s reagent, THF, −78 °C to rt; (j) I<sub>2</sub>, AgOCN, aq. NH<sub>4</sub>OH, CH<sub>3</sub>CN, EtOAc, 40 °C; (k) RB(OH)<sub>2</sub>, Pd[P(Ph)<sub>3</sub>]<sub>4</sub>, aq. Na<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C; diastereomers were separated. All chiral compounds depicted above were racemic, except for compounds <b>77</b>, <b>78</b>, <b>92</b>, and <b>93</b> as discussed below.</p></p></figure><div class="NLM_p">3-Fluoro chromans <b>92</b> and <b>93</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) were synthesized from <b>28</b> in an analogous fashion to compounds <b>77</b>–<b>82</b> according to Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Relative stereochemistries for compounds <b>92</b> and <b>93</b> were determined by NMR comparison with compounds <b>77</b>–<b>82</b>, for which absolute stereochemistry had been unambiguously determined by cocrystal structure of <b>79</b> with BACE1.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR of 7-THP 3-Fluoro Chromans<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0016.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Compounds were racemic, with relative stereochemistry as depicted, unless specified otherwise. All assay data was obtained at least in triplicate, and the values listed are the average from multiple experiments.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">BACE1 enzyme assay performed at 20 nM substrate concentration.</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">Cathepsin D enzyme assay was performed using enzyme derived from liver cells.</p></div><div class="footnote" id="t4fn4"><sup>Table d</sup><p class="last">Cell assay measuring Aβ<sub>1–40</sub> production.</p></div><div class="footnote" id="t4fn5"><sup>Table e</sup><p class="last">Efflux ratio is the (B to A)/(A to B) value derived from LLC-PK1 cells transfected with human MDR1 (P-gp). Compounds were tested at 1 μM concentration. Control P-gp substrate, digoxin, had an average efflux ratio of 51 ± 30.</p></div><div class="footnote" id="t4fn6"><sup>Table f</sup><p class="last"><i>P</i><sub>app</sub> AB was determined using the LLC-PK1 parental cell line, in units of 10<sup>–6</sup> cm/s.</p></div><div class="footnote" id="t4fn7"><sup>Table g</sup><p class="last">MLM: mouse liver microsomes.</p></div><div class="footnote" id="t4fn8"><sup>Table h</sup><p class="last">Single enantiomer with <i>R</i> configuration at the spirocyclic center and <i>S</i>,<i>S</i> configuration at the ring fusion.</p></div></div><div></div></div><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> depicts the synthesis of compounds <b>83</b>–<b>85</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), substituted with a methyl group at the 8-position. Acetyl-substituted chromenone <b>40</b> was prepared using published procedures for related hydroxy aryl ethanones.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> For the synthesis of these analogues, as well as for compounds <b>90</b> and <b>91</b> (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>), the THP A-ring was built via a hetero Diels–Alder reaction (e.g., <b>40</b> to <b>41</b>). The stereochemistry of adduct <b>41</b> was not unambiguously determined, thus the depicted stereochemistry is analogous to structurally related hetero Diels–Alder products described previously.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Compound <b>42</b> was generated as a single diastereomer by DIBALH reduction of <b>41</b>. Triethyl silane with boron trifluoride etherate effected reduction of the acetal functionality of <b>42</b> to afford THP <b>43</b>. The relative stereochemistry for <b>43</b> as well as for the other compounds in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> were assigned from cocrystal structures of final products <b>83</b>–<b>85</b> with BACE1.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Methyl hydantoin <b>44</b> was prepared from THP <b>43</b> in an analogous manner to compound <b>11</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>), and obtained as a 60:40 mixture of trans diastereomers at the ring fusion. The two trans diastereomers were separated by silica gel chromatography to provide a single diastereomer <b>44</b>, which was converted to final product <b>83</b> in an analogous fashion to compounds <b>56</b>–<b>68</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Compounds <b>84</b> and <b>85</b> were similarly prepared from THP <b>43</b> as described for <b>69</b>–<b>76</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), and the diastereomers were separated at final product by silica gel chromatography.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DMF-dimethyl acetal, toluene, reflux; (b) Ac<sub>2</sub>O, py, rt; (c) ethyl vinyl ether, 100 °C; (d) DIBALH, THF, −78 °C; (e) Et<sub>3</sub>SiH, BF<sub>3</sub>-Et<sub>2</sub>O, DCM, rt; (f) KCN, (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, NaHSO<sub>3</sub>, EtOH, 130 °C; (g) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; diastereomers were separated; (h) Lawesson’s reagent, toluene, 90 °C; (i) <i>t</i>-BuOOH, aq. NH<sub>4</sub>OH, MeOH, 50 °C; (j) (2-fluoropyridin-3-yl)boronic acid, Pd[P(Ph)<sub>3</sub>]<sub>4</sub>, aq. Na<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C; (k) Tebbe’s reagent, THF, rt; (l) I<sub>2</sub>, AgXCN (X = O or S), aq. NH<sub>4</sub>OH, CH<sub>3</sub>CN, THF, rt. All chiral compounds depicted above were racemic.</p></p></figure><div class="NLM_p">7-THP chromans <b>86</b>–<b>89</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) substituted with a methyl group at the α-position were formed according to Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. Chromanone <b>9</b>, prepared as described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, was methylated using LDA with HMPA to yield <b>45</b> in >90% diastereomeric purity after silica gel chromatography. Conversion of <b>45</b> to products <b>86</b>–<b>88</b> was executed analogous to compounds <b>56</b>–<b>68</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). The Bucherer–Bergs reaction of ketone <b>45</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>, step b) gave >85% diastereomerically pure spirocyclic hydantoin (not depicted), which was subsequently transformed (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>, steps c–f) to products <b>86</b>–<b>88</b>. The stereochemistry of ketone <b>45</b> and products <b>86</b>–<b>88</b> was determined by cocrystal structure of analogue <b>87</b> with BACE1.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Product <b>89</b> was prepared analogous to compounds from Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Formation of the aminooxazoline moiety (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>, step h) was >90% diastereoselective giving the relative stereochemistry depicted for <b>89</b>, which was confirmed by cocrystal structure with BACE1.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LDA, HMPA, MeI, THF, −78 °C; (b) KCN, (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, NaHSO<sub>3</sub>, EtOH, 130 °C; (c) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (d) Lawesson’s reagent, toluene, 90 °C; (e) <i>t</i>-BuOOH, aq. NH<sub>4</sub>OH, MeOH, 50 °C; (f) RB(OH)<sub>2</sub>, Pd[P(Ph)<sub>3</sub>]<sub>4</sub>, aq. Na<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C; (g) Tebbe’s reagent, THF, rt; (h) I<sub>2</sub>, AgOCN, aq. NH<sub>4</sub>OH, CH<sub>3</sub>CN, THF, rt. All chiral compounds depicted above were racemic.</p></p></figure><div class="NLM_p">Spirocyclic acyl guanidines <b>90</b> and <b>91</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) with fluoro substitution at the C-ring’s 3-position were prepared according to Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. In order to avoid competing nucleophilic aromatic substitution (S<sub>N</sub>Ar) with a potentially reactive 3-fluoro 2-bromo chromanone during the Bucherer–Bergs reaction (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>, step h), we chose to utilize a methoxy group in place of the bromo substituent previously used as a handle for Suzuki couplings in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>–<a class="ref internalNav" href="#sch5" aria-label="5">5</a>. Baeyer–Villiger oxidation of starting material <b>46</b> yielded <b>47</b>, which was subjected to a Fries rearrangement to give phenyl ethanone <b>48</b>. Reaction of <b>48</b> with triphosgene afforded aldehyde <b>49</b>, which was converted to <b>50</b> via a hetero Diels–Alder reaction analogous to compound <b>41</b> in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Hydrogenation of olefin <b>50</b> lead to partial reduction of the ketone functionality, so the crude was stirred with MnO<sub>2</sub> in DCM to provide <b>51</b>. Removal of the acetal functionality was accomplished with Et<sub>3</sub>SiH/BF<sub>3</sub>-Et<sub>2</sub>O to give ketone <b>52</b>, which was transformed to <b>53</b> (mixture of diastereomers) analogous to compound <b>13</b> in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Acyl guanidine <b>53</b> was carried forward as a mixture to give triflate <b>54</b> after HBr-mediated deprotection of the methoxy group, protection as an amidine, and conversion of the phenol to a triflate. The amidine protecting group made the diastereomers of <b>54</b> more amenable to separation by silica gel chromatography. Final products <b>90</b> and <b>91</b> were generated by Suzuki couplings with triflate <b>54</b>, and the amidine protecting group was simultaneously removed under the Suzuki reaction conditions. The relative stereochemistry for racemates <b>90</b> and <b>91</b> was assigned based on NMR comparison with compounds <b>56</b>–<b>68</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>), for which the stereochemistry had been unambiguously determined by cocrystal structure of compound <b>62</b> with BACE1 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>m</i>-CPBA, DCM, 40 °C; (b) TfOH, 60 °C; (c) triphosgene, DMF, DCE, rt; (d) ethyl vinyl ether, 100 °C; (e) Pd/C, EtOH, H<sub>2</sub> (50 psi), rt; (f) MnO<sub>2</sub>, DCM, rt; (g) Et<sub>3</sub>SiH, BF<sub>3</sub>–Et<sub>2</sub>O, DCM, rt; (h) KCN, (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, NaHSO<sub>3</sub>, EtOH, 130 °C; (i) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (j) Lawesson’s reagent, toluene, 90 °C; (k) <i>t</i>-BuOOH, aq. NH<sub>4</sub>OH, MeOH, 50 °C; (l) 48% aq. HBr, 100 °C; (m) DMF–dimethyl acetal, DMF, rt; (n) Tf<sub>2</sub>NPh, Et<sub>3</sub>N, DCM, rt; diastereomers were separated; (o) RB(OH)<sub>2</sub>, Pd[P(Ph)<sub>3</sub>]<sub>4</sub>, aq. Na<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C. All chiral compounds depicted above were racemic.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32506" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32506" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Structure–Activity Relationships (SAR)</h3><div class="NLM_p">7-THP chroman analogues were evaluated for activity in BACE1 and CatD enzyme assays, a cell assay for production of Aβ<sub>1–40</sub>, and for efflux ratio and permeability in an MDR1-transfected LLC-PK1 cell line. Identification of compounds with <100 nM cell potency, >100-fold selectivity for CatD (due to its role in multiple physiological functions<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a>), an efflux ratio <2 (to minimize P-gp liability), and apparent cell permeability in the apical to basolateral direction (<i>P</i><sub>app</sub> AB) > 10 × 10<sup>–6</sup> cm/s was the goal. Coverage ratio<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (C<sub>free,brain</sub>/cell IC<sub>50</sub>) was a key assessment that incorporated PK, potency, and brain penetration. Although we were unable to identify a compound meeting all of these criteria, we discovered that some of our compounds were still able to attain sufficient coverage ratios to decrease Aβ in the CSF (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, vide infra). We utilized the SAR from Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> to select compounds with different profiles of cell potency, efflux, and permeability to evaluate in mouse PK. The results from mouse PK (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), in particular the coverage ratio, then guided the optimization and selection of compounds to progress to PD studies.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Mouse PK: iv, po Dose<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0017.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">Racemic compounds (unless specified otherwise) were dosed at 3 mg/kg iv and 10 mg/kg po in male CD-1 mice: 3 animals/cohort.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">iv and po formulation: 40% PEG 400/10% EtOH/50% H<sub>2</sub>O.</p></div><div class="footnote" id="t5fn3"><sup>Table c</sup><p class="last">iv and po formulation: 30% captisol in H<sub>2</sub>O.</p></div><div class="footnote" id="t5fn4"><sup>Table d</sup><p class="last">iv formulation: 50 mM citrate in saline (pH 4). po formulation: 1% carboxymethyl cellulose (CMC)/0.5% Tween/5 mM citrate in H<sub>2</sub>O.</p></div><div class="footnote" id="t5fn5"><sup>Table e</sup><p class="last">iv formulation: 40% PEG 400/10% EtOH/50% H<sub>2</sub>O. po formulation: 1% CMC/0.5% Tween/5 mM citrate in H<sub>2</sub>O.</p></div><div class="footnote" id="t5fn6"><sup>Table f</sup><p class="last">Single enantiomer with <i>R</i> configuration at the spirocyclic center and <i>S</i>,<i>S</i> configuration at the ring fusion.</p></div><div class="footnote" id="t5fn7"><sup>Table g</sup><p class="last">Compounds (1 μM) incubated with mouse liver microsomes for 20 min at 37 °C in the presence of NADPH.</p></div><div class="footnote" id="t5fn8"><sup>Table h</sup><p class="last">CL<sub>hep,syst,u</sub> = CL<sub>hep,syst</sub>/F<sub>u,plasma</sub>.</p></div><div class="footnote" id="t5fn9"><sup>Table i</sup><p class="last">Compound levels were BLQ.</p></div><div class="footnote" id="t5fn10"><sup>Table j</sup><p class="last">Coverage ratio = C<sub>free,brain</sub>/cell IC<sub>50</sub>.</p></div><div class="footnote" id="t5fn11"><sup>Table k</sup><p class="last">Control P-gp substrate, digoxin, had an average efflux ratio of 51 ± 30.</p></div><div class="footnote" id="t5fn12"><sup>Table l</sup><p class="last">See ref <a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">28</a>.</p></div></div><div></div></div><div class="NLM_p">From our previous work<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and others,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> we expected the three different Asp-binding warheads to anchor inhibitors in the BACE1 active site such that substitution off the aromatic C-ring with various R groups would gain potency by projection into the S3 pocket (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). This was found to be the case, as compound <b>55</b> (R = Br) was >17-fold less potent than compounds in which R was a larger aromatic moiety. As a result of this preferred binding orientation, enantiomers were expected to have dramatically different potencies. Indeed, pure enantiomer <b>63</b> was 52-fold less potent for BACE1 than its antipode <b>62</b>. The various aromatic R groups of Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> were chosen based on our earlier SAR<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and supported by crystallography, so as to maximize binding affinity to BACE1. Thus, compounds <b>56</b>–<b>62</b> and <b>64</b>–<b>68</b> were all <40 nM in the enzyme assay. These compounds were also highly potent in the cell assay, wherein the two most potent racemic analogues were <b>61</b> and <b>66</b> (R = 2-fluoropyridin-3-yl and 5-methoxypyridin-3-yl; IC<sub>50</sub>s = 9.9 and 8.3 nM, respectively).</div><div class="NLM_p">Consistent with our earlier SAR,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> selectivity against CatD for compounds of Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> generally improved with more polar R groups. The most selective were <b>64</b> and <b>66</b>–<b>68</b> (190–280-fold), and these compounds had low cLogPs, which ranged from −1.0 to 0.3. In addition to selectivity from the more polar aromatic R groups, the THP A-ring also contributed to selectivity for BACE1. For example, 7-THP chroman <b>56</b> was both more potent against BACE1 and less potent against CatD than the corresponding dimethyl chroman (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). This result is consistent with data on other chromans from our previous work.<a onclick="showRef(event, 'cit15b'); return false;" href="javascript:void(0);" class="ref cit15b">(15b)</a></div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of 7-THP chroman <b>56</b> with a less selective dimethyl chroman (both compounds were racemic).<a onclick="showRef(event, 'cit15b'); return false;" href="javascript:void(0);" class="ref cit15b">(15b)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">From a cocrystal crystal structure of <b>62</b> with BACE1 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), the THP A-ring projects into the S2′ pocket and the A-ring oxygen interacts with a well-defined water network. Comparisons of this structure with the published structure of CatD (pdb code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1LYA">1LYA</a>) show that there are many differences between the two active sites, both in the flexible loop and in the S1 and S2′ pockets (see Figure S1, <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). It is likely that several of these structural differences, including the interaction of the A-ring with the water network, contribute to the selectivity of these compounds for BACE1 over CatD.</div><div class="NLM_p">None of the spirocyclic acyl guanidines of Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> met our goal of an efflux ratio <2. We partially attributed the large efflux ratios to the compounds’ tPSAs (77–110) and the presence of two hydrogen bond donors, both of which are likely to increase P-gp mediated efflux.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> As one might expect, there was a general trend for compounds containing more polar R groups (e.g., compounds <b>66</b>–<b>68</b>) to be less permeable. However, we appreciate that recognition by transporters such as P-gp is a whole molecule property since <b>60</b> (R = 3-chloro-5-fluorophenyl) had an 8-fold greater efflux ratio than <b>55</b> (R = Br), despite the fact that their tPSAs are both 77 and that they both contain acyl guanidines.</div><div class="NLM_p">We hypothesized that reducing tPSA by changing from the acyl guanidine (e.g., <b>61</b>, tPSA = 90) to the aminooxazoline (e.g., <b>71</b>, tPSA = 78) or aminothiazoline moieties (e.g., <b>76</b>, tPSA = 69) would have a positive impact on both efflux and permeability. To our satisfaction, compounds of Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> all exhibited lower efflux ratios and greater permeability. It was recently reported that efflux ratio was directly correlated with p<i>K</i><sub>a</sub> for a series of BACE1 inhibitors;<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> however, we observed the opposite trend in this work. For example, acylguanidine <b>62</b> (efflux ratio = 67) had a measured p<i>K</i><sub>a</sub> of 5.8, whereas aminooxazolines <b>78</b>, <b>84</b>, and <b>89</b> (efflux ratios < 2.5) had p<i>K</i><sub>a</sub> values of 6.7, 6.4, and 6.4, respectively. Apparently the lower tPSA values for the aminooxazolines had a greater influence on efflux ratio than p<i>K</i><sub>a</sub>.</div><div class="NLM_p">Unfortunately, changing to the alternate Asp binders resulted in an 8–64-fold decrease in BACE1 potency with a commensurate drop in cell potency. For aminooxazolines <b>69</b>–<b>74</b>, the two diastereomers (type A and B) with opposite trans stereochemistry at the ring fusion were synthetically accessible (via Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), whereas only diastereomer B for aminothiazolines <b>75</b> and <b>76</b> was generated in sufficient quantity for isolation. Significant differences in selectivity were observed between pairs of trans diastereomers <b>69</b>–<b>74</b>. Diastereomers of type B were found to be significantly more selective for BACE1 than type A, supporting our previous hypothesis that the THP A-ring contributes to CatD selectivity. Changing from the acyl guanidine in type A diastereomers <b>65</b>, <b>61</b>, and <b>68</b> to the aminooxazoline in <b>69</b>, <b>71</b>, and <b>73</b>, respectively, resulted in decreased selectivity. Because these aminooxazolines and aminothiazolines provided lower efflux ratios and improved permeability relative to the acyl guanidines, we were prompted to further explore the SAR around the THP A-ring with a goal of increasing potency. On the basis of the cocrystal structure for <b>62</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), we identified the α-, β-, and 8-positions on the THP A-ring as sites for substitution.</div><div class="NLM_p">Since the flexible loops of BACE1 and CatD are very different (see Figure S1, <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), it was suggested that addition of a methyl group to the β-position of the A-ring might increase CatD selectivity. Aminooxazolines with methyl substitution at the β-position (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> demonstrated improved enzyme and cell potencies relative to the corresponding diastereomers from Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. The β-methyl group also provided a dramatic increase in selectivity for BACE1 (e.g., <b>81</b>, 190-fold, vs <b>71</b>, 12-fold). Moreover, compound <b>82</b> was inactive against CatD (40% inhibition at 200 μM).</div><div class="NLM_p">Low efflux ratios and high permeability were maintained for <b>77</b>–<b>82</b>. Methyl substitution at the 8-position<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> also resulted in improved enzyme and cell potencies for analogues <b>84</b> and <b>85</b> relative to the corresponding diastereomers <b>72</b> and <b>76</b>. However, incorporation of the 8-methyl group was not sufficient to provide potency comparable to the corresponding acyl guanidine <b>83</b>. Selectivities for 8-methyl analogues <b>84</b> and <b>85</b> were similar to des-methyl analogues <b>72</b> and <b>76</b> and easily met our criteria for selectivity (>100-fold). Methyl substitution at the α-position for compound <b>89</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> resulted in a modest decrease in potency relative to comparator <b>72</b>. The α-methyl substituted acyl guanidines <b>86</b>–<b>88</b> had similar enzyme potencies to the corresponding des-methyl analogues in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> (<b>58</b>, <b>61</b>, and <b>68</b>), but gained a ∼2–3-fold improvement in cell potency. The α-methyl group offered no significant benefit toward reducing efflux for acyl guanidines <b>86</b>–<b>88</b>. Although methyl substitution at the β- and 8-positions of the THP A-ring generally improved potency relative to their des-methyl counterparts, analogues prepared with aminooxazolines or aminothiazolines still had inferior potency relative to the corresponding acyl guanidines.</div><div class="NLM_p">Compounds from Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> were generally predicted to have high hepatic clearance based on a mouse liver microsome (MLM) assay, and several analogues selected for mouse PK also suffered from high systemic clearance (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). It is known that replacement of hydrogen with fluorine can improve metabolic stability.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> On the basis of observations made from our previous work on chromans,<a onclick="showRef(event, 'cit15b cit15c'); return false;" href="javascript:void(0);" class="ref cit15b cit15c">(15b, 15c)</a> we hypothesized that substitution of the C-ring’s 3-position with a fluorine would improve metabolic stability. To test this hypothesis, 3-fluoro chromans of Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> were prepared as described in Schemes <a class="ref internalNav" href="#sch3" aria-label="3">3</a> and <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. Contrary to what we hoped, stability in MLMs was not substantially different for the two acyl guanidines <b>90</b> and <b>91</b> (CL<sub>hep</sub> = 21 and 40 mL/min/kg, respectively) compared to des-fluoro analogues <b>57</b> and <b>61</b> (CL<sub>hep</sub> = 10 and 46 mL/min/kg, respectively). In like manner, the two aminooxazolines <b>92</b> and <b>93</b> also demonstrated no improvement in microsome stability by comparison with <b>79</b> and <b>81</b> (CL<sub>hep</sub> = 60 and 61 mL/min/kg, respectively). The enzyme and cell potencies for the two acyl guanidines <b>90</b> and <b>91</b> were ∼2–5-fold less than those for des-fluoro analogues <b>57</b> and <b>61</b>. Aminooxazolines <b>92</b> and <b>93</b> were tested as eutomers, so their enzyme and cell potencies were likewise not substantially different (∼1–3-fold) from the analogous racemates <b>79</b> and <b>81</b>, after correcting for the difference in enantiomeric purity. A more marked effect of fluorine substitution was on selectivity, as compounds <b>90</b>–<b>93</b> demonstrated a ∼3–4-fold decrease relative to their des-fluoro versions. In light of these disappointing results, fluorine substitution at the 3-position was not pursued on the other 7-THP chroman cores from Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><div class="NLM_p">As the acyl guanidines (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) suffered from high efflux, we wanted to further improve their cell potencies; and by doing so, potentially increase coverage ratios. From our previously published work,<a onclick="showRef(event, 'cit15b'); return false;" href="javascript:void(0);" class="ref cit15b">(15b)</a> we had determined that replacing the chroman-based scaffold (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, X = O) with a tetrahydronaphthalene (THN; Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, X = C) generally resulted in greater cell potency. Indeed, compound <b>94</b> was ∼6-fold more potent in our cell assay than <b>61</b>, even though their enzyme potencies were within 2-fold of each other. Besides a difference in cell potency, <b>94</b> and <b>61</b> had similar selectivity, were both highly effluxed, and both had acceptable permeability. Unfortunately, the THN-based 7-THP analogues were synthetically less accessible than the corresponding chromans, and they were not pursued further.</div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of racemic compounds <b>61</b> and <b>94</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Pharmacokinetic Studies in Mice</h3><div class="NLM_p">From the 7-THP chromans described above, we selected seven acyl guanidines <b>58</b>, <b>60</b>, <b>61</b>, <b>64</b>, <b>65</b>, <b>83</b>, and <b>87</b> and two aminooxazolines <b>78</b> and <b>79</b> to evaluate in mouse PK (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). In spite of the efflux liability for the acyl guanidines, we wanted to assess their coverage ratios (C<sub>free,brain</sub>/cell IC<sub>50</sub>) to prioritize analogues for progression to pharmacodynamic studies. Aminooxazolines <b>78</b> and <b>79</b> were selected to determine if their lower efflux ratios (1.5 and 4.3, respectively) would translate to greater brain levels.</div><div class="NLM_p">Compounds were dosed iv and po (3 and 10 mg/kg, respectively) in male CD-1 mice, with plasma samples withdrawn and brains harvested (oral groups only) at 1 and 4 h time points (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Generally, MLM’s underpredicted hepatic clearance for the acyl guanidines, with most having moderate to high systemic clearance. Compounds <b>64</b> and <b>65</b> were cleared faster than hepatic blood flow, resulting in brain levels that were below level of quantitation (BLQ) at the 4 h time point. Despite having the lowest in vivo clearance, <b>60</b> had free brain levels that were 91-fold lower than its cell IC<sub>50</sub> at the 4 h time point, due in part to a very low free fraction (F<sub>u,brain</sub> = 0.0018). In contrast, acyl guanidines <b>58</b>, <b>61</b>, and <b>87</b> were moderate to high clearance compounds, but they had ∼10–50-fold greater free fraction in the brain than <b>60</b>. A large free fraction contributed to their achieving coverage ratios of 0.31–0.85 at the 4 h time point, in spite of moderate to high clearance and high efflux. However, free brain to plasma (b/p) ratios for <b>58</b>, <b>61</b>, and <b>87</b> were poor (0.025–0.15, 4 h time point), likely due to their high efflux. Oral bioavailability (<i>F</i>%) for <b>58</b> and <b>61</b> was very good (<i>F</i>%: 103<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and 86, respectively), but <b>87</b> had <i>F</i>% of 15, even though its permeability was comparable to <b>61</b>. It might be that addition of the α-methyl group in <b>87</b> lead to increased first pass metabolism, but this was unverified. Though <b>83</b> had similar PK and brain tissue binding to structurally related <b>61</b>, its brain levels were below the level of quantitation (BLQ) at the 4 h time point for reasons not readily apparent.</div><div class="NLM_p last">Aminooxazolines <b>78</b> and <b>79</b> demonstrated moderate systemic clearance that was better than predicted in vitro, and both had low to moderate <i>F</i>%. Compound <b>79</b> achieved free brain concentrations comparable to <b>61</b>, but because of its being ∼2-fold less potent, the coverage ratio was inferior. Aminooxazoline <b>78</b>, one of the least effluxed (efflux ratio = 1.5) of the 7-THP chromans in this work, also demonstrated a superior free b/p ratio (0.68, 4 h time point). However, its moderate cell potency (IC<sub>50</sub> = 41 nM) and high brain tissue binding (F<sub>u,brain</sub> = 0.0031) contributed to a poor coverage ratio of 0.061 at the 4 h time point.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Pharmacokinetics for <b>62</b> in Multiple Species</h3><div class="NLM_p">Compound <b>61</b> demonstrated the best coverage ratio in the mouse (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>: 1.1, 1 h; 0.85, 4 h), and its eutomer <b>62</b> passed multiple in vitro toxicological hurdles (e.g., hERG patch clamp >100 μM, IC<sub>50</sub> >10 μM against CYP’s, clean in Ames and micronucleus assays, and highly selective in receptor, kinase, and protease panels). Thus, the PK for <b>62</b> in multiple species (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>) was evaluated to enable in vivo toxicology as well as PD studies in guinea pig, rat, and cyno. There was a good in vitro–in vivo correlation (IVIVC) of microsome and hepatocyte stability with in vivo clearances observed for mouse and rat. For cyno, there was a good IVIVC for microsomes; however, hepatocytes underpredicted clearance. In contrast, guinea pig demonstrated very high in vivo clearance with no apparent IVIVC. Oral bioavailability was good for mouse and rat (<i>F</i>% = 61 and >100, respectively), but poor for guinea pig and cyno (<i>F</i>% = 17 and 10, respectively). Unbound levels of <b>62</b> in plasma were ∼10–50-fold greater than in brain for mouse and rat, and ∼10–30-fold greater than CSF levels in rat and cyno, likely a result of the compound’s high efflux. Because of the exceptionally high clearance in guinea pig, it was not surprising that plasma levels of <b>62</b> were >20-fold lower than for rat and cyno. However, the difference between plasma and brain/CSF levels (∼1–7-fold) was significantly smaller in guinea pig than the other species. In spite of this disconnect, CSF concentrations for <b>62</b> in rat, guinea pig, and cyno, the three species chosen for PD studies (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) were greater than cell IC<sub>50</sub> at both time points.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. PK for Eutomer <b>62</b> in Multiple Species: iv, po Dose</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0018.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">mouse<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">rat<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">guinea pig<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">cyno<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">dose (mg/kg)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">IV: 3</td><td class="colsep0 rowsep0" align="left">IV: 3</td><td class="colsep0 rowsep0" align="left">IV: 3</td><td class="colsep0 rowsep0" align="left">IV: 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">PO: 10</td><td class="colsep0 rowsep0" align="left">PO: 60</td><td class="colsep0 rowsep0" align="left">PO: 60</td><td class="colsep0 rowsep0" align="left">PO: 100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">F<sub>u,plasma</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.20</td><td class="colsep0 rowsep0" align="left">0.22</td><td class="colsep0 rowsep0" align="left">0.37</td><td class="colsep0 rowsep0" align="left">0.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">F<sub>u,brain</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.14</td><td class="colsep0 rowsep0" align="left">0.12</td><td class="colsep0 rowsep0" align="left">0.077</td><td class="colsep0 rowsep0" align="left">0.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">CL<sub>hep,int</sub><a class="ref internalNav" href="#t6fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">9.7</td><td class="colsep0 rowsep0" align="left">5.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>hep,in vitro</sub><a class="ref internalNav" href="#t6fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">38</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>hep,syst</sub></td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">110</td><td class="colsep0 rowsep0" align="left">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i>%</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">61</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">C<sub>free,plasma</sub> (nM)</td><td class="colsep0 rowsep0" align="left"><b>1h</b></td><td class="colsep0 rowsep0" align="left">300</td><td class="colsep0 rowsep0" align="left">3100</td><td class="colsep0 rowsep0" align="left">140</td><td class="colsep0 rowsep0" align="left">3200<a class="ref internalNav" href="#t6fn6" aria-label="f">f</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4h</b></td><td class="colsep0 rowsep0" align="left">78</td><td class="colsep0 rowsep0" align="left">2200<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">23<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">1700</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">C<sub>free,brain</sub> (nM)</td><td class="colsep0 rowsep0" align="left"><b>1h</b></td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">68</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4h</b></td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">66<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">34<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">free b/p</td><td class="colsep0 rowsep0" align="left"><b>1h</b></td><td class="colsep0 rowsep0" align="left">0.080</td><td class="colsep0 rowsep0" align="left">0.022</td><td class="colsep0 rowsep0" align="left">0.14</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4h</b></td><td class="colsep0 rowsep0" align="left">0.19</td><td class="colsep0 rowsep0" align="left">0.030<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">1.5<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">C<sub>CSF</sub> (nM)</td><td class="colsep0 rowsep0" align="left"><b>1h</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">290</td><td class="colsep0 rowsep0" align="left">69</td><td class="colsep0 rowsep0" align="left">110<a class="ref internalNav" href="#t6fn6" aria-label="f">f</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4h</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">150<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">23<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">84</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">CSF/free plasma</td><td class="colsep0 rowsep0" align="left"><b>1h</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.094</td><td class="colsep0 rowsep0" align="left">0.49</td><td class="colsep0 rowsep0" align="left">0.034<a class="ref internalNav" href="#t6fn6" aria-label="f">f</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4h</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.068<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">1.0<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">0.049</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">iv formulation: 5 mM citrate in saline. po formulation: 1% CMC/0.5% Tween/5 mM citrate in H<sub>2</sub>O. Male CD-1 mice: 3 animials/cohort.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">iv formulation: 30% captisol/5 mM citrate in saline. po formulation: 1% CMC/0.5% Tween/5 mM citrate in H<sub>2</sub>O. Male Sprague–Dawley rats: 3 animals/cohort.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">iv formulation: 30% captisol/5 mM citrate in saline. po formulation: 1% CMC/0.5% Tween/5 mM citrate in H<sub>2</sub>O. Male Hartley guinea pigs: 4 animals/iv route and 6 animals/po route.</p></div><div class="footnote" id="t6fn4"><sup>d</sup><p class="last">iv formulation: PEG400/EtOH/water (40/10/50) solution. po formulation: 1% carboxymethylcellulose sodium (CMC), 0.5% Tween 80, 5 mM citrate buffer, suspension. Female cynos: 3 animals/dosing route.</p></div><div class="footnote" id="t6fn5"><sup>e</sup><p class="last">Measured at the 3 h time point.</p></div><div class="footnote" id="t6fn6"><sup>f</sup><p class="last">Measured at the 2 h time point.</p></div><div class="footnote" id="t6fn7"><sup>g</sup><p class="last">Compounds (2 μM) incubated with cryopreserved hepatocytes for 60 and 120 min at 37 °C.</p></div><div class="footnote" id="t6fn8"><sup>h</sup><p class="last">Compounds (1 μM) incubated with mouse liver microsomes for 20 min at 37 °C in the presence of NADPH.</p></div></div></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. PD in Guinea Pig and Rat</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">formulation</th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">PO dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">time point (h)</th><th class="colsep0 rowsep0" align="center">C<sub>free,plasma</sub> (nM)</th><th class="colsep0 rowsep0" align="center">C<sub>free,brain</sub> (nM)</th><th class="colsep0 rowsep0" align="center">b/p free</th><th class="colsep0 rowsep0" align="center">C<sub>CSF</sub> (nM)</th><th class="colsep0 rowsep0" align="center">coverage ratio<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">CSF Aβ<sub>1–40</sub> Reduction (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="13" align="left"><b>62</b></td><td class="colsep0 rowsep0" rowspan="13" align="left">1% CMC/0.5% Tween/5 mM citrate in H<sub>2</sub>O</td><td class="colsep0 rowsep0" rowspan="7" align="left">guinea pig<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">30<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">5.8</td><td class="colsep0 rowsep0" align="left">9.5</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">9.9</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">60<a class="ref internalNav" href="#t7fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">140</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">0.14</td><td class="colsep0 rowsep0" align="left">69</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">34</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">6.3</td><td class="colsep0 rowsep0" align="left">58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">7.0</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">6.9</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">7.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left"><3.0<a class="ref internalNav" href="#t7fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">5.2</td><td class="colsep0 rowsep0" align="left">>1.7</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">0.96</td><td class="colsep0 rowsep0" align="left">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left"><3.0<a class="ref internalNav" href="#t7fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">>3.7</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">100<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">38</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">56</td><td class="colsep0 rowsep0" align="left">9.3</td><td class="colsep0 rowsep0" align="left">58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="5" align="left">rat<a class="ref internalNav" href="#t7fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">60<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">3100</td><td class="colsep0 rowsep0" align="left">68</td><td class="colsep0 rowsep0" align="left">0.022</td><td class="colsep0 rowsep0" align="left">290</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">2200</td><td class="colsep0 rowsep0" align="left">66</td><td class="colsep0 rowsep0" align="left">0.030</td><td class="colsep0 rowsep0" align="left">150</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">2700</td><td class="colsep0 rowsep0" align="left">79</td><td class="colsep0 rowsep0" align="left">0.029</td><td class="colsep0 rowsep0" align="left">200</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">1700</td><td class="colsep0 rowsep0" align="left">84</td><td class="colsep0 rowsep0" align="left">0.049</td><td class="colsep0 rowsep0" align="left">130</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">960</td><td class="colsep0 rowsep0" align="left">46</td><td class="colsep0 rowsep0" align="left">0.048</td><td class="colsep0 rowsep0" align="left">85</td><td class="colsep0 rowsep0" align="left">8.5</td><td class="colsep0 rowsep0" align="left">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>59</b></td><td class="colsep0 rowsep0" rowspan="2" align="left">40/10/50 PEG/EtOH/H<sub>2</sub>O</td><td class="colsep0 rowsep0" rowspan="2" align="left">guinea pig<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" rowspan="2" align="left">60</td><td class="colsep0 rowsep0" align="left">3<a class="ref internalNav" href="#t7fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">260</td><td class="colsep0 rowsep0" align="left">12<a class="ref internalNav" href="#t7fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">0.046</td><td class="colsep0 rowsep0" align="left">90</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">79</td><td class="colsep0 rowsep0" align="left">6.7<a class="ref internalNav" href="#t7fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">0.085</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">0.92</td><td class="colsep0 rowsep0" align="left">15</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Coverage ratio = C<sub>free,brain</sub>/cell IC<sub>50</sub>.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Male Hartley guinea pigs.</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last">Eight animals/cohort.</p></div><div class="footnote" id="t7fn4"><sup>d</sup><p class="last">Six animals/cohort.</p></div><div class="footnote" id="t7fn5"><sup>e</sup><p class="last">Male Sprague–Dawley rats.</p></div><div class="footnote" id="t7fn6"><sup>f</sup><p class="last">Compound levels were BLQ.</p></div><div class="footnote" id="t7fn7"><sup>g</sup><p class="last">Three animals were used to determine brain concentration.</p></div></div></div><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cyno CSF concentration of Aβ<sub>1–40</sub> (dotted line) and compound <b>62</b> (solid line). Po formulation: 1% carboxymethylcellulose sodium (CMC), 0.5% Tween 80, 5 mM citrate buffer, suspension; 10 male cynomolgus monkeys, crossover design (<i>n</i> = 10 vehicle, <i>n</i> = 10 at 100 mg/kg).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Pharmacodynamic Studies</h3><div class="NLM_p">Enantiopure compounds <b>59</b> and <b>62</b> were selected for PD studies in guinea pig (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>), and <b>62</b> was also evaluated in rat and cyno PD models (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, respectively). The maximum reduction observed in guinea pig CSF Aβ<sub>1–40</sub> was 58% at the 3 h time point, for both the 60 and 100 mg/kg doses of <b>62</b>. For guinea pig, there was a crude correlation between free brain concentration of <b>59</b> and <b>62</b> and PD response, with the maximum response (52% and 58%, respectively) for both compounds corresponding with their peak brain concentrations at the 3 h time point. In rat, <b>62</b> had a relatively constant free brain concentration between 46–84 nM, which lead to a sustained PD effect out to the 12 h time point. Even though <b>59</b> had ∼10-fold greater unbound plasma levels than <b>62</b> in guinea pig, it had a lower free brain concentration due in part to increased brain tissue binding (F<sub>u,brain</sub> = 0.021 for <b>59</b> vs 0.077 for <b>62</b>). Despite a lower coverage ratio, <b>59</b> demonstrated a comparable PD effect to <b>62</b> at both time points. For compound <b>62</b>, coverage ratios corresponding with maximum CSF Aβ<sub>1–40</sub> reduction for guinea pig and rat were significantly different (6.3 vs 15, respectively). This discrepancy may be due to interspecies differences in the APP sequence.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p last">For cyno, the maximum observed reduction in CSF Aβ<sub>1–40</sub> for <b>62</b> was 63% at 8 h, which lagged behind its maximum CSF concentration of 120 nM at 2 h (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). As with rat, there was a sustained PD response in cyno, with a 49% reduction in CSF Aβ<sub>1–40</sub> at the 24 h time point. However, the PD response in cyno persisted even though the CSF concentration for <b>62</b> had decreased by 24-fold from its peak concentration after 24 h. By the 48 h time point, cyno CSF Aβ<sub>1–40</sub> levels had returned to baseline. Full details of this cyno PD study are published elsewhere.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Summary</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70183" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70183" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Using structure-based design, we substituted a 1,3,4,4a,10,10a-hexahydropyrano[4,3-b]chromene (“7-THP chroman”) core to improve affinity for BACE1 and selectivity against CatD. Three different warheads (spirocyclic acyl guanidine, aminooxazoline, and aminothiazoline), which anchored the molecules in the active site by binding to the catalytic Asp residues, were examined for their effect on potency, selectivity, efflux, and permeability. The acyl guanidine moiety provided the most potent analogues, but at the expense of high efflux ratios and lower permeability than the two alternative warheads. On the basis of crystallography and modeling of the S2′ site, methyl substitution was explored at three different positions (α-, β-, and 8-positions) around the 7-THP A-ring in order to boost potency and selectivity. Although we did identify BACE1 inhibitors with superior potency and selectivity relative to their des-methyl counterparts, the improvements in potency were unable to provide compounds (e.g., <b>78</b> and <b>79</b>) with free brain levels sufficient to cover their cell IC<sub>50</sub> values in vivo. Substitution with various aromatic R groups, which provided potency and selectivity through binding to the S3 site, resulted in the identification of lead molecule <b>62</b> (R = 2-fluoropyridin-3-yl). In spite of high efflux (efflux ratio = 67), <b>62</b> demonstrated the best coverage ratio of the various 7-THP chromans evaluated in mouse PK. Furthermore, <b>62</b> significantly reduced CSF Aβ<sub>1–40</sub> in three different species (i.e., guinea pig, rat, and cyno). Our initial criteria for selectivity against CatD had been >100-fold, but to minimize risks associated with inhibition of CatD in vivo,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> we chose to pursue compounds with even greater selectivity. Guided by modeling and the SAR presented in this work, we discovered a series of THP A-ring chromans with much improved selectivity (>1000-fold against CatD), which will be the subject of a future publication.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08110" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08110" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Chemistry</h3><div class="NLM_p last">Column chromatography was done on a Biotage system (Manufacturer: Dyax Corporation) having a silica gel column, on a silica SepPak cartridge (Waters), or using silica gel 60 (EMD brand, 230–400 mesh) (unless otherwise stated). Preparative TLC purification was performed using PLC-type silica gel 60, F<sub>254</sub>, 20 × 20 cm plates (EMD brand; 0.5, 1.0, or 2.0 mm thickness). <sup>1</sup>H NMR were recorded on a Varian or Bruker instrument operating at 400 MHz. <sup>1</sup>H NMR spectra were obtained as CDCl<sub>3</sub>, CD<sub>3</sub>OD, D<sub>2</sub>O, (CD<sub>3</sub>)<sub>2</sub>SO, (CD<sub>3</sub>)<sub>2</sub>CO, C<sub>6</sub>D<sub>6</sub>, and CD<sub>3</sub>CN solutions (reported in ppm), using tetramethylsilane (0.00 ppm) or residual solvent (CDCl<sub>3</sub>, 7.26 ppm; CD<sub>3</sub>OD, 3.31 ppm; D<sub>2</sub>O, 4.79; (CD<sub>3</sub>)<sub>2</sub>SO, 2.50 ppm; (CD<sub>3</sub>)<sub>2</sub>CO, 2.05 ppm; C<sub>6</sub>D<sub>6</sub>, 7.16 ppm; CD<sub>3</sub>CN, 1.94 ppm) as the reference standard. When peak multiplicities are reported, the following abbreviations are used: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br (broadened), dd (doublet of doublets), and dt (doublet of triplets). Coupling constants, when given, are reported in Hertz (Hz). All temperatures are set forth in degrees Celsius. Low-resolution mass spectral (MS) data were obtained on an Agilent Technologies 6120 series quadrupole LC–MS with UV detection at 220 and 254 nm and multimode ionization using atmospheric-pressure chemical ionization (APCI) or ESI. The reactions set forth below were done generally under a positive pressure of nitrogen or argon or with a drying tube (unless specified otherwise) in anhydrous solvents, and the reaction flasks were typically fitted with rubber septa for the introduction of substrates and reagents via syringe. Glassware was oven-dried and/or heat dried using a heat gun while under vacuum. Reagents were purchased from commercial suppliers such as Sigma-Aldrich, Alfa Aesar, TCI, or Acros and were used without further purification unless otherwise indicated. Anhydrous solvents (e.g., THF, DMF, DMA, DMSO, MeOH, DCM, and toluene) were purchased from EMD chemicals (DriSolv line) or from Sigma-Aldrich and used directly. Unless indicated otherwise, final compounds were purified to ≥95% purity as determined by high-performance liquid chromatography (HPLC) or liquid chromatography mass spectrometry (LC–MS). HPLC purity was measured using a Varian ProStar with UV detection at 220 and 254 nm, a Waters YMC ODS-AQ C18 3.0 mm × 50 mm, 3.0 μm, 5–95% CH<sub>3</sub>CN in H<sub>2</sub>O with 0.1% NH<sub>4</sub>OAc for 5 min at 1.0 mL/min. LC–MS purity was measured using an Agilent Technologies 6120 series LC–MS with UV detection at 220 and 254 nm, a Halo C18 2.1 mm × 30 mm, 2.7 μm, 5–95% CH<sub>3</sub>CN in H<sub>2</sub>O with 0.1% NH<sub>4</sub>OAc for 3 min at 1.0 mL/min. p<i>K</i><sub>a</sub> values were determined at Analiza using a 24 point parallel capillary electrophoresis method with quantitation by UV absorbance at 229 nm.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 4-(3,6-Dihydro-2<i>H</i>-pyran-4-yl)morpholine (<b>5</b>)</h3><div class="NLM_p last">A mixture of dihydro-2<i>H</i>-pyran-4(3H)-one <b>4</b> (100 g, 999 mmol) and morpholine (131 mL, 1498 mmol) in toluene (333 mL) was refluxed under Dean–Stark trap overnight. More than 1 equiv of water was collected. This reaction mixture was then concentrated down to give crude <b>5</b> (169 g) as an oil, which was carried forward to the next step without purification.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 8-Bromo-4a-morpholino-1,3,4,4a,10,10a-hexahydropyrano[4,3-b]chromen-10-ol (<b>7</b>)</h3><div class="NLM_p last">A mixture of <b>5</b> (178.1 g, 1052 mmol) and 5-bromo-2-hydroxybenzaldehyde <b>6</b> (211.6 g, 1052 mmol) in toluene (351 mL) was stirred overnight at rt. A white solid crashed out and was filtered off. This was washed with toluene (50 mL). The solid product was collected and dried to give <b>7</b> (306.8 g, 79% yield) as a 2:1 mixture of diastereomers, which were not separated. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) isomer 1 (major diastereomer) δ 7.55 (m, 1H), 7.29 (dd, <i>J</i> = 3, 9 Hz, 1H), 6.71 (d, <i>J</i> = 9 Hz, 1H), 5.10 (d, <i>J</i> = 6 Hz, 1H), 4.08 (m, 1H), 3.96 (m, 1H), 3.61–3.85 (m, 2H), 3.58 (m, 4H), 3.31 (t, <i>J</i> = 11 Hz, 1H), 2.59–2.84 (m, 5H), 1.83 (m, 2H); isomer 2 (minor diastereomer) δ 7.47 (m, 1H), 7.35 (dd, <i>J</i> = 3, 9 Hz, 1H), 6.79 (d, <i>J</i> = 9 Hz, 1H), 4.08 (m, 1H), 3.96 (m, 1H), 3.61–3.85 (m, 2H), 3.58 (m, 4H), 3.02 (<i>t</i>, J = 11 Hz, 1H), 2.59–2.84 (m, 5H), 2.00 (m, 2H), 1.89 (m, 1H).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 8-Bromo-3,4-dihydropyrano[4,3-b]chromen-10(1<i>H</i>)-one (<b>8</b>)</h3><div class="NLM_p last">DMSO (204 mL, 2878 mmol) was added dropwise to oxalyl chloride (1726.9 mmol) in DCM (8 L) at −78 °C. This was added such that the temperature did not rise above −65 °C. This was then stirred for 40 min at −78 °C. Compd <b>7</b> (533 g, 1439 mmol) was added as a solid (temperature did not rise), and this was stirred for 2 h at −78 °C. The solid did not fully go into solution. Triethylamine (602 mL, 4317 mmol) was added dropwise (some exotherm was seen; however, the reaction temperature did not get above −65 °C). This was stirred for 30 min at −78 °C. During the entire course of the reaction, the mixture was continually purged with N<sub>2</sub>, which exited the flask via a line fed into a bleach trap. The mixture was then concentrated down. Glacial acetic acid (1000 mL) was added to the mixture. The material went into solution initially; however, after 5 min of stirring, product began to crash out. The material was stirred overnight at rt. White solid had crashed out and this was filtered. The white solid was washed with glacial acetic acid (200 mL). This gave <b>8</b> (340.8 g, 84% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.31 (d, <i>J</i> = 3 Hz, 1H), 7.74 (dd, <i>J</i> = 2, 9 Hz, 1H), 7.32 (d, <i>J</i> = 9 Hz, 1H), 4.65 (m, 2H), 4.02 (m, 2H), 2.79 (m, 2H).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (4a<i>S</i>*,10a<i>S</i>*)-8-Bromo-1,4,4a,10a-tetrahydropyrano[4,3-b]chromen-10(3<i>H</i>)-one (<b>9</b>)</h3><div class="NLM_p last"><span class="smallcaps smallerCapital">l</span>-Selectride (587 mL, 587 mmol, 1 M in THF) was added to a mixture of <b>8</b> (150 g, 534 mmol) in DCM (2809 mL) at −78 °C. This was stirred for 45 min. TLC showed that the reaction was complete. The mixture was placed in an ice bath. Aqueous Rochelle’s salt (0.5 M) was added to the mixture as it was warming to 0 °C. This was then worked up with EtOAc/water. The organics were extracted twice, washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The crude was then triturated with hexanes to give <b>9</b> (100 g, 66% yield) in >95% diastereomeric purity by <sup>1</sup>H NMR. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.96 (d, <i>J</i> = 3 Hz, 1H), 7.57 (dd, <i>J</i> = 3, 9 Hz, 1H), 6.89 (d, <i>J</i> = 9 Hz, 1H), 4.51 (m, 1H), 4.32 (m, 1H), 4.12 (m, 1H), 3.45 (td, <i>J</i> = 3, 12 Hz, 1H), 3.38 (m, 1H), 2.83 (m, 1H), 2.05–2.20 (m, 2H).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (4<i>S</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-8′-Bromo-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>-spiro[imidazolidine-4,10′-pyrano[4,3-b]chromene]-2,5-dione (<b>10</b>)</h3><div class="NLM_p last">A mixture of <b>9</b> (75 g, 265 mmol), KCN (34.5 g, 530 mmol), ammonium carbonate (204 g, 2119 mmol), and NaHSO<sub>3</sub> (11.0 g, 106 mmol) in EtOH (265 mL) was heated to 130 °C overnight in a steel bomb with stirring. The mixture was poured into an Erlenmeyer flask with side arm in an ice bath. The flask was purged with N<sub>2</sub>, and the outlet line was fed into a 2 N NaOH soln to quench HCN. To the flask was carefully added concentrated HCl until the pH was about 1. This was then stirred in an ice bath for 1 h while purging with N<sub>2</sub>. The resulting white solid was filtered off and collected. This solid was dried and then taken up in i-PrOH (500 mL) and heated at reflux for 30 min. This was then cooled to rt and then to 5 °C in an ice bath. The white solid was filtered and washed with i-PrOH (50 mL) to give <b>10</b> (44.8 g, 43% yield) in 84% diastereomeric purity by <sup>1</sup>H NMR. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 11.14 (s, 1H), 8.45 (s, 1H), 7.44 (dd, <i>J</i> = 2, 9 Hz, 1H), 7.22 (d, <i>J</i> = 2 Hz, 1H), 6.89 (d, <i>J</i> = 9 Hz, 1H), 4.74 (td, <i>J</i> = 5, 11 Hz, 1H), 3.97 (m, 2H), 3.40 (m, 1H), 3.06 (t, <i>J</i> = 11 Hz, 1H), 2.10 (m, 2H), 1.69 (m, 1H).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-8′-Bromo-1-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>-spiro[imidazolidine-4,10′-pyrano[4,3-b]chromene]-2,5-dione (<b>11</b>)</h3><div class="NLM_p last">A round bottomed flask plus stir bar was charged with DMF (100 mL) and <b>10</b> (16.3 g, 46.2 mmol). The mixture was cooled in an ice bath under N<sub>2</sub>, and K<sub>2</sub>CO<sub>3</sub> (9.6 g, 69 mmol) and iodomethane (2.9 mL, 46 mmol) were added sequentially. It was stirred in the ice bath for 10 min, and then removed from the bath and allowed to stir at rt for 2 h. The reaction mixture was diluted with EtOAc (300 mL) and water (200 mL). The phases were separated and re-extracted with aqueous EtOAc (150 mL). Combined organic phases were washed with water (200 mL), brine (200 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated. Yield of <b>11</b>: 15.9 g (94% yield). Product was approximately 85% pure based on HPLC, and was carried forward to the next step without purification. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 8.72 (s, 1H), 7.42 (dd, <i>J</i> = 2, 9 Hz, 1H), 7.28 (d, <i>J</i> = 2 Hz, 1H), 6.89 (d, <i>J</i> = 9 Hz, 1H), 4.76 (td, <i>J</i> = 5, 11 Hz, 1H), 3.97 (m, 1H), 3.88 (m, 1H), 3.37 (m, 1H), 2.97 (t, <i>J</i> = 11 Hz, 1H), 2.88 (s, 3H), 2.13 (m, 2H), 1.68 (m, 1H).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-8′-Bromo-1-methyl-2-thioxo-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>-spiro[imidazolidine-4,10′-pyrano[4,3-b]chromen]-5-one (<b>12</b>)</h3><div class="NLM_p last">A thick walled, glass pressure vessel with <b>11</b> (15.9 g, 43.3 mmol), Lawesson’s reagent (10.5 g, 26.0 mmol), and toluene (150 mL) was charged. The mixture was degassed with N<sub>2</sub> for several minutes. The mixture was then heated to 90 °C for 15 h with stirring. Reaction had gone to approx 50% conversion by HPLC and <sup>1</sup>H NMR. Then more Lawesson’s reagent (3.5 g, 0.2 equiv) was added and heated to 100 °C for an additional 22 h. HPLC indicated >95% consumption of starting material. After cooling to rt, much solid had formed. The suspension was cooled in a freezer at 5 °C for 2 h, then solids were filtered (14.9 g) and washed with toluene. The mother liquor was saved. This solid (14.9 g) was mostly desired product by <sup>1</sup>H NMR, and it was partially purified by silica gel plug, eluting with 10% Et<sub>2</sub>O in DCM. The mother liquor that had been saved was partitioned between EtOAc (200 mL) and satd. aq. NaHCO<sub>3</sub> (200 mL). Phases were separated, and the aqueous phase was re-extracted with EtOAc (150 mL). Combined organic phases were washed with brine (200 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated to obtain 15.3 g of crude material. By <sup>1</sup>H NMR, this crude contained approx 20% desired product. To improve upon the product yield, it was chromatographed on a Biotage Flash 75L system, eluting with 5% Et<sub>2</sub>O/DCM isocratic. From this column recovered 2.1 g additional product, which was combined with the 13 g of product purified by silica gel plug, to obtain 15.1 g (59% yield) of <b>12</b>. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 10.76 (s, 1H), 7.47 (dd, <i>J</i> = 2, 9 Hz, 1H), 7.07 (d, <i>J</i> = 2 Hz, 1H), 6.93 (d, <i>J</i> = 9 Hz, 1H), 4.75 (td, <i>J</i> = 5, 11 Hz, 1H), 3.97 (m, 1H), 3.73 (m, 1H), 3.38 (m, 1H), 3.14 (s, 3H), 2.98 (t, <i>J</i> = 11 Hz, 1H), 2.19 (m, 2H), 1.70 (m, 1H).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-2-Amino-8′-bromo-1-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-5(1<i>H</i>)-one (<b>13</b>)</h3><div class="NLM_p last">A round bottomed flask plus stir bar with <b>12</b> (15.1 g, 39.4 mmol), MeOH (200 mL), 70% aqueous <i>t</i>-butyl hydroperoxide (38 mL, 276 mmol), and 30% aq. NH<sub>4</sub>OH (77 mL, 591 mmol) was charged. The mixture was heated to 50 °C for 2 h with stirring. After cooling to rt, the mixture was diluted with water (20 mL) and concentrated (but not to dryness) in vacuo. The residue was diluted with EtOAc (150 mL), and phases were separated and re-extracted with aqueous EtOAc (2 × 75 mL). Combined organic phases were washed with brine (150 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated. Purified crude (15.6 g) by silica gel chromatography on a Biotage Flash 75L system, eluting with 7–10% MeOH/DCM. A total of 7.4 g (47%) of <b>13</b> as a white powde was obtained, in >95% diastereomeric purity by <sup>1</sup>H NMR. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.27 (dd, <i>J</i> = 2, 9 Hz, 1H), 7.01 (d, <i>J</i> = 2 Hz, 1H), 6.76 (d, <i>J</i> = 9 Hz, 1H), 4.85 (td, <i>J</i> = 5, 11 Hz, 1H), 4.68 (br s, 2H), 4.05 (m, 1H), 3.94 (m, 1H), 3.45 (m, 1H), 3.05 (s, 3H), 3.00 (t, <i>J</i> = 11 Hz, 1H), 2.11 (m, 2H), 1.82 (m, 1H).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (4a<i>S</i>*,10a<i>S</i>*)-8-Bromo-10-methylene-1,3,4,4a,10,10a-hexahydropyrano[4,3-b]chromene (<b>14</b>)</h3><div class="NLM_p last">A round bottomed flask plus stir bar with <b>9</b> (544 mg, 1.92 mmol) and anhyd. THF (5 mL) was charged and cooled to 0 °C under N<sub>2</sub>, and added Tebbe’s reagent (5.7 mL, 2.9 mmol, 0.5 M in toluene). This mixture was stirred for 2 h at rt. Then, it was cooled in an ice bath and added MeOH (5 mL) very carefully (vigorous exotherm and bubbling), then added aq. 2 N NaOH (5 mL) dropwise. To enable stirring, DCM (10 mL) was added. The biphasic suspension was stirred for 15 min at rt. The biphase was filtered to remove solids through celite, rinsing with DCM. Phases were separated and re-extracted with aqueous DCM (5 mL). Combined organics were washed with brine (20 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated. Purified crude by Biotage Flash 40 silica gel chromatography, eluting with 10–15% EtOAc/hexanes. Yield of <b>14</b>: 168 mg (30%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.63 (d, <i>J</i> = 2 Hz, 1H), 7.27 (dd, <i>J</i> = 2, 9 Hz, 1H), 6.74 (d, <i>J</i> = 9 Hz, 1H), 5.48 (d, <i>J</i> = 2 Hz, 1H), 4.71 (d, <i>J</i> = 2 Hz, 1H), 4.44 (m, 1H), 4.12 (m, 1H), 3.79–3.89 (m, 1H), 3.48 (m, 1H), 3.35 (m, 1H), 2.51 (m, 1H), 2.09 (m, 1H), 1.96 (m, 1H).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-8′-Bromo-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>,5<i>H</i>-spiro[oxazole-4,10′-pyrano[4,3-b]chromen]-2-amine (15a) and (4<i>R</i>*,4a′<i>R</i>*,10a′<i>R</i>*)-8′-Bromo-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>,5<i>H</i>-spiro[oxazole-4,10′-pyrano[4,3-b]chromen]-2-amine (<b>15b</b>)</h3><div class="NLM_p last">This analogue was prepared from <b>14</b>, as described for 8-bromo-3,4,4a,10a-tetrahydro-1H,5′H-spiro[pyrano[4,3-b]chromene-10,4′-thiazol]-2′-amine <b>16</b>, replacing silver thiocyanate with silver cyanate. Diastereomers were partially separated by preparative TLC (2 mm thickness), eluting with 10% MeOH/DCM. Mixed fractions were repurified by Biotage Flash 40 column, eluting with a gradient of 1:1 EtOAc/hexanes, neat EtOAc, then 2.5%–5% MeOH/EtOAc. Yield of <b>15a</b>: 62 mg (16%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.42 (d, <i>J</i> = 2 Hz, 1H), 7.25 (dd, <i>J</i> = 2, 9 Hz, 1H), 6.67 (d, <i>J</i> = 9 Hz, 1H), 4.57 (br s, 2H), 4.39 (d, <i>J</i> = 9 Hz, 1H), 4.10 (m, 2H), 3.97 (d, <i>J</i> = 9 Hz, 1H), 3.46 (m, 1H), 3.23 (t, <i>J</i> = 11 Hz, 1H), 2.15 (m, 2H), 1.91 (m, 2H). Yield of <b>15b</b>: 49 mg (15%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 7.31 (d, <i>J</i> = 2 Hz, 1H), 7.26 (dd, <i>J</i> = 2, 9 Hz, 1H), 6.72 (d, <i>J</i> = 9 Hz, 1H), 4.54 (d, <i>J</i> = 9 Hz, 1H), 4.36 (d, <i>J</i> = 9 Hz, 1H), 4.19 (td, <i>J</i> = 5, 11 Hz, 1H), 4.05 (m, 2H), 3.52 (m, 1H), 3.37 (m, 1H), 2.16 (m, 1H), 1.88 (m, 2H).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 8-Bromo-3,4,4a,10a-tetrahydro-1<i>H</i>,5′<i>H</i>-spiro[pyrano[4,3-b]chromene-10,4′-thiazol]-2′-amine (<b>16</b>)</h3><div class="NLM_p last">A stirred solution of <b>14</b> (168 mg, 0.598 mmol) in diethyl ether (2 mL) was cooled to 0 °C under N<sub>2</sub>. In a separate flask, silver thiocyanate (397 mg, 2.39 mmol) was suspended in CH<sub>3</sub>CN (1 mL), and to this suspension, iodine (303 mg, 1.20 mmol) in THF (1 mL) was added, and the resulting mixture was shaken for 30 s. The suspension was then poured into the alkene solution at 0 °C, and the vial was rinsed with CH<sub>3</sub>CN and added to the reaction mixture. The reaction mixture was stirred at rt for 4 h. Aqueous NH<sub>4</sub>OH (1 mL) was added directly to the reaction mixture, and it was stirred at rt for 2 h, then left sitting for 18 h at rt. Filtered salts through Celite, rinsing with EtOAc. The filtrate was washed with aq. satd. Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> (20 mL). After shaking and then separating the phases, the aqueous layer was re-extracted with EtOAc (20 mL). The combined organic layers were washed with brine (20 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated. Crude was partially purified by preparative TLC (2 mm thickness) eluting with 10% MeOH/DCM and then carried forward to the next step as a mixture of diastereomers.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 8-Bromo-2-methyl-2,3,4,6-tetrahydro-2,6-methanobenzo[b][1,5]dioxocin-4-ol (<b>19</b>)</h3><div class="NLM_p last">To a solution of 5-bromo-2-hydroxybenzaldehyde <b>18</b> (30 g, 150 mmol) and Et<sub>3</sub>N (10.5 mL, 75 mmol) in dioxane (56 mL) and H<sub>2</sub>O (19 mL) was added methylbut-2-enal <b>17</b> (12.6 g, 150 mmol). The mixture was stirred at 55 °C for 12 h. Saturated aq. NaHCO<sub>3</sub> was then added to the mixture and the aqueous phase was extracted with EtOAc. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give the crude product, which was purified by column chromatography on silica gel (eluting with 1:1 EtOAc/hexanes) to give yellow solid <b>19</b> (26.5 g, 63%) as a single unknown diastereomer. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.30–7.26 (m, 2H), 6.69 (d, <i>J</i> = 10 Hz, 1H), 4.85–4.80 (m, 2H), 3.17 (d, <i>J</i> = 6 Hz, 1H), 2.20–2.10 (m, 2H), 1.81–1.77 (m, 1H), 1.60–1.55 (m, 1H), 1.45 (s, 3H).</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 6-Bromo-2-(2-hydroxyethyl)-2-methylchroman-4-ol (<b>20</b>)</h3><div class="NLM_p last">To a solution of <b>19</b> (20.5 g, 71.8 mmol) in MeOH (60 mL) and THF (240 mL) was added NaBH<sub>4</sub> (1.4 g, 35.9 mmol). The mixture was stirred at 0 °C for 2 h. The reaction was quenched with satd. aq. NaHCO<sub>3</sub> and extracted with DCM. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give white solid <b>20</b> (16.6 g, 81%) as a single unknown diastereomer. <sup>1</sup>H NMR (400 MHz, CDCl3) δ 7.58 (dd, <i>J</i> = 0.8, 2 Hz, 1H), 7.28–7.25 (m, 1H), 6.68 (d, <i>J</i> = 9 Hz, 1H), 4.84–4.81 (m, 1H), 3.90–3.82 (m, 2H), 2.16–1.90 (m, 6H), 1.35 (s, 3H).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 6-Bromo-2-(2-hydroxyethyl)-2-methylchroman-4-one (<b>21</b>)</h3><div class="NLM_p last">To a solution of <b>20</b> (16.6 g, 58 mmol) in DCM (300 mL) was added MnO<sub>2</sub> (25.2 g, 290 mmol). The reaction mixture was stirred at rt for 12 h. The reaction was filtered, and the filtrate was concentrated to give the crude product, which was purified by column chromatography on silica gel (2:1 hexanes/EtOAc) to give <b>21</b> (10.8 g, 65% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.96 (d, <i>J</i> = 3 Hz, 1H), 7.56 (dd, <i>J</i> = 3, 9 Hz, 1H), 6.84 (d, <i>J</i> = 9 Hz, 1H), 3.89–3.86 (m, 2H), 2.93–2.64 (m, 2H), 2.11–1.95 (m, 2H), 1.45 (s, 3H).</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 6-Bromo-2-(2-(methoxymethoxy)ethyl)-2-methylchroman-4-one (<b>22</b>)</h3><div class="NLM_p last">To a solution of <b>21</b> (10.8 g, 38 mmol) and i-Pr<sub>2</sub>EtN (13.5 mL, 76 mmol) in DCM (30 mL) was added MOMCl (4.4 mL, 57 mmol) at 0 °C. The reaction mixture was stirred at rt for 12 h. The reaction was then quenched with satd. aq. NH<sub>4</sub>Cl and extracted with DCM. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give the crude product, which was purified by column chromatography on silica gel (10:1 hexanes/EtOAc) to give <b>22</b> (10.1 g, 81%) as an oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.96 (d, <i>J</i> = 2 Hz, 1H), 7.55 (dd, <i>J</i> = 3, 9 Hz, 1H), 6.84 (d, <i>J</i> = 9 Hz, 1H), 4.59 (d, <i>J</i> = 0.8 Hz, 2H), 3.72–3.68 (m, 2H), 3.34 (s, 3H), 2.91–2.86 (m, 1H), 2.70–2.66 (m, 1H), 2.12–1.99 (m, 2H), 1.44 (s, 3H).</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> ((6-Bromo-2-(2-(methoxymethoxy)ethyl)-2-methyl-2<i>H</i>-chromen-4-yl)oxy)trimethylsilane (<b>23</b>)</h3><div class="NLM_p last">To a solution of <b>22</b> (20.0 g, 60.9 mmol) in THF (300 mL) was added dropwise LHMDS (66.9 mL, 66.9 mmol, 1 M in THF) at −70 °C. The mixture was stirred for 10 min. Then TMSCl (7.26 g, 66.8 mmol) was added to the mixture. After 30 min, the reaction was quenched with 10% aq. NaHCO<sub>3</sub> at −70 °C, and extracted with DCM. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford crude <b>23</b>, which was carried to the next step without further purification.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (4a<i>S</i>*,10a<i>R</i>*)-8-Bromo-4a-methyl-1,4,4a,10a-tetrahydropyrano[4,3-b]chromen-10(3<i>H</i>)-one (<b>24</b>)</h3><div class="NLM_p last">To a solution of TiCl<sub>4</sub> (23.4 mL, 213 mmol) in DCM (200 mL) was added <b>23</b> in DCM (100 mL) at −40 °C. The mixture was stirred at −40 °C for 30 min. The mixture was then poured into satd. aq. NaHCO<sub>3</sub>, extracted with DCM twice, washed with brine, and the organic layer was then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give the crude product, which was purified by column chromatography on silica gel (10:1 hexanes/EtOAc) to give <b>24</b> (12.0 g, 67% yield, 2 steps), which was the pure cis stereoisomer at the ring fusion. <sup>1</sup>H NMR (400 MHz, CDCl3) δ 7.96 (d, <i>J</i> = 2 Hz, 1H), 7.59 (dd, <i>J</i> = 2, 8 Hz, 1H), 6.90 (d, <i>J</i> = 9 Hz, 1H), 3.89–3.82 (m, 3H), 3.60 (t, <i>J</i> = 11 Hz, 1H), 2.71 (dd, <i>J</i> = 11, 5 Hz, 1H), 2.00–1.96 (dt, <i>J</i> = 14, 3 Hz, 1H), 1.78 (ddd, <i>J</i> = 14, 11, 6 Hz, 1H), 1.37 (s, 3H).</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (4a<i>S</i>*,10a<i>S</i>*)-8-Bromo-4a-methyl-1,4,4a,10a-tetrahydropyrano[4,3-b]chromen-10(3<i>H</i>)-one (<b>25</b>)</h3><div class="NLM_p last">Compound <b>24</b> (7.0 g, 24 mmol) was dissolved in THF (150 mL) and cooled to −78 °C. LHMDS (25 mL, 25 mmol, 1 M in THF) was then added slowly via syringe. After stirring for 10 min at −78 °C, the enolate-containing solution was added over 10 min via cannula to a solution of ethyl 2-hydroxybenzoate (14 mL, 94 mmol) in THF (100 mL) also cooled to −78 °C. After stirring for 10 min, the reaction mixture was quenched with satd. aq. NH<sub>4</sub>Cl, partitioned between DCM and brine, and the phases were then separated. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was then purified by silica gel eluting with a linear gradient of 0–20% EtOAc/heptane to provide a 5:1 mixture of trans/cis stereoisomers at the ring fusion. Yield of <b>25</b>: 6.3 g, 90%.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (4a<i>S</i>*,10a<i>S</i>*)-8-Bromo-4a-methyl-10-methylene-1,3,4,4a,10,10a-hexahydropyrano[4,3-b]chromene (<b>26</b>)</h3><div class="NLM_p last">Compound <b>25</b> (2.45 g, 8.25 mmol) was dissolved in THF (25 mL) and cooled to −78 °C. Tebbe’s reagent (24.7 mL, 12.4 mmol, 0.5 M in toluene) was then added slowly via syringe. The reaction mixture was allowed to warm to rt overnight. The next morning, the reaction mixture was cooled to 0 °C and slowly quenched with MeOH (∼20 mL) followed by the addition of 1 N aq. NaOH (∼10 mL). After stirring 15 min at rt, the mixture was diluted with DCM (200 mL) and filtered through Celite. The filtrate was partitioned between additional DCM and brine, phases separated, and the organic layer was then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by silica gel eluting with a linear gradient of 0–30% EtOAc/heptane to provide <b>26</b> (1.47 g, 60% yield) as a 3:1 mixture of trans/cis stereoisomers at the ring fusion.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 8′-Bromo-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>,5<i>H</i>-spiro[oxazole-4,10′-pyrano[4,3-b]chromen]-2-amine (<b>27</b>)</h3><div class="NLM_p last">Iodine (1.38 g, 5.44 mmol) dissolved in EtOAc (39 mL) was added over 5 min to a suspension of <b>26</b> (1.46 g, 4.95 mmol) and silver cyanate (899 mg, 5.93 mmol) in EtOAc (6.0 mL) and CH<sub>3</sub>CN (13.2 mL) at 0 °C. The reaction mixture was then warmed to rt and allowed to stir for 30 min and then heated at 40 °C for an additional 30 min. The heterogeneous reaction mixture was then filtered through celite and concentrated. The crude material was redissolved in THF (30 mL) and NH<sub>4</sub>OH solution (20 mL). The mixture was then heated at 40 °C for 1 h. The reaction mixture was then partitioned between DCM and brine, phases separated, and the organic layer dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was then purified by silica gel eluting with a linear gradient of 0–6% MeOH/DCM + 1% NH<sub>4</sub>OH solution to provide <b>27</b> (585 mg, 33% yield) as a mixture of diastereomers, which was carried on to the next reaction without additional purification.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 5-Bromo-4-fluoro-2-hydroxybenzaldehyde (<b>28</b>)</h3><div class="NLM_p last">To a solution of 3-fluorophenol (100.0 g, 893 mmol) in anhydrous CH<sub>3</sub>CN (1.0 L) was added MgCl<sub>2</sub> (254.7 g, 2.7 mol) portionwise at 0 °C. Et<sub>3</sub>N (494 mL, 3.5 mol) was added dropwise to the mixture over 25 min, followed by portionwise addition of paraformaldehyde (160.7 g, 5.3 mol). After complete addition, the mixture was heated at reflux for 3 h. The mixture was cooled and quenched by the addition of cold conc. HCl (347 mL) and extracted with EtOAc. The combined EtOAc layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give 4-fluoro-2-hydroxybenzaldehyde (100.0 g, 80% yield) as a yellow oil, which was carried forward without purification. To a solution of 4-fluoro-2-hydroxy-benzaldehyde (100.0 g, 714 mmol) in acetic acid (1.0 L) was added bromine (118.5 g, 750 mmol) dropwise at 10 °C. The mixture was stirred at rt overnight. To the reaction mixture was added dropwise satd. aq. Na<sub>2</sub>SO<sub>3</sub> slowly at 0 °C until the brown color disappeared. The reaction was then poured into ice–water, the solid was collected by filtration and dried to give <b>28</b> (50.0 g, 26% yield, 2 steps) as a yellow solid. It was used in the next step without purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.34 (br, 1H), 9.77 (s, 1 H), 7.74 (dd, <i>J</i> = 3, 7 Hz, 1H), 6.79 (d, <i>J</i> = 10 Hz, 1H).</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (<i>E</i>)-1-(5-Bromo-2-hydroxyphenyl)-3-(dimethylamino)prop-2-en-1-one (<b>39</b>)</h3><div class="NLM_p last">Similar to a published procedure for related compounds,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> a mixture of 1-(5-bromo-2-hydroxyphenyl)ethanone <b>38</b> (50 g, 233 mmol) and DMF-dimethylacetal (42 g, 349 mmol) in dry toluene (250 mL) was refluxed for 3 h. After cooling to rt, the mixture was concentrated to half volume, and the resulting suspension was cooled in an ice bath, then the solids were filtered and washed with minimum amounts of toluene. Yield of <b>39</b>: 56 g (87%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 13.95 (s, 1H), 7.88 (d, <i>J</i> = 12 Hz, 1H), 7.76 (d, <i>J</i> = 2 Hz, 1H), 7.42 (dd, <i>J</i> = 2, 9 Hz, 1H), 6.83 (d, <i>J</i> = 9 Hz, 1H), 5.67 (d, <i>J</i> = 12 Hz, 1H), 3.20 (s, 3H), 2.99 (s, 3H).</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 3-Acetyl-6-bromo-4<i>H</i>-chromen-4-one (<b>40</b>)</h3><div class="NLM_p last">Similar to a published procedure for related compounds,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> to a solution of <b>39</b> (56 g, 207 mmol) in dry pyridine (84 mL) was added acetic anhydride (196 mL), and the mixture was stirred at rt for 18 h. The mixture was concentrated on the rotovap to one-half volume at 80 °C. Cooled the resulting suspension to rt, and then filtered the solids. Washed solids with hexanes. Dried under high vacuum. Yield of <b>40</b>: 48 g (85%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.59 (s, 1H), 8.39 (d, <i>J</i> = 2 Hz, 1H), 7.81 (dd, <i>J</i> = 2, 9 Hz, 1H), 7.42 (d, <i>J</i> = 9 Hz, 1H), 2.73 (s, 3H).</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (3<i>R</i>*,4a<i>R</i>*)-8-Bromo-3-ethoxy-1-methyl-4,4a-dihydropyrano[4,3-b]chromen-10(3<i>H</i>)-one (<b>41</b>)</h3><div class="NLM_p last">A stainless steel bomb plus stir bar with ethyl vinyl ether (169 mL, 1760 mmol) and <b>40</b> (47 g, 176 mmol) was charged and heated to 100 °C for 15 h. After cooling to rt, the reaction mixture was filtered, and the solids were washed with a minimum amount of EtOAc. Yield of <b>41</b>: 44 g (72%), isolated as a single diastereomer.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.05 (d, <i>J</i> = 2 Hz, 1H), 7.49 (dd, <i>J</i> = 2, 9 Hz, 1H), 6.83 (d, <i>J</i> = 9 Hz, 1H), 5.14 (dd, <i>J</i> = 2, 9 Hz, 1H), 5.07 (m, 1H), 3.99 (m, 1H), 3.67 (m, 1H), 2.53 (m, 1H), 2.38 (d, <i>J</i> = 2 Hz, 3H), 2.32 (m, 1H), 1.28 (t, <i>J</i> = 7 Hz, 3H).</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (1<i>R</i>*,3<i>R</i>*,4a<i>R</i>*,10a<i>R</i>*)-8-Bromo-3-ethoxy-1-methyl-1,4,4a,10a-tetrahydropyrano[4,3-b]chromen-10(3<i>H</i>)-one (<b>42</b>)</h3><div class="NLM_p last">A round bottomed flask plus stir bar with <b>41</b> (43 g, 127 mmol) and THF (500 mL) was charged and cooled to −78 °C in a dry ice/acetone bath. To the mixture was added DIBALH (101 mL, 152 mmol, 1.5 M in toluene) dropwise, and it was stirred at −78 °C for 1 h. Reaction remained a suspension the entire time. The reaction mixture was quenched by inverse addition (via cannula) to Rochelle’s salt (500 mL) and was stirred at rt. The mixture was worked up by extraction with EtOAc (2 × 500 mL). The combined organics were washed with brine (500 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated. The crude was purified by Biotage Flash 75 silica gel chromatography, eluting with 5–10% EtOAc/hexanes. Yield of <b>42</b>: 22.4 g (36%), which contained approximately 30% unreacted starting material, carried forward without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.91 (d, <i>J</i> = 2 Hz, 1H), 7.56 (dd, <i>J</i> = 2, 9 Hz, 1H), 6.87 (d, J = 9 Hz, 1H), 4.47 (dd, <i>J</i> = 2, 10 Hz, 1H), 4.36 (m, 1H), 3.98 (m, 1H), 3.69 (m, 1H), 3.57 (m, 1H), 2.49 (m, 1H), 2.43 (m, 1H), 2.00 (m, 1H), 1.62 (d, <i>J</i> = 6 Hz, 3H), 1.26 (t, <i>J</i> = 7 Hz, 3H).</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (1<i>R</i>*,4a<i>R</i>*,10a<i>R</i>*)-8-Bromo-1-methyl-1,4,4a,10a-tetrahydropyrano[4,3-b]chromen-10(3<i>H</i>)-one (<b>43</b>)</h3><div class="NLM_p last">A round bottomed flask plus stir bar with <b>42</b> (22.2 g, 65.1 mmol), DCM (200 mL), and Et<sub>3</sub>SiH (51.8 mL, 325 mmol) was charged and cooled in an ice bath under N<sub>2</sub>. Then BF<sub>3</sub>-Et<sub>2</sub>O (24.7 mL, 195 mmol) was added dropwise and stirred overnight at rt. The mixture was carefully quenched with satd. aq. NaHCO<sub>3</sub> (200 mL) and stirred for 1 h. Phases were separated and re-extracted with aqueous DCM (2 × 75 mL). Combined organic phases were washed with brine (200 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated. The crude was purified by Biotage Flash 65 silica gel chromatography, eluting with 10–20% EtOAc/hexanes. Yield of <b>43</b>: 13.6 g (60%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.91 (d, <i>J</i> = 2 Hz, 1H), 7.55 (dd, <i>J</i> = 2, 9 Hz, 1H), 6.86 (d, <i>J</i> = 9 Hz, 1H), 4.35 (m, 1H), 4.07 (m, 1H), 3.64 (m, 1H), 3.49 (m, 1H), 2.52 (dd, <i>J</i> = 9, 13 Hz, 1H), 2.13 (m, 2H), 1.57 (d, <i>J</i> = 6 Hz, 3H).</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (1′<i>R</i>*,4<i>R</i>*,4a′<i>R</i>*,10a′<i>R</i>*)-8′-Bromo-1,1′-dimethyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>-spiro[imidazolidine-4,10′-pyrano[4,3-b]chromene]-2,5-dione (<b>44</b>)</h3><div class="NLM_p last">A stainless steel bomb plus stir bar with EtOH (10 mL) and <b>43</b> (3 g, 10 mmol) was charged. Next ammonium carbonate (4.9 g, 50 mmol), KCN (1.3 g, 20 mmol) and sodium hydrogensulfite (0.26 g, 2.5 mmol) were added. The reaction was heated to 130 °C for 16 h with stirring in an oil bath. After cooling to rt, reaction contents were transferred to an Erlenmeyer flask using EtOAc (20 mL) and water (10 mL) to aid in transfer. The mixture was chilled in an ice bath and carefully acidified with conc. HCl, then bubbled N<sub>2</sub> through mixture for 30 min to sparge HCN (near back of hood). Phases were separated, and the aqueous phase was re-extracted with EtOAc (2 × 10 mL). The combined organic phases were washed with brine (50 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated. The crude was subjected to a Biotage Flash 65 silica gel chromatography column, eluting with 5–10% MeOH/DCM. A 60:40 mixture of diastereomers was obtained and carried forward without separation as follows. A round bottomed flask plus stir bar with DMF (10 mL) and the two diastereomers (1.6 g, 4.36 mmol) was charged and cooled in an ice bath under N<sub>2</sub>, then K<sub>2</sub>CO<sub>3</sub> (0.903 g, 6.54 mmol) and MeI (0.217 mL, 3.49 mmol) were added sequentially. The mixture was stirred at rt overnight. The mixture was diluted with EtOAc (20 mL) and water (20 mL). Phases were separated and re-extracted with aqueous EtOAc (20 mL). Combined organic phases were washed with water (20 mL), brine (20 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated. Diastereomers were separated by Biotage Flash 40 silica gel chromatography, eluting with a gradient of 20% EtOAc/hexanes to 1:1 EtOAc/hexanes. Yield of <b>44</b>: 554 mg (15%, 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.35 (m, 1H), 6.99 (m, 1H), 6.79 (d, <i>J</i> = 9 Hz, 1H), 6.24 (br s, 1H), 4.06 (m, 1H), 3.85 (m, 1H), 3.52 (m, 1H), 3.16 (s, 3H), 2.36 (m, 1H), 2.21 (m, 1H), 2.00 (m, 1H), 1.27 (m, 1H), 1.11 (d, <i>J</i> = 6 Hz, 3H).</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (4a<i>S</i>*,10a<i>S</i>*)-8-Bromo-10a-methyl-1,4,4a,10a-tetrahydropyrano[4,3-b]chromen-10(3<i>H</i>)-one (<b>45</b>)</h3><div class="NLM_p last">A round bottomed flask plus stir bar with THF (25 mL) and i-Pr<sub>2</sub>NH (2.40 mL, 17.1 mmol) was charged. The reaction vessel was cooled to −78 °C (dry ice/acetone) under N<sub>2</sub> and added <i>n</i>-BuLi (6.22 mL, 15.5 mmol, 2.5 M in hexanes). Next a solution of <b>9</b> (2.2 g, 7.77 mmol) in THF (10 mL) was added. The reaction vessel was transferred to a −10 °C ice/NaCl bath and stirred for 20 min in the bath. The vessel was recooled to −78 °C and added HMPA (9.46 mL, 54.4 mmol) followed by MeI (1.45 mL, 23.3 mmol) and stirred for 1 h at −78 °C. It was quenched by the addition of satd. aq. NH<sub>4</sub>Cl (20 mL) at −78 °C. The mixture was removed from dry ice bath and stirred for 15 min as reaction mixture warmed. Phases were partitioned between EtOAc (50 mL) and water (50 mL). Phases were separated and re-extracted with aqueous EtOAc (30 mL). Combined organic phases were washed with water (50 mL), brine (50 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated. The crude was purified by Biotage Flash 40, eluting with 10% EtOAc/hexanes. Yield of <b>45</b>: 850 mg (31%). Isolated product was >90% diastereomerically pure by <sup>1</sup>H NMR. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.96 (d, <i>J</i> = 2 Hz, 1H), 7.57 (dd, <i>J</i> = 2, 9 Hz, 1H), 6.89 (d, <i>J</i> = 9 Hz, 1H), 4.30 (dd, <i>J</i> = 5, 12 Hz, 1H), 4.09 (m, 2H), 3.43 (m, 2H), 2.22 (m, 1H), 1.93 (m, 1H), 1.26 (s, 3H).</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 3-Fluoro-4-methoxyphenyl acetate (<b>47</b>)</h3><div class="NLM_p last">A stirred solution of 1-(3-fluoro-4-methoxyphenyl)ethanone <b>46</b> (50 g, 297 mmol) in DCM (1.2 L) was treated with <i>m</i>-CPBA (83.3 g, 372 mmol). The suspension was heated to 40 °C with stirring, and the suspension became a yellow solution. The reaction was stirred for 72 h at 40 °C, and TLC suggested only partial conversion. The reaction was cooled to rt, and an additional 80 g of <i>m</i>-CPBA was added in a single portion. The reaction was returned to 40 °C, and the reaction stirred for an additional 48 h. TLC confirmed conversion of starting material, and the reaction was cooled to rt and washed with aq. 1 N NaOH, repeating until organic phase was clear. The organic phase was then washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated to a yellow oil. Yield of <b>47</b>: 47.7 g (87%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.92 (d, <i>J</i> = 9 Hz, 1H), 6.83 (dd, <i>J</i> = 3, 11 Hz, 1H), 6.83 (m, 1H), 3.88 (s, 3H), 2.27 (s, 3H).</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 1-(4-Fluoro-2-hydroxy-5-methoxyphenyl)ethanone (<b>48</b>)</h3><div class="NLM_p last">Neat TfOH (194 g, 1295 mmol) was added dropwise by addition funnel into <b>47</b> (47.7 g, 259 mmol) with stirring at 0 °C. The reaction was heated to 60 °C for 1 h and cooled to rt. The reaction was poured carefully into an ice slurry (1 L). The resulting suspension was filtered, and the solid was partitioned between Et<sub>2</sub>O and satd. aq. NaHCO<sub>3</sub>. The organic phase was washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under vacuum. Yield of <b>48</b>: 44.2 g, (93%) as a brown oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.31 (s, 1H), 7.23 (d, <i>J</i> = 9 Hz, 1H), 6.72 (d, <i>J</i> = 12 Hz, 1H), 3.89 (s, 3H), 2.60 (s, 3H).</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 7-Fluoro-6-methoxy-4-oxo-4<i>H</i>-chromene-3-carbaldehyde (<b>49</b>)</h3><div class="NLM_p last">A solution of triphosgene (71.2 g, 240 mmol) in DCE (160 mL) was added dropwise to a flask containing a mixture of DMF (254 mL, 2880 mmol) and DCE (300 mL) that was stirred in an ice bath. The reaction temperature was maintained below 25 °C. After addition, the reaction was cooled to 0 °C and treated with a solution of <b>48</b> (44.2 g, 240 mmol) in DCE (160 mL). The ice bath was removed and the reaction was allowed to warm to rt while monitoring by HPLC. After 5 h of stirring at rt, the reaction was poured into a 2 L ice slurry and stirred for an additional 2 h. The aqueous was extracted multiple times with DCE, and the combined organic extracts were washed with satd. aq. NaHCO<sub>3</sub> and brine, and then the organic phase was concentrated in vacuo. The resulting solid was placed in a vacuum oven and heated to 60 °C overnight. Yield of <b>49</b>: 28 g (53%) as a brown powder. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.39 (s, 1H), 8.52 (s, 1H), 7.76 (d, <i>J</i> = 9 Hz, 1H), 7.29 (d, <i>J</i> = 10 Hz, 1H), 4.02 (s, 3H).</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (3<i>S</i>*,4a<i>S</i>*)-3-Ethoxy-7-fluoro-8-methoxy-4,4a-dihydropyrano[4,3-b]chromen-10(3<i>H</i>)-one (<b>50</b>)</h3><div class="NLM_p last">A stirred suspension of <b>49</b> (31.4 g, 141 mmol) and ethyl vinyl ether (67.9 mL, 707 mmol) was heated at 100 °C in a Teflon-lined stainless steel bomb for 8 h with stirring. The heat was removed, and the reaction continued to stir an additional 7 h at rt. The resulting residue was crystallized from hot EtOH, and the solids were filtered. Yield of <b>50</b>: 16.6 g (40%) as a single diastereomer.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a><sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 7.57 (d, <i>J</i> = 1 Hz, 1H), 7.41 (d, <i>J</i> = 10 Hz, 1H), 7.04 (d, <i>J</i> = 12 Hz, 1H), 5.39 (dd, <i>J</i> = 2, 10 Hz, 1H), 5.31 (m, 1H), 3.90 (m, 1H), 3.85 (s, 3H), 3.68 (m, 1H), 2.55 (m, 1H), 2.11 (m, 1H), 1.19 (t, <i>J</i> = 7 Hz, 3H).</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (3<i>S</i>*,4a<i>S</i>*,10a<i>S</i>*)-3-Ethoxy-7-fluoro-8-methoxy-1,4,4a,10a-tetrahydropyrano[4,3-b]chromen-10(3<i>H</i>)-one (<b>51</b>)</h3><div class="NLM_p last">A suspension of <b>50</b> (13.3 g, 45.3 mmol) in EtOH (100 mL) was treated with Pd/C (10 wt %, 0.8 g) and shaken in a Parr shaker under H<sub>2</sub> (50 psi) for 3 h. The reaction was filtered through GF/F paper, and the filtrate was concentrated. The solid was suspended in DCM (100 mL) and stirred with MnO<sub>2</sub> (7.9 g, 90.5 mmol) overnight. The crude was filtered and concentrated to provide <b>51</b> (12.1 g) as a white solid, which was carried forward crude without purification at this step.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (4a<i>S</i>*,10a<i>S</i>*)-7-Fluoro-8-methoxy-1,4,4a,10a-tetrahydropyrano[4,3-b]chromen-10(3<i>H</i>)-one (<b>52</b>)</h3><div class="NLM_p last">A solution of <b>51</b> (11.1 g, 37 mmol) in DCM (3 mL) was cooled to 0 °C and treated with Et<sub>3</sub>SiH (18 mL, 112 mmol), then BF<sub>3</sub>–Et<sub>2</sub>O (9.2 mL, 75 mmol). The reaction was allowed to stir at rt overnight. The reaction was incomplete so an additional 3 equiv of Et<sub>3</sub>SiH and 2 equiv of BF<sub>3</sub>–Et<sub>2</sub>O were added and the reaction continued to stir at rt. After 40 h, the reaction mixture was dissolved in EtOAc (30 mL) and MeOH (5 mL), then quenched with satd. aq. NaHCO<sub>3</sub> and stirred for 4 h. The organic phase was separated and washed with brine. The organic phase was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo to provide <b>52</b> (8.58 g), which was carried forward crude without purification at this step.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 2-Amino-7′-fluoro-8′-methoxy-1-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-5(1H)-one (<b>53</b>)</h3><div class="NLM_p last">Prepared from <b>52</b> using reaction conditions described for the synthesis of compounds <b>10</b>–<b>13</b>, crude <b>53</b> was purified by silica gel chromatography (gradient: 0–10% (80% DCM/19% MeOH/1% NH<sub>4</sub>OH)/DCM) to obtain a 60:40 mixture of trans/cis stereoisomers at the ring fusion, which was carried forward without separation at this step. Yield: 1.70 g (12%, 4 steps). <sup>1</sup>H NMR (400 MHz, CDCl3) trans isomer, δ 6.65 (d, <i>J</i> = 12 Hz, 1H), 6.46 (m, 1H), 5.32 (br, 2H), 4.82 (td, <i>J</i> = 5, 11 Hz, 1H), 4.02 (m, 1H), 3.92 (m, 1H), 3.76 (s, 3H), 3.44 (m, 1H), 3.07 (s, 3H), 3.00 (t, <i>J</i> = 11 Hz, 1H), 1.73–2.16 (m, 3H); cis isomer δ 6.71 (d, <i>J</i> = 12 Hz, 1H), 6.46 (m, 1H), 5.32 (br, 2H), 5.16 (m, 1H), 3.92 (m, 1H), 3.78 (m, 1H), 3.76 (s, 3H), 3.75 (m, 1H), 3.35 (t, <i>J</i> = 12 Hz, 1H), 3.08 (s, 3H), 1.73–2.16 (m, 3H).</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (4<i>R*</i>,4a′<i>S*</i>,10a′<i>S*</i>)-2-((<i>E</i>)-((Dimethylamino)methylene)amino)-7′-fluoro-1-methyl-5-oxo-1,3′,4′,4a′,5,10a′-hexahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-8′-yl Trifluoromethanesulfonate (<b>54</b>)</h3><div class="NLM_p last">Compound <b>53</b> (500 mg, 1.49 mmol) was treated with 48% aq. HBr (7.5 mL, 1.49 mmol) and heated to 100 °C in a sealed vessel for 3 h. The reaction was cooled to rt and treated with DCM (50 mL) and satd. aq. NaHCO<sub>3</sub> until slightly basic. The pH was brought to ∼5 by careful addition of aq. 1 N HCl. The biphasic mixture was then concentrated in vacuo, and the residue was triturated with 10% MeOH/DCM. The resulting suspension was filtered, and the filtrate was concentrated to provide a crude oil, which was then stirred with DMF-dimethylacetal (0.90 mL, 7.45 mmol) in DMF (10 mL) at rt for 15 h. The reaction mixture was then concentrated in vacuo to an oil. This oil was subsequently stirred with Et<sub>3</sub>N (0.42 mL, 3.0 mmol) and DCM (7 mL) and treated with 1,1,1-trifluoro-<i>N</i>-phenyl-<i>N</i>-(trifluoromethylsulfonyl)methanesulfonamide (0.799 g, 2.24 mmol). The reaction was stirred for 15 h at rt. The reaction mixture was washed with water and brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The crude was purified by silica gel chromatography to provide <b>54</b> (90 mg, 12% yield, 3 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.59 (s, 1H), 7.17 (m, 1H), 6.74 (m, 1H), 4.98 (td, <i>J</i> = 5, 11 Hz, 1H), 4.05 (m, 1H), 3.85 (m, 1H), 3.46 (m, 1H), 3.18 (s, 3H), 3.17 (s, 3H), 3.07 (s, 3H), 3.01 (t, <i>J</i> = 11 Hz, 1H), 2.26 (m, 1H), 2.15 (m, 1H), 1.82 (m, 1H).</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (4<i>R</i>,4a′<i>S</i>,10a′<i>S</i>)-2-Amino-8′-bromo-1-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-5(1<i>H</i>)-one (<b>55</b>)</h3><div class="NLM_p last">The title compound was obtained by resolution of the racemate <b>13</b> using chiral SFC, performed as follows. System, Thar 350; column, Chiralpak IB, 5 cm × 25 cm, 5 μm; mobile phase A, CO<sub>2</sub>; mobile phase B, 80% MeOH with 0.1% NH<sub>4</sub>OH, 20% DCM; isocratic conditions, 65% A, 35% B; flow rate, 300 mL/min; backpressure, 100 bar; temperature, 40 °C; UV detection, 220 nm; racemic <b>13</b> was dissolved in a 50:35:15 mixture of MeOH/DCM/formic acid, which was loaded on the column in 3 mL injections every 5.5 min. Compound <b>55</b> was >98% pure by LC–MS (254 nm) and >98% ee by chiral SFC analysis. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.27 (dd, <i>J</i> = 2, 9 Hz, 1H), 7.01 (d, <i>J</i> = 2 Hz, 1H), 6.76 (d, <i>J</i> = 9 Hz, 1H), 4.84 (m, 1H), 4.68 (br s, 2H), 4.03 (m, 1H), 3.94 (m, 1H), 3.45 (m, 1H), 3.05 (s, 3H), 3.00 (t, <i>J</i> = 11 Hz, 1H), 2.11 (m, 2H), 1.82 (m, 1H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 366, 368.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-2-Amino-8′-(3-methoxyphenyl)-1-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-5(1<i>H</i>)-one (<b>56</b>)</h3><div class="NLM_p last">Compound <b>56</b> was prepared from <b>13</b>, as described for <b>61</b>, replacing 2-fluoropyridin-3-ylboronic acid with 3-methoxyphenylboronic acid. Crude product was purified by preparative TLC (0.5 mm thickness, <i>R</i><sub>f</sub> = 0.49) eluting with 10% MeOH (containing 7N NH<sub>3</sub>)/DCM. Yield: 9 mg (41%). 99% pure by LC–MS (220 nm). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 7.42 (m, 1H), 7.31 (t, <i>J</i> = 8 Hz, 1H), 7.08 (m, 1H), 7.06 (m, 1H), 6.99 (m, 1H), 6.96 (d, <i>J</i> = 9 Hz, 1H), 6.85 (m, 1H), 4.94 (td, <i>J</i> = 5, 11 Hz, 1H), 4.08 (m, 1H), 3.95 (m, 1H), 3.84 (s, 3H), 3.51 (m, 1H), 3.08 (s, 3H), 3.06 (t, <i>J</i> = 11 Hz, 1H), 2.25 (m, 2H), 1.89 (m, 1H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 394.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-2-Amino-8′-(3-(difluoromethoxy)phenyl)-1-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-5(1<i>H</i>)-one (<b>57</b>)</h3><div class="NLM_p last">Compound <b>57</b> was prepared from <b>13</b>, as described for <b>61</b>, replacing 2-fluoropyridin-3-ylboronic acid with 3-(difluoromethoxy)phenylboronic acid. Crude product was purified by preparative TLC (0.5 mm thickness, <i>R</i><sub>f</sub> = 0.49) eluting with 10% MeOH (containing 7 N NH<sub>3</sub>)/DCM. Yield: 10 mg (42%), >98% pure by LC–MS (220 nm). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 7.39 (dd, <i>J</i> = 2, 8 Hz, 1H), 7.37 (t, <i>J</i> = 8 Hz, 1H), 7.31 (m, 1H), 7.20 (m, 1H), 7.06 (d, <i>J</i> = 2 Hz, 1H), 7.05 (m, 1H), 6.97 (d, <i>J</i> = 9 Hz, 1H), 6.56 (t, <i>J</i> = 74 Hz, 1H), 4.94 (td, <i>J</i> = 5, 11 Hz, 1H), 4.06 (m, 1H), 3.96 (m, 1H), 3.50 (m, 1H), 3.08 (s, 3H), 3.05 (t, <i>J</i> = 12 Hz, 1H), 2.27 (m, 2H), 1.89 (m, 1H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 430.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 3-((4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-2-Amino-1-methyl-5-oxo-1,3′,4′,4a′,5,10a′-hexahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-8′-yl)benzonitrile (<b>58</b>)</h3><div class="NLM_p last">Compound <b>58</b> was prepared from <b>13</b>, as described for <b>61</b>, replacing 2-fluoropyridin-3-ylboronic acid with 3-cyanophenylboronic acid. Crude product was purified by preparative TLC (0.5 mm thickness, <i>R</i><sub>f</sub> = 0.51) eluting with 10% MeOH (containing 7 N NH<sub>3</sub>)/DCM. Yield: 11 mg (50%), 97% pure by LC–MS (220 nm). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 7.74 (s, 1H), 7.70 (m, 1H), 7.57 (m, 1H), 7.51 (m, 1H), 7.41 (m, 1H), 7.06 (m, 1H), 7.00 (d, <i>J</i> = 9 Hz, 1H), 4.95 (td, <i>J</i> = 5, 11 Hz, 1H), 4.07 (m, 1H), 3.96 (m, 1H), 3.51 (m, 1H), 3.10 (s, 3H), 3.05 (t, <i>J</i> = 11 Hz, 1H), 2.24 (m, 2H), 1.91 (m, 1H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 389.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 3-((4<i>R</i>,4a′<i>S</i>,10a′<i>S</i>)-2-Amino-1-methyl-5-oxo-1,3′,4′,4a′,5,10a′-hexahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-8′-yl)benzonitrile (<b>59</b>)</h3><div class="NLM_p last">Compound <b>59</b> was prepared from <b>55</b> (700 mg, 1.91 mmol), as described for <b>61</b>, replacing 2-fluoropyridin-3-ylboronic acid with 3-cyanophenylboronic acid (421 mg, 2.87 mmol). Yield: 474 mg (63%), >98% pure by LC–MS (220 nm). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 7.74 (s, 1H), 7.70 (m, 1H), 7.57 (m, 1H), 7.51 (m, 1H), 7.41 (m, 1H), 7.06 (m, 1H), 7.00 (d, <i>J</i> = 9 Hz, 1H), 4.95 (td, <i>J</i> = 5, 11 Hz, 1H), 4.07 (m, 1H), 3.96 (m, 1H), 3.51 (m, 1H), 3.10 (s, 3H), 3.05 (t, <i>J</i> = 11 Hz, 1H), 2.24 (m, 2H), 1.91 (m, 1H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 389.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-2-Amino-8′-(3-chloro-5-fluorophenyl)-1-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-5(1<i>H</i>)-one (<b>60</b>)</h3><div class="NLM_p last">Compound <b>60</b> was repared from <b>13</b>, as described for <b>61</b>, replacing 2-fluoropyridin-3-ylboronic acid with 3-chloro-5-fluorophenylboronic acid. Crude product was purified by preparative TLC (1 mm thickness, <i>R</i><sub>f</sub> = 0.29) eluting with 5% MeOH/EtOAc. Yield: 19 mg (16%), >98% pure by LC–MS (220 nm). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.37 (dd, <i>J</i> = 2, 8 Hz, 1H), 7.22 (s, 1H), 7.05 (m, 2H), 7.00 (m, 1H), 6.97 (d, <i>J</i> = 9 Hz, 1H), 4.93 (td, <i>J</i> = 5, 11 Hz, 1H), 4.07 (dd, <i>J</i> = 5, 12 Hz, 1H), 3.99 (dd, <i>J</i> = 4, 11 Hz, 1H), 3.48 (td, <i>J</i> = 2, 13 Hz, 1H), 3.13 (s, 3H), 3.04 (t, <i>J</i> = 11 Hz, 1H), 3.03 (br s, 2H), 2.27 (td, <i>J</i> = 4, 11 Hz, 1H), 2.18 (m, 1H), 1.87 (m, 1H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 416.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-2-Amino-8′-(2-fluoropyridin-3-yl)-1-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-5(1<i>H</i>)-one (<b>61</b>)</h3><div class="NLM_p last">A thick walled, glass pressure vessel plus stir bar with <b>13</b> (2.2 g, 6.0 mmol), dioxane (30 mL), 2-fluoropyridin-3-ylboronic acid (1.3 g, 9.0 mmol), Pd[P(Ph)<sub>3</sub>]<sub>4</sub> (0.17 g, 0.15 mmol), and 2 N aq. Na<sub>2</sub>CO<sub>3</sub> (9.0 mL, 18 mmol) was charged. The mixture was sparged with N<sub>2</sub> for 15 min, then heated to 90 °C for 1 h with stirring.  The reaction mixture was partitioned between EtOAc (50 mL) and water (50 mL). Phases were separated and re-extracted with aqueous EtOAc (2 × 30 mL). The combined organic phases were washed with brine (50 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated. The crude was taken up in DCM (30 mL) and concentrated again to remove residual solvents from the workup. Then the crude solid was triturated in DCM (10 mL) at rt. The solids were filtered, rinsing with DCM (3 × 5 mL). Compound <b>61</b> was obtained as an off-white solid (1.7 g, 74% yield) in 96% purity (HPLC, 220 nm). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.05 (m, 1H), 7.75 (m, 1H), 7.36 (m, 1H), 7.18 (m, 1H), 7.14 (m, 1H), 6.98 (d, <i>J</i> = 9 Hz, 1H), 5.73 (br s, 2H), 4.95 (td, <i>J</i> = 5, 11 Hz, 1H), 4.05 (dd, <i>J</i> = 5, 12 Hz, 1H), 3.98 (dd, <i>J</i> = 4, 11 Hz, 1H), 3.47 (m, 1H), 3.04 (s, 3H), 3.03 (m, 1H), 2.18 (m, 2H), 1.83 (m, 1H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 383.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (4<i>R</i>,4a′<i>S</i>,10a′<i>S</i>)-2-Amino-8′-(2-fluoropyridin-3-yl)-1-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-5(1<i>H</i>)-one (<b>62</b>) and (4<i>S</i>,4a′<i>R</i>,10a′<i>R</i>)-2-Amino-8′-(2-fluoropyridin-3-yl)-1-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-5(1<i>H</i>)-one (<b>63</b>)</h3><div class="NLM_p last">The title compounds were obtained by resolution of the racemate <b>61</b> using chiral SFC, performed as follows. System, Thar 350; column, Phenomenex Lux Cellulose-2, 3 cm × 25 cm, 5 μm; mobile phase A, CO<sub>2</sub>; mobile phase B, MeOH with 0.1% NH<sub>4</sub>OH; isocratic conditions, 50% A, 50% B; flow rate, 200 mL/min; backpressure, 100 bar; temperature, 40 °C; UV detection, 220 nm; racemic <b>61</b> was dissolved in a 3:1 mixture of MeOH/formic acid, which was loaded on the column in 3 mL injections every 4 min. Compounds <b>62</b> and <b>63</b> were 98% and 99% chemically pure, respectively (HPLC, 220 nm). Both compounds were >98% ee by chiral SFC analysis. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.05 (m, 1H), 7.75 (m, 1H), 7.36 (m, 1H), 7.18 (m, 1H), 7.14 (m, 1H), 6.98 (d, <i>J</i> = 9 Hz, 1H), 5.73 (br s, 2H), 4.95 (td, <i>J</i> = 5, 11 Hz, 1H), 4.05 (dd, <i>J</i> = 5, 12 Hz, 1H), 3.98 (dd, <i>J</i> = 4, 11 Hz, 1H), 3.47 (m, 1H), 3.04 (s, 3H), 3.03 (m, 1H), 2.18 (m, 2H), 1.83 (m, 1H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 383.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-2-Amino-8′-(5-fluoropyridin-3-yl)-1-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-5(1<i>H</i>)-one (<b>64</b>)</h3><div class="NLM_p last">Compound <b>64</b> was prepared from <b>13</b>, as described for <b>61</b>, replacing 2-fluoropyridin-3-ylboronic acid with 5-fluoropyridin-3-ylboronic acid. Crude product was purified by preparative TLC (0.5 mm thickness, <i>R</i><sub>f</sub> = 0.29) eluting with 10% MeOH (containing 7 N NH<sub>3</sub>)/DCM. Yield: 12 mg (55%), 96% pure by LC–MS (220 nm). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 8.50 (m, 1H), 8.34 (d, <i>J</i> = 3 Hz, 1H), 7.56 (m, 1H), 7.43 (dd, <i>J</i> = 2, 9 Hz, 1H), 7.09 (d, <i>J</i> = 2 Hz, 1H), 7.02 (d, <i>J</i> = 9 Hz, 1H), 4.97 (td, <i>J</i> = td, 1H), 4.09 (m, 1H), 3.96 (m, 1H), 3.51 (m, 1H), 3.10 (s, 3H), 3.05 (t, <i>J</i> = 11 Hz, 1H), 2.27 (m, 2H), 1.90 (m, 1H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 383.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-2-Amino-8′-(5-chloropyridin-3-yl)-1-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-5(1<i>H</i>)-one (<b>65</b>)</h3><div class="NLM_p last">Compound <b>65</b> was prepared from <b>13</b>, as described for <b>61</b>, replacing 2-fluoropyridin-3-ylboronic acid with 5-chloropyridin-3-ylboronic acid. Crude product was purified by preparative TLC (0.5 mm thickness, <i>R</i><sub>f</sub> = 0.50) eluting with 10% MeOH (containing 7 N NH<sub>3</sub>)/DCM. Yield: 14 mg (50%), 97% pure by LC–MS (220 nm). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.56 (d, <i>J</i> = 2 Hz, 1H), 8.45 (d, <i>J</i> = 2 Hz, 1H), 7.70 (t, <i>J</i> = 2 Hz, 1H), 7.37 (dd, <i>J</i> = 2, 9H, 1H), 7.06 (d, <i>J</i> = 2 Hz, 1H), 6.99 (d, <i>J</i> = 9 Hz, 1H), 4.91 (td, <i>J</i> = 5, 11 Hz, 1H), 4.77 (br s, 2H), 4.03 (dd, <i>J</i> = 5, 11 Hz, 1H), 3.94 (dd, <i>J</i> = 4, 11 Hz, 1H), 3.46 (m, 1H), 3.08 (s, 3H), 3.02 (m, 1H), 2.13 (m, 2H), 1.82 (m, 1H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 399.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-2-Amino-8′-(5-methoxypyridin-3-yl)-1-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-5(1<i>H</i>)-one (<b>66</b>)</h3><div class="NLM_p last">Compound <b>66</b> was prepared from <b>13</b>, as described for <b>61</b>, replacing 2-fluoropyridin-3-ylboronic acid with 5-methoxypyridin-3-ylboronic acid. Crude product was purified by preparative TLC (0.5 mm thickness, <i>R</i><sub>f</sub> = 0.24) eluting with 10% MeOH (containing 7 N NH<sub>3</sub>)/DCM. Yield: 10 mg (45%), >98% pure by LC–MS (220 nm). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 8.25 (d, <i>J</i> = 2 Hz, 1H), 8.16 (d, <i>J</i> = 3 Hz, 1H), 7.41 (m, 1H), 7.33 (m, 1H), 7.08 (d, <i>J</i> = 2 Hz, 1H), 7.01 (d, <i>J</i> = 9 Hz, 1H), 4.96 (td, <i>J</i> = 5, 11 Hz, 1H), 4.09 (m, 1H), 3.94 (m, 1H), 3.92 (s, 3H), 3.51 (m, 1H), 3.10 (s, 3H), 3.05 (t, <i>J</i> = 11 Hz, 1H), 2.27 (m, 2H), 1.88 (m, 1H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 395.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 5-((4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-2-Amino-1-methyl-5-oxo-1,3′,4′,4a′,5,10a′-hexahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-8′-yl)nicotinonitrile (<b>67</b>)</h3><div class="NLM_p last">Compound <b>67</b> was prepared from <b>13</b>, as described for <b>61</b>, replacing 2-fluoropyridin-3-ylboronic acid with 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinonitrile. Crude product was purified by preparative TLC (2 mm thickness, <i>R</i><sub>f</sub> = 0.56) eluting with 10% MeOH (containing 7 N NH<sub>3</sub>)/DCM. Yield: 64 mg (59%), 98% pure by LC–MS (220 nm). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 8.90 (m, 1H), 8.76 (m, 1H), 8.06 (m, 1H), 7.42 (m, 1H), 7.08 (m, 1H), 7.03 (d, <i>J</i> = 9 Hz, 1H), 4.97 (m, 1H), 4.08 (m, 1H), 3.95 (m, 1H), 3.47 (d, <i>J</i> = 12 Hz, 1H), 3.09 (s, 3H), 3.03 (t, <i>J</i> = 12 Hz, 1H), 2.20 (m, 2H), 1.88 (m, 1H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 390.</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-2-Amino-1-methyl-8′-(pyrimidin-5-yl)-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-5(1<i>H</i>)-one (<b>68</b>)</h3><div class="NLM_p last">Compound <b>68</b> was prepared from <b>13</b>, as described for <b>61</b>, replacing 2-fluoropyridin-3-ylboronic acid with pyrimidin-5-ylboronic acid. Crude product was purified by preparative TLC (0.5 mm thickness, <i>R</i><sub>f</sub> = 0.33) eluting with 10% MeOH (containing 7 N NH<sub>3</sub>)/DCM. Yield: 9 mg (44%), >98% pure by LC–MS (220 nm). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 9.10 (s, 1H), 8.87 (s, 2H), 7.46 (m, 1H), 7.12 (s, 1H), 7.06 (d, <i>J</i> = 9 Hz, 1H), 4.96 (td, <i>J</i> = 5, 11 Hz, 1H), 4.10 (m, 1H), 3.97 (m, 1H), 3.51 (m, 1H), 3.12 (s, 3H), 3.05 (t, <i>J</i> = 11 Hz, 1H), 2.27 (m, 2H), 1.91 (m, 1H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 366.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (4R*,4a′S*,10a′S*)-8′-(5-Chloropyridin-3-yl)-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>,5<i>H</i>-spiro[oxazole-4,10′-pyrano[4,3-b]chromen]-2-amine (<b>69</b>)</h3><div class="NLM_p last">Compound <b>69</b> was prepared from <b>15a</b>, as described for <b>61</b>, replacing 2-fluoropyridin-3-ylboronic acid with 5-chloropyridin-3-ylboronic acid. Crude product was purified by preparative TLC (1 mm thickness, <i>R</i><sub>f</sub> = 0.57) eluting with 10% MeOH (containing 7 N NH<sub>3</sub>)/DCM. Yield: 12 mg (41%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 8.47 (d, <i>J</i> = 2 Hz, 1H), 8.30 (d, <i>J</i> = 2 Hz, 1H), 7.75 (m, 1H), 7.38 (d, <i>J</i> = 2 Hz, 1H), 7.25 (m, 1H), 6.77 (d, <i>J</i> = 8 Hz, 1H), 4.36 (d, <i>J</i> = 9 Hz, 1H), 3.95 (m, 3H), 3.90 (d, <i>J</i> = 9.0 Hz, 1H), 3.38 (m, 1H), 3.16 (d, <i>J</i> = 11 Hz, 1H), 2.04 (m, 2H), 1.78 (m, 1H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 372; 93% pure by LC–MS (220 nm).</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (4R*,4a′R*,10a′R*)-8′-(5-Chloropyridin-3-yl)-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>,5<i>H</i>-spiro[oxazole-4,10′-pyrano[4,3-b]chromen]-2-amine (<b>70</b>)</h3><div class="NLM_p last">Compound <b>70</b> was prepared from <b>15b</b>, as described for <b>61</b>, replacing 2-fluoropyridin-3-ylboronic acid with 5-chloropyridin-3-ylboronic acid. Crude product was purified by preparative TLC (1 mm thickness, <i>R</i><sub>f</sub> = 0.57) eluting with 10% MeOH (containing 7 N NH<sub>3</sub>)/DCM. Yield: 9 mg (40%), >98% purity by LC–MS (220 nm). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 8.49 (d, <i>J</i> = 2 Hz, 1H), 8.36 (d, <i>J</i> = 2 Hz, 1H), 7.74 (t, <i>J</i> = 2 Hz, 1H), 7.29 (m, 2H), 6.85 (d, <i>J</i> = 9 Hz, 1H), 4.54 (d, <i>J</i> = 9 Hz, 1H), 4.32 (d, <i>J</i> = 9 Hz, 1H), 4.17 (td, <i>J</i> = 5, 11 Hz, 1H), 3.97 (m, 2H), 3.44 (m, 1H), 3.30 (d, <i>J</i> = 12 Hz, 1H), 2.09 (m, 1H), 1.85 (m, 2H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 372.</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-8′-(2-Fluoropyridin-3-yl)-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>,5<i>H</i>-spiro[oxazole-4,10′-pyrano[4,3-b]chromen]-2-amine (<b>71</b>)</h3><div class="NLM_p last">Compound <b>71</b> was prepared from <b>15a</b>, as described for <b>61</b>. Crude product was purified by preparative TLC (0.5 mm thickness, <i>R</i><sub>f</sub> = 0.65) eluting with 10% MeOH (containing 7 N NH<sub>3</sub>)/DCM. Yield: 7 mg (36%), 97% pure by LC-MS (220 nm). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 8.12 (m, 1H), 7.88 (m, 1H), 7.51 (m, 1H), 7.41 (m, 1H), 7.29 (m, 1H), 6.90 (d, <i>J</i> = 9 Hz, 1H), 4.48 (d, <i>J</i> = 9 Hz, 1H), 4.02–4.14 (m, 4H), 3.52 (m, 1H), 3.30 (m, 1H), 2.20 (m, 2H), 1.97 (m, 1H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 356.</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> (4<i>R</i>*,4a′<i>R</i>*,10a′<i>R</i>*)-8′-(2-Fluoropyridin-3-yl)-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>,5<i>H</i>-spiro[oxazole-4,10′-pyrano[4,3-b]chromen]-2-amine (<b>72</b>)</h3><div class="NLM_p last">Compound <b>72</b> was prepared from <b>15b</b>, as described for <b>61</b>. Crude product was purified by preparative TLC (0.5 mm thickness, <i>R</i><sub>f</sub> = 0.62) eluting with 10% MeOH (containing 7 N NH<sub>3</sub>)/DCM. Relative stereochemistry was confirmed from cocrystal structures with BACE1 using the same conditions as described for compound <b>62</b>. Yield: 10 mg (67%), >98% purity by LC–MS (220 nm). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 8.05 (m, 1H), 7.77 (m, 1H), 7.34 (m, 2H), 7.22 (m, 1H), 6.86 (d, <i>J</i> = 8 Hz, 1H), 4.55 (d, <i>J</i> = 9 Hz, 1H), 4.34 (d, <i>J</i> = 9 Hz, 1H), 4.20 (m, 1H), 3.99 (m, 2H), 3.47 (m, 1H), 3.32 (m, 1H), 2.11 (m, 1H), 1.91 (m, 1H), 1.81 (m, 1H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 356.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-8′-(Pyrimidin-5-yl)-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>,5<i>H</i>-spiro[oxazole-4,10′-pyrano[4,3-b]chromen]-2-amine (<b>73</b>)</h3><div class="NLM_p last">Compound <b>73</b> was prepared from <b>15a</b>, as described for <b>61</b>, replacing 2-fluoropyridin-3-ylboronic acid with pyrimidin-5-ylboronic acid. Crude product was purified by preparative TLC (0.5 mm thickness, <i>R</i><sub>f</sub> = 0.48) eluting with 10% MeOH (containing 7 N NH<sub>3</sub>)/DCM. Yield: 7 mg (38%), >98% purity by LC–MS (220 nm). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 9.03 (s, 1H), 8.84 (s, 2H), 7.47 (m, 1H), 7.34 (m, 1H), 6.88 (d, <i>J</i> = 9 Hz, 1H), 4.42 (d, <i>J</i> = 9 Hz, 1H), 4.03 (m, 3H), 3.97 (d, <i>J</i> = 9 Hz, 1H), 3.44 (m, 1H), 3.23 (m, 1H), 2.12 (m, 2H), 1.88 (m, 1H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 339.</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> (4<i>R</i>*,4a′<i>R</i>*,10a′<i>R</i>*)-8′-(Pyrimidin-5-yl)-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>,5<i>H</i>-spiro[oxazole-4,10′-pyrano[4,3-b]chromen]-2-amine (<b>74</b>)</h3><div class="NLM_p last">Compound <b>74</b> was prepared from <b>15b</b>, as described for <b>61</b>, replacing 2-fluoropyridin-3-ylboronic acid with pyrimidin-5-ylboronic acid. Crude product was purified by preparative TLC (0.5 mm thickness, <i>R</i><sub>f</sub> = 0.51) eluting with 10% MeOH (containing 7 N NH<sub>3</sub>)/DCM. Yield: 5 mg (35%), >98% purity by LC–MS (220 nm). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 9.12 (s, 1H), 8.90 (s, 2H), 7.43 (m, 2H), 7.00 (d, <i>J</i> = 9 Hz, 1H), 4.64 (d, <i>J</i> = 9 Hz, 1H), 4.43 (d, <i>J</i> = 9 Hz, 1H), 4.28 (m, 1H), 4.08 (m, 2H), 3.56 (m, 1H), 3.41 (m, 1H), 2.21 (m, 1H), 2.00 (m, 1H), 1.90 (m, 1H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 339.</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> (4a<i>R</i>*,4′<i>R</i>*,10a<i>R</i>*)-8-(5-Chloropyridin-3-yl)-3,4,4a,10a-tetrahydro-1<i>H</i>,5′<i>H</i>-spiro[pyrano[4,3-b]chromene-10,4′-thiazol]-2′-amine (<b>75</b>)</h3><div class="NLM_p last">Compound <b>75</b> was prepared from <b>16</b>, as described for <b>61</b>, replacing 2-fluoropyridin-3-ylboronic acid with 5-chloropyridin-3-ylboronic acid. Crude product was purified by preparative TLC (1 mm thickness, <i>R</i><sub>f</sub> = 0.66) eluting with 10% MeOH (containing 7 N NH<sub>3</sub>)/DCM. Diastereomer <b>75</b> was repurified by a second preparative TLC (0.5 mm thickness, <i>R</i><sub>f</sub> = 0.45) eluting with 10% MeOH/DCM. The minor diastereomer was not isolated. Yield of <b>75</b>: 10 mg (21%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.65 (d, <i>J</i> = 2 Hz, 1H), 8.50 (d, <i>J</i> = 2 Hz, 1H), 7.77 (t, <i>J</i> = 2 Hz, 1H), 7.73 (d, <i>J</i> = 2 Hz, 1H), 7.38 (dd, <i>J</i> = 2, 9 Hz, 1H), 6.95 (d, <i>J</i> = 9 Hz, 1H), 4.63 (br s, 2H), 4.36 (m, 1H), 4.14 (m, 1H), 4.09 (m, 1H), 3.87 (d, <i>J</i> = 12 Hz, 1H), 3.76 (d, <i>J</i> = 12 Hz, 1H), 3.53 (m, 1H), 3.39 (m, 1H), 2.17 (m, 1H), 2.05 (m, 1H), 1.90 (m, 1H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 388; 88% purity by LC–MS (220 nm).</div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> (4a<i>R</i>*,4′<i>R</i>*,10a<i>R</i>*)-8-(2-Fluoropyridin-3-yl)-3,4,4a,10a-tetrahydro-1<i>H</i>,5′<i>H</i>-spiro[pyrano[4,3-b]chromene-10,4′-thiazol]-2′-amine (<b>76</b>)</h3><div class="NLM_p last">Compound <b>76</b> was prepared from <b>16</b>, as described for <b>61</b>. Crude product was purified by preparative TLC (1 mm thickness, <i>R</i><sub>f</sub> = 0.68) eluting with 10% MeOH (containing 7 N NH<sub>3</sub>)/DCM. The alternate diastereomer was not isolated. Relative stereochemistry was confirmed from cocrystal structures with BACE1 using the same conditions as described for compound <b>62</b>. Yield: 9 mg (21%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.14 (d, <i>J</i> = 5 Hz, 1H), 7.80 (m, 1H), 7.75 (m, 1H), 7.36 (m, 1H), 7.24 (m, 1H), 6.93 (d, <i>J</i> = 9 Hz, 1H), 4.56 (br s, 2H), 4.37 (m, 1H), 4.16 (m, 1H), 4.08 (m, 1H), 3.90 (d, <i>J</i> = 12 Hz, 1H), 3.75 (d, <i>J</i> = 12 Hz, 1H), 3.53 (m, 1H), 3.39 (t, <i>J</i> = 11 Hz, 1H), 2.19 (m, 1H), 2.05 (m, 1H), 1.92 (m, 1H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 372; 92% purity by LC–MS (220 nm).</div></div><div id="sec5_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 3-((4<i>R</i>,4a′<i>S</i>,10a′<i>S</i>)-2-Amino-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>,5<i>H</i>-spiro[oxazole-4,10′-pyrano[4,3-b]chromene]-8′-yl)benzonitrile (<b>77</b>)</h3><div class="NLM_p last">Compound <b>77</b> was prepared from <b>27</b> as described for <b>79</b>, replacing (5-chloro-3-pyridyl)boronic acid with (3-cyano-phenyl)boronic acid. Purification by silica gel provided a mixture of product diastereomers. The mixture was further purified by chiral SFC on a Chiralpak AD (2 × 15 cm) column eluting with 25% MeOH (0.1% NH<sub>4</sub>OH)/CO<sub>2</sub> at 100 bar at a flow rate of 70 mL/min. The peaks isolated were analyzed on a Chiralpak AD (50 × 0.46 cm) column eluting with 25% MeOH (0.1% NH<sub>4</sub>OH)/CO<sub>2</sub>, at 120 bar (flow rate 5 mL/min, 220 nm). From this purification, <b>77</b> (peak-3, 8.0 mg, 8% yield, chemical purity >99%, > 99% ee) was isolated. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.05–8.01 (m, 1H), 7.88 (d, <i>J</i> = 8.0 Hz, 1H), 7.76 (d, <i>J</i> = 7.6 Hz, 1H), 7.64 (t, <i>J</i> = 7.8 Hz, 1H), 7.51 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 7.39 (d, <i>J</i> = 2.4 Hz, 1H), 6.84 (d, <i>J</i> = 8.5 Hz, 1H), 6.13 (s, 2H), 4.46 (d, <i>J</i> = 8.9 Hz, 1H), 4.11 (d, <i>J</i> = 9.0 Hz, 1H), 3.92 (dd, <i>J</i> = 11.9, 4.5 Hz, 1H), 3.71 (dd, <i>J</i> = 11.2, 4.3 Hz, 1H), 3.55 (td, <i>J</i> = 11.9, 2.7 Hz, 2H), 2.19 (dd, <i>J</i> = 11.3, 4.2 Hz, 1H), 1.89 (td, <i>J</i> = 12.8, 5.0 Hz, 1H), 1.80 (d, <i>J</i> = 12.5 Hz, 1H), 1.32 (s, 3H); <i>m</i>/<i>z</i> (ESI-pos) M + 1 = 376.2.</div></div><div id="sec5_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> (4<i>R</i>,4a′<i>S</i>,10a′<i>S</i>)-8′-(3-Chloro-5-fluorophenyl)-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>,5<i>H</i>-spiro[oxazole-4,10′-pyrano[4,3-b]chromen]-2-amine (<b>78</b>)</h3><div class="NLM_p last">Compound <b>78</b> was prepared from 8′-bromo-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>,5<i>H</i>-spiro[oxazole-4,10′-pyrano[4,3-b]chromen]-2-amine <b>27</b>, as described for <b>79</b>, replacing (5-chloro-3-pyridyl)boronic acid with (3-chloro-5-fluoro-phenyl)boronic acid. Purification by silica gel provided a mixture of diastereomers. The mixture was further purified by chiral SFC on a Chiralpak AD (2 × 15 cm) column eluting with 25% MeOH (0.1% NH<sub>4</sub>OH)/CO<sub>2</sub> at 100 bar at a flow rate of 70 mL/min. The peaks isolated were analyzed on Chiralpak AD (50 × 0.46 cm) column eluting with 25% MeOH (0.1% NH<sub>4</sub>OH)/CO<sub>2</sub>, at 120 bar (flow rate 5 mL/min, 220 nm). From the chiral SFC separation, <b>78</b> (peak-4, 43 mg, 15% yield, chemical purity >99%, > 99% ee) was isolated. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 7.51 (dd, <i>J</i> = 7, 3 Hz, 1H), 7.42 (ddd, <i>J</i> = 9, 4, 3 Hz, 1H), 7.34 (dd, <i>J</i> = 13, 6 Hz, 2H), 7.26 (s, 1H), 6.83 (d, <i>J</i> = 9 Hz, 1H), 6.13 (s, 2H), 4.44 (d, <i>J</i> = 9 Hz, 1H), 4.06 (d, <i>J</i> = 9 Hz, 1H), 3.92 (dd, <i>J</i> = 12, 4 Hz, 1H), 3.71 (dd, <i>J</i> = 11, 4 Hz, 1H), 3.54 (t, <i>J</i> = 11 Hz, 2H), 2.21 (dd, <i>J</i> = 11, 4 Hz, 1H), 1.96 – 1.83 (m, 1H), 1.80 (d, <i>J</i> = 13 Hz, 1H), 1.32 (s, 3H); <i>m</i>/<i>z</i> (ESI-pos) M + 1 = 403.0.</div></div><div id="sec5_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-8′-(5-Chloropyridin-3-yl)-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>,5<i>H</i>-spiro[oxazole-4,10′-pyrano[4,3-b]chromen]-2-amine (<b>79</b>)</h3><div class="NLM_p last">Diastereomers <b>27</b> (95 mg, 0.269 mmol), (5-chloro-3-pyridyl)boronic acid (55 mg, 0.350 mmol), Na<sub>2</sub>CO<sub>3</sub> (86 mg, 0.807 mmol), and Pd[P(Ph)<sub>3</sub>]<sub>4</sub> (31.1 mg, 0.0269 mmol) were added as solids to a vial, followed by the simultaneous addition of dioxane (4.6 mL) and degassed water (0.5 mL). The vial was sealed and heated at 90 °C for 4 h. The reaction mixture was then cooled and diluted with DCM and a mixture of brine and NH<sub>4</sub>OH solution. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by silica gel eluting with a linear gradient of 0–6% MeOH/DCM + 1% NH<sub>4</sub>OH solution to provide <b>79</b> (17.5 mg, 17% yield) as the second eluting UV active fraction. Relative stereochemistry was confirmed from cocrystal structures with BACE1 using the same conditions as described for compound <b>62</b>. HPLC purity: 100% (254 nm). <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 8.74 (d, <i>J</i> = 2 Hz, 1H), 8.56 (d, <i>J</i> = 2 Hz, 1H), 8.12 (t, <i>J</i> = 2 Hz, 1H), 7.55 (dd, <i>J</i> = 9, 2 Hz, 1H), 7.42 (d, <i>J</i> = 2 Hz, 1H), 6.85 (d, <i>J</i> = 9 Hz, 1H), 6.13 (s, 2H), 4.46 (d, <i>J</i> = 9 Hz, 1H), 4.13 (d, <i>J</i> = 9 Hz, 1H), 3.92 (dd, <i>J</i> = 11, 4 Hz, 1H), 3.71 (dd, <i>J</i> = 11, 4 Hz, 1H), 3.55 (t, <i>J</i> = 11 Hz, 2H), 2.19 (dd, <i>J</i> = 11, 4 Hz, 1H), 1.88 (dd, <i>J</i> = 13, 5 Hz, 1H), 1.80 (d, <i>J</i> = 13 Hz, 1H), 1.32 (s, 3H); <i>m</i>/<i>z</i> (ESI-pos) M + 1 = 386.1.</div></div><div id="sec5_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-8′-(5-Fluoropyridin-3-yl)-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>,5<i>H</i>-spiro[oxazole-4,10′-pyrano[4,3-b]chromen]-2-amine (<b>80</b>)</h3><div class="NLM_p last">Compound <b>80</b> was prepared from <b>27</b> as described for <b>79</b>, replacing (5-chloro-3-pyridyl)boronic acid with (5-fluoropyridin-3-yl)boronic acid. Yield: 29.4 mg (30%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.69–8.65 (m, 1H), 8.51 (d, <i>J</i> = 2.7 Hz, 1H), 7.93 (dt, <i>J</i> = 10.5, 2.3 Hz, 1H), 7.54 (dd, <i>J</i> = 8.5, 2.4 Hz, 1H), 7.42 (d, <i>J</i> = 2.4 Hz, 1H), 6.86 (d, <i>J</i> = 8.5 Hz, 1H), 6.13 (s, 2H), 4.46 (d, <i>J</i> = 9.0 Hz, 1H), 4.12 (d, <i>J</i> = 8.9 Hz, 1H), 3.92 (dd, <i>J</i> = 11.7, 4.6 Hz, 1H), 3.71 (dd, <i>J</i> = 11.3, 4.3 Hz, 1H), 3.55 (td, <i>J</i> = 11.6, 3.0 Hz, 2H), 2.19 (dd, <i>J</i> = 11.3, 4.3 Hz, 1H), 1.90 (td, <i>J</i> = 12.6, 5.0 Hz, 1H), 1.80 (d, <i>J</i> = 12.4 Hz, 1H), 1.32 (s, 3H). <i>m</i>/<i>z</i> (ESI-pos) M + 1 = 370.2. HPLC purity: 88% (254 nm).</div></div><div id="sec5_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-8′-(2-Fluoropyridin-3-yl)-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>,5<i>H</i>-spiro[oxazole-4,10′-pyrano[4,3-b]chromen]-2-amine (<b>81</b>)</h3><div class="NLM_p last">Compound <b>81</b> was prepared from <b>27</b> as described for <b>79</b>, replacing (5-chloro-3-pyridyl)boronic acid with (2-fluoropyridin-3-yl)boronic acid. Yield: 23.0 mg (20%). HPLC purity: 99% (254 nm). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.20–8.15 (m, 1H), 8.02 (ddd, <i>J</i> = 10.0, 7.5, 1.9 Hz, 1H), 7.44 (ddd, <i>J</i> = 7.0, 4.7, 1.9 Hz, 1H), 7.39 (dt, <i>J</i> = 8.5, 2.0 Hz, 1H), 7.34–7.27 (m, 1H), 6.85 (d, 1H), 6.13 (s, 2H), 4.44 (d, <i>J</i> = 8.9 Hz, 1H), 4.04 (d, <i>J</i> = 8.9 Hz, 1H), 3.92 (dd, <i>J</i> = 11.8, 4.5 Hz, 1H), 3.71 (dd, <i>J</i> = 11.3, 4.3 Hz, 1H), 3.61–3.49 (m, 2H), 2.22 (dd, <i>J</i> = 11.3, 4.2 Hz, 1H), 1.90 (td, <i>J</i> = 12.8, 5.2 Hz, 1H), 1.84–1.73 (m, 1H), 1.32 (s, 3H). <i>m</i>/<i>z</i> (ESI-pos) M + 1 = 370.1.</div></div><div id="sec5_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-4a′-Methyl-8′-(pyrimidin-5-yl)-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>,5<i>H</i>-spiro[oxazole-4,10′-pyrano[4,3-b]chromen]-2-amine (<b>82</b>)</h3><div class="NLM_p last">Compound <b>82</b> was prepared from <b>27</b> as described for <b>79</b>, replacing (5-chloro-3-pyridyl)boronic acid with pyrimidin-5-ylboronic acid. Yield: 18.3 mg (18%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.13 (s, 1H), 9.02 (s, 2H), 7.57 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 7.44 (d, <i>J</i> = 2.3 Hz, 1H), 6.89 (d, <i>J</i> = 8.4 Hz, 1H), 6.13 (s, 2H), 4.46 (d, <i>J</i> = 8.9 Hz, 1H), 4.12 (d, <i>J</i> = 8.9 Hz, 1H), 3.92 (dd, <i>J</i> = 11.7, 4.7 Hz, 1H), 3.71 (dd, <i>J</i> = 11.3, 4.3 Hz, 1H), 3.55 (td, <i>J</i> = 10.8, 10.1, 2.4 Hz, 2H), 2.20 (dd, <i>J</i> = 11.3, 4.3 Hz, 1H), 1.90 (td, <i>J</i> = 12.7, 5.1 Hz, 1H), 1.81 (d, <i>J</i> = 12.4 Hz, 1H), 1.33 (s, 3H). <i>m</i>/<i>z</i> (ESI-pos) M + 1 = 353.1. HPLC purity: 87% (254 nm).</div></div><div id="sec5_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> (1′<i>R</i>*,4<i>R</i>*,4a′<i>R</i>*,10a′<i>R</i>*)-2-Amino-8′-(2-fluoropyridin-3-yl)-1,1′-dimethyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-5(1<i>H</i>)-one (<b>83</b>)</h3><div class="NLM_p last">Compound <b>83</b> was prepared from <b>44</b> in three steps using reaction conditions described for the synthesis of compounds <b>12</b>, <b>13</b>, and <b>61</b>. Crude <b>83</b> was purified by preparative TLC (2 mm thickness, <i>R</i><sub>f</sub> = 0.44) eluting with 10% MeOH (containing 7 N NH<sub>3</sub>)/DCM. Then the resulting product was triturated with a minimum amount of DCM and filtered. Relative stereochemistry was confirmed from cocrystal structures with BACE1 using the same conditions as described for compound <b>62</b>. Yield: 23 mg (7%, 3 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 8.11 (m, 1H), 7.78 (m, 1H), 7.37 (m, 1H), 7.25 (m, 1H), 6.97 (d, <i>J</i> = 9 Hz, 1H), 6.93 (m, 1H), 4.18 (m, 1H), 4.02 (m, 1H), 3.55 (m, 1H), 3.46 (m, 1H), 3.18 (s, 3H), 2.25 (m, 2H), 2.00 (m, 1H), 1.03 (d, <i>J</i> = 6 Hz, 3H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 397; 94% purity by LC–MS (220 nm).</div></div><div id="sec5_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> (1′<i>R</i>*,4<i>R</i>*,4a′<i>R</i>*,10a′<i>R</i>*)-8′-(2-Fluoropyridin-3-yl)-1′-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>,5<i>H</i>-spiro[oxazole-4,10′-pyrano[4,3-b]chromen]-2-amine (<b>84</b>)</h3><div class="NLM_p last">Compound <b>84</b> was prepared from <b>43</b> in three steps using reaction conditions described for the synthesis of compounds <b>14</b>, <b>15</b>, and <b>61</b>. Diastereomers were partially separated by preparative TLC (1 mm thickness) eluting with 10% MeOH/DCM. Then <b>84</b> was repurified by preparative TLC (1 mm thickness) eluting with 7.5% MeOH (containing 7 N NH<sub>3</sub>)/DCM. Relative stereochemistry was confirmed from cocrystal structures with BACE1 using the same conditions as described for compound <b>62</b>. Yield: 13 mg (6%, 3 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 8.14 (m, 1H), 8.13 (m, 1H), 7.86 (m, 1H), 7.38 (m, 1H), 7.31 (m, 1H), 6.92 (d, <i>J</i> = 8 Hz, 1H), 4.56 (d, <i>J</i> = 9 Hz, 1H), 4.51 (d, <i>J</i> = 9 Hz, 1H), 4.07 (m, 2H), 3.59 (m, 2H), 2.19 (m, 1H), 1.95 (m, 1H), 1.76 (t, <i>J</i> = 10 Hz, 1H), 1.35 (d, <i>J</i> = 6 Hz, 3H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 370; 91% purity by LC–MS (220 nm).</div></div><div id="sec5_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> (1<i>R</i>*,4a<i>R</i>*,4′<i>R</i>*,10a<i>R</i>*)-8-(2-Fluoropyridin-3-yl)-1-methyl-3,4,4a,10a-tetrahydro-1<i>H</i>,5′<i>H</i>-spiro[pyrano[4,3-b]chromene-10,4′-thiazol]-2′-amine (<b>85</b>)</h3><div class="NLM_p last">Compound <b>85</b> was prepared from <b>43</b> in three steps using reaction conditions described for the synthesis of compounds <b>14</b>, <b>16</b>, and <b>61</b>. Diastereomers were separated by preparative TLC (2 mm thickness) eluting with 10% MeOH/DCM + 1% HOAc. Compound <b>85</b> was then triturated with 1:1 DCM/Et<sub>2</sub>O and filtered. Relative stereochemistry was confirmed from cocrystal structures with BACE1 using the same conditions as described for compound <b>62</b>. Yield: 53 mg (8%, 3 steps), >98% purity by LC–MS (220 nm). <sup>1</sup>H NMR (CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 8.13 (m, 1H), 7.87 (m, 1H), 7.81 (s, 1H), 7.34 (m, 2H), 6.93 (d, <i>J</i> = 8 Hz, 1H), 4.14 (m, 1H), 4.04 (m, 1H), 3.75 (m, 2H), 3.61 (m, 1H), 3.53 (m, 1H), 2.17 (m, 1H), 1.95 (m, 1H), 1.82 (m, 1H), 1.43 (d, <i>J</i> = 5 Hz, 3H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 386.</div></div><div id="sec5_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 3-((4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-2-Amino-1,10a′-dimethyl-5-oxo-1,3′,4′,4a′,5,10a′-hexahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-8′-yl)benzonitrile (<b>86</b>)</h3><div class="NLM_p last">Compound <b>86</b> was prepared from <b>45</b> using reaction conditions described for the synthesis of compounds <b>10</b>–<b>13</b> and <b>61</b>, and replacing 2-fluoropyridin-3-ylboronic acid with (3-cyanophenyl)boronic acid. Crude <b>86</b> was purified by preparative TLC (2 mm thickness, <i>R</i><sub>f</sub> = 0.47), eluting with 10% MeOH (containing 7 N NH<sub>3</sub>)/DCM. Yield: 39 mg (12%, 5 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 7.75 (s, 1H), 7.72 (d, <i>J</i> = 8 Hz, 1H), 7.56 (m, 1H), 7.50 (t, <i>J</i> = 8 Hz, 1H), 7.42 (m, 1H), 7.08 (m, 1H), 7.00 (d, <i>J</i> = 9 Hz, 1H), 5.29 (m, 1H), 4.07 (m, 1H), 3.60 (d, <i>J</i> = 11 Hz, 1H), 3.48 (t, <i>J</i> = 12 Hz, 1H), 3.13 (m, 1H), 3.09 (s, 3H), 2.10 (m, 1H), 1.94 (m, 1H), 1.19 (s, 3H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 403; 93% purity by LC–MS (220 nm).</div></div><div id="sec5_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-2-Amino-8′-(2-fluoropyridin-3-yl)-1,10a′-dimethyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-5(1<i>H</i>)-one (<b>87</b>)</h3><div class="NLM_p last">Compound <b>87</b> was prepared from <b>45</b> using reaction conditions described for the synthesis of compounds <b>10</b>–<b>13</b> and <b>61</b>. Crude <b>87</b> was purified by preparative TLC (2 mm thickness, <i>R</i><sub>f</sub> = 0.46), eluting with 10% MeOH (containing 7 N NH<sub>3</sub>)/DCM. Relative stereochemistry was confirmed from cocrystal structures with BACE1 using the same conditions as described for compound <b>62</b>. Yield: 46 mg (14%, 5 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 8.11 (m, 1H), 7.84 (t, <i>J</i> = 8 Hz, 1H), 7.43 (m, 1H), 7.29 (m, 1H), 7.11 (m, 1H), 7.00 (d, <i>J</i> = 9 Hz, 1H), 5.29 (m, 1H), 4.10 (m, 1H), 3.60 (d, <i>J</i> = 11 Hz, 1H), 3.49 (t, <i>J</i> = 12 Hz, 1H), 3.12 (d, <i>J</i> = 11 Hz, 1H), 3.07 (s, 3H), 2.14 (m, 1H), 1.98 (m, 1H), 1.19 (s, 3H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 397; 91% purity by LC–MS (220 nm).</div></div><div id="sec5_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-2-Amino-1,10a′-dimethyl-8′-(pyrimidin-5-yl)-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-5(1<i>H</i>)-one (<b>88</b>)</h3><div class="NLM_p last">Compound <b>88</b> was prepared from <b>45</b> using reaction conditions described for the synthesis of compounds <b>10</b>–<b>13</b> and <b>61</b>, and replacing 2-fluoropyridin-3-ylboronic acid with pyrimidin-5-ylboronic acid. Crude <b>88</b> was purified by preparative TLC (2 mm thickness, <i>R</i><sub>f</sub> = 0.29), eluting with 10% MeOH (containing 7N NH<sub>3</sub>)/DCM. Yield: 31 mg (12%, 5 steps), 89% purity by LC–MS (220 nm). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 9.00 (s, 1H), 8.78 (s, 2H), 7.38 (m, 1H), 7.03 (m, 1H), 6.98 (m, 1H), 5.25 (m, 1H), 3.0–4.2 (m, 4H), 3.01 (s, 3H), 2.07 (m, 1H), 1.90 (m, 1H), 1.10 (s, 3H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 380.</div></div><div id="sec5_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> (4<i>R*</i>,4a′<i>R*</i>,10a′<i>R*</i>)-8′-(2-Fluoropyridin-3-yl)-10a′-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>,5<i>H</i>-spiro[oxazole-4,10′-pyrano[4,3-b]chromen]-2-amine (<b>89</b>)</h3><div class="NLM_p last">Compound <b>89</b> was prepared from <b>45</b> using reaction conditions described for the synthesis of compounds <b>14</b>, <b>15</b>, and <b>61</b>. Crude <b>89</b> was purified by preparative TLC (2 mm thickness, <i>R</i><sub>f</sub> = 0.71), eluting with 10% MeOH (containing 7 N NH<sub>3</sub>)/DCM. Relative stereochemistry was confirmed from cocrystal structures with BACE1 using the same conditions as described for compound <b>62</b>. Yield: 37 mg (20%, 3 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 8.13 (m, 1H), 7.87 (m, 1H), 7.46 (m, 1H), 7.39 (m, 1H), 7.30 (m, 1H), 6.94 (m, 1H), 4.64 (m, 1H), 4.51 (m, 1H), 4.43 (m, 1H), 3.67 (m, 1H), 3.3–3.6 (m, 3H), 2.06 (m, 1H), 1.97 (m, 1H), 1.00 (s, 3H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 370; 94% purity by LC–MS (220 nm).</div></div><div id="sec5_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-2-Amino-8′-(3-(difluoromethoxy)phenyl)-7′-fluoro-1-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-5(1<i>H</i>)-one (<b>90</b>)</h3><div class="NLM_p last">Compound <b>90</b> was prepared from <b>54</b>, as described for compound <b>61</b>, replacing 2-fluoropyridin-3-ylboronic acid with (3-(difluoromethoxy)phenyl)boronic acid. The crude was purified by silica gel chromatography (gradient: 0–100% (80% EtOAc/19% MeOH/1% Et<sub>3</sub>N)/EtOAc). Yield: 2.3 mg (9%), 95% purity by LC–MS (254 nm). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.38 (m, 1H), 7.31–7.25 (m, 1H), 7.19 (m, 1H), 7.09 (m, 1H), 6.94 (m, 1H), 6.72 (m, 1H), 6.54 (t, <i>J</i> = 74 Hz, 1H), 4.96 (m, 1H), 4.10–3.91 (m, 2H), 3.48 (m, 1H), 3.08 (s, 3H), 3.04 (m, 1H), 2.23–2.11 (m, 2H), 1.91–1.78 (m, 1H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 448.</div></div><div id="sec5_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>S</i>*)-2-Amino-7′-fluoro-8′-(2-fluoropyridin-3-yl)-1-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>-spiro[imidazole-4,10′-pyrano[4,3-b]chromen]-5(1<i>H</i>)-one (<b>91</b>)</h3><div class="NLM_p last">Compound <b>91</b> was prepared from <b>54</b>, as described for compound <b>61</b>. The crude was purified by silica gel chromatography (gradient: 0–100% (80% EtOAc/19% MeOH/1% Et<sub>3</sub>N)/EtOAc). Yield: 2.5 mg (11%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.16 (s, 1H), 7.77 (m, 1H), 7.22 (m, 1H), 6.97 (m, 1H), 6.73 (m, 1H), 4.98 (m, 1H), 4.10–3.92 (m, 2H), 3.48 (m, 1H), 3.14–3.02 (m, 1H), 3.07 (s, 3H), 2.28–2.10 (m, 2H), 1.92–1.77 (m, 1H); <i>m</i>/<i>z</i> (APCI-pos) M + 1 = 401; 90% purity by LC–MS (254 nm).</div></div><div id="sec5_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> (4<i>R</i>,4a′<i>S</i>,10a′<i>S</i>)-8′-(5-Chloropyridin-3-yl)-7′-fluoro-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>,5<i>H</i>-spiro[oxazole-4,10′-pyrano[4,3-b]chromen]-2-amine (<b>92</b>)</h3><div class="NLM_p last">Compound <b>92</b> was prepared from <b>28</b> using reaction conditions described for the synthesis of compounds <b>19</b>–<b>27</b> and <b>79</b>. Crude <b>92</b> (mixture of diastereomers) was purified by silica gel eluting with a linear gradient of 0–6% DCM/MeOH + 1% NH<sub>4</sub>OH to provide 8′-(5-chloropyridin-3-yl)-7′-fluoro-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>,5<i>H</i>-spiro[oxazole-4,10′-pyrano[4,3-b]chromen]-2-amine (42 mg) as a 2:1 mixture of diastereomers. This material was further purified by chiral SFC on a Chiralpak AD (2 × 15 cm) column eluting with 25% MeOH (0.1% NH<sub>4</sub>OH)/CO<sub>2</sub> at 100 bar at a flow rate of 70 mL/min. The peaks isolated were analyzed on Chiralpak AD (50 × 0.46 cm) column eluting with 25% MeOH (0.1% NH<sub>4</sub>OH)/CO<sub>2</sub>, at 120 bar (flow rate 5 mL/min, 220 nm). Compound <b>92</b> (peak-3, 16 mg, 0.1% yield for 10 steps, chemical purity >99%, >99% ee) was isolated. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.69–8.59 (m, 2H), 8.05 (s, 1H), 7.26 (d, <i>J</i> = 8.8 Hz, 1H), 6.77 (d, <i>J</i> = 12.0 Hz, 1H), 6.13 (s, 2H), 4.45 (d, <i>J</i> = 8.9 Hz, 1H), 4.12 (d, <i>J</i> = 8.9 Hz, 1H), 3.92 (dd, <i>J</i> = 12.2, 4.4 Hz, 1H), 3.70 (dd, <i>J</i> = 11.4, 4.4 Hz, 1H), 3.60–3.48 (m, 2H), 2.18 (dd, <i>J</i> = 11.3, 4.3 Hz, 1H), 1.90 (td, <i>J</i> = 12.5, 4.9 Hz, 1H), 1.81 (d, <i>J</i> = 12.5 Hz, 1H), 1.34 (s, 3H). <i>m</i>/<i>z</i> (ESI-pos) M + 1 = 404.1. HPLC purity = 100% (254 nm).</div></div><div id="sec5_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> (4<i>R</i>,4a′<i>S</i>,10a′<i>S</i>)-7′-Fluoro-8′-(2-fluoropyridin-3-yl)-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-1′<i>H</i>,5<i>H</i>-spiro[oxazole-4,10′-pyrano[4,3-b]chromen]-2-amine (<b>93</b>)</h3><div class="NLM_p last">Compound <b>93</b> was prepared from <b>28</b> using reaction conditions described for the synthesis of compounds <b>19</b>–<b>27</b> and <b>79</b>, and replacing (5-chloropyridin-3-yl)boronic acid with (2-fluoropyridin-3-yl)boronic acid. Crude <b>93</b> (mixture of diastereomers) was purified as described for compound <b>92</b>. Compound <b>93</b> (17 mg, 0.1% yield for 10 steps, chemical purity >99%, >99% ee) was isolated. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.27 (d, <i>J</i> = 5.1 Hz, 1H), 8.06–7.96 (m, 1H), 7.46 (ddd, <i>J</i> = 7.1, 4.8, 1.8 Hz, 1H), 7.17 (d, <i>J</i> = 8.4 Hz, 1H), 6.77 (d, <i>J</i> = 11.3 Hz, 1H), 6.08 (s, 2H), 4.30 (s, 2H), 3.92 (dd, <i>J</i> = 11.9, 4.9 Hz, 1H), 3.85 (dd, <i>J</i> = 11.7, 4.0 Hz, 1H), 3.58 (td, <i>J</i> = 12.4, 2.6 Hz, 1H), 3.32 (dd, <i>J</i> = 14.1, 8.4 Hz, 1H), 2.11 (dd, <i>J</i> = 10.9, 4.0 Hz, 1H), 1.87 (dd, <i>J</i> = 12.7, 5.1 Hz, 1H), 1.79 (d, <i>J</i> = 12.7 Hz, 1H), 1.49 (s, 3H); <i>m</i>/<i>z</i> (ESI-pos) M + 1 = 388.1.</div></div><div id="sec5_76" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> X-ray Crystal Structure</h3><div class="NLM_p">Human BACE1 (residues 57–453) was expressed in <i>E. coli</i> with a noncleavable 6-His tag at the C-terminus. The protein was refolded and purified in a manner similar to that from Tomasselli et al.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Briefly, cells were lysed using mechanical disruption and inclusion bodies recovered by differential centrifugation. Inclusion body proteins were solubilized in urea and refolded by dilution into water. Following a 3 week refold period, BACE protein was recovered by Q-Sepharose anion-exchange chromatography. Fractions containing active protein were pooled and further purified over Source-Q anion exchange and Sephadex 200 size-exclusion columns. Purified BACE protein was concentrated to 10 mg/mL and frozen for crystallographic studies. Crystals were grown by hanging drop vapor diffusion with a precipitant of 20% PEG200, 0.1 M sodium acetate, pH 4.5–5.6, and 0–2 mM cobalt chloride. Crystals grew in space group C2221 in approximately 1 week. Crystals were then transferred to a soaking solution (27–30% PEG200, 0.1 M NaOAc, pH 5.0–5.6, 0–2 mM CoCl<sub>2</sub>, and 10% DMSO) with compound at a final concentration of 1 mM. Crystals were soaked for 18–24 h and either flash-frozen in liquid nitrogen or mounted directly for data collection. The soaking solution also served as a cryprotectant for data collection at 100 K.</div><div class="NLM_p last">Diffraction data were collected on a Rigaku FR-E generator and Raxis IV++ detector (Rigaku Inc., Woodlands, TX). Data were processed in Moslfm,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and the initial structure was solved by molecular replacement from pdb code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FNK">1FNK</a> using Molrep. All crystal structures were refined in Refmac, all three of these programs being part of the CCP4 suite (Winn et al., 2011).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Model building was performed in Coot.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div></div><div id="sec5_77" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> BACE1 Enzyme Assay</h3><div class="NLM_p last">The activity of purified recombinant human BACE1, expressed in CHO cells, was determined using a custom synthesized biotinylated peptide based upon sAPP. Uncleaved substrate was detected via HTRF whereby europium-labeled anti-Aβ (amino acids 1–17, clone 6E10) was combined with D2-labeled streptavidin. Specifically, 20 nM enzyme was incubated with 150 nM peptide (Biotin-Lys-Thr-Glu-Glu-Ile-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu, representing P10–P17′) for 6 h at 22 °C in an assay buffer consisting of 50 mM sodium acetate (pH 4.4) and 0.1% CHAPS. In IC<sub>50</sub> studies, compounds were serially diluted (1:2.5) in DMSO (11 points); compound and enzyme were preincubated for 15 min at room temperature and the enzymatic reaction was initiated with peptide. The detection solution consisted of 43 nM streptavidin-D2 and 1.1 nM antibody in 200 mM Tris (pH 8.0), 20 mM EDTA (pH 8.0), 0.1% BSA, and 0.8 M KF. Following an incubation for 2 h at 22 °C, the samples were excited at 320 nm and the emission ratio of 665 nm/615 nm was determined.</div></div><div id="sec5_78" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> Cathepsin D Enzyme Assay</h3><div class="NLM_p last">The catalytic activity of Cathepsin D, purified from human spleen (Calbiochem), was assessed in a FRET peptide substrate assay using 50 mM sodium acetate (pH 4.4) and 0.1% CHAPS. In IC<sub>50</sub> studies, compounds were serially diluted (1:2.5) in DMSO (11 points). The substrate (Anaspec catalog # 72097) contains a 5-FAM/QXL 520 pair whereby cleavage results in an increase of 5-FAM fluorescence that is measured using an excitation of 485 nm and an emission of 535 nm. The fluorescence was monitored continuously for one hour at room temperature and initial rates were calculated from the fluorescence increase. The final concentrations were 10 nM enzyme and 2 μM substrate.</div></div><div id="sec5_79" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> Cell-Based Assay</h3><div class="NLM_p last">Human embryonic kidney cells (HEK293) stably expressing APP<sub>wt</sub> were plated at a density of 35K cells/well in 96-well collagen coated plates (BD-Biosciences). The cells were cultivated overnight at 37 °C and 5% CO<sub>2</sub> in DMEM supplemented with 10% FBS. The following day the media was changed, and the cells were incubated for 48 h with test compounds at concentrations ranging from 0.0008 to 16 μM. Following incubation with the test compounds, the conditioned medium was collected, and the Aβ<sub>1–40</sub> levels were determined using an HTRF assay (CisBio). The IC<sub>50</sub> was calculated from the percent of control Aβ<sub>40</sub> as a function of the concentration of the test compound. The HTRF to detect Aβ<sub>1–40</sub> was performed in 384-well microtiter plates (Corning). The antibody pair that was used to detect Aβ<sub>1–40</sub> from cell supernatants was a pair of monoclonal antibodies, one labeled with Cryptate and one labeled with XL655 as supplied by the manufacturer (CisBio). Conditioned medium was incubated with antibody pair overnight at 4 °C. The plates were measured for timeresolved fluorescence on a Victor2 plate reader (Wallac).</div></div><div id="sec5_80" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> Permeability and Efflux Assays</h3><div class="NLM_p last">Both LLC-PK1 and MDR1 transfected LLC-PK1 cells were cultured and plated according to manufacturer’s recommendations with the exception that the passage media contained only 2% fetal bovine serum so as to extend passage time out to seven days. Both positive and negative controls were used to assess functionality of P-gp efflux in the assay. Stock solutions for assay controls and the test article were prepared in DMSO for final test concentrations of 10 and 1 μM, respectively. Final organic concentration in the assay was 1%. All dosing solutions contained 10 μM lucifer yellow to monitor LLC-PK1 cell monolayer integrity. For the apical to basolateral determination (A to B), 75 μL of the test article in transport buffer were added to the apical side of the individual transwells and 250 μL of basolateral media, without compound or lucifer yellow, were added to each well. For the basolateral to apical determination (B to A), 250 μL of test article in transport buffer were added to each well and 75 μL transport buffer, without compound or lucifer yellow, were added to each transwell. All tests were performed in triplicate, and each compound was tested for both apical to basolateral and basolateral to apical transport. Propranolol, a high permeability compound (<i>P</i><sub>app</sub> AB > 8 × 10<sup>–6</sup> cm/s), sulfasalazine, a medium permeability compound (<i>P</i><sub>app</sub> > 2 × 10<sup>–6</sup> cm/s; <i>P</i><sub>app</sub> < 8 × 10<sup>–6</sup> cm/s), and cefuroximine, a low permeability compound (<i>P</i><sub>app</sub> AB < 2 × 10<sup>–6</sup> cm/s), were used as negative controls for P-gp efflux (ER < 2). Digoxin, a medium permeability compound, and quinidine, a high permeability compound, were used as positive controls for P-gp efflux (ER > 2). The plates were incubated for 2 h on a Lab-line Instruments Titer Orbital Shaker (VWR, West Chester, PA) at 50 rpm and 37 °C with 5% CO<sub>2</sub>. All culture plates were removed from the incubator, and 50 μL of media were removed from the apical and basolateral portion of each well and added to 150 μL of 1 μM labetalol in 2:1 CH<sub>3</sub>CN: H<sub>2</sub>O, v/v. The plates were read using a Molecular Devices (Sunnyvale, CA) Gemini Fluorometer to evaluate the lucifer yellow concentrations at excitation/emission wavelengths of 425/535 nm. These values were accepted when found to be below 5% for apical to basolateral and basolateral to apical flux across the MDR1 transfected LLC-PK1 cell monolayers. The plates were sealed, and the contents of each well analyzed by LC–MS/MS. The compound concentrations were determined from the ratio of the peak areas of the compound to the internal standard (labetalol) in comparison to the dosing solution. The LC–MS/MS system comprised an HTS-PAL autosampler (Leap Technologies, Carrboro, NC), an HP1200 HPLC (Agilent, Palo Alto, CA), and an MDS Sciex 4000 Q Trap system (Applied Biosystems, Foster City, CA). Chromatographic separation of the analyte and internal standard was achieved at rt using a C18 column (Kinetics, 50 × 300 mm, 2.6 μm particle size, Phenomenex, Torrance, CA) in conjunction with gradient conditions using mobile phases A (water containing 1% i-PrOH and 0.1% formic acid) and B (0.1% formic acid in CH<sub>3</sub>CN). The total run time, including re-equilibration time, for a single injection was 1.2 min. Mass spectrometric detection of the analytes was accomplished using the ion spray positive mode. Analyte responses were measured by multiple reaction monitoring (MRM) of transitions unique to each compound (the protonated precursor ion and selected product ions for each test article and <i>m</i>/<i>z</i> 329 to <i>m</i>/<i>z</i> 162 for labetalol, the internal standard).</div></div><div id="sec5_81" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> Plasma Protein and Brain Tissue Binding</h3><div class="NLM_p last">Aliquots of undiluted plasma or diluted brain samples (three volumes of 0.1 M sodium phosphate buffer, pH 7.4) from each animal species were spiked with test compound in DMSO to give final concentrations of 5 μM (0.1% final DMSO) test article. Rapid equilibrium dialysis (RED) inserts were prepared in triplicate by adding 500 μL of PBS for plasma protein binding or 0.1 M sodium phosphate for brain tissue binding to one chamber and 300 μL of spiked plasma or brain homogenate to the opposing chamber. The RED units (inserts and bases) were sealed and incubated at 37 °C on a plate shaker at 300 rpm for 6 h to equilibrate the samples. One hundred microliters of each spiked matrix sample and respective buffer were transferred to a 96-deep well plate for sample extraction. The matrix samples were diluted with 100 μL of either PBS or 0.1 M sodium phosphate buffer, and the buffer samples were diluted with 100 μL of either brain tissue homogenate or plasma to yield identical matrixes between buffer and nonbuffer samples. Plasma or brain proteins were precipitated with 800 μL of CH<sub>3</sub>CN spiked with 0.2 μM final concentration (0.02% DMSO) of labetalol, the internal standard. The plates were spun in a centrifuge for 10 min at 3000<i>g</i>. One hundred microliters of the supernatant were transferred into a shallow 96-well plate and diluted 1:1 (v/v) with HPLC grade water and sealed for LC–MS/MS analysis (method described below).</div></div><div id="sec5_82" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> Liver Microsomal Incubations</h3><div class="NLM_p last">A 100 mM potassium phosphate assay buffer solution (KPB) was prepared as follows. Both KH<sub>2</sub>PO<sub>4</sub> and K<sub>2</sub>HPO<sub>4</sub> were dissolved separately in reagent grade water resulting in a final concentration of 100 mM. A 75:25 mixture v/v of K<sub>2</sub>HPO<sub>4</sub>/KH<sub>2</sub>PO<sub>4</sub> was prepared, and the pH of the solution was adjusted to 7.4 using diluted HCl or diluted NaOH solutions. A stock solution of the test article(s) was prepared at 10 mM (active compound) in DMSO. The stock solution was diluted immediately before use to 2.5 μM using the KPB solution to create the working standard. All test compounds were completely soluble by visual inspection at rt. The NADPH-regenerating solution (NRS) was prepared on the day of analysis by diluting one volume of 17 mg/mL NADP+ with one volume of 78 mg/mL glucose-6-phosphate (both prepared in KPB, pH 7.4) and 7.9 volumes of 20 mM MgCl<sub>2</sub>. The final concentrations of NADP+ and glucose-6-phosphate were 1.7 and 7.8 mg/mL, respectively. Immediately prior to use, the NRS was activated by the addition of 10 μL of glucose-6-phosphate dehydrogenase (150 units/mL in KPB, pH 7.4) per mL of NRS stock solution. Liver microsomes were diluted to 2.5 mg protein/mL using KPB. For each test article or positive control (i.e., dextromethorphan, diazepam, diltiazem, phenacetin, tolbutamide, and verapamil), 20 μL of 2.5 μM working standard solution of test compound and 20 μL of microsomes (2.5 mg protein/mL) were added to each well of a 96-well polypropylene plate (Costar, VWR, West Chester, PA) in duplicate. The plates were placed in an incubator at 37 °C for 5 min before adding the start solution. A 10 μL aliquot of the NRS solution was added to each original well to initiate metabolism. The concentration of the test compound during incubation was 1 μM. One incubation plate was prepared for each time point (i.e., 0 and 20 min). Incubations were conducted at 37 °C and 100% relative humidity. At each time point, the appropriate incubation plate was removed from the incubator and a solution containing internal standard (150 μL, 0.25 μM labetalol in 60% CH<sub>3</sub>CN) was added to each well. The plate was immediately spun in a centrifuge at 2095<i>g</i> for 7 min at rt using an Allegra benchtop centrifuge (Beckman Coulter, Fullerton, CA). A 200 μL aliquot of the supernatant was transferred from each well to a 96-well shallow plate (Costar). The plates were sealed using reusable plate mats. Analysis was performed as described below.</div></div><div id="sec5_83" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> Hepatocyte Incubations</h3><div class="NLM_p last">A stock solution of the test article(s) was prepared at 10 mM (active compound) in DMSO. The in vitro stability of each test article or positive control was assessed in the presence of hepatocytes as follows. Cryopreserved hepatocytes were thawed, isolated from shipping media, and diluted to a density of 1 × 10<sup>6</sup> viable cells/mL, according to the supplier’s guidelines, using Dulbecco’s Modified Eagle Medium, 1×, high glucose (DMEM, Invitrogen, Carlsbad, CA). Viability was determined by trypan blue exclusion using a hemocytometer (3500 Hausser, VWR, West Chester, PA). The 10 mM stock solution of test article(s) or control compound was diluted to 2 μM using supplemented DMEM to create the working standard. A 20 μL aliquot of test compound or control (antipyrine, diazepam, diltiazem, lorazepam, propranolol, verapamil, and 7-ethyl-10-hydroxycamptothecin [SN-38]) was added to each test well of a 96-well polypropylene plate (Costar, VWR, West Chester, PA) immediately followed by the addition of 20 μL of the hepatocyte suspension. One incubation plate was prepared for each time point (i.e., 0, 60, and 120 min) with samples being prepared in duplicate. Incubations were conducted at 37 °C and 100% relative humidity. At each time point, the appropriate incubation plate was removed from the incubator and a solution containing internal standard (200 μL, 0.25 μM labetalol in 60% CH<sub>3</sub>CN) was added to each well. The plate was mixed at 700 rpm for 1 min on a plate shaker (IKA MTS 2/4 Digital Microtiter Shaker, VWR) and immediately spun in a centrifuge at 2095<i>g</i> for 10 min at rt using an Allegra benchtop centrifuge (Beckman Coulter, Fullerton, CA). A 200 μL aliquot of the supernatant was transferred from each well to a 96-well shallow plate (Costar). The plates were sealed using reusable plate mats.</div></div><div id="sec5_84" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> Analytical Quantitation for Microsomal/Hepatocyte Stability and Tissue Binding Assays</h3><div class="NLM_p last">The LC–MS/MS system comprised an HTS-PAL autosampler (Leap Technologies, Carrboro, NC), an HP1200 HPLC (Agilent, Palo Alto, CA), and an API4000 triple quadrupole mass spectrometer (PE Sciex, a division of Applied Biosystems, Foster City, CA). Chromatographic separation of the analyte and internal standard was achieved at rt using a C18 column (Kinetex, 30 × 3.0 mm, 2.6 μm particle size, Phenomenex, Torrance, CA) in conjunction with gradient conditions using mobile phases A (aqueous 0.1% formic acid with 1% i-PrOH) and B (0.1% formic acid in CH<sub>3</sub>CN). The total run time, including re-equilibration, for a single injection was 2 min. Mass spectrometric detection of the analytes was accomplished using the ESI+ ionization mode. Ion current was optimized during infusion of a stock solution of each test article. Analyte responses were measured by multiple reaction monitoring (MRM) of transitions unique to each compound. Data were acquired, and peak areas were calculated for test compounds and the internal standard using Analyst 1.5.1 software (Sciex). For the liver microsomal and hepatocyte stability assessments, peak area tables were exported to BioAssay Enterprise (CambridgeSoft, Cambridge, MA), where the average analyte to internal standard peak area ratios were used to calculate percent remaining (%REM), half-life (<i>t</i><sub>1/2</sub>), predicted hepatic clearance (CL<sub>hep</sub>), and predicted hepatic extraction ratio (ER).</div></div><div id="sec5_85" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> Pharmacokinetic Studies</h3><div class="NLM_p last">Animals and Drug Treatment: Male CD-1 mice (4–6 weeks old, 25–35 g) and Male Hartley guinea pigs (surgically implanted jugular cannulas, 6–8 weeks old, 250–300 g) were obtained from Charles River (Portage, MI, and Kingston, NY, respectively). The cannulae were exteriorized at the back of the neck, and each animal was placed singly in a metabolic cage. Male Sprague–Dawley rats (6–8 weeks old, 250–300 g) were obtained from Harlan (Indianapolis, IN). All the animals were housed at controlled temperature and humidity in an alternating 12 h light and dark cycle with free access to food and water, in accordance with Array BioPharma Institutional Animal Care and Use Committee guidelines and in harmony with the Guide for Laboratory Animal Care and Use. The guinea pigs were housed individually according to NIH guidelines. Mice (3 per group, per time-point) received a 3 mg/kg dose of drug (5 mL/kg) intravenously or 10 mg/kg dose (10 mL/kg) orally. Rats (3 per group) received a 3 mg/kg dose of compound intravenously or 60 mg/kg dose orally. Guinea pigs (4 per group) received a 3 mg/kg dose (1 mL/kg) of compound intravenously via cannula or 60 mg/kg dose (5 mL/kg) orally. Plasma collection: Mice were euthanized by CO<sub>2</sub> inhalation, rats and guinea pigs were anesthetized by isoflurane at designated times between 1 min and 24 h postdose. The whole blood samples were drawn via cardiac puncture (mice), tail vein (rats), and jugular vein cannula (guinea pigs) in tubes containing 1.5% EDTA. The blood samples were centrifuged at 14000 rpm for 10 min; plasma was decanted and stored at −20 °C before drug concentration analysis. In guinea pigs, after each blood draw, the cannulas were flushed with heparinized saline (volume equal to the cannula volume). At termination of the study, guinea pigs were euthanized by euthasol (250 mg/kg) via intraperitoneal injection. Brain collection: The orally dosed mice, postmortem at 30 min to 8 h postdose, were perfused with 5 mL sterile saline. Brains were harvested, and the tissue weights were recorded. The brains were snap frozen immediately in liquid nitrogen and stored at −80 °C until determination of drug concentration in brain samples.</div></div><div id="sec5_86" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> Rat and Guinea Pig Pharmacodynamic Studies</h3><div class="NLM_p last">Animals and Drug Treatment: Male Sprague–Dawley rats and male Hartley guinea pigs (6–8 weeks old, 250–350 g), were obtained from Harlan (Indianapolis, IN) and Charles River Laboratories (Kingston, NY), respectively. The animals were housed in groups of 3, at controlled temperature and humidity in an alternating 12 h light and dark cycle with free access to food and water, in accordance with Array BioPharma Institutional Animal Care and Use Committee guidelines and in harmony with the Guide for Laboratory Animal Care and Use. Rats (8 per group) received orally either vehicle (1% carboxymethyl cellulose/0.5% Tween 80) or <b>62</b> (60 mg/kg) at a volume of 4 mL/kg. Guinea pigs (6–8 per group) received orally either vehicle (a) 1% carboxymethyl cellulose/0.5% Tween 80 or (b) 40% PEG400/10% ethanol/50% water or drugs: <b>62</b> (30, 10, and 60 mg/kg) or <b>59</b> (60 mg/kg) at a volume of 4–5 mL/kg. Plasma, CSF, and brain collection: At 1, 3, 5, 8, and 12 h after receiving the vehicle or drug dose, the rats were euthanized by CO<sub>2</sub> inhalation, and guinea pigs were euthanized by euthasol (250 mg/kg) via intraperitoneal injection. The whole blood samples were collected postmortem via cardiac puncture, in tubes containing 1.5% EDTA, centrifuged at 14000 rpm for 10 min. The plasma was stored at −20 °C until drug concentration analysis. The CSF samples were drawn postmortem via cisterna magna puncture through a 25 gauge needle (Becton Dickinson Franklin Lakes, NJ), into tubes containing 50 μL of 10% BSA in water. The CSF samples were snap frozen in liquid nitrogen and stored at −80 °C until Aβ 40 assay. Sample weights were recorded to determine the actual volume of CSF collected. The postmortem animals were perfused with 20 mL of sterile saline and brain hemispheres were dissected (brain stem and cerebellum were not collected), halved longitudinally, weighed, and placed only left half of the brain in a 15 mL conical tube and snap frozen in liquid nitrogen. All tissues were stored at −80 °C until drug concentration determination. CSF Aβ 40 assay: CSF Aβ 40 concentration in rat and guinea pig CSF samples was analyzed by MSD 96-Well MULTI-ARRAY  Human/Rodent (4G8) Aβ 40 Ultra-Sensitive Assay (rat) or Human (6E10) Aβ 40 Ultra-Sensitive Kit (Meso Scale Discovery, Gaithersburg, MD). The 96- well MULTI-SPOT Aβ 40 peptide plate was incubated with 1% BSA solution at room temperature with shaking for 1 h and washed as per manufacturer’s instructions with Tris wash buffer (Tris wash buffer in deionized water). The detection antibody solution (25 μL/well, sulfo-tag 4G8 in 1% BSA) and CSF samples or standards (25 μL/well) were added to the plate for incubation at room temperature for 2 h. The plate was washed three times before the addition of MSD read buffer and was read on Sector Imager 2400 (Meso Scale Discovery, Gaithersburg, MD) immediately after. The Aβ 40 levels in neat CSF samples were then determined using a standard curve, values were obtained as pg/mL, and the results were expressed as mean Aβ 40 reduction percentage (%) of control samples from vehicle-treated animals.</div></div><div id="sec5_87" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> Cyno Pharmacodynamic Studies</h3><div class="NLM_p last">A single oral dose of compound at 100 mg/kg was given to 10 male cynomolgus monkeys (3–5 year, 2–3 kg) at Maccine. The study utilized a crossover design: <i>n</i> = 10 vehicle, <i>n</i> = 10 at 100 mg/kg, with an 18–20 days washout period between vehicle and treatment. Baseline was established 216–24 h before dosing. PK was determined for parent drug concentration in plasma and CSF, and PD was determined by measuring Aβ<sub>1–40</sub> levels in plasma and CSF. Full details are published elsewhere.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i104"><a href="/doi/suppl/10.1021/jm401635n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26171" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26171" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Figure S1 and experimental details for compound <b>94</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401635n/suppl_file/jm401635n_si_001.pdf">jm401635n_si_001.pdf (355.17 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB accession number for the coordinates of the cocrystal structure of BACE1 + compound <b>62</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4N00">4N00</a>.</p><div class="testing" data-doi="10.1021/jm401635n" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78863" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78863" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allen A. Thomas</span> - <span class="hlFld-Affiliation affiliation">Array
BioPharma, 3200 Walnut
Street, Boulder, Colorado 80301, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2d4c414148434c594542404c5e6d4e42404e4c5e5903434859"><span class="__cf_email__" data-cfemail="2e4f42424b404f5a4641434f5d6e4d41434d4f5d5a00404b5a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin W. Hunt</span> - <span class="hlFld-Affiliation affiliation">Array
BioPharma, 3200 Walnut
Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew Volgraf</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ryan J. Watts</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xingrong Liu</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guy Vigers</span> - <span class="hlFld-Affiliation affiliation">Array
BioPharma, 3200 Walnut
Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Darin Smith</span> - <span class="hlFld-Affiliation affiliation">Array
BioPharma, 3200 Walnut
Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas Sammond</span> - <span class="hlFld-Affiliation affiliation">Array
BioPharma, 3200 Walnut
Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tony P. Tang</span> - <span class="hlFld-Affiliation affiliation">Array
BioPharma, 3200 Walnut
Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan P. Rhodes</span> - <span class="hlFld-Affiliation affiliation">Array
BioPharma, 3200 Walnut
Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew T. Metcalf</span> - <span class="hlFld-Affiliation affiliation">Array
BioPharma, 3200 Walnut
Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karin D. Brown</span> - <span class="hlFld-Affiliation affiliation">Array
BioPharma, 3200 Walnut
Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer N. Otten</span> - <span class="hlFld-Affiliation affiliation">Array
BioPharma, 3200 Walnut
Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Burkard</span> - <span class="hlFld-Affiliation affiliation">Array
BioPharma, 3200 Walnut
Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">April A. Cox</span> - <span class="hlFld-Affiliation affiliation">Array
BioPharma, 3200 Walnut
Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary K. Geck Do</span> - <span class="hlFld-Affiliation affiliation">Array
BioPharma, 3200 Walnut
Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Darrin Dutcher</span> - <span class="hlFld-Affiliation affiliation">Array
BioPharma, 3200 Walnut
Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sumeet Rana</span> - <span class="hlFld-Affiliation affiliation">Array
BioPharma, 3200 Walnut
Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert K. DeLisle</span> - <span class="hlFld-Affiliation affiliation">Array
BioPharma, 3200 Walnut
Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kelly Regal</span> - <span class="hlFld-Affiliation affiliation">Array
BioPharma, 3200 Walnut
Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Albion D. Wright</span> - <span class="hlFld-Affiliation affiliation">Array
BioPharma, 3200 Walnut
Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Groneberg</span> - <span class="hlFld-Affiliation affiliation">Array
BioPharma, 3200 Walnut
Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kimberly Scearce-Levie</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Siu</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hans E. Purkey</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph P. Lyssikatos</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Indrani W. Gunawardana</span> - <span class="hlFld-Affiliation affiliation">Array
BioPharma, 3200 Walnut
Street, Boulder, Colorado 80301, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1297e9635-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i114">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30011" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30011" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the following people from Array BioPharma: Andrew Allen for multidimensional NMR spectroscopy support and chiral HPLC methods development; Julie Harris for PK/PD work; and Jaimie Rogan for LLC-PK1 cell permeability/efflux assays. We thank the following people from Genentech: Chris Hamman and Mengling Wong for chiral separation; and Young Shin and Melis Coraggio for bioanalytical analysis for cyno PK/PD.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i115" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i115"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i116" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i116"> Abbreviations Used</h2><tr><td class="NLM_term">BLQ</td><td class="NLM_def"><p class="first last">below the level of quantitation</p></td></tr><tr><td class="NLM_term">IVIVC</td><td class="NLM_def"><p class="first last">in vitro–in vivo correlation</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub> AB</td><td class="NLM_def"><p class="first last">apparent cell permeability in the apical to basolateral direction</p></td></tr><tr><td class="NLM_term">APCI</td><td class="NLM_def"><p class="first last">atmospheric-pressure chemical ionization</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">HTRF</td><td class="NLM_def"><p class="first last">homogeneous time-resolved fluorescence</p></td></tr><tr><td class="NLM_term">5-FAM</td><td class="NLM_def"><p class="first last">5-carboxyfluorescein</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s modified eagle medium</p></td></tr><tr><td class="NLM_term">LLC-PK1</td><td class="NLM_def"><p class="first last">pig kidney epithelial cells</p></td></tr><tr><td class="NLM_term">RED</td><td class="NLM_def"><p class="first last">rapid equilibrium dialysis</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">extraction ratio</p></td></tr><tr><td class="NLM_term">KPB</td><td class="NLM_def"><p class="first last">potassium phosphate buffer</p></td></tr><tr><td class="NLM_term">NRS</td><td class="NLM_def"><p class="first last">NADPH-regenerating solution</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">protein data bank</p></td></tr><tr><td class="NLM_term">tPSA</td><td class="NLM_def"><p class="first last">total polar surface area</p></td></tr><tr><td class="NLM_term">S<sub>N</sub>Ar</td><td class="NLM_def"><p class="first last">nucleophilic aromatic substitution</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i117">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00834" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00834" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 34 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span>2011 Alzheimer’s Disease Facts and Figures. <a href="http://www.alz.org/downloads/Facts_Figures_2011.pdf" class="extLink">http://www.alz.org/downloads/Facts_Figures_2011.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=2011+Alzheimer%E2%80%99s+Disease+Facts+and+Figures.+http%3A%2F%2Fwww.alz.org%2Fdownloads%2FFacts_Figures_2011.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span>World Alzheimer Report 2009. <a href="http://www.alz.co.uk/research/files/WorldAlzheimerReport-ExecutiveSummary.pdf" class="extLink">http://www.alz.co.uk/research/files/WorldAlzheimerReport-ExecutiveSummary.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Alzheimer+Report+2009.+http%3A%2F%2Fwww.alz.co.uk%2Fresearch%2Ffiles%2FWorldAlzheimerReport-ExecutiveSummary.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: strategies for disease modification</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=387-398&author=M.+Citron&title=Alzheimer%E2%80%99s+disease%3A+strategies+for+disease+modification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520strategies%2520for%2520disease%2520modification%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D387%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+progress+and+problems+on+the+road+to+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lgUtjyuwM3xgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Younkin, S. G.</span><span> </span><span class="NLM_article-title">The role of A beta 42 in Alzheimer’s disease</span> <span class="citation_source-journal">J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADyaK1cXmsV2ms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1998&pages=289-292&author=S.+G.+Younkin&title=The+role+of+A+beta+42+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">The role of Aβ42 in Alzheimer's disease</span></div><div class="casAuthors">Younkin, Steven G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Paris)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">289-292</span>CODEN:
                <span class="NLM_cas:coden">JHYSEM</span>;
        ISSN:<span class="NLM_cas:issn">0928-4257</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">A review, with 32 refs.  The authors' recent studies of plasma, fibroblasts, transfected cells and transgenic mice show that a fundamental effect of the mutations linked to familial Alzheimer's disease (FAD) is to increase the extracellular concn. of Aβ42.  This effect of the FAD-linked mutations is likely to be directly related to the pathogenesis of Alzheimer's disease (AD) because Aβ42 is deposited early and selectively in the senile plaques that are an invariant feature of all forms of AD.  Thus, the authors' results provide strong evidence that the FAD-linked mutations all cause AD by increasing the extracellular concn. of Aβ42, thereby fostering Aβ deposition, and they support the hypothesis that cerebral Aβ deposition is an essential early event in the pathogenesis of all forms of AD.  Interactions between the basal forebrain cholinergic system and Aβ that could influence AD pathogenesis are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSyp7Jwfo1OrVg90H21EOLACvtfcHk0liURKe_fBNQTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsV2ms7s%253D&md5=f65018862a0daa181209286af8c1bcb9</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYounkin%26aufirst%3DS.%2BG.%26atitle%3DThe%2520role%2520of%2520A%2520beta%252042%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Physiol.%26date%3D1998%26volume%3D92%26spage%3D289%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Querfurth, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFeral, F. M.</span><span> </span><span class="NLM_article-title">Mechanisms of Disease: Alzheimer’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1056%2FNEJMra0909142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=20107219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=329-344&author=H.+W.+Querfurthauthor=F.+M.+LaFeral&title=Mechanisms+of+Disease%3A+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Querfurth, Henry W.; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">329-344</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  The role of β-amyloid peptide in spontaneous self-aggregation in brain in Alzheimer's disease is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPeniV_Jn6orVg90H21EOLACvtfcHk0liURKe_fBNQTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D&md5=c116f6a6b8fed9af9f5282cc4b755c70</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0909142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0909142%26sid%3Dliteratum%253Aachs%26aulast%3DQuerfurth%26aufirst%3DH.%2BW.%26aulast%3DLaFeral%26aufirst%3DF.%2BM.%26atitle%3DMechanisms%2520of%2520Disease%253A%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D329%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T.</span><span> </span><span class="NLM_article-title">The secretases: enzymes with therapeutic potential in Alzheimer’s disease</span> <span class="citation_source-journal">Nat. Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1038%2Fnrneurol.2009.218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=20139999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=99-107&author=B.+De+Strooperauthor=R.+Vasarauthor=T.+Golde&title=The+secretases%3A+enzymes+with+therapeutic+potential+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">The secretases: enzymes with therapeutic potential in Alzheimer disease</span></div><div class="casAuthors">De Strooper, Bart; Vassar, Robert; Golde, Todd</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-107</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The three secretases that process amyloid precursor protein are central to the generation of amyloid-β, and the accumulation of this peptide in extracellular plaques is one of the hallmarks of Alzheimer disease.  In this Review, De Strooper et al. discuss the evidence that suggests that these enzymes are potential therapeutic targets for Alzheimer disease drug treatments.  The amyloid hypothesis has yielded a series of well-validated candidate drug targets with potential for the treatment of Alzheimer disease (AD).  Three proteases that are involved in the processing of amyloid precursor protein-α-secretase, β-secretase and γ-secretase-are of particular interest as they are central to the generation and modulation of amyloid-β peptide and can be targeted by small compds. in vitro and in vivo.  Given that these proteases also fulfill other important biol. roles, inhibiting their activity will clearly be inherently assocd. with mechanism-based toxicity.  Carefully detg. a suitable therapeutic window and optimizing the selectivity of the drug treatments towards amyloid precursor protein processing might be ways of overcoming this potential complication.  Secretase inhibitors are likely to be the first small-mol. therapies aimed at AD modification that will be fully tested in the clinic.  Success or failure of these first-generation AD therapies will have enormous consequences for further drug development efforts for AD and possibly other neurodegenerative conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQBldqS_TKy7Vg90H21EOLACvtfcHk0lgJZizJzrot4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D&md5=40135a0a59da6b70e4856a81ddfa6088</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2009.218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2009.218%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DVasar%26aufirst%3DR.%26aulast%3DGolde%26aufirst%3DT.%26atitle%3DThe%2520secretases%253A%2520enzymes%2520with%2520therapeutic%2520potential%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2010%26volume%3D6%26spage%3D99%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeloff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edenson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biere, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J. C.</span><span> </span><span class="NLM_article-title">Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1126%2Fscience.286.5440.735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=10531052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.+C.+Louis&title=Beta-secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+BACE"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</span></div><div class="casAuthors">Vassar, Robert; Bennett, Brian D.; Babu-Khan, Safura; Kahn, Steve; Mendiaz, Elizabeth A.; Denis, Paul; Teplow, David B.; Ross, Sandra; Amarante, Patricia; Loeloff, Richard; Luo, Yi; Fisher, Seth; Fuller, Janis; Edenson, Steven; Lile, Jackson; Jarosinski, Mark A.; Biere, Anja Leona; Curran, Eileen; Burgess, Teresa; Louis, Jean-Claude; Collins, Frank; Treanor, James; Rogers, Gary; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5440</span>),
    <span class="NLM_cas:pages">735-741</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cerebral deposition of amyloid β peptide (Aβ) is an early and crit. feature of Alzheimer's disease.  Aβ generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: β-secretase and γ-secretase.  These proteases are prime therapeutic targets.  A transmembrane aspartic protease with all the known characteristics of β-secretase was cloned and characterized.  Overexpression of this protease, termed BACE (for beta-site APP-cleaving enzyme) increased the amt. of β-secretase cleavage products, and these were cleaved exactly and only at known β-secretase positions.  Antisense inhibition of endogenous BACE mRNA decreased the amt. of β-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same sequence specificity as β-secretase.  Finally, the expression pattern and subcellular localization of BACE were consistent with that expected for β-secretase.  Future development of BACE inhibitors may prove beneficial for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSx3s1NFyByrVg90H21EOLACvtfcHk0lgJZizJzrot4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D&md5=3f36e8e5b5e9441c7670ccaeb0d2dd4f</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.735%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.%2BC.%26atitle%3DBeta-secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520BACE%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovacs, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span> </span><span class="NLM_article-title">The β-secretase enzyme in health and Alzheimer’s disease: regulation, cell biology, function, and therapeutic potential</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">12787</span><span class="NLM_x">–</span> <span class="NLM_lpage">12794</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1523%2FJNEUROSCI.3657-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=19828790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=12787-12794&author=R.+Vassarauthor=D.+M.+Kovacsauthor=R.+Yanauthor=P.+C.+Wong&title=The+%CE%B2-secretase+enzyme+in+health+and+Alzheimer%E2%80%99s+disease%3A+regulation%2C+cell+biology%2C+function%2C+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">The β-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential</span></div><div class="casAuthors">Vassar, Robert; Kovacs, Dora M.; Yan, Riqiang; Wong, Philip C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">12787-12794</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A review.  The β-amyloid (Aβ) peptide is the major constituent of amyloid plaques in Alzheimer's disease (AD) brain and is likely to play a central role in the pathogenesis of this devastating neurodegenerative disorder.  The β-secretase, β-site amyloid precursor protein cleaving enzyme (BACE1; also called Asp2, memapsin 2), is the enzyme responsible for initiating Aβ generation.  Thus, BACE is a prime drug target for the therapeutic inhibition of Aβ prodn. in AD.  Since its discovery 10 years ago, much has been learned about BACE.  This review summarizes BACE properties, describes BACE translation dysregulation in AD, and discusses BACE physiol. functions in sodium current, synaptic transmission, myelination, and schizophrenia.  The therapeutic potential of BACE will also be considered.  This is a summary of topics covered at a symposium held at the 39th annual meeting of the Society for Neuroscience and is not meant to be a comprehensive review of BACE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGn8h_x-7_bVg90H21EOLACvtfcHk0liS79rQ1hX5qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP&md5=a462ad002cf3801570725719d71647c6</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3657-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3657-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DKovacs%26aufirst%3DD.%2BM.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DP.%2BC.%26atitle%3DThe%2520%25CE%25B2-secretase%2520enzyme%2520in%2520health%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520regulation%252C%2520cell%2520biology%252C%2520function%252C%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D12787%26epage%3D12794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: γ-secretase inhibitors</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=169-175&author=B.+P.+Imbimbo&title=Alzheimer%E2%80%99s+disease%3A+%CE%B3-secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520%25CE%25B3-secretase%2520inhibitors%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2008%26volume%3D5%26spage%3D169%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Wu, W.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">γ-Secretase inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2009&pages=94-100&author=W.-L.+Wuauthor=L.+Zhang&title=%CE%B3-Secretase+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.-L.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3D%25CE%25B3-Secretase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2009%26volume%3D70%26spage%3D94%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kha, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span> </span><span class="NLM_article-title">Mice deficient in BACE1, the Alzheimer’s beta-secretase, have normal phenotype and abolished beta-amyloid generation</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1038%2F85059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=11224535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=231-232&author=Y.+Luoauthor=B.+Bolonauthor=S.+Kahnauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=P.+Denisauthor=W.+Fanauthor=H.+Khaauthor=J.+Zhangauthor=Y.+Gongauthor=L.+Martinauthor=J.-C.+Louisauthor=Q.+Yanauthor=W.+G.+Richardsauthor=M.+Citronauthor=R.+Vassar&title=Mice+deficient+in+BACE1%2C+the+Alzheimer%E2%80%99s+beta-secretase%2C+have+normal+phenotype+and+abolished+beta-amyloid+generation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation</span></div><div class="casAuthors">Luo, Yi; Bolon, Brad; Kahn, Steve; Bennett, Brian D.; Babu-Khan, Safura; Denis, Paul; Fan, Wei; Kha, Hue; Zhang, Jianhua; Gong, Yunhua; Martin, Laura; Louis, Jean-Claude; Yan, Qiao; Richards, William G.; Citron, Martin; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">231-232</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Mice deficient in beta-site APP-cleaving enzyme 1 (BACE1) lack Aβ- and β-secretase-cleaved APP C-terminal fragments (CTFs) in the brain.  Moreover, BACE1-/- mice are normal in appearance and behavior and are healthy and fertile.  These results provide validation of BACE1 as the major β-secretase in vivo and indicated that BACE2 is not significant in β-secretase cleavage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx9Z5X-KkqkbVg90H21EOLACvtfcHk0liS79rQ1hX5qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbY%253D&md5=f733e8c48464c6521ce302be48c76b12</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1038%2F85059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F85059%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DBolon%26aufirst%3DB.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DFan%26aufirst%3DW.%26aulast%3DKha%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DLouis%26aufirst%3DJ.-C.%26aulast%3DYan%26aufirst%3DQ.%26aulast%3DRichards%26aufirst%3DW.%2BG.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DMice%2520deficient%2520in%2520BACE1%252C%2520the%2520Alzheimer%25E2%2580%2599s%2520beta-secretase%252C%2520have%2520normal%2520phenotype%2520and%2520abolished%2520beta-amyloid%2520generation%26jtitle%3DNat.%2520Neurosci.%26date%3D2001%26volume%3D4%26spage%3D231%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Roberds, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienkowski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branstetter, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigon, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Games, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson-Wood, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kappenman, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabe, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shopp, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuck, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tintrup, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijsman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConlogue, L.</span><span> </span><span class="NLM_article-title">BACE knockout mice are healthy despite lacking the primary beta secretase activity in brain: implications for Alzheimer’s disease therapeutics</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1317</span><span class="NLM_x">–</span> <span class="NLM_lpage">1324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1093%2Fhmg%2F10.12.1317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=11406613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkslSrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2001&pages=1317-1324&author=S.+L.+Roberdsauthor=J.+Andersonauthor=G.+Basiauthor=M.+J.+Bienkowskiauthor=D.+G.+Branstetterauthor=K.+S.+Chenauthor=S.+B.+Freedmanauthor=N.+L.+Frigonauthor=D.+Gamesauthor=K.+Huauthor=K.+Johnson-Woodauthor=K.+E.+Kappenmanauthor=T.+T.+Kawabeauthor=I.+Kolaauthor=R.+Kuehnauthor=M.+Leeauthor=W.+Liuauthor=R.+Motterauthor=N.+F.+Nicholsauthor=M.+Powerauthor=D.+W.+Robertsonauthor=D.+Schenkauthor=M.+Schoorauthor=G.+M.+Shoppauthor=M.+E.+Shuckauthor=S.+Sinhaauthor=K.+A.+Svenssonauthor=G.+Tatsunoauthor=H.+Tintrupauthor=J.+Wijsmanauthor=S.+Wrightauthor=L.+McConlogue&title=BACE+knockout+mice+are+healthy+despite+lacking+the+primary+beta+secretase+activity+in+brain%3A+implications+for+Alzheimer%E2%80%99s+disease+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">BACE knockout mice are healthy despite lacking the primary β-secretase activity in brain: implications for Alzheimer's disease therapeutics</span></div><div class="casAuthors">Roberds, Steven L.; Anderson, John; Basi, Guriqbal; Bienkowski, Michael J.; Branstetter, Daniel G.; Chen, Karen S.; Freedman, Stephen B.; Frigon, Normand L.; Games, Dora; Hu, Kang; Johnson-Wood, Kelly; Kappenman, Karl E.; Kawabe, Thomas T.; Kola, Ismail; Kuehn, Ralf; Lee, Michael; Liu, Weiqun; Motter, Ruth; Nichols, Nanette F.; Power, Michael; Robertson, David W.; Schenk, Dale; Schoor, Michael; Shopp, George M.; Shuck, Mary E.; Sinha, Sukanto; Svensson, Kjell A.; Tatsuno, Gwen; Tintrup, Hartmut; Wijsman, John; Wright, Sarah; McConlogue, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1317-1324</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disorder characterized by accumulation of amyloid plaques and neurofibrillary tangles in the brain.  The major components of plaque, β-amyloid peptides (Aβs), are produced from amyloid precursor protein (APP) by the activity of β- and γ-secretases.  β-Secretase activity cleaves APP to define the N-terminus of the Aβ1-x peptides and, therefore, has been a long-sought therapeutic target for treatment of AD.  The gene encoding a β-secretase for beta-site APP cleaving enzyme (BACE) was identified recently.  However, it was not known whether BACE was the primary β-secretase in mammalian brain nor whether inhibition of β-secretase might have effects in mammals that would preclude its utility as a therapeutic target.  In the work described herein, the authors generated two lines of BACE knockout mice and characterized them for pathol., β-secretase activity and Aβ prodn.  These mice appeared to develop normally and showed no consistent phenotypic differences from their wild-type littermates, including overall normal tissue morphol. and brain histochem., normal blood and urine chemistries, normal blood-cell compn., and no overt behavioral and neuromuscular effects.  Brain and primary cortical cultures from BACE knockout mice showed no detectable β-secretase activity, and primary cortical cultures from BACE knockout mice produced much less Aβ from APP.  The findings that BACE is the primary β-secretase activity in brain and that loss of β-secretase activity produces no profound phenotypic defects with a concomitant redn. in β-amyloid peptide clearly indicate that BACE is an excellent therapeutic target for treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ78rSt6xEe7Vg90H21EOLACvtfcHk0liM1TTmeh40KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkslSrurs%253D&md5=c18a9ff9f800eebd994476badc6ec1bc</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F10.12.1317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F10.12.1317%26sid%3Dliteratum%253Aachs%26aulast%3DRoberds%26aufirst%3DS.%2BL.%26aulast%3DAnderson%26aufirst%3DJ.%26aulast%3DBasi%26aufirst%3DG.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DBranstetter%26aufirst%3DD.%2BG.%26aulast%3DChen%26aufirst%3DK.%2BS.%26aulast%3DFreedman%26aufirst%3DS.%2BB.%26aulast%3DFrigon%26aufirst%3DN.%2BL.%26aulast%3DGames%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DK.%26aulast%3DJohnson-Wood%26aufirst%3DK.%26aulast%3DKappenman%26aufirst%3DK.%2BE.%26aulast%3DKawabe%26aufirst%3DT.%2BT.%26aulast%3DKola%26aufirst%3DI.%26aulast%3DKuehn%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMotter%26aufirst%3DR.%26aulast%3DNichols%26aufirst%3DN.%2BF.%26aulast%3DPower%26aufirst%3DM.%26aulast%3DRobertson%26aufirst%3DD.%2BW.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DSchoor%26aufirst%3DM.%26aulast%3DShopp%26aufirst%3DG.%2BM.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DTatsuno%26aufirst%3DG.%26aulast%3DTintrup%26aufirst%3DH.%26aulast%3DWijsman%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DS.%26aulast%3DMcConlogue%26aufirst%3DL.%26atitle%3DBACE%2520knockout%2520mice%2520are%2520healthy%2520despite%2520lacking%2520the%2520primary%2520beta%2520secretase%2520activity%2520in%2520brain%253A%2520implications%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapeutics%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2001%26volume%3D10%26spage%3D1317%26epage%3D1324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ohno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sametsky, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younkin, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakley, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younkin, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Disterhoft, J. F.</span><span> </span><span class="NLM_article-title">BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2004&pages=27-33&author=M.+Ohnoauthor=E.+A.+Sametskyauthor=L.+H.+Younkinauthor=H.+Oakleyauthor=S.+G.+Younkinauthor=M.+Citronauthor=R.+Vassarauthor=J.+F.+Disterhoft&title=BACE1+deficiency+rescues+memory+deficits+and+cholinergic+dysfunction+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhno%26aufirst%3DM.%26aulast%3DSametsky%26aufirst%3DE.%2BA.%26aulast%3DYounkin%26aufirst%3DL.%2BH.%26aulast%3DOakley%26aufirst%3DH.%26aulast%3DYounkin%26aufirst%3DS.%2BG.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DDisterhoft%26aufirst%3DJ.%2BF.%26atitle%3DBACE1%2520deficiency%2520rescues%2520memory%2520deficits%2520and%2520cholinergic%2520dysfunction%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D2004%26volume%3D41%26spage%3D27%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">McConlogue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buttini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brigham, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Games, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson Wood, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, S.</span><span> </span><span class="NLM_article-title">Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">26326</span><span class="NLM_x">–</span> <span class="NLM_lpage">26334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=26326-26334&author=L.+McConlogueauthor=M.+Buttiniauthor=J.+P.+Andersonauthor=E.+F.+Brighamauthor=K.+S.+Chenauthor=S.+B.+Freedmanauthor=D.+Gamesauthor=K.+Johnson+Woodauthor=M.+Leeauthor=M.+Zellerauthor=W.+Liuauthor=R.+Motterauthor=S.+Sinha&title=Partial+reduction+of+BACE1+has+dramatic+effects+on+Alzheimer+plaque+and+synaptic+pathology+in+APP+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DButtini%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DJ.%2BP.%26aulast%3DBrigham%26aufirst%3DE.%2BF.%26aulast%3DChen%26aufirst%3DK.%2BS.%26aulast%3DFreedman%26aufirst%3DS.%2BB.%26aulast%3DGames%26aufirst%3DD.%26aulast%3DJohnson%2BWood%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DZeller%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMotter%26aufirst%3DR.%26aulast%3DSinha%26aufirst%3DS.%26atitle%3DPartial%2520reduction%2520of%2520BACE1%2520has%2520dramatic%2520effects%2520on%2520Alzheimer%2520plaque%2520and%2520synaptic%2520pathology%2520in%2520APP%2520transgenic%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D26326%26epage%3D26334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemere, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lannfelt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The Swedish mutation causes early-onset Alzheimer’s disease by β-secretase cleavage within the secretory pathway</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1291</span><span class="NLM_x">–</span> <span class="NLM_lpage">1296</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1038%2Fnm1295-1291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=7489411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADyaK2MXpslGhtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=1291-1296&author=C.+Haassauthor=C.+A.+Lemereauthor=A.+Capellauthor=M.+Citronauthor=P.+Seubertauthor=D.+Schenkauthor=L.+Lannfeltauthor=D.+J.+Selkoe&title=The+Swedish+mutation+causes+early-onset+Alzheimer%E2%80%99s+disease+by+%CE%B2-secretase+cleavage+within+the+secretory+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway</span></div><div class="casAuthors">Haass, Christian; Lemere, Cynthia A.; Capell, Anja; Citron, Martin; Seubert, Peter; Schenk, Dale; Lannfelt, Lars; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1291-6</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">Several missense mutations causing early-onset Alzheimer's disease (AD) have been described in the gene coding for the β-amyloid precursor protein (βAPP).  A double mutation found in a Swedish family is located before the amyloid β-peptide (Aβ) region of βAPP and results in the increased prodn. and secretion of Aβ.  Here the authors show that the increased prodn. of Aβ results from a cellular mechanism, which differs substantially from that responsible for the prodn. of Aβ from wild-type βAPP.  In the latter case, Aβ generation requires reinternalization and recycling of βAPP.  In the case of the Swedish mutation the N-terminal β-secretase cleavage of Aβ occurs in Golgi-derived vesicles, most likely within secretory vesicles.  Therefore, this cleavage occurs in the same compartment as the α-secretase cleavage, which normally prevents Aβ prodn., explaining the increased Aβ generation by a competition between α- and β-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwY2_Dmv4aPrVg90H21EOLACvtfcHk0lhlz9jyH0_Huw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpslGhtbk%253D&md5=af21095fbb11e8dfc6ffb0b9f9afb38b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnm1295-1291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1295-1291%26sid%3Dliteratum%253Aachs%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DLemere%26aufirst%3DC.%2BA.%26aulast%3DCapell%26aufirst%3DA.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520Swedish%2520mutation%2520causes%2520early-onset%2520Alzheimer%25E2%2580%2599s%2520disease%2520by%2520%25CE%25B2-secretase%2520cleavage%2520within%2520the%2520secretory%2520pathway%26jtitle%3DNat.%2520Med.%26date%3D1995%26volume%3D1%26spage%3D1291%26epage%3D1296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Jonsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snaedal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulem, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudbjartsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyte, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhangale, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huttenlocher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsdottir, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreassen, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jönsson, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palotie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsteinsdottir, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span> </span><span class="NLM_article-title">A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+J%C3%B6nssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+mutation+in+APP+protects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0lg58WdV6i2m1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJ%25C3%25B6nsson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520mutation%2520in%2520APP%2520protects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith Labell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greg Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">16507</span><span class="NLM_x">–</span> <span class="NLM_lpage">16516</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+Smith+Labellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+Greg+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-%CE%B2+in+humans+with+an+orally+available%2C+non-peptidic+%CE%B2-secretase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0lggmrd5jydypg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DSmith%2BLabell%26aufirst%3DE.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DGreg%2BHall%26aufirst%3DD.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-%25CE%25B2%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520%25CE%25B2-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Stone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleijn, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dockendorf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palcza, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forman, M.</span><span> </span><span class="NLM_article-title">Consistency of Bace inhibitor-mediated brain amyloid production inhibition by MK-8931 in Alzheimer’s disease patients and healthy young adults</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">P690</span><span class="NLM_x">–</span> <span class="NLM_lpage">P691</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=P690-P691&issue=4&author=J.+Stoneauthor=H.+J.+Kleijnauthor=M.+Dockendorfauthor=L.+Maauthor=J.+Palczaauthor=J.+Tsengauthor=M.+Tanenauthor=M.+Forman&title=Consistency+of+Bace+inhibitor-mediated+brain+amyloid+production+inhibition+by+MK-8931+in+Alzheimer%E2%80%99s+disease+patients+and+healthy+young+adults"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DKleijn%26aufirst%3DH.%2BJ.%26aulast%3DDockendorf%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DPalcza%26aufirst%3DJ.%26aulast%3DTseng%26aufirst%3DJ.%26aulast%3DTanen%26aufirst%3DM.%26aulast%3DForman%26aufirst%3DM.%26atitle%3DConsistency%2520of%2520Bace%2520inhibitor-mediated%2520brain%2520amyloid%2520production%2520inhibition%2520by%2520MK-8931%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%2520and%2520healthy%2520young%2520adults%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2013%26volume%3D9%26issue%3D4%26spage%3DP690%26epage%3DP691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cheret, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wende, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulf-Goldenberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahirovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nave, K.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garratt, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span> </span><span class="NLM_article-title">Bace1 and Neuregulin-1 cooperate to control formation and maintenance of muscle spindles</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2015</span><span class="NLM_x">–</span> <span class="NLM_lpage">2028</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=2015-2028&author=C.+Cheretauthor=M.+Willemauthor=F.+R.+Frickerauthor=H.+Wendeauthor=A.+Wulf-Goldenbergauthor=S.+Tahirovicauthor=K.-A.+Naveauthor=P.+Saftigauthor=C.+Haassauthor=A.+N.+Garrattauthor=D.+L.+Bennettauthor=C.+Birchmeier&title=Bace1+and+Neuregulin-1+cooperate+to+control+formation+and+maintenance+of+muscle+spindles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheret%26aufirst%3DC.%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DFricker%26aufirst%3DF.%2BR.%26aulast%3DWende%26aufirst%3DH.%26aulast%3DWulf-Goldenberg%26aufirst%3DA.%26aulast%3DTahirovic%26aufirst%3DS.%26aulast%3DNave%26aufirst%3DK.-A.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DGarratt%26aufirst%3DA.%2BN.%26aulast%3DBennett%26aufirst%3DD.%2BL.%26aulast%3DBirchmeier%26aufirst%3DC.%26atitle%3DBace1%2520and%2520Neuregulin-1%2520cooperate%2520to%2520control%2520formation%2520and%2520maintenance%2520of%2520muscle%2520spindles%26jtitle%3DEMBO%2520J.%26date%3D2013%26volume%3D32%26spage%3D2015%26epage%3D2028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Willem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garratt, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeStrooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Control of peripheral nerve myelination by the beta-secretase BACE1</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">666</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=664-666&author=M.+Willemauthor=A.+N.+Garrattauthor=B.+Novakauthor=M.+Citronauthor=S.+Kaufmannauthor=A.+Rittgerauthor=B.+DeStrooperauthor=P.+Saftigauthor=C.+Birchmeierauthor=C.+Haass&title=Control+of+peripheral+nerve+myelination+by+the+beta-secretase+BACE1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DGarratt%26aufirst%3DA.%2BN.%26aulast%3DNovak%26aufirst%3DB.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DKaufmann%26aufirst%3DS.%26aulast%3DRittger%26aufirst%3DA.%26aulast%3DDeStrooper%26aufirst%3DB.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DControl%2520of%2520peripheral%2520nerve%2520myelination%2520by%2520the%2520beta-secretase%2520BACE1%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D664%26epage%3D666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kandalepas, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span> </span><span class="NLM_article-title">Identification and biology of β-secretase</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1111%2Fj.1471-4159.2011.07512.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=22122287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFynsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=55-61&issue=Suppl+1&author=P.+C.+Kandalepasauthor=R.+Vassar&title=Identification+and+biology+of+%CE%B2-secretase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and biology of β-secretase</span></div><div class="casAuthors">Kandalepas, Patty C.; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">55-61</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Our knowledge of the etiol. of Alzheimer's disease (AD) has advanced tremendously since the discovery of amyloid beta (Aβ) aggregation in diseased brains.  Accumulating evidence suggests that Aβ plays a causative role in AD.  The β-secretase enzyme, beta-site APP cleaving enzyme-1 (BACE1), is also implicated in AD pathogenesis, given that BACE1 cleavage of amyloid precursor protein is the initiating step in the formation of Aβ.  As a result, BACE1 inhibition has been branded as a potential AD therapy.  In this study, we review the identification and basic characteristics of BACE1, as well as the progress in our understanding of BACE1 cell biol., substrates, and phenotypes of BACE1 knockout mice that are informative about the physiol. functions of BACE1 beyond amyloid precursor protein cleavage.  These data are crucial for predicting potential mechanism-based toxicity that would arise from inhibiting BACE1 for the treatment or prevention of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa4bt1FCIVq7Vg90H21EOLACvtfcHk0lgdliQQLxzdEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFynsrc%253D&md5=84dd150d53c2012280933f886cc4d1d6</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07512.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07512.x%26sid%3Dliteratum%253Aachs%26aulast%3DKandalepas%26aufirst%3DP.%2BC.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DIdentification%2520and%2520biology%2520of%2520%25CE%25B2-secretase%26jtitle%3DJ.%2520Neurochem.%26date%3D2012%26volume%3D120%26issue%3DSuppl%25201%26spage%3D55%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Kuhn, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koroniak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeitschel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volbracht, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schepers, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imhof, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmeister, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brase, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenthaler, S. F.</span><span> </span><span class="NLM_article-title">Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">3157</span><span class="NLM_x">–</span> <span class="NLM_lpage">3168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=3157-3168&author=P.+H.+Kuhnauthor=K.+Koroniakauthor=S.+Hoglauthor=A.+Colomboauthor=U.+Zeitschelauthor=M.+Willemauthor=C.+Volbrachtauthor=U.+Schepersauthor=A.+Imhofauthor=A.+Hoffmeisterauthor=C.+Haassauthor=S.+Rossnerauthor=S.+Braseauthor=S.+F.+Lichtenthaler&title=Secretome+protein+enrichment+identifies+physiological+BACE1+protease+substrates+in+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DP.%2BH.%26aulast%3DKoroniak%26aufirst%3DK.%26aulast%3DHogl%26aufirst%3DS.%26aulast%3DColombo%26aufirst%3DA.%26aulast%3DZeitschel%26aufirst%3DU.%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DVolbracht%26aufirst%3DC.%26aulast%3DSchepers%26aufirst%3DU.%26aulast%3DImhof%26aufirst%3DA.%26aulast%3DHoffmeister%26aufirst%3DA.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DRossner%26aufirst%3DS.%26aulast%3DBrase%26aufirst%3DS.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26atitle%3DSecretome%2520protein%2520enrichment%2520identifies%2520physiological%2520BACE1%2520protease%2520substrates%2520in%2520neurons%26jtitle%3DEMBO%2520J.%26date%3D2012%26volume%3D31%26spage%3D3157%26epage%3D3168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bockstael, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annaert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevaert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">25927</span><span class="NLM_x">–</span> <span class="NLM_lpage">25940</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=25927-25940&author=L.+Zhouauthor=S.+Baraoauthor=M.+Lagaauthor=K.+Bockstaelauthor=M.+Borgersauthor=H.+Gijsenauthor=W.+Annaertauthor=D.+Moecharsauthor=M.+Merckenauthor=K.+Gevaertauthor=B.+De+Strooper&title=The+neural+cell+adhesion+molecules+L1+and+CHL1+are+cleaved+by+BACE1+protease+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DBarao%26aufirst%3DS.%26aulast%3DLaga%26aufirst%3DM.%26aulast%3DBockstael%26aufirst%3DK.%26aulast%3DBorgers%26aufirst%3DM.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DAnnaert%26aufirst%3DW.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DGevaert%26aufirst%3DK.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520neural%2520cell%2520adhesion%2520molecules%2520L1%2520and%2520CHL1%2520are%2520cleaved%2520by%2520BACE1%2520protease%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D25927%26epage%3D25940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Tseng, J.; Dockendorf, M.; Krishna, G.; Ma, L.; Palcza, J.; Leempoels, J.; Ramael, S.; Han, D.; Jhee, S.; Ereshefsky, L.; Wagner, J.; Troyer, M.; Forman, M.</span><span> </span><span class="NLM_article-title">Safety and pharmacokinetics of the novel BACE inhibitor MK-8931 in healthy subjects following single- and multiple-dose administration</span>.  <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span>),   <span class="NLM_fpage">P184</span><span class="NLM_x">–</span> <span class="NLM_lpage">P185</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=P184-P185&issue=4&author=J.+Tseng&author=M.+Dockendorf&author=G.+Krishna&author=L.+Ma&author=J.+Palcza&author=J.+Leempoels&author=S.+Ramael&author=D.+Han&author=S.+Jhee&author=L.+Ereshefsky&author=J.+Wagner&author=M.+Troyer&author=M.+Forman&title=Safety+and+pharmacokinetics+of+the+novel+BACE+inhibitor+MK-8931+in+healthy+subjects+following+single-+and+multiple-dose+administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTseng%26aufirst%3DJ.%26atitle%3DSafety%2520and%2520pharmacokinetics%2520of%2520the%2520novel%2520BACE%2520inhibitor%2520MK-8931%2520in%2520healthy%2520subjects%2520following%2520single-%2520and%2520multiple-dose%2520administration%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2012%26volume%3D8%26issue%3D4%26spage%3DP184%26epage%3DP185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span>An Efficacy and Safety Trial of MK-8931 in Mild to Moderate Alzheimer's Disease (P07738) (EPOCH). <a href="http://clinicaltrials.gov/show/NCT01739348" class="extLink">http://clinicaltrials.gov/show/NCT01739348</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=An+Efficacy+and+Safety+Trial+of+MK-8931+in+Mild+to+Moderate+Alzheimer%27s+Disease+%28P07738%29+%28EPOCH%29.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01739348."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lhA-aaC2OpJQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Clark, D. E.</span><span> </span><span class="NLM_article-title">Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood–brain barrier penetration</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">815</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=815-821&author=D.+E.+Clark&title=Rapid+calculation+of+polar+molecular+surface+area+and+its+application+to+the+prediction+of+transport+phenomena.+2.+Prediction+of+blood%E2%80%93brain+barrier+penetration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%2BE.%26atitle%3DRapid%2520calculation%2520of%2520polar%2520molecular%2520surface%2520area%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520transport%2520phenomena.%25202.%2520Prediction%2520of%2520blood%25E2%2580%2593brain%2520barrier%2520penetration%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D815%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tang, T. P.; Thomas, A. A.; Metcalf, A. T.; Hunt, K. W.; Vigers, G.; Rizzi, J. P.; Watts, R. J.; Liu, X.; Smith, D.; Rhodes, S. P.; Brown, K. D.; Otten, J. N.; Burkard, M.; Cox, A. A.; Geck Do, M. K.; Dutcher, D.; Rana, S.; DeLisle, R. K.; Regal, K.; Wright, A. D.; Scearce-Levie, K.; Siu, M.; Purkey, H. E.; Lyssikatos, J. P.</span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Tang%2C+T.+P.%3B+Thomas%2C+A.+A.%3B+Metcalf%2C+A.+T.%3B+Hunt%2C+K.+W.%3B+Vigers%2C+G.%3B+Rizzi%2C+J.+P.%3B+Watts%2C+R.+J.%3B+Liu%2C+X.%3B+Smith%2C+D.%3B+Rhodes%2C+S.+P.%3B+Brown%2C+K.+D.%3B+Otten%2C+J.+N.%3B+Burkard%2C+M.%3B+Cox%2C+A.+A.%3B+Geck+Do%2C+M.+K.%3B+Dutcher%2C+D.%3B+Rana%2C+S.%3B+DeLisle%2C+R.+K.%3B+Regal%2C+K.%3B+Wright%2C+A.+D.%3B+Scearce-Levie%2C+K.%3B+Siu%2C+M.%3B+Purkey%2C+H.+E.%3B+Lyssikatos%2C+J.+P.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DT.%2BP." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hunt, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawardana, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geck Do, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutcher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLisle, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammond, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groneberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purkey, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marlow, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, T. P.</span><span> </span><span class="NLM_article-title">Spirocyclic β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: from hit to lowering of cerebrospinal fluid (CSF) amyloid β in a higher species</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3379</span><span class="NLM_x">–</span> <span class="NLM_lpage">3403</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4002154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3379-3403&author=K.+W.+Huntauthor=A.+W.+Cookauthor=R.+J.+Wattsauthor=C.+T.+Clarkauthor=G.+Vigersauthor=D.+Smithauthor=A.+T.+Metcalfauthor=I.+W.+Gunawardanaauthor=M.+Burkardauthor=A.+A.+Coxauthor=M.+K.+Geck+Doauthor=D.+Dutcherauthor=A.+A.+Thomasauthor=S.+Ranaauthor=N.+C.+Kallanauthor=R.+K.+DeLisleauthor=J.+P.+Rizziauthor=K.+Regalauthor=D.+Sammondauthor=R.+Gronebergauthor=M.+Siuauthor=H.+Purkeyauthor=J.+P.+Lyssikatosauthor=A.+Marlowauthor=X.+Liuauthor=T.+P.+Tang&title=Spirocyclic+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+from+hit+to+lowering+of+cerebrospinal+fluid+%28CSF%29+amyloid+%CE%B2+in+a+higher+species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Fjm4002154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4002154%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DCook%26aufirst%3DA.%2BW.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DClark%26aufirst%3DC.%2BT.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DMetcalf%26aufirst%3DA.%2BT.%26aulast%3DGunawardana%26aufirst%3DI.%2BW.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%2BA.%26aulast%3DGeck%2BDo%26aufirst%3DM.%2BK.%26aulast%3DDutcher%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DKallan%26aufirst%3DN.%2BC.%26aulast%3DDeLisle%26aufirst%3DR.%2BK.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DSammond%26aufirst%3DD.%26aulast%3DGroneberg%26aufirst%3DR.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPurkey%26aufirst%3DH.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMarlow%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DT.%2BP.%26atitle%3DSpirocyclic%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520from%2520hit%2520to%2520lowering%2520of%2520cerebrospinal%2520fluid%2520%2528CSF%2529%2520amyloid%2520%25CE%25B2%2520in%2520a%2520higher%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3379%26epage%3D3403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hunt, K. H.; Cook, A. W.; Watts, R. J.; Clark, C. T.; Vigers, G.; Smith, D.; Metcalf, A. T.; Gunawardana, I. W.; Burkard, M.; Cox, A. A.; Geck Do, M. K.; Dutcher, D.; Thomas, A. A.; Rana, S.; Kallan, N. C.; DeLisle, R. K.; Rizzi, J. P.; Regal, K.; Sammond, D.; Groneberg, R.; Siu, M.; Purkey, H.; Lyssikatos, J. P.; Marlow, A.; Liu, X.; Tang, T. P.</span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hunt%2C+K.+H.%3B+Cook%2C+A.+W.%3B+Watts%2C+R.+J.%3B+Clark%2C+C.+T.%3B+Vigers%2C+G.%3B+Smith%2C+D.%3B+Metcalf%2C+A.+T.%3B+Gunawardana%2C+I.+W.%3B+Burkard%2C+M.%3B+Cox%2C+A.+A.%3B+Geck+Do%2C+M.+K.%3B+Dutcher%2C+D.%3B+Thomas%2C+A.+A.%3B+Rana%2C+S.%3B+Kallan%2C+N.+C.%3B+DeLisle%2C+R.+K.%3B+Rizzi%2C+J.+P.%3B+Regal%2C+K.%3B+Sammond%2C+D.%3B+Groneberg%2C+R.%3B+Siu%2C+M.%3B+Purkey%2C+H.%3B+Lyssikatos%2C+J.+P.%3B+Marlow%2C+A.%3B+Liu%2C+X.%3B+Tang%2C+T.+P.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DK.%2BH." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Im, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazlauskas, A.</span><span> </span><span class="NLM_article-title">The role of cathepsins in ocular physiology and pathology</span> <span class="citation_source-journal">Exp. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1016%2Fj.exer.2006.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=16893541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhs1Cmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2007&pages=383-388&author=E.+Imauthor=A.+Kazlauskas&title=The+role+of+cathepsins+in+ocular+physiology+and+pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">The role of cathepsins in ocular physiology and pathology</span></div><div class="casAuthors">Im, Eunok; Kazlauskas, Andrius</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Eye Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">383-388</span>CODEN:
                <span class="NLM_cas:coden">EXERA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cathepsins are proteases that were originally identified in the lysosome, where they participate in house keeping tasks such as degrdn. of phagocytosed photoreceptors.  More recently, cathepsins have been detected outside of the lysosome, and assocd. with numerous diseases (keratoconus, retinal detachment, age related macular degeneration, and glaucoma).  The most likely mechanism by which cathepsins contribute to ocular pathologies is via degrdn. of the extracellular matrix, and/or regulation of angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjhnlC2VGrKrVg90H21EOLACvtfcHk0lhAs3vDGFEibA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhs1Cmsrk%253D&md5=baec6bd7a6e1e1e894dd4b4ba7abe2a2</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1016%2Fj.exer.2006.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exer.2006.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DIm%26aufirst%3DE.%26aulast%3DKazlauskas%26aufirst%3DA.%26atitle%3DThe%2520role%2520of%2520cathepsins%2520in%2520ocular%2520physiology%2520and%2520pathology%26jtitle%3DExp.%2520Eye%2520Res.%26date%3D2007%26volume%3D84%26spage%3D383%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Benes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetvicka, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusek, M.</span><span> </span><span class="NLM_article-title">Cathepsin D--many functions of one aspartic protease</span> <span class="citation_source-journal">Crit. Rev. Oncol. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1016%2Fj.critrevonc.2008.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=18396408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A280%3ADC%252BD1crnsVehsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=12-28&author=P.+Benesauthor=V.+Vetvickaauthor=M.+Fusek&title=Cathepsin+D%2D%2Dmany+functions+of+one+aspartic+protease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin D--many functions of one aspartic protease</span></div><div class="casAuthors">Benes Petr; Vetvicka Vaclav; Fusek Martin</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-28</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">For years, it has been held that cathepsin D (CD) is involved in rather non-specific protein degradation in a strongly acidic milieu of lysosomes.  Studies with CD knock-out mice revealed that CD is not necessary for embryonal development, but it is indispensable for postnatal tissue homeostasis.  Mutation that abolishes CD enzymatic activity causes neuronal ceroid lipofuscinosis (NCL) characterized by severe neurodegeneration, developmental regression, visual loss and epilepsy in both animals and humans.  In the last decade, however, an increasing number of studies demonstrated that enzymatic function of CD is not restricted solely to acidic milieu of lysosomes with important consequences in regulation of apoptosis.  In addition to CD enzymatic activity, it has been shown that apoptosis is also regulated by catalytically inactive mutants of CD which suggests that CD interacts with other important molecules and influences cell signaling.  Moreover, procathepsin D (pCD), secreted from cancer cells, acts as a mitogen on both cancer and stromal cells and stimulates their pro-invasive and pro-metastatic properties.  Numerous studies found that pCD/CD level represents an independent prognostic factor in a variety of cancers and is therefore considered to be a potential target of anti-cancer therapy.  Studies dealing with functions of cathepsin D are complicated by the fact that there are several simultaneous forms of CD in a cell-pCD, intermediate enzymatically active CD and mature heavy and light chain CD.  It became evident that these forms may differently regulate the above-mentioned processes.  In this article, we review the possible functions of CD and its various forms in cells and organisms during physiological and pathological conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS9gz1Ed--NTiEJCPKhJPuqfW6udTcc2eaOjboMogTOqrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1crnsVehsw%253D%253D&md5=eb34f9d185621ee4b845685ec1efa125</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1016%2Fj.critrevonc.2008.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.critrevonc.2008.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DBenes%26aufirst%3DP.%26aulast%3DVetvicka%26aufirst%3DV.%26aulast%3DFusek%26aufirst%3DM.%26atitle%3DCathepsin%2520D--many%2520functions%2520of%2520one%2520aspartic%2520protease%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D2008%26volume%3D68%26spage%3D12%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hassner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorber, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heathcock, C.</span><span> </span><span class="NLM_article-title">Addition of iodine isocyanate to olefins. Scope and synthetic utility</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">549</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01278a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1967&pages=540-549&author=A.+Hassnerauthor=M.+E.+Lorberauthor=C.+Heathcock&title=Addition+of+iodine+isocyanate+to+olefins.+Scope+and+synthetic+utility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Fjo01278a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01278a006%26sid%3Dliteratum%253Aachs%26aulast%3DHassner%26aufirst%3DA.%26aulast%3DLorber%26aufirst%3DM.%2BE.%26aulast%3DHeathcock%26aufirst%3DC.%26atitle%3DAddition%2520of%2520iodine%2520isocyanate%2520to%2520olefins.%2520Scope%2520and%2520synthetic%2520utility%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1967%26volume%3D32%26spage%3D540%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wittekind, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenau, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poos, G. I.</span><span> </span><span class="NLM_article-title">Ring cleavage reactions of <i>trans</i>-2-amino-3a,4,5,6,7,7a-hexahydrobenzoxazole</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">444</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01061a041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1961&pages=444-446&author=R.+R.+Wittekindauthor=J.+D.+Rosenauauthor=G.+I.+Poos&title=Ring+cleavage+reactions+of+trans-2-amino-3a%2C4%2C5%2C6%2C7%2C7a-hexahydrobenzoxazole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fjo01061a041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01061a041%26sid%3Dliteratum%253Aachs%26aulast%3DWittekind%26aufirst%3DR.%2BR.%26aulast%3DRosenau%26aufirst%3DJ.%2BD.%26aulast%3DPoos%26aufirst%3DG.%2BI.%26atitle%3DRing%2520cleavage%2520reactions%2520of%2520trans-2-amino-3a%252C4%252C5%252C6%252C7%252C7a-hexahydrobenzoxazole%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1961%26volume%3D26%26spage%3D444%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gebelein, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swern, D.</span><span> </span><span class="NLM_article-title">Observations on the mechanism of addition of iodine isocyanate to unsaturated compounds</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1677</span><span class="NLM_x">–</span> <span class="NLM_lpage">1679</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01258a031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1969&pages=1677-1679&author=C.+G.+Gebeleinauthor=S.+Rosenauthor=D.+Swern&title=Observations+on+the+mechanism+of+addition+of+iodine+isocyanate+to+unsaturated+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.1021%2Fjo01258a031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01258a031%26sid%3Dliteratum%253Aachs%26aulast%3DGebelein%26aufirst%3DC.%2BG.%26aulast%3DRosen%26aufirst%3DS.%26aulast%3DSwern%26aufirst%3DD.%26atitle%3DObservations%2520on%2520the%2520mechanism%2520of%2520addition%2520of%2520iodine%2520isocyanate%2520to%2520unsaturated%2520compounds%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1969%26volume%3D34%26spage%3D1677%26epage%3D1679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="note"><p class="first last">Final products <b>72</b>, <b>76</b>, <b>79</b>, <b>83</b>–<b>85</b>, <b>87</b>, and <b>89</b> were each cocrystallized with BACE1 using the same conditions as for compound <b>62</b>, in order to unambiguously assign relative stereochemistry.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Badawy, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandeel, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awad, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Rahman, A.-R. H.</span><span> </span><span class="NLM_article-title">Synthesis of some new naphthopyran, pyrazole, pyridine, and thienobenzochromene derivatives using 1-(1-hydroxy-2-naphthyl) ethanone as a versatile starting material</span> <span class="citation_source-journal">Phosphorus, Sulfur Silicon Relat. Elem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">184</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1080%2F10426500802083158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWktbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2009&pages=179-196&author=D.+S.+Badawyauthor=E.+M.+Kandeelauthor=N.+M.+Awadauthor=A.-R.+H.+Abdel-Rahman&title=Synthesis+of+some+new+naphthopyran%2C+pyrazole%2C+pyridine%2C+and+thienobenzochromene+derivatives+using+1-%281-hydroxy-2-naphthyl%29+ethanone+as+a+versatile+starting+material"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of some new naphthopyran, pyrazole, pyridine, and thienobenzochromene derivatives using 1-(1-hydroxy-2-naphthyl)ethanone as a versatile starting material</span></div><div class="casAuthors">Badawy, Doria S.; Kandeel, E. M.; Awad, Noha M.; Abdel-Rahman, Abdel-Rahman H.</div><div class="citationInfo"><span class="NLM_cas:title">Phosphorus, Sulfur and Silicon and the Related Elements</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">179-196</span>CODEN:
                <span class="NLM_cas:coden">PSSLEC</span>;
        ISSN:<span class="NLM_cas:issn">1042-6507</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Treatment of the enaminone (I) prepd. from 1-(1-hydroxy-2-naphthyl)ethanone (II) with N,N-dimethylformamide dimethylacetal with acetic acid, thionyl chloride, or bromine, gave the corresponding 4-oxo-4H-naphtho[1,2-b]pyran derivs.  Refluxing of p-toluidine or p-anisidine with I afforded the N-aryl analogs.  2-Methyl-4-oxo-4H-naphtho[1,2-b]pyran-3-carboxaldehyde (III) was prepd. via the acetylation of I.  Condensation of III with malononitrile or Et cyanoacetate gave 2-nicotinoylnaphthols.  Refluxing of III with hydrazine hydrate, phenylhydrazine, semicarbazide hydrochloride, or thiosemicarbazide afforded pyrazole derivs.  Reaction of I with malononitrile gave the chromenecarbonitrile deriv.  Treatment of this with malononitrile afforded the chromenemalononitrile.  This compd. was obtained directly by reaction of I with excess of malononitrile and catalytic piperidine.  Further reactions of the chromenecarbonitrile are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoly3AR0SA9ZbVg90H21EOLACvtfcHk0lhi5R_FAtuUEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWktbvK&md5=e8f2995a48e5445d1047f42f14964bd7</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1080%2F10426500802083158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10426500802083158%26sid%3Dliteratum%253Aachs%26aulast%3DBadawy%26aufirst%3DD.%2BS.%26aulast%3DKandeel%26aufirst%3DE.%2BM.%26aulast%3DAwad%26aufirst%3DN.%2BM.%26aulast%3DAbdel-Rahman%26aufirst%3DA.-R.%2BH.%26atitle%3DSynthesis%2520of%2520some%2520new%2520naphthopyran%252C%2520pyrazole%252C%2520pyridine%252C%2520and%2520thienobenzochromene%2520derivatives%2520using%25201-%25281-hydroxy-2-naphthyl%2529%2520ethanone%2520as%2520a%2520versatile%2520starting%2520material%26jtitle%3DPhosphorus%252C%2520Sulfur%2520Silicon%2520Relat.%2520Elem%26date%3D2009%26volume%3D184%26spage%3D179%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">Compound <b>40</b> has reportedly been synthesized by an alternative procedure:</p></div><span class="NLM_contrib-group">Shaw, G.</span><span> </span><span class="NLM_article-title">A novel high yield γ-chromone synthesis</span> <span class="citation_source-journal">J. Chem. Soc., Chem. Comm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_fpage">1735</span><span class="NLM_x">–</span> <span class="NLM_lpage">1736</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1039%2Fc39870001735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADyaL1cXhvVKmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1987&pages=1735-1736&author=G.+Shaw&title=A+novel+high+yield+%CE%B3-chromone+synthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">A novel high yield γ-chromone synthesis</span></div><div class="casAuthors">Shaw, Gordon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society, Chemical Communications</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1735-6</span>CODEN:
                <span class="NLM_cas:coden">JCCCAT</span>;
        ISSN:<span class="NLM_cas:issn">0022-4936</span>.
    </div><div class="casAbstract">Chromones I (R = H, Cl, Br, R1 = H, OMe, OEt, Br) were prepd. in > 90% yields by cyclocondensation of salicylaldehydes II with enamine III in hot EtOH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSpdiYNAppsLVg90H21EOLACvtfcHk0lhi5R_FAtuUEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhvVKmsrw%253D&md5=6141f715b670933fe215fb1710d02bfb</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1039%2Fc39870001735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc39870001735%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DG.%26atitle%3DA%2520novel%2520high%2520yield%2520%25CE%25B3-chromone%2520synthesis%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Comm.%26date%3D1987%26spage%3D1735%26epage%3D1736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="note"><p class="first last">Stereochemistry for compounds <b>41</b> and <b>50</b> assigned by analogy to related compounds from the literature.</p></div><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Saengchantara, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, T. W.</span><span> </span><span class="NLM_article-title">Heterodiene cycloadditions of 3-acylchromones with enol ethers</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. I</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">794</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1986&pages=789-794&author=S.+T.+Saengchantaraauthor=T.+W.+Wallace&title=Heterodiene+cycloadditions+of+3-acylchromones+with+enol+ethers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaengchantara%26aufirst%3DS.%2BT.%26aulast%3DWallace%26aufirst%3DT.%2BW.%26atitle%3DHeterodiene%2520cycloadditions%2520of%25203-acylchromones%2520with%2520enol%2520ethers%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%2520I%26date%3D1986%26spage%3D789%26epage%3D794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Coutts, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, T. W.</span><span> </span><span class="NLM_article-title">Heterodiene cycloadditions: Preparation and transformations of some substituted pyrano[4,3-b][1]benzopyrans</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">11755</span><span class="NLM_x">–</span> <span class="NLM_lpage">11780</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=11755-11780&author=S.+J.+Couttsauthor=T.+W.+Wallace&title=Heterodiene+cycloadditions%3A+Preparation+and+transformations+of+some+substituted+pyrano%5B4%2C3-b%5D%5B1%5Dbenzopyrans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoutts%26aufirst%3DS.%2BJ.%26aulast%3DWallace%26aufirst%3DT.%2BW.%26atitle%3DHeterodiene%2520cycloadditions%253A%2520Preparation%2520and%2520transformations%2520of%2520some%2520substituted%2520pyrano%255B4%252C3-b%255D%255B1%255Dbenzopyrans%26jtitle%3DTetrahedron%26date%3D1994%26volume%3D50%26spage%3D11755%26epage%3D11780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="note"><p class="first last">We found that using the 1 and 4 h time points for evaluating coverage ratio gave a comparable result to using an AUC-based coverage ratio for rank ordering compounds.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvester, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aharony, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andisik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folmer, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwindner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koether, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumrine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spear, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, G.</span><span> </span><span class="NLM_article-title">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5912</span><span class="NLM_x">–</span> <span class="NLM_lpage">5925</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070829p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5912-5925&author=P.+D.+Edwardsauthor=J.+S.+Albertauthor=M.+Sylvesterauthor=D.+Aharonyauthor=D.+Andisikauthor=O.+Callaghanauthor=J.+B.+Campbellauthor=R.+A.+Carrauthor=G.+Chessariauthor=M.+Congreveauthor=M.+Fredericksonauthor=R.+H.+Folmerauthor=S.+Geschwindnerauthor=G.+Koetherauthor=K.+Kolmodinauthor=J.+Krumrineauthor=R.+C.+Maugerauthor=C.+W.+Murrayauthor=L.+L.+Olssonauthor=S.+Patelauthor=N.+Spearauthor=G.+Tian&title=Application+of+fragment-based+lead+generation+to+the+discovery+of+novel%2C+cyclic+amidine+%CE%B2-secretase+inhibitors+with+nanomolar+potency%2C+cellular+activity%2C+and+high+ligand+efficiency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span></div><div class="casAuthors">Edwards, Philip D.; Albert, Jeffrey S.; Sylvester, Mark; Aharony, David; Andisik, Donald; Callaghan, Owen; Campbell, James B.; Carr, Robin A.; Chessari, Gianni; Congreve, Miles; Frederickson, Martyn; Folmer, Rutger H. A.; Geschwindner, Stefan; Koether, Gerard; Kolmodin, Karin; Krumrine, Jennifer; Mauger, Russell C.; Murray, Christopher W.; Olsson, Lise-Lotte; Patel, Sahil; Spear, Nate; Tian, Gaochao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5912-5925</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based lead generation has led to the discovery of a novel series of cyclic amidine-based inhibitors of β-secretase (BACE-1).  Initial fragment hits with an isocytosine core having millimolar potency were identified via NMR affinity screening.  Structure-guided evolution of these fragments using x-ray crystallog. together with potency detn. using surface plasmon resonance and functional enzyme inhibition assays afforded micromolar inhibitors.  Similarity searching around the isocytosine core led to the identification of a related series of inhibitors, the dihydroisocytosines.  By leveraging the knowledge of the ligand-BACE-1 recognition features generated from the isocytosines, the dihydroisocytosines were efficiently optimized to submicromolar potency.  Compd. (I), with an IC50 of 80 nM, a ligand efficiency of 0.37, and cellular activity of 470 nM, emerged as the lead structure for future optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmm71A2gRltrVg90H21EOLACvtfcHk0lhi5R_FAtuUEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP&md5=140f3ade2b7754f62eb73589c5de4d7b</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fjm070829p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070829p%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26aulast%3DSylvester%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAndisik%26aufirst%3DD.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%2BB.%26aulast%3DCarr%26aufirst%3DR.%2BA.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DFolmer%26aufirst%3DR.%2BH.%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DKoether%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKrumrine%26aufirst%3DJ.%26aulast%3DMauger%26aufirst%3DR.%2BC.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DOlsson%26aufirst%3DL.%2BL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSpear%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DG.%26atitle%3DApplication%2520of%2520fragment-based%2520lead%2520generation%2520to%2520the%2520discovery%2520of%2520novel%252C%2520cyclic%2520amidine%2520%25CE%25B2-secretase%2520inhibitors%2520with%2520nanomolar%2520potency%252C%2520cellular%2520activity%252C%2520and%2520high%2520ligand%2520efficiency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5912%26epage%3D5925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6314</span><span class="NLM_x">–</span> <span class="NLM_lpage">6323</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9006752" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6314-6323&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=K.+Barnesauthor=M.+Johnsonauthor=Y.+Huiauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=A.+Ollandauthor=J.+Bardauthor=A.+J.+Robichaud&title=Aminoimidazoles+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Fjm9006752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9006752%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DBarnes%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DY.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DAminoimidazoles%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6314%26epage%3D6323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plobeck, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehgelmeble, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelissen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as BACE-1 inhibitors: the challenge to achieve in vivo brain efficacy</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1854</span><span class="NLM_x">–</span> <span class="NLM_lpage">1859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1854-1859&author=B.-M.+Swahnauthor=J.+Holenzauthor=J.+Kihlstr%C3%B6mauthor=K.+Kolmodinauthor=J.+Lindstr%C3%B6mauthor=N.+Plobeckauthor=D.+Rotticciauthor=F.+Sehgelmebleauthor=M.+Sundstr%C3%B6mauthor=S.+von+Bergauthor=J.+F%C3%A4ltingauthor=B.+Georgievskaauthor=S.+Gustavssonauthor=J.+Neelissenauthor=M.+Ekauthor=L.-L.+Olssonauthor=S.+Berg&title=Aminoimidazoles+as+BACE-1+inhibitors%3A+the+challenge+to+achieve+in+vivo+brain+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DPlobeck%26aufirst%3DN.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DSehgelmeble%26aufirst%3DF.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DNeelissen%26aufirst%3DJ.%26aulast%3DEk%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DBerg%26aufirst%3DS.%26atitle%3DAminoimidazoles%2520as%2520BACE-1%2520inhibitors%253A%2520the%2520challenge%2520to%2520achieve%2520in%2520vivo%2520brain%2520efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1854%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiang, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span> </span><span class="NLM_article-title">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9156</span><span class="NLM_x">–</span> <span class="NLM_lpage">9169</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300598e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9156-9169&author=H.+Huangauthor=D.+S.+Laauthor=A.+C.+Chengauthor=D.+A.+Whittingtonauthor=V.+F.+Patelauthor=K.+Chenauthor=T.+A.+Dineenauthor=O.+Epsteinauthor=R.+Graceffaauthor=D.+Hickmanauthor=Y.-H.+Kiangauthor=S.+Louieauthor=Y.+Luoauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=R.+T.+Fremeau&title=Structure-+and+property-based+design+of+aminooxazoline+xanthenes+as+selective%2C+orally+efficacious%2C+and+CNS+penetrable+BACE+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22d&amp;dbid=16384&amp;doi=10.1021%2Fjm300598e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300598e%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DKiang%26aufirst%3DY.-H.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DStructure-%2520and%2520property-based%2520design%2520of%2520aminooxazoline%2520xanthenes%2520as%2520selective%252C%2520orally%2520efficacious%252C%2520and%2520CNS%2520penetrable%2520BACE%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9156%26epage%3D9169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Jean, D. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span> </span><span class="NLM_article-title">From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5836</span><span class="NLM_x">–</span> <span class="NLM_lpage">5857</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200544q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22e&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5836-5857&author=Y.+Chengauthor=T.+C.+Juddauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=R.+T.+Fremeauauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=B.+Jordanauthor=V.+Liauthor=P.+Lopezauthor=S.+W.+Louieauthor=Y.+Luoauthor=K.+Michelsenauthor=T.+Nixeyauthor=T.+S.+Powersauthor=C.+Rattanauthor=E.+A.+Sickmierauthor=D.+J.+St.+Jeanauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Wood&title=From+fragment+screening+to+in+vivo+efficacy%3A+optimization+of+a+series+of+2-aminoquinolines+as+potent+inhibitors+of+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22eR"><div class="casContent"><span class="casTitleNuber">22e</span><div class="casTitle"><span class="NLM_cas:atitle">From Fragment Screening to In Vivo Efficacy: Optimization of a Series of 2-Aminoquinolines as Potent Inhibitors of Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)</span></div><div class="casAuthors">Cheng, Yuan; Judd, Ted C.; Bartberger, Michael D.; Brown, James; Chen, Kui; Fremeau, Robert T.; Hickman, Dean; Hitchcock, Stephen A.; Jordan, Brad; Li, Vivian; Lopez, Patricia; Louie, Steven W.; Luo, Yi; Michelsen, Klaus; Nixey, Thomas; Powers, Timothy S.; Rattan, Claire; Sickmier, E. Allen; St. Jean, David J.; Wahl, Robert C.; Wen, Paul H.; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5836-5857</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using fragment-based screening of a focused fragment library, 2-aminoquinoline 1 was identified as an initial hit for BACE1.  Further SAR development was supported by X-ray structures of BACE1 cocrystd. with various ligands and mol. modeling studies to expedite the discovery of potent compds.  These strategies enabled us to integrate the C-3 side chain on 2-aminoquinoline 1 extending deep into the P2' binding pocket of BACE1 and enhancing the ligand's potency.  We were able to improve the BACE1 potency to subnanomolar range, over 106-fold more potent than the initial hit (900 μM).  Further elaboration of the phys. properties of the lead compds. to those more consistent with good blood-brain barrier permeability led to inhibitors with greatly improved cellular activity and permeability.  Compd. 59 showed an IC50 value of 11 nM on BACE1 and cellular activity of 80 nM.  This compd. was advanced into rat pharmacokinetic and pharmacodynamic studies and demonstrated significant redn. of Aβ levels in cerebrospinal fluid (CSF).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLRGyUyxO1fLVg90H21EOLACvtfcHk0lghxqP2KBCKiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D&md5=fa0f2b9b7524a1c3b75e162801f54d90</span></div><a href="/servlet/linkout?suffix=cit22e&amp;dbid=16384&amp;doi=10.1021%2Fjm200544q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200544q%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DJudd%26aufirst%3DT.%2BC.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DJordan%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%2BW.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DNixey%26aufirst%3DT.%26aulast%3DPowers%26aufirst%3DT.%2BS.%26aulast%3DRattan%26aufirst%3DC.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DFrom%2520fragment%2520screening%2520to%2520in%2520vivo%2520efficacy%253A%2520optimization%2520of%2520a%2520series%2520of%25202-aminoquinolines%2520as%2520potent%2520inhibitors%2520of%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5836%26epage%3D5857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Gravenfors, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viklund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kieseritzky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slivo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strömberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahm, F.</span><span> </span><span class="NLM_article-title">New aminoimidazoles as β-secretase (BACE-1) inhibitors showing amyloid-β (aβ) lowering in brain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9297</span><span class="NLM_x">–</span> <span class="NLM_lpage">9311</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300991n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9297-9311&author=Y.+Gravenforsauthor=J.+Viklundauthor=J.+Blidauthor=T.+Ginmanauthor=S.+Karlstr%C3%B6mauthor=J.+Kihlstr%C3%B6mauthor=K.+Kolmodinauthor=J.+Lindstr%C3%B6mauthor=S.+von+Bergauthor=F.+von+Kieseritzkyauthor=C.+Slivoauthor=B.-M.+Swahnauthor=L.-L.+Olssonauthor=P.+Johanssonauthor=S.+Eketj%C3%A4llauthor=J.+F%C3%A4ltingauthor=F.+Jeppssonauthor=K.+Str%C3%B6mbergauthor=J.+Jansonauthor=F.+Rahm&title=New+aminoimidazoles+as+%CE%B2-secretase+%28BACE-1%29+inhibitors+showing+amyloid-%CE%B2+%28a%CE%B2%29+lowering+in+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22f&amp;dbid=16384&amp;doi=10.1021%2Fjm300991n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300991n%26sid%3Dliteratum%253Aachs%26aulast%3DGravenfors%26aufirst%3DY.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DBlid%26aufirst%3DJ.%26aulast%3DGinman%26aufirst%3DT.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DStr%25C3%25B6mberg%26aufirst%3DK.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DRahm%26aufirst%3DF.%26atitle%3DNew%2520aminoimidazoles%2520as%2520%25CE%25B2-secretase%2520%2528BACE-1%2529%2520inhibitors%2520showing%2520amyloid-%25CE%25B2%2520%2528a%25CE%25B2%2529%2520lowering%2520in%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9297%26epage%3D9311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Mandal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzelak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buevich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9331</span><span class="NLM_x">–</span> <span class="NLM_lpage">9345</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301039c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22g&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9331-9345&author=M.+Mandalauthor=Z.+Zhuauthor=J.+N.+Cummingauthor=X.+Liuauthor=C.+Stricklandauthor=R.+D.+Mazzolaauthor=J.+P.+Caldwellauthor=P.+Leachauthor=M.+Grzelakauthor=L.+Hydeauthor=Q.+Zhangauthor=G.+Terracinaauthor=L.+Zhangauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=K.+Coxauthor=P.+Orthauthor=A.+Buevichauthor=J.+Voigtauthor=H.+Wangauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Design+and+validation+of+bicyclic+iminopyrimidinones+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors%3A+conformational+constraint+to+favor+a+bioactive+conformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22gR"><div class="casContent"><span class="casTitleNuber">22g</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation</span></div><div class="casAuthors">Mandal, Mihirbaran; Zhu, Zhaoning; Cumming, Jared N.; Liu, Xiaoxiang; Strickland, Corey; Mazzola, Robert D.; Caldwell, John P.; Leach, Prescott; Grzelak, Michael; Hyde, Lynn; Zhang, Qi; Terracina, Giuseppe; Zhang, Lili; Chen, Xia; Kuvelkar, Reshma; Kennedy, Matthew E.; Favreau, Leonard; Cox, Kathleen; Orth, Peter; Buevich, Alexei; Voigt, Johannes; Wang, Hongwu; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9331-9345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our observation that the biaryl substituent of iminopyrimidinone 7 must be in a pseudoaxial conformation to occupy the contiguous S1-S3 subsites of BACE1, we have designed a novel fused bicyclic iminopyrimidinone scaffold intended to favor this bioactive conformation.  Strategic incorporation of a nitrogen atom in the new constrained ring allowed us to develop SAR around the S2' binding pocket and ultimately resulted in analogs with low nanomolar potency for BACE1.  In particular, optimization of the prime side substituent led to major improvements in potency by displacement of two conserved water mols. from a region near S2'.  Further optimization of the pharmacokinetic properties of this fused pyrrolidine series, in conjunction with facile access to a rat pharmacodynamic model, led to identification of compd. 43, which is an orally active, brain penetrant inhibitor that reduces Aβ40 in the plasma, CSF, and cortex of rats in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlJsgY-3wuLVg90H21EOLACvtfcHk0lghxqP2KBCKiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP&md5=6fd0bc5ac847ded7e235939594d4b20d</span></div><a href="/servlet/linkout?suffix=cit22g&amp;dbid=16384&amp;doi=10.1021%2Fjm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301039c%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLeach%26aufirst%3DP.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDesign%2520and%2520validation%2520of%2520bicyclic%2520iminopyrimidinones%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%253A%2520conformational%2520constraint%2520to%2520favor%2520a%2520bioactive%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9331%26epage%3D9345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Söderman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slivo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyring, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kieseritzky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors with in vivo brain reduction of β-amyloid peptides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9346</span><span class="NLM_x">–</span> <span class="NLM_lpage">9361</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3009025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22h&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9346-9361&author=B.-M.+Swahnauthor=K.+Kolmodinauthor=S.+Karlstr%C3%B6mauthor=S.+von+Bergauthor=P.+S%C3%B6dermanauthor=J.+Holenzauthor=S.+Bergauthor=J.+Lindstr%C3%B6mauthor=M.+Sundstr%C3%B6mauthor=D.+Turekauthor=J.+Kihlstr%C3%B6mauthor=C.+Slivoauthor=L.+Anderssonauthor=D.+Pyringauthor=D.+Rotticciauthor=L.+Ohbergauthor=A.+Kersauthor=K.+Bogarauthor=F.+von+Kieseritzkyauthor=M.+Berghauthor=L.-L.+Olssonauthor=J.+Jansonauthor=S.+Eketj%C3%A4llauthor=B.+Georgievskaauthor=F.+Jeppssonauthor=J.+F%C3%A4lting&title=Design+and+synthesis+of+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE1%29+inhibitors+with+in+vivo+brain+reduction+of+%CE%B2-amyloid+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22hR"><div class="casContent"><span class="casTitleNuber">22h</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides</span></div><div class="casAuthors">Swahn, Britt-Marie; Kolmodin, Karin; Karlstroem, Sofia; von Berg, Stefan; Soederman, Peter; Holenz, Joerg; Berg, Stefan; Lindstroem, Johan; Sundstroem, Marie; Turek, Dominika; Kihlstroem, Jacob; Slivo, Can; Andersson, Lars; Pyring, David; Rotticci, Didier; Oehberg, Liselotte; Kers, Annika; Bogar, Krisztian; Bergh, Margareta; Olsson, Lise-Lotte; Janson, Juliette; Eketjaell, Susanna; Georgievska, Biljana; Jeppsson, Fredrik; Faelting, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9346-9361</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The evaluation of a series of aminoisoindoles as β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors and the discovery of a clin. candidate drug for Alzheimer's disease, (S)-32 (I, AZD3839), are described.  The improvement in permeability properties by the introduction of fluorine adjacent to the amidine moiety, resulting in in vivo brain redn. of Aβ40, is discussed.  Due to the basic nature of these compds., they displayed affinity for the human ether-a-go-go related gene (hERG) ion channel.  Different ways to reduce hERG inhibition and increase hERG margins for this series are described, culminating in (S)-16 (II) and (R)-41 (III) showing large in vitro margins with BACE1 cell IC50 values of 8.6 and 0.16 nM, resp., and hERG IC50 values of 16 and 2.8 μM, resp.  Several compds. were advanced into pharmacodynamic studies and demonstrated significant redn. of β-amyloid peptides in mouse brain following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox062OT8a6ubVg90H21EOLACvtfcHk0li3a9ObF0gwAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM&md5=da7685d90f56449caa77b6e6393e0a7d</span></div><a href="/servlet/linkout?suffix=cit22h&amp;dbid=16384&amp;doi=10.1021%2Fjm3009025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009025%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DS%25C3%25B6derman%26aufirst%3DP.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DTurek%26aufirst%3DD.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DAndersson%26aufirst%3DL.%26aulast%3DPyring%26aufirst%3DD.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DOhberg%26aufirst%3DL.%26aulast%3DKers%26aufirst%3DA.%26aulast%3DBogar%26aufirst%3DK.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DBergh%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE1%2529%2520inhibitors%2520with%2520in%2520vivo%2520brain%2520reduction%2520of%2520%25CE%25B2-amyloid%2520peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9346%26epage%3D9361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2444</span><span class="NLM_x">–</span> <span class="NLM_lpage">2449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22i&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1016%2Fj.bmcl.2012.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22i&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=22390835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22i&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2444-2449&author=J.+N.+Cummingauthor=E.+M.+Smithauthor=L.+Wangauthor=J.+Misiaszekauthor=J.+Durkinauthor=J.+Panauthor=U.+Iserlohauthor=Y.+Wuauthor=Z.+Zhuauthor=C.+Stricklandauthor=J.+Voigtauthor=X.+Chenauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=M.+F.+Czarnieckiauthor=W.+J.+Greenleeauthor=B.+A.+McKittrickauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Structure+based+design+of+iminohydantoin+BACE1+inhibitors%3A+identification+of+an+orally+available%2C+centrally+active+BACE1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22iR"><div class="casContent"><span class="casTitleNuber">22i</span><div class="casTitle"><span class="NLM_cas:atitle">Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitor</span></div><div class="casAuthors">Cumming, Jared N.; Smith, Elizabeth M.; Wang, Lingyan; Misiaszek, Jeffrey; Durkin, James; Pan, Jianping; Iserloh, Ulrich; Wu, Yusheng; Zhu, Zhaoning; Strickland, Corey; Voigt, Johannes; Chen, Xia; Kennedy, Matthew E.; Kuvelkar, Reshma; Hyde, Lynn A.; Cox, Kathleen; Favreau, Leonard; Czarniecki, Michael F.; Greenlee, William J.; McKittrick, Brian A.; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2444-2449</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">From an initial lead 2-imino-1-methyl-4,4-diphenyl-5-imidazolidinone, a structure-based design approach led to identification of the novel, high-affinity iminohydantoin BACE1 inhibitor I that lowers CNS-derived Aβ following oral administration to rats.  SAR development in the S3 and F' subsites of BACE1 for this series, the synthetic approaches employed in this effort, and in vivo data for I are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3tWBE09QKNLVg90H21EOLACvtfcHk0li3a9ObF0gwAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D&md5=783b6cb9a6d9608ff5e9dc4f5d634397</span></div><a href="/servlet/linkout?suffix=cit22i&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCzarniecki%26aufirst%3DM.%2BF.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DStructure%2520based%2520design%2520of%2520iminohydantoin%2520BACE1%2520inhibitors%253A%2520identification%2520of%2520an%2520orally%2520available%252C%2520centrally%2520active%2520BACE1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2444%26epage%3D2449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of 5,5′-disubstituted aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1146</span><span class="NLM_x">–</span> <span class="NLM_lpage">1158</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901414e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22j&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1146-1158&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=R.+Chopraauthor=A.+Ollandauthor=J.+Bardauthor=S.+Jacobsenauthor=R.+L.+Magoldaauthor=M.+Pangalosauthor=A.+J.+Robichaud&title=Design+and+synthesis+of+5%2C5%E2%80%B2-disubstituted+aminohydantoins+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22jR"><div class="casContent"><span class="casTitleNuber">22j</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of 5,5'-Disubstituted Aminohydantoins as Potent and Selective Human β-Secretase (BACE1) Inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Erdei, Jim; Gunawan, Iwan; Turner, Jim; Hu, Yun; Wagner, Erik; Fan, Kristi; Chopra, Rajiv; Olland, Andrea; Bard, Jonathan; Jacobsen, Steve; Magolda, Ronald L.; Pangalos, Menelas; Robichaud, Albert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1146-1158</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of small mol. aminohydantoins as potent and selective human β-secretase inhibitors is reported.  These analogs exhibit low nanomolar potency for BACE1, show comparable activity in a cell-based (ELISA) assay, and demonstrate > 100 × selectivity for the other structurally related aspartyl proteases BACE2, cathepsinD, renin, and pepsin.  On the basis of the cocrystal structure of the HTS-hit I in the BACE1 active site and by use of a structure-based drug design approach, we methodically explored the comparatively large binding pocket of the BACE1 enzyme and identified key interactions between the ligand and the protein that contributed to the affinity.  One of the more potent compds., (S)-II, displayed an IC50 value for BACE1 of 10 nM and exhibited comparable cellular activity (EC50 = 20 nM) in the ELISA assay.  Acute oral administration of (S)-II at 100 mg/kg resulted in a 69% redn. of plasma Aβ40 at 8 h in a Tg2576 mouse (p < 0.001).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovSHqfBBe70bVg90H21EOLACvtfcHk0ljchnsODmZSgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN&md5=a27e4fbd64ed167ca7baae773c178fbc</span></div><a href="/servlet/linkout?suffix=cit22j&amp;dbid=16384&amp;doi=10.1021%2Fjm901414e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901414e%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DPangalos%26aufirst%3DM.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25205%252C5%25E2%2580%25B2-disubstituted%2520aminohydantoins%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1146%26epage%3D1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Hilpert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woltering, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayweg, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers-Evans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krummenacher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnider, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergadano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochstrasser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David-Pierson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narquizian, R.</span><span> </span><span class="NLM_article-title">β-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3980</span><span class="NLM_x">–</span> <span class="NLM_lpage">3995</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400225m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3980-3995&author=H.+Hilpertauthor=W.+Gubaauthor=T.+J.+Wolteringauthor=W.+Wostlauthor=E.+Pinardauthor=H.+Mauserauthor=A.+V.+Maywegauthor=M.+Rogers-Evansauthor=R.+Hummauthor=D.+Krummenacherauthor=T.+Muserauthor=C.+Schniderauthor=H.+Jacobsenauthor=L.+Ozmenauthor=A.+Bergadanoauthor=D.+W.+Bannerauthor=R.+Hochstrasserauthor=A.+Kuglstatterauthor=P.+David-Piersonauthor=H.+Fischerauthor=A.+Polaraauthor=R.+Narquizian&title=%CE%B2-Secretase+%28BACE1%29+inhibitors+with+high+in+vivo+efficacy+suitable+for+clinical+evaluation+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm400225m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400225m%26sid%3Dliteratum%253Aachs%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DMayweg%26aufirst%3DA.%2BV.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DHumm%26aufirst%3DR.%26aulast%3DKrummenacher%26aufirst%3DD.%26aulast%3DMuser%26aufirst%3DT.%26aulast%3DSchnider%26aufirst%3DC.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DBergadano%26aufirst%3DA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHochstrasser%26aufirst%3DR.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DDavid-Pierson%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DPolara%26aufirst%3DA.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3D%25CE%25B2-Secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520high%2520in%2520vivo%2520efficacy%2520suitable%2520for%2520clinical%2520evaluation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3980%26epage%3D3995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="note"><p class="first last">The alternate trans diastereomers (not depicted), analogous to diastereomers B in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, were significantly less potent.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="note"><p class="first last">The alternate trans diastereomers (not depicted), analogous to diastereomers A in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, were significantly less potent.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="note"><p class="first last">The alternate trans diastereomer (not depicted), analogous to diastereomers A in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, was not accessible using the synthetic route described by Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0ljchnsODmZSgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="note"><p class="first last"><i>F</i>% of 103% was within experimental error of 100%.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Du, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosner, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K. F.</span><span> </span><span class="NLM_article-title">Dominance of amyloid precursor protein sequence over host cell secretases in determining β-amyloid profiles studies of interspecies variation and drug action by internally standardized immunoprecipitation/mass spectrometry</span> <span class="citation_source-journal">J. Pharm. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">1144</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1124%2Fjpet.106.114561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=17202404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1Wgtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=1144-1152&author=P.+Duauthor=K.+M.+Woodauthor=M.+H.+Rosnerauthor=D.+Cunninghamauthor=B.+Tateauthor=K.+F.+Geoghegan&title=Dominance+of+amyloid+precursor+protein+sequence+over+host+cell+secretases+in+determining+%CE%B2-amyloid+profiles+studies+of+interspecies+variation+and+drug+action+by+internally+standardized+immunoprecipitation%2Fmass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Dominance of amyloid precursor protein sequence over host cell secretases in determining β-amyloid profiles studies of interspecies variation and drug action by internally standardized immunoprecipitation/mass spectrometry</span></div><div class="casAuthors">Du, Ping; Wood, Kathleen M.; Rosner, Michele H.; Cunningham, David; Tate, Barbara; Geoghegan, Kieran F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1144-1152</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">β-Amyloid peptides, tentatively regarded as the principal neurotoxins responsible for Alzheimer's Disease, make up a set of products that varies significantly among different biol. systems.  The full implications of this complexity and its variations have yet to be defined.  In this work, Aβ peptide populations were extd. from animal brain tissue or cell-conditioned media, immunopptd. with specific antibodies, and analyzed by matrix-assisted laser desorption time-of-flight mass spectrometry.  15N-Substituted Aβ internal stds. were added to gauge variations in the profile of captured peptides.  Results from a range of species, including guinea pig, dog, rabbit, and wild-type and transgenic mice, showed that the Aβ peptide population in each system was mainly detd. by the species of origin of the amyloid precursor protein (APP) and not by the host tissue or cell line.  The same method was used to gauge the effect on the Aβ peptide profile of an inhibitor of γ-secretase, one of the two proteinases that excises Aβ peptides from the precursor protein with different effects on specific peptides.  Overall, the results demonstrate that the species of origin of the APP substrate dictates the outcome of APP processing to a greater extent than the origin of the processing enzymes, an important consideration in rationalizing the properties of different model systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ4VzPbVJHdLVg90H21EOLACvtfcHk0ljchnsODmZSgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1Wgtbs%253D&md5=954075f0f5b303e83eda3d571aaa81a7</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.114561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.114561%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DRosner%26aufirst%3DM.%2BH.%26aulast%3DCunningham%26aufirst%3DD.%26aulast%3DTate%26aufirst%3DB.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26atitle%3DDominance%2520of%2520amyloid%2520precursor%2520protein%2520sequence%2520over%2520host%2520cell%2520secretases%2520in%2520determining%2520%25CE%25B2-amyloid%2520profiles%2520studies%2520of%2520interspecies%2520variation%2520and%2520drug%2520action%2520by%2520internally%2520standardized%2520immunoprecipitation%252Fmass%2520spectrometry%26jtitle%3DJ.%2520Pharm.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D1144%26epage%3D1152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coraggio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wildsmith, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mango, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schauer, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hop, C. E. C. A.</span><span> </span><span class="NLM_article-title">Mechanistic pharmacokinetic–pharmacodynamic modeling of BACE1 inhibition in monkeys: development of a predictive model for amyloid precursor protein processing</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1319</span><span class="NLM_x">–</span> <span class="NLM_lpage">1328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=1319-1328&author=X.+Liuauthor=H.+Wongauthor=K.+Scearce-Levieauthor=R.+J.+Wattsauthor=M.+Coraggioauthor=Y.+G.+Shinauthor=K.+Pengauthor=K.+R.+Wildsmithauthor=J.+K.+Atwalauthor=J.+Mangoauthor=S.+P.+Schauerauthor=K.+Regalauthor=K.+W.+Huntauthor=A.+A.+Thomasauthor=M.+Siuauthor=J.+Lyssikatosauthor=G.+Deshmukhauthor=C.+E.+C.+A.+Hop&title=Mechanistic+pharmacokinetic%E2%80%93pharmacodynamic+modeling+of+BACE1+inhibition+in+monkeys%3A+development+of+a+predictive+model+for+amyloid+precursor+protein+processing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DCoraggio%26aufirst%3DM.%26aulast%3DShin%26aufirst%3DY.%2BG.%26aulast%3DPeng%26aufirst%3DK.%26aulast%3DWildsmith%26aufirst%3DK.%2BR.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DMango%26aufirst%3DJ.%26aulast%3DSchauer%26aufirst%3DS.%2BP.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DLyssikatos%26aufirst%3DJ.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DHop%26aufirst%3DC.%2BE.%2BC.%2BA.%26atitle%3DMechanistic%2520pharmacokinetic%25E2%2580%2593pharmacodynamic%2520modeling%2520of%2520BACE1%2520inhibition%2520in%2520monkeys%253A%2520development%2520of%2520a%2520predictive%2520model%2520for%2520amyloid%2520precursor%2520protein%2520processing%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26spage%3D1319%26epage%3D1328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paddock, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mildner, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lull, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cialdella, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prince, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span> </span><span class="NLM_article-title">High yield expression of human BACE constructs in <i>Eschericia coli</i> for refolding, purification, and high resolution diffracting crystal forms</span> <span class="citation_source-journal">Protein Pept. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.2174%2F092986608783489553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=18289105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVarurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=131-143&author=A.+G.+Tomasselliauthor=D.+J.+Paddockauthor=T.+L.+Emmonsauthor=A.+M.+Mildnerauthor=J.+W.+Leoneauthor=J.+M.+Lullauthor=J.+I.+Cialdellaauthor=D.+B.+Princeauthor=H.+D.+Fischerauthor=R.+L.+Heinriksonauthor=T.+E.+Benson&title=High+yield+expression+of+human+BACE+constructs+in+Eschericia+coli+for+refolding%2C+purification%2C+and+high+resolution+diffracting+crystal+forms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">High yield expression of human BACE constructs in Escherichia coli for refolding, purification, and high resolution diffracting crystal forms</span></div><div class="casAuthors">Tomasselli, A. G.; Paddock, D. J.; Emmons, T. L.; Mildner, A. M.; Leone, J. W.; Lull, J. M.; Cialdella, J. I.; Prince, D. B.; Fischer, H. D.; Heinrikson, R. L.; Benson, T. E.</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Peptide Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-143</span>CODEN:
                <span class="NLM_cas:coden">PPELEN</span>;
        ISSN:<span class="NLM_cas:issn">0929-8665</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">BACE (β-site APP cleaving enzyme) or β-secretase, the enzyme responsible for processing APP to give the N-terminal portion of the Aβ peptide, is a membrane bound aspartyl protease consisting of an ectodomain catalytic unit, a C-terminal transmembrane segment and a cytoplasmic domain.  Three BACE constructs, pET11a-BACE, pQE80L-BACE, and pQE70-BACE were designed to terminate at a position just before the transmembrane domain (Ser432) and are described schematically below.  (1) PET11a-T7.Tag-G-S-M-(A-8GV......QTDES432),.  (2) PQE80L-Met-R-G-S-(His)6-G-S-I-E-T-D-(T1QH...QTDES432), and.  (3) PQE70-Met-BACE (R36GSFVEMG....PQTDES432(His)6).  Each construct was over-expressed in Escherichia coli as inclusion bodies.  The inclusion body proteins were solubilized in urea and refolded by diln. in water to yield active enzyme.  Maximal activity for pET11a-BACE and pQE80L-BACE was usually reached at day 3 to 4, while construct pQE70-BACE required about 21 days.  Active BACE was purified to homogeneity by anion-exchange chromatog. and affinity chromatog. over a column of immobilized peptide inhibitor.  The process, easily scalable to 60 L of cell culture, yielded in excess of 400 mg of active enzyme for crystallog. anal.  Highly purified pET11a-BACE and pQE70-BACE formed complexes with various inhibitors, the latter protein giving crystals diffracting up to 1.45 Å resoln.  In addn., a crystal form that does not require the presence of an inhibitor has been obtained for pQE70-BACE.  This ligand-free crystal form has proven useful for the prepn. of BACE-inhibitor complexes in soaking expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEJA1PQtQJMrVg90H21EOLACvtfcHk0liwXLl1PIhk1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVarurY%253D&md5=b4b34ea8ea98fe464c924be9e583238d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F092986608783489553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986608783489553%26sid%3Dliteratum%253Aachs%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DPaddock%26aufirst%3DD.%2BJ.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DMildner%26aufirst%3DA.%2BM.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DLull%26aufirst%3DJ.%2BM.%26aulast%3DCialdella%26aufirst%3DJ.%2BI.%26aulast%3DPrince%26aufirst%3DD.%2BB.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DHigh%2520yield%2520expression%2520of%2520human%2520BACE%2520constructs%2520in%2520Eschericia%2520coli%2520for%2520refolding%252C%2520purification%252C%2520and%2520high%2520resolution%2520diffracting%2520crystal%2520forms%26jtitle%3DProtein%2520Pept.%2520Lett.%26date%3D2008%26volume%3D15%26spage%3D131%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Leslie, A. G. W.; Powell, H. R.</span><span> </span><span class="NLM_article-title">Processing Diffraction Data with Mosfim</span>. In  <span class="citation_source-book">Evolving Methods for Macromolecular Crystallography</span>; <span class="NLM_contrib-group">Read, R. J.; Sussman, J. L.</span>, Eds.; NATO Science Series II: Mathematics, Physics, and Chemistry 245; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1007%2F978-1-4020-6316-9_4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=41-51&author=A.+G.+W.+Leslie&author=H.+R.+Powellauthor=R.+J.+Read&author=J.+L.+Sussman&title=Evolving+Methods+for+Macromolecular+Crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2F978-1-4020-6316-9_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4020-6316-9_4%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26atitle%3DProcessing%2520Diffraction%2520Data%2520with%2520Mosfim%26btitle%3DEvolving%2520Methods%2520for%2520Macromolecular%2520Crystallography%26aulast%3DRead%26aufirst%3DR.%2BJ.%26pub%3DSpringer%26date%3D2007%26spage%3D41%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krissinel, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. S.</span><span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">D67</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0liwXLl1PIhk1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3DD67%26spage%3D235%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0liV-asenNRh0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5a','cit5b','cit5c','cit5d','cit5e'],'ref6':['cit6a','cit6b','cit6c','cit6d'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11a','cit11b','cit11c','cit11d','cit11e'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b','cit14c'],'ref15':['cit15a','cit15b','cit15c'],'ref16':['cit16a','cit16b'],'ref17':['cit17a','cit17b','cit17c'],'ref18':[],'ref19':['cit19a','cit19b'],'ref20':['cit20a','cit20b'],'ref21':[],'ref22':['cit22a','cit22b','cit22c','cit22d','cit22e','cit22f','cit22g','cit22h','cit22i','cit22j'],'ref23':['cit23'],'ref24':[],'ref25':[],'ref26':[],'ref27':['cit27'],'ref28':[],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 29 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jianzhong Chen, Baohua Yin, Wei Wang, <span class="NLM_string-name hlFld-ContribAuthor">Haibo Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of Disulfide Bonds on Binding of Inhibitors to β-Amyloid Cleaving Enzyme 1 Decoded by Multiple Replica Accelerated Molecular Dynamics Simulations. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (12)
                                     , 1811-1826. <a href="https://doi.org/10.1021/acschemneuro.0c00234" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00234</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00234%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DEffects%252Bof%252BDisulfide%252BBonds%252Bon%252BBinding%252Bof%252BInhibitors%252Bto%252B%2525CE%2525B2-Amyloid%252BCleaving%252BEnzyme%252B1%252BDecoded%252Bby%252BMultiple%252BReplica%252BAccelerated%252BMolecular%252BDynamics%252BSimulations%26aulast%3DChen%26aufirst%3DJianzhong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21042020%26date%3D27052020%26date%3D08062020%26date%3D27052020%26volume%3D11%26issue%3D12%26spage%3D1811%26epage%3D1826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Prati</span>, <span class="hlFld-ContribAuthor ">Giovanni  Bottegoni</span>, <span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>, and <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>  . </span><span class="cited-content_cbyCitation_article-title">BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 619-637. <a href="https://doi.org/10.1021/acs.jmedchem.7b00393" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00393</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00393%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBACE-1%252BInhibitors%25253A%252BFrom%252BRecent%252BSingle-Target%252BMolecules%252Bto%252BMultitarget%252BCompounds%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPrati%26aufirst%3DFederica%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D13032017%26date%3D08082017%26date%3D08022018%26date%3D27072017%26volume%3D61%26issue%3D3%26spage%3D619%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linda  Åkerbladh</span>, <span class="hlFld-ContribAuthor ">Luke S.  Schembri</span>, <span class="hlFld-ContribAuthor ">Mats  Larhed</span>, and <span class="hlFld-ContribAuthor ">Luke R.  Odell</span>  . </span><span class="cited-content_cbyCitation_article-title">Palladium(0)-Catalyzed Carbonylative One-Pot Synthesis of N-Acylguanidines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (23)
                                     , 12520-12529. <a href="https://doi.org/10.1021/acs.joc.7b02294" title="DOI URL">https://doi.org/10.1021/acs.joc.7b02294</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b02294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b02294%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPalladium%2525280%252529-Catalyzed%252BCarbonylative%252BOne-Pot%252BSynthesis%252Bof%252BN-Acylguanidines%26aulast%3D%25C3%2585kerbladh%26aufirst%3DLinda%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D12092017%26date%3D27102017%26date%3D01122017%26date%3D13102017%26volume%3D82%26issue%3D23%26spage%3D12520%26epage%3D12529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Myriam  Ciordia</span>, <span class="hlFld-ContribAuthor ">Laura  Pérez-Benito</span>, <span class="hlFld-ContribAuthor ">Francisca  Delgado</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>, and <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>  . </span><span class="cited-content_cbyCitation_article-title">Application of Free Energy Perturbation for the Design of BACE1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2016,</strong> <em>56 </em>
                                    (9)
                                     , 1856-1871. <a href="https://doi.org/10.1021/acs.jcim.6b00220" title="DOI URL">https://doi.org/10.1021/acs.jcim.6b00220</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.6b00220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.6b00220%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DApplication%252Bof%252BFree%252BEnergy%252BPerturbation%252Bfor%252Bthe%252BDesign%252Bof%252BBACE1%252BInhibitors%26aulast%3DCiordia%26aufirst%3DMyriam%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D19042016%26date%3D24082016%26date%3D26092016%26date%3D08082016%26volume%3D56%26issue%3D9%26spage%3D1856%26epage%3D1871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan  Cheng</span>, <span class="hlFld-ContribAuthor ">James  Brown</span>, <span class="hlFld-ContribAuthor ">Ted C.  Judd</span>, <span class="hlFld-ContribAuthor ">Patricia  Lopez</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Qian</span>, <span class="hlFld-ContribAuthor ">Timothy S.  Powers</span>, <span class="hlFld-ContribAuthor ">Jian Jeffrey  Chen</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">Kui  Chen</span>, <span class="hlFld-ContribAuthor ">Robert T.  Dunn, II</span>, <span class="hlFld-ContribAuthor ">Oleg  Epstein</span>, <span class="hlFld-ContribAuthor ">Robert T.  Fremeau, Jr.</span>, <span class="hlFld-ContribAuthor ">Scott  Harried</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Stephen A.  Hitchcock</span>, <span class="hlFld-ContribAuthor ">Yi  Luo</span>, <span class="hlFld-ContribAuthor ">Ana Elena  Minatti</span>, <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>, <span class="hlFld-ContribAuthor ">Hugo M.  Vargas</span>, <span class="hlFld-ContribAuthor ">Robert C.  Wahl</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Paul H.  Wen</span>, <span class="hlFld-ContribAuthor ">Ryan D.  White</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Xiao Mei  Zheng</span>, and <span class="hlFld-ContribAuthor ">Stephen  Wood</span>  . </span><span class="cited-content_cbyCitation_article-title">An Orally Available BACE1 Inhibitor That Affords Robust CNS Aβ Reduction without Cardiovascular Liabilities. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (2)
                                     , 210-215. <a href="https://doi.org/10.1021/ml500458t" title="DOI URL">https://doi.org/10.1021/ml500458t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml500458t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml500458t%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAn%252BOrally%252BAvailable%252BBACE1%252BInhibitor%252BThat%252BAffords%252BRobust%252BCNS%252BA%2525CE%2525B2%252BReduction%252Bwithout%252BCardiovascular%252BLiabilities%26aulast%3DCheng%26aufirst%3DYuan%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D06112014%26date%3D29122014%26date%3D07012015%26date%3D12022015%26date%3D29122014%26volume%3D6%26issue%3D2%26spage%3D210%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oleg  Epstein</span>, <span class="hlFld-ContribAuthor ">Marian C.  Bryan</span>, <span class="hlFld-ContribAuthor ">Alan C.  Cheng</span>, <span class="hlFld-ContribAuthor ">Katayoun  Derakhchan</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Dineen</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Zihao  Hua</span>, <span class="hlFld-ContribAuthor ">Jason B.  Human</span>, <span class="hlFld-ContribAuthor ">Charles  Kreiman</span>, <span class="hlFld-ContribAuthor ">Isaac E.  Marx</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Robert C.  Wahl</span>, <span class="hlFld-ContribAuthor ">Paul H.  Wen</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Xiao Mei  Zheng</span>, <span class="hlFld-ContribAuthor ">Robert T.  Fremeau, Jr.</span>, <span class="hlFld-ContribAuthor ">Ryan D.  White</span>, and <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>  . </span><span class="cited-content_cbyCitation_article-title">Lead Optimization and Modulation of hERG Activity in a Series of Aminooxazoline Xanthene β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (23)
                                     , 9796-9810. <a href="https://doi.org/10.1021/jm501266w" title="DOI URL">https://doi.org/10.1021/jm501266w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501266w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501266w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLead%252BOptimization%252Band%252BModulation%252Bof%252BhERG%252BActivity%252Bin%252Ba%252BSeries%252Bof%252BAminooxazoline%252BXanthene%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B%252528BACE1%252529%252BInhibitors%26aulast%3DEpstein%26aufirst%3DOleg%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D18082014%26date%3D12112014%26date%3D11122014%26volume%3D57%26issue%3D23%26spage%3D9796%26epage%3D9810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Allen A.  Thomas</span>, <span class="hlFld-ContribAuthor ">Kevin W.  Hunt</span>, <span class="hlFld-ContribAuthor ">Brad  Newhouse</span>, <span class="hlFld-ContribAuthor ">Ryan J.  Watts</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Guy  Vigers</span>, <span class="hlFld-ContribAuthor ">Darin  Smith</span>, <span class="hlFld-ContribAuthor ">Susan P.  Rhodes</span>, <span class="hlFld-ContribAuthor ">Karin D.  Brown</span>, <span class="hlFld-ContribAuthor ">Jennifer N.  Otten</span>, <span class="hlFld-ContribAuthor ">Michael  Burkard</span>, <span class="hlFld-ContribAuthor ">April A.  Cox</span>, <span class="hlFld-ContribAuthor ">Mary K.  Geck Do</span>, <span class="hlFld-ContribAuthor ">Darrin  Dutcher</span>, <span class="hlFld-ContribAuthor ">Sumeet  Rana</span>, <span class="hlFld-ContribAuthor ">Robert K.  DeLisle</span>, <span class="hlFld-ContribAuthor ">Kelly  Regal</span>, <span class="hlFld-ContribAuthor ">Albion D.  Wright</span>, <span class="hlFld-ContribAuthor ">Robert  Groneberg</span>, <span class="hlFld-ContribAuthor ">Jiangpeng  Liao</span>, <span class="hlFld-ContribAuthor ">Kimberly  Scearce-Levie</span>, <span class="hlFld-ContribAuthor ">Michael  Siu</span>, <span class="hlFld-ContribAuthor ">Hans E.  Purkey</span>, and <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>  . </span><span class="cited-content_cbyCitation_article-title">8-Tetrahydropyran-2-yl Chromans: Highly Selective Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (23)
                                     , 10112-10129. <a href="https://doi.org/10.1021/jm5015132" title="DOI URL">https://doi.org/10.1021/jm5015132</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5015132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5015132%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D8-Tetrahydropyran-2-yl%252BChromans%25253A%252BHighly%252BSelective%252BBeta-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252B%252528BACE1%252529%252BInhibitors%26aulast%3DThomas%26aufirst%3DAllen%2BA.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D01102014%26date%3D26112014%26date%3D11122014%26date%3D20112014%26volume%3D57%26issue%3D23%26spage%3D10112%26epage%3D10129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muslum  Yildiz</span>. </span><span class="cited-content_cbyCitation_article-title">Docking studies suggest the important role of interactions among the catalytic dyad and inhibitors for designing Bace1 specific inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1208 </em>, 127893. <a href="https://doi.org/10.1016/j.molstruc.2020.127893" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.127893</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.127893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.127893%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DDocking%252Bstudies%252Bsuggest%252Bthe%252Bimportant%252Brole%252Bof%252Binteractions%252Bamong%252Bthe%252Bcatalytic%252Bdyad%252Band%252Binhibitors%252Bfor%252Bdesigning%252BBace1%252Bspecific%252Binhibitors%26aulast%3DYildiz%26aufirst%3DMuslum%26date%3D2020%26volume%3D1208%26spage%3D127893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Md. Sahab  Uddin</span>, <span class="hlFld-ContribAuthor ">Md. Tanvir  Kabir</span>, <span class="hlFld-ContribAuthor ">Philippe  Jeandet</span>, <span class="hlFld-ContribAuthor ">Bijo  Mathew</span>, <span class="hlFld-ContribAuthor ">Ghulam Md  Ashraf</span>, <span class="hlFld-ContribAuthor ">Asma  Perveen</span>, <span class="hlFld-ContribAuthor ">May N.  Bin-Jumah</span>, <span class="hlFld-ContribAuthor ">Shaker A.  Mousa</span>, <span class="hlFld-ContribAuthor ">Mohamed M.  Abdel-Daim</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Anti-Alzheimer’s Therapeutic Molecules Targeting Amyloid Precursor Protein Processing. </span><span class="cited-content_cbyCitation_journal-name">Oxidative Medicine and Cellular Longevity</span><span> <strong>2020,</strong> <em>2020 </em>, 1-19. <a href="https://doi.org/10.1155/2020/7039138" title="DOI URL">https://doi.org/10.1155/2020/7039138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2020/7039138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2020%2F7039138%26sid%3Dliteratum%253Aachs%26jtitle%3DOxidative%2520Medicine%2520and%2520Cellular%2520Longevity%26atitle%3DNovel%252BAnti-Alzheimer%2525E2%252580%252599s%252BTherapeutic%252BMolecules%252BTargeting%252BAmyloid%252BPrecursor%252BProtein%252BProcessing%26aulast%3DUddin%26aufirst%3DMd.%2BSahab%26date%3D2020%26volume%3D2020%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aida  Iraji</span>, <span class="hlFld-ContribAuthor ">Mahsima  Khoshneviszadeh</span>, <span class="hlFld-ContribAuthor ">Omidreza  Firuzi</span>, <span class="hlFld-ContribAuthor ">Mehdi  Khoshneviszadeh</span>, <span class="hlFld-ContribAuthor ">Najmeh  Edraki</span>. </span><span class="cited-content_cbyCitation_article-title">Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>97 </em>, 103649. <a href="https://doi.org/10.1016/j.bioorg.2020.103649" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103649%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNovel%252Bsmall%252Bmolecule%252Btherapeutic%252Bagents%252Bfor%252BAlzheimer%252Bdisease%25253A%252BFocusing%252Bon%252BBACE1%252Band%252Bmulti-target%252Bdirected%252Bligands%26aulast%3DIraji%26aufirst%3DAida%26date%3D2020%26volume%3D97%26spage%3D103649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cedric S.  Graebin</span>, <span class="hlFld-ContribAuthor ">Felipe V.  Ribeiro</span>, <span class="hlFld-ContribAuthor ">Kamilla R.  Rogério</span>, <span class="hlFld-ContribAuthor ">Arthur E.  Kümmerle</span>. </span><span class="cited-content_cbyCitation_article-title">Multicomponent Reactions for the Synthesis of Bioactive Compounds: A Review. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Synthesis</span><span> <strong>2019,</strong> <em>16 </em>
                                    (6)
                                     , 855-899. <a href="https://doi.org/10.2174/1570179416666190718153703" title="DOI URL">https://doi.org/10.2174/1570179416666190718153703</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570179416666190718153703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570179416666190718153703%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Synthesis%26atitle%3DMulticomponent%252BReactions%252Bfor%252Bthe%252BSynthesis%252Bof%252BBioactive%252BCompounds%25253A%252BA%252BReview%26aulast%3DGraebin%26aufirst%3DCedric%2BS.%26date%3D2019%26volume%3D16%26issue%3D6%26spage%3D855%26epage%3D899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yung-Chih  Kuo</span>, <span class="hlFld-ContribAuthor ">Rajendiran  Rajesh</span>. </span><span class="cited-content_cbyCitation_article-title">Challenges in the treatment of Alzheimer’s disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Neurotherapeutics</span><span> <strong>2019,</strong> <em>19 </em>
                                    (7)
                                     , 623-652. <a href="https://doi.org/10.1080/14737175.2019.1621750" title="DOI URL">https://doi.org/10.1080/14737175.2019.1621750</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737175.2019.1621750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737175.2019.1621750%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Neurotherapeutics%26atitle%3DChallenges%252Bin%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252Brecent%252Bprogress%252Band%252Btreatment%252Bstrategies%252Bof%252Bpharmaceuticals%252Btargeting%252Bnotable%252Bpathological%252Bfactors%26aulast%3DKuo%26aufirst%3DYung-Chih%26date%3D2019%26date%3D2019%26volume%3D19%26issue%3D7%26spage%3D623%26epage%3D652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chaima  Boureghda</span>, <span class="hlFld-ContribAuthor ">Aurélie  Macé</span>, <span class="hlFld-ContribAuthor ">Fabienne  Berrée</span>, <span class="hlFld-ContribAuthor ">Thierry  Roisnel</span>, <span class="hlFld-ContribAuthor ">Abdelmadjid  Debache</span>, <span class="hlFld-ContribAuthor ">Bertrand  Carboni</span>. </span><span class="cited-content_cbyCitation_article-title">Ene reactions of 2-borylated α-methylstyrenes: a practical route to 4-methylenechromanes and derivatives. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (23)
                                     , 5789-5800. <a href="https://doi.org/10.1039/C9OB00963A" title="DOI URL">https://doi.org/10.1039/C9OB00963A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB00963A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB00963A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DEne%252Breactions%252Bof%252B2-borylated%252B%2525CE%2525B1-methylstyrenes%25253A%252Ba%252Bpractical%252Broute%252Bto%252B4-methylenechromanes%252Band%252Bderivatives%26aulast%3DBoureghda%26aufirst%3DChaima%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D23%26spage%3D5789%26epage%3D5800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miguel  Maia</span>, <span class="hlFld-ContribAuthor ">Emília  Sousa</span>. </span><span class="cited-content_cbyCitation_article-title">BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2019,</strong> <em>12 </em>
                                    (1)
                                     , 41. <a href="https://doi.org/10.3390/ph12010041" title="DOI URL">https://doi.org/10.3390/ph12010041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph12010041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph12010041%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DBACE-1%252Band%252B%2525CE%2525B3-Secretase%252Bas%252BTherapeutic%252BTargets%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DMaia%26aufirst%3DMiguel%26date%3D2019%26date%3D2019%26volume%3D12%26issue%3D1%26spage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Judite R. M.  Coimbra</span>, <span class="hlFld-ContribAuthor ">Daniela F. F.  Marques</span>, <span class="hlFld-ContribAuthor ">Salete J.  Baptista</span>, <span class="hlFld-ContribAuthor ">Cláudia M. F.  Pereira</span>, <span class="hlFld-ContribAuthor ">Paula I.  Moreira</span>, <span class="hlFld-ContribAuthor ">Teresa C. P.  Dinis</span>, <span class="hlFld-ContribAuthor ">Armanda E.  Santos</span>, <span class="hlFld-ContribAuthor ">Jorge A. R.  Salvador</span>. </span><span class="cited-content_cbyCitation_article-title">Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2018,</strong> <em>6 </em><a href="https://doi.org/10.3389/fchem.2018.00178" title="DOI URL">https://doi.org/10.3389/fchem.2018.00178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2018.00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2018.00178%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DHighlights%252Bin%252BBACE1%252BInhibitors%252Bfor%252BAlzheimer%252527s%252BDisease%252BTreatment%26aulast%3DCoimbra%26aufirst%3DJudite%2BR.%2BM.%26date%3D2018%26date%3D2018%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.M.  Tice</span>, <span class="hlFld-ContribAuthor ">Y.  Zheng</span>, <span class="hlFld-ContribAuthor ">S.B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Spirocyclic Scaffolds in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 211-263. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12291-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12291-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12291-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12291-7%26sid%3Dliteratum%253Aachs%26atitle%3DSpirocyclic%252BScaffolds%252Bin%252BDrug%252BDiscovery%26aulast%3DTice%26aufirst%3DC.M.%26date%3D2017%26spage%3D211%26epage%3D263%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Hall</span>, <span class="hlFld-ContribAuthor ">H.J.M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting β-Secretase (BACE) for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 326-383. <a href="https://doi.org/10.1016/B978-0-12-409547-2.13809-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13809-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13809-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13809-0%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252B%2525CE%2525B2-Secretase%252B%252528BACE%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DHall%26aufirst%3DA.%26date%3D2017%26spage%3D326%26epage%3D383%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Z.  Gharib</span>, <span class="hlFld-ContribAuthor ">M.  Nikpassand</span>. </span><span class="cited-content_cbyCitation_article-title">3,3-(Butane-1,4-diyl)bis(1,2-dimethyl-1H-imidazole-3-ium)bromide–cerium(IV) ammonium nitrate: A novel reagent for mild synthesis of 12-aryldibenzo[i,b]pyrano[4,3-b]chromenone of benzyl alcohols. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of General Chemistry</span><span> <strong>2016,</strong> <em>86 </em>
                                    (12)
                                     , 2759-2767. <a href="https://doi.org/10.1134/S1070363216120379" title="DOI URL">https://doi.org/10.1134/S1070363216120379</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070363216120379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070363216120379%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520General%2520Chemistry%26atitle%3D3%25252C3-%252528Butane-1%25252C4-diyl%252529bis%2525281%25252C2-dimethyl-1H-imidazole-3-ium%252529bromide%2525E2%252580%252593cerium%252528IV%252529%252Bammonium%252Bnitrate%25253A%252BA%252Bnovel%252Breagent%252Bfor%252Bmild%252Bsynthesis%252Bof%252B12-aryldibenzo%25255Bi%25252Cb%25255Dpyrano%25255B4%25252C3-b%25255Dchromenone%252Bof%252Bbenzyl%252Balcohols%26aulast%3DGharib%26aufirst%3DZ.%26date%3D2016%26date%3D2017%26volume%3D86%26issue%3D12%26spage%3D2759%26epage%3D2767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdulkadir  Kocak</span>, <span class="hlFld-ContribAuthor ">Ismail  Erol</span>, <span class="hlFld-ContribAuthor ">Muslum  Yildiz</span>, <span class="hlFld-ContribAuthor ">Hatice  Can</span>. </span><span class="cited-content_cbyCitation_article-title">Computational insights into the protonation states of catalytic dyad in BACE1–acyl guanidine based inhibitor complex. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2016,</strong> <em>70 </em>, 226-235. <a href="https://doi.org/10.1016/j.jmgm.2016.10.013" title="DOI URL">https://doi.org/10.1016/j.jmgm.2016.10.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2016.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2016.10.013%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DComputational%252Binsights%252Binto%252Bthe%252Bprotonation%252Bstates%252Bof%252Bcatalytic%252Bdyad%252Bin%252BBACE1%2525E2%252580%252593acyl%252Bguanidine%252Bbased%252Binhibitor%252Bcomplex%26aulast%3DKocak%26aufirst%3DAbdulkadir%26date%3D2016%26volume%3D70%26spage%3D226%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manjunatha  Vishwanath</span>, <span class="hlFld-ContribAuthor ">Poopathy  Vinayagam</span>, <span class="hlFld-ContribAuthor ">V Pratap Reddy  Gajulapalli</span>, <span class="hlFld-ContribAuthor ">Venkitasamy  Kesavan</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric Organocatalytic Assembly of Oxindoles Fused with Spiro-3,4-dihydropyrans with Three Contiguous Stereocenters Consisting of Vicinal Quaternary Centers. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>5 </em>
                                    (5)
                                     , 613-616. <a href="https://doi.org/10.1002/ajoc.201600051" title="DOI URL">https://doi.org/10.1002/ajoc.201600051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.201600051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.201600051%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAsymmetric%252BOrganocatalytic%252BAssembly%252Bof%252BOxindoles%252BFused%252Bwith%252BSpiro-3%25252C4-dihydropyrans%252Bwith%252BThree%252BContiguous%252BStereocenters%252BConsisting%252Bof%252BVicinal%252BQuaternary%252BCenters%26aulast%3DVishwanath%26aufirst%3DManjunatha%26date%3D2016%26date%3D2016%26volume%3D5%26issue%3D5%26spage%3D613%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arun K.  Ghosh</span>, <span class="hlFld-ContribAuthor ">Emilio L.  Cárdenas</span>, <span class="hlFld-ContribAuthor ">Heather L.  Osswald</span>. </span><span class="cited-content_cbyCitation_article-title">The Design, Development, and Evaluation of BACE1 Inhibitors for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 27-85. <a href="https://doi.org/10.1007/7355_2016_16" title="DOI URL">https://doi.org/10.1007/7355_2016_16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2016_16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2016_16%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDesign%25252C%252BDevelopment%25252C%252Band%252BEvaluation%252Bof%252BBACE1%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DGhosh%26aufirst%3DArun%2BK.%26date%3D2016%26date%3D2016%26spage%3D27%26epage%3D85%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DAlzheimer%2525E2%252580%252599s%252BDisease%252BII%26aulast%3DWolfe%26aufirst%3DMichael%2BS.%26date%3D2017%26volume%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rachel K.  Chambers</span>, <span class="hlFld-ContribAuthor ">Tanweer A.  Khan</span>, <span class="hlFld-ContribAuthor ">David B.  Olsen</span>, <span class="hlFld-ContribAuthor ">Brad E.  Sleebs</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of amino heterocycle aspartyl protease inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (22)
                                     , 4970-4985. <a href="https://doi.org/10.1039/C5OB01842K" title="DOI URL">https://doi.org/10.1039/C5OB01842K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB01842K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB01842K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bamino%252Bheterocycle%252Baspartyl%252Bprotease%252Binhibitors%26aulast%3DChambers%26aufirst%3DRachel%2BK.%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D22%26spage%3D4970%26epage%3D4985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalia  Mateu</span>, <span class="hlFld-ContribAuthor ">Myriam  Ciordia</span>, <span class="hlFld-ContribAuthor ">Oscar  Delgado</span>, <span class="hlFld-ContribAuthor ">María  Sánchez-Roselló</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>, <span class="hlFld-ContribAuthor ">Michiel  Van Gool</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">Laura  Pérez-Benito</span>, <span class="hlFld-ContribAuthor ">Santos  Fustero</span>. </span><span class="cited-content_cbyCitation_article-title">A Versatile Approach to CF
              3
              -Containing 2-Pyrrolidones by Tandem Michael Addition-Cyclization: Exemplification in the Synthesis of Amidine Class BACE1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2015,</strong> <em>21 </em>
                                    (33)
                                     , 11719-11726. <a href="https://doi.org/10.1002/chem.201501662" title="DOI URL">https://doi.org/10.1002/chem.201501662</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201501662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201501662%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DA%252BVersatile%252BApproach%252Bto%252BCF%252B3%252B-Containing%252B2-Pyrrolidones%252Bby%252BTandem%252BMichael%252BAddition-Cyclization%25253A%252BExemplification%252Bin%252Bthe%252BSynthesis%252Bof%252BAmidine%252BClass%252BBACE1%252BInhibitors%26aulast%3DMateu%26aufirst%3DNatalia%26date%3D2015%26date%3D2015%26volume%3D21%26issue%3D33%26spage%3D11719%26epage%3D11726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Annamalai  Murali</span>, <span class="hlFld-ContribAuthor ">Federico  Medda</span>, <span class="hlFld-ContribAuthor ">Matthias  Winkler</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Giordanetto</span>, <span class="hlFld-ContribAuthor ">Kamal  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Branching cascades provide access to two amino-oxazoline compound libraries. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (11)
                                     , 2656-2665. <a href="https://doi.org/10.1016/j.bmc.2015.01.009" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.01.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.01.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DBranching%252Bcascades%252Bprovide%252Baccess%252Bto%252Btwo%252Bamino-oxazoline%252Bcompound%252Blibraries%26aulast%3DMurali%26aufirst%3DAnnamalai%26date%3D2015%26volume%3D23%26issue%3D11%26spage%3D2656%26epage%3D2665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eugenia  Marqués-López</span>, <span class="hlFld-ContribAuthor ">Raquel P.  Herrera</span>. </span><span class="cited-content_cbyCitation_article-title">Bucherer-Bergs and Strecker Multicomponent Reactions. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 331-357. <a href="https://doi.org/10.1002/9781118863992.ch10" title="DOI URL">https://doi.org/10.1002/9781118863992.ch10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118863992.ch10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118863992.ch10%26sid%3Dliteratum%253Aachs%26atitle%3DBucherer-Bergs%252Band%252BStrecker%252BMulticomponent%252BReactions%26aulast%3DMarqu%25C3%25A9s-L%25C3%25B3pez%26aufirst%3DEugenia%26date%3D2015%26date%3D2015%26spage%3D331%26epage%3D357%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DMulticomponent%252BReactions%26aulast%3DHerrera%26aufirst%3DRaquel%2BP.%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian Jeffrey  Chen</span>, <span class="hlFld-ContribAuthor ">Qingyian  Liu</span>, <span class="hlFld-ContribAuthor ">Chester  Yuan</span>, <span class="hlFld-ContribAuthor ">Vijay  Gore</span>, <span class="hlFld-ContribAuthor ">Patricia  Lopez</span>, <span class="hlFld-ContribAuthor ">Vu  Ma</span>, <span class="hlFld-ContribAuthor ">Albert  Amegadzie</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Qian</span>, <span class="hlFld-ContribAuthor ">Ted C.  Judd</span>, <span class="hlFld-ContribAuthor ">Ana E.  Minatti</span>, <span class="hlFld-ContribAuthor ">James  Brown</span>, <span class="hlFld-ContribAuthor ">Yuan  Cheng</span>, <span class="hlFld-ContribAuthor ">May  Xue</span>, <span class="hlFld-ContribAuthor ">Wenge  Zhong</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Dineen</span>, <span class="hlFld-ContribAuthor ">Oleg  Epstein</span>, <span class="hlFld-ContribAuthor ">Jason  Human</span>, <span class="hlFld-ContribAuthor ">Charles  Kreiman</span>, <span class="hlFld-ContribAuthor ">Isaac  Marx</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Stephen A.  Hitchcock</span>, <span class="hlFld-ContribAuthor ">Timothy S.  Powers</span>, <span class="hlFld-ContribAuthor ">Kui  Chen</span>, <span class="hlFld-ContribAuthor ">Paul H.  Wen</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Alan C.  Cheng</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Jonathan A.  Werner</span>, <span class="hlFld-ContribAuthor ">Hugo M.  Vargas</span>, <span class="hlFld-ContribAuthor ">Nancy E.  Everds</span>, <span class="hlFld-ContribAuthor ">Steven L.  Vonderfecht</span>, <span class="hlFld-ContribAuthor ">Robert T.  Dunn</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Robert T.  Fremeau</span>, <span class="hlFld-ContribAuthor ">Ryan D.  White</span>, <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>. </span><span class="cited-content_cbyCitation_article-title">Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (4)
                                     , 767-774. <a href="https://doi.org/10.1016/j.bmcl.2014.12.092" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.12.092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.12.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.12.092%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252B2-aminooxazoline%252B3-azaxanthenes%252Bas%252Borally%252Befficacious%252B%2525CE%2525B2-secretase%252Binhibitors%252Bfor%252Bthe%252Bpotential%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DChen%26aufirst%3DJian%2BJeffrey%26date%3D2015%26volume%3D25%26issue%3D4%26spage%3D767%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.  Rajasekhar</span>, <span class="hlFld-ContribAuthor ">Malabika  Chakrabarti</span>, <span class="hlFld-ContribAuthor ">T.  Govindaraju</span>. </span><span class="cited-content_cbyCitation_article-title">Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2015,</strong> <em>51 </em>
                                    (70)
                                     , 13434-13450. <a href="https://doi.org/10.1039/C5CC05264E" title="DOI URL">https://doi.org/10.1039/C5CC05264E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5CC05264E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5CC05264E%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DFunction%252Band%252Btoxicity%252Bof%252Bamyloid%252Bbeta%252Band%252Brecent%252Btherapeutic%252Binterventions%252Btargeting%252Bamyloid%252Bbeta%252Bin%252BAlzheimer%252527s%252Bdisease%26aulast%3DRajasekhar%26aufirst%3DK.%26date%3D2015%26date%3D2015%26volume%3D51%26issue%3D70%26spage%3D13434%26epage%3D13450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yajun  Zheng</span>, <span class="hlFld-ContribAuthor ">Colin M.  Tice</span>, <span class="hlFld-ContribAuthor ">Suresh B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">The use of spirocyclic scaffolds in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (16)
                                     , 3673-3682. <a href="https://doi.org/10.1016/j.bmcl.2014.06.081" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.06.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.06.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.06.081%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Buse%252Bof%252Bspirocyclic%252Bscaffolds%252Bin%252Bdrug%252Bdiscovery%26aulast%3DZheng%26aufirst%3DYajun%26date%3D2014%26volume%3D24%26issue%3D16%26spage%3D3673%26epage%3D3682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew  Volgraf</span>, <span class="hlFld-ContribAuthor ">Lina  Chan</span>, <span class="hlFld-ContribAuthor ">Malcolm P.  Huestis</span>, <span class="hlFld-ContribAuthor ">Hans E.  Purkey</span>, <span class="hlFld-ContribAuthor ">Michael  Burkard</span>, <span class="hlFld-ContribAuthor ">Mary  Geck Do</span>, <span class="hlFld-ContribAuthor ">Julie  Harris</span>, <span class="hlFld-ContribAuthor ">Kevin W.  Hunt</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>, <span class="hlFld-ContribAuthor ">Sumeet  Rana</span>, <span class="hlFld-ContribAuthor ">Allen A.  Thomas</span>, <span class="hlFld-ContribAuthor ">Guy P.A.  Vigers</span>, <span class="hlFld-ContribAuthor ">Michael  Siu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization, and PK/PD studies of a series of spirocyclic pyranochromene BACE1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (11)
                                     , 2477-2480. <a href="https://doi.org/10.1016/j.bmcl.2014.04.012" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.04.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.04.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%25252C%252Bcharacterization%25252C%252Band%252BPK%25252FPD%252Bstudies%252Bof%252Ba%252Bseries%252Bof%252Bspirocyclic%252Bpyranochromene%252BBACE1%252Binhibitors%26aulast%3DVolgraf%26aufirst%3DMatthew%26date%3D2014%26volume%3D24%26issue%3D11%26spage%3D2477%26epage%3D2480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Numbering system and ring designation to be used for 1,3,4,4a,10,10a-hexahydropyrano[4,3-b]chromene analogues (“7-THP chromans”) discussed in this article. Spirocyclic warheads (WH): acyl guanidine (<b>1</b>), aminooxazoline (<b>2</b>), and aminothiazoline (<b>3</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray cocrystal structure of BACE1 and <b>62</b>. The two key active site aspartic acids, Asp32 and Asp228, are labeled. The distances between water oxygens (depicted as red spheres) and <b>62</b> are given in angstroms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) morpholine, toluene, reflux, Dean–Stark trap; (b) toluene, rt; (c) oxalyl chloride, DMSO, Et<sub>3</sub>N, DCM, −78 °C; (d) HOAc, rt; (e) <span class="smallcaps smallerCapital">l</span>-selectride, THF, −78 °C; (f) KCN, (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, NaHSO<sub>3</sub>, EtOH, 130 °C; (g) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (h) Lawesson’s reagent, toluene, 90 °C; (i) <i>t</i>-BuOOH, aq. NH<sub>4</sub>OH, MeOH, 50 °C; (j) RB(OH)<sub>2</sub>, Pd[P(Ph)<sub>3</sub>]<sub>4</sub>, aq. Na<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C. All chiral compounds depicted above were racemic, except for compounds <b>59</b>, <b>62</b>, and <b>63</b> as discussed below.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Tebbe’s reagent, THF, rt; (b) I<sub>2</sub>, AgXCN (X = O or S), aq. NH<sub>4</sub>OH, CH<sub>3</sub>CN, THF, rt; for X = O, diastereomers were separated; (c) RB(OH)<sub>2</sub>, Pd[P(Ph)<sub>3</sub>]<sub>4</sub>, aq. Na<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C, for X = S, single diastereomers were isolated. All chiral compounds depicted above were racemic.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Et<sub>3</sub>N, dioxane, 55 °C; (b) NaBH<sub>4</sub>, MeOH, THF, 0 °C; (c) MnO<sub>2</sub>, DCM, rt; (d) MOMCl, i-Pr<sub>2</sub>EtN, DCM, rt; (e) LHMDS, TMSCl, THF, −70 °C; (f) TiCl<sub>4</sub>, DCM, −40 °C; (g) LHMDS, THF, −78 °C; (h) ethyl 2-hydroxybenzoate, THF, −78 °C; (i) Tebbe’s reagent, THF, −78 °C to rt; (j) I<sub>2</sub>, AgOCN, aq. NH<sub>4</sub>OH, CH<sub>3</sub>CN, EtOAc, 40 °C; (k) RB(OH)<sub>2</sub>, Pd[P(Ph)<sub>3</sub>]<sub>4</sub>, aq. Na<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C; diastereomers were separated. All chiral compounds depicted above were racemic, except for compounds <b>77</b>, <b>78</b>, <b>92</b>, and <b>93</b> as discussed below.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DMF-dimethyl acetal, toluene, reflux; (b) Ac<sub>2</sub>O, py, rt; (c) ethyl vinyl ether, 100 °C; (d) DIBALH, THF, −78 °C; (e) Et<sub>3</sub>SiH, BF<sub>3</sub>-Et<sub>2</sub>O, DCM, rt; (f) KCN, (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, NaHSO<sub>3</sub>, EtOH, 130 °C; (g) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; diastereomers were separated; (h) Lawesson’s reagent, toluene, 90 °C; (i) <i>t</i>-BuOOH, aq. NH<sub>4</sub>OH, MeOH, 50 °C; (j) (2-fluoropyridin-3-yl)boronic acid, Pd[P(Ph)<sub>3</sub>]<sub>4</sub>, aq. Na<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C; (k) Tebbe’s reagent, THF, rt; (l) I<sub>2</sub>, AgXCN (X = O or S), aq. NH<sub>4</sub>OH, CH<sub>3</sub>CN, THF, rt. All chiral compounds depicted above were racemic.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LDA, HMPA, MeI, THF, −78 °C; (b) KCN, (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, NaHSO<sub>3</sub>, EtOH, 130 °C; (c) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (d) Lawesson’s reagent, toluene, 90 °C; (e) <i>t</i>-BuOOH, aq. NH<sub>4</sub>OH, MeOH, 50 °C; (f) RB(OH)<sub>2</sub>, Pd[P(Ph)<sub>3</sub>]<sub>4</sub>, aq. Na<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C; (g) Tebbe’s reagent, THF, rt; (h) I<sub>2</sub>, AgOCN, aq. NH<sub>4</sub>OH, CH<sub>3</sub>CN, THF, rt. All chiral compounds depicted above were racemic.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>m</i>-CPBA, DCM, 40 °C; (b) TfOH, 60 °C; (c) triphosgene, DMF, DCE, rt; (d) ethyl vinyl ether, 100 °C; (e) Pd/C, EtOH, H<sub>2</sub> (50 psi), rt; (f) MnO<sub>2</sub>, DCM, rt; (g) Et<sub>3</sub>SiH, BF<sub>3</sub>–Et<sub>2</sub>O, DCM, rt; (h) KCN, (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, NaHSO<sub>3</sub>, EtOH, 130 °C; (i) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (j) Lawesson’s reagent, toluene, 90 °C; (k) <i>t</i>-BuOOH, aq. NH<sub>4</sub>OH, MeOH, 50 °C; (l) 48% aq. HBr, 100 °C; (m) DMF–dimethyl acetal, DMF, rt; (n) Tf<sub>2</sub>NPh, Et<sub>3</sub>N, DCM, rt; diastereomers were separated; (o) RB(OH)<sub>2</sub>, Pd[P(Ph)<sub>3</sub>]<sub>4</sub>, aq. Na<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C. All chiral compounds depicted above were racemic.</p></p></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of 7-THP chroman <b>56</b> with a less selective dimethyl chroman (both compounds were racemic).<a onclick="showRef(event, 'cit15b'); return false;" href="javascript:void(0);" class="ref cit15b">(15b)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of racemic compounds <b>61</b> and <b>94</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/medium/jm-2013-01635n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cyno CSF concentration of Aβ<sub>1–40</sub> (dotted line) and compound <b>62</b> (solid line). Po formulation: 1% carboxymethylcellulose sodium (CMC), 0.5% Tween 80, 5 mM citrate buffer, suspension; 10 male cynomolgus monkeys, crossover design (<i>n</i> = 10 vehicle, <i>n</i> = 10 at 100 mg/kg).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401635n/production/images/large/jm-2013-01635n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401635n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i117">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43745" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43745" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 34 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span>2011 Alzheimer’s Disease Facts and Figures. <a href="http://www.alz.org/downloads/Facts_Figures_2011.pdf" class="extLink">http://www.alz.org/downloads/Facts_Figures_2011.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=2011+Alzheimer%E2%80%99s+Disease+Facts+and+Figures.+http%3A%2F%2Fwww.alz.org%2Fdownloads%2FFacts_Figures_2011.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span>World Alzheimer Report 2009. <a href="http://www.alz.co.uk/research/files/WorldAlzheimerReport-ExecutiveSummary.pdf" class="extLink">http://www.alz.co.uk/research/files/WorldAlzheimerReport-ExecutiveSummary.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Alzheimer+Report+2009.+http%3A%2F%2Fwww.alz.co.uk%2Fresearch%2Ffiles%2FWorldAlzheimerReport-ExecutiveSummary.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: strategies for disease modification</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=387-398&author=M.+Citron&title=Alzheimer%E2%80%99s+disease%3A+strategies+for+disease+modification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520strategies%2520for%2520disease%2520modification%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D387%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+progress+and+problems+on+the+road+to+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0liQiNFVk0TirQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Younkin, S. G.</span><span> </span><span class="NLM_article-title">The role of A beta 42 in Alzheimer’s disease</span> <span class="citation_source-journal">J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADyaK1cXmsV2ms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1998&pages=289-292&author=S.+G.+Younkin&title=The+role+of+A+beta+42+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">The role of Aβ42 in Alzheimer's disease</span></div><div class="casAuthors">Younkin, Steven G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Paris)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">289-292</span>CODEN:
                <span class="NLM_cas:coden">JHYSEM</span>;
        ISSN:<span class="NLM_cas:issn">0928-4257</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">A review, with 32 refs.  The authors' recent studies of plasma, fibroblasts, transfected cells and transgenic mice show that a fundamental effect of the mutations linked to familial Alzheimer's disease (FAD) is to increase the extracellular concn. of Aβ42.  This effect of the FAD-linked mutations is likely to be directly related to the pathogenesis of Alzheimer's disease (AD) because Aβ42 is deposited early and selectively in the senile plaques that are an invariant feature of all forms of AD.  Thus, the authors' results provide strong evidence that the FAD-linked mutations all cause AD by increasing the extracellular concn. of Aβ42, thereby fostering Aβ deposition, and they support the hypothesis that cerebral Aβ deposition is an essential early event in the pathogenesis of all forms of AD.  Interactions between the basal forebrain cholinergic system and Aβ that could influence AD pathogenesis are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSyp7Jwfo1OrVg90H21EOLACvtfcHk0lgdWrGkowIYUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsV2ms7s%253D&md5=f65018862a0daa181209286af8c1bcb9</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYounkin%26aufirst%3DS.%2BG.%26atitle%3DThe%2520role%2520of%2520A%2520beta%252042%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Physiol.%26date%3D1998%26volume%3D92%26spage%3D289%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Querfurth, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFeral, F. M.</span><span> </span><span class="NLM_article-title">Mechanisms of Disease: Alzheimer’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1056%2FNEJMra0909142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=20107219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=329-344&author=H.+W.+Querfurthauthor=F.+M.+LaFeral&title=Mechanisms+of+Disease%3A+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Querfurth, Henry W.; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">329-344</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  The role of β-amyloid peptide in spontaneous self-aggregation in brain in Alzheimer's disease is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPeniV_Jn6orVg90H21EOLACvtfcHk0lgdWrGkowIYUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D&md5=c116f6a6b8fed9af9f5282cc4b755c70</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0909142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0909142%26sid%3Dliteratum%253Aachs%26aulast%3DQuerfurth%26aufirst%3DH.%2BW.%26aulast%3DLaFeral%26aufirst%3DF.%2BM.%26atitle%3DMechanisms%2520of%2520Disease%253A%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D329%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T.</span><span> </span><span class="NLM_article-title">The secretases: enzymes with therapeutic potential in Alzheimer’s disease</span> <span class="citation_source-journal">Nat. Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1038%2Fnrneurol.2009.218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=20139999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=99-107&author=B.+De+Strooperauthor=R.+Vasarauthor=T.+Golde&title=The+secretases%3A+enzymes+with+therapeutic+potential+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">The secretases: enzymes with therapeutic potential in Alzheimer disease</span></div><div class="casAuthors">De Strooper, Bart; Vassar, Robert; Golde, Todd</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-107</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The three secretases that process amyloid precursor protein are central to the generation of amyloid-β, and the accumulation of this peptide in extracellular plaques is one of the hallmarks of Alzheimer disease.  In this Review, De Strooper et al. discuss the evidence that suggests that these enzymes are potential therapeutic targets for Alzheimer disease drug treatments.  The amyloid hypothesis has yielded a series of well-validated candidate drug targets with potential for the treatment of Alzheimer disease (AD).  Three proteases that are involved in the processing of amyloid precursor protein-α-secretase, β-secretase and γ-secretase-are of particular interest as they are central to the generation and modulation of amyloid-β peptide and can be targeted by small compds. in vitro and in vivo.  Given that these proteases also fulfill other important biol. roles, inhibiting their activity will clearly be inherently assocd. with mechanism-based toxicity.  Carefully detg. a suitable therapeutic window and optimizing the selectivity of the drug treatments towards amyloid precursor protein processing might be ways of overcoming this potential complication.  Secretase inhibitors are likely to be the first small-mol. therapies aimed at AD modification that will be fully tested in the clinic.  Success or failure of these first-generation AD therapies will have enormous consequences for further drug development efforts for AD and possibly other neurodegenerative conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQBldqS_TKy7Vg90H21EOLACvtfcHk0lgdWrGkowIYUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D&md5=40135a0a59da6b70e4856a81ddfa6088</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2009.218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2009.218%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DVasar%26aufirst%3DR.%26aulast%3DGolde%26aufirst%3DT.%26atitle%3DThe%2520secretases%253A%2520enzymes%2520with%2520therapeutic%2520potential%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2010%26volume%3D6%26spage%3D99%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeloff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edenson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biere, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J. C.</span><span> </span><span class="NLM_article-title">Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1126%2Fscience.286.5440.735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=10531052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.+C.+Louis&title=Beta-secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+BACE"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</span></div><div class="casAuthors">Vassar, Robert; Bennett, Brian D.; Babu-Khan, Safura; Kahn, Steve; Mendiaz, Elizabeth A.; Denis, Paul; Teplow, David B.; Ross, Sandra; Amarante, Patricia; Loeloff, Richard; Luo, Yi; Fisher, Seth; Fuller, Janis; Edenson, Steven; Lile, Jackson; Jarosinski, Mark A.; Biere, Anja Leona; Curran, Eileen; Burgess, Teresa; Louis, Jean-Claude; Collins, Frank; Treanor, James; Rogers, Gary; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5440</span>),
    <span class="NLM_cas:pages">735-741</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cerebral deposition of amyloid β peptide (Aβ) is an early and crit. feature of Alzheimer's disease.  Aβ generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: β-secretase and γ-secretase.  These proteases are prime therapeutic targets.  A transmembrane aspartic protease with all the known characteristics of β-secretase was cloned and characterized.  Overexpression of this protease, termed BACE (for beta-site APP-cleaving enzyme) increased the amt. of β-secretase cleavage products, and these were cleaved exactly and only at known β-secretase positions.  Antisense inhibition of endogenous BACE mRNA decreased the amt. of β-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same sequence specificity as β-secretase.  Finally, the expression pattern and subcellular localization of BACE were consistent with that expected for β-secretase.  Future development of BACE inhibitors may prove beneficial for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSx3s1NFyByrVg90H21EOLACvtfcHk0ljIUpl-enlDgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D&md5=3f36e8e5b5e9441c7670ccaeb0d2dd4f</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.735%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.%2BC.%26atitle%3DBeta-secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520BACE%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovacs, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span> </span><span class="NLM_article-title">The β-secretase enzyme in health and Alzheimer’s disease: regulation, cell biology, function, and therapeutic potential</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">12787</span><span class="NLM_x">–</span> <span class="NLM_lpage">12794</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1523%2FJNEUROSCI.3657-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=19828790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=12787-12794&author=R.+Vassarauthor=D.+M.+Kovacsauthor=R.+Yanauthor=P.+C.+Wong&title=The+%CE%B2-secretase+enzyme+in+health+and+Alzheimer%E2%80%99s+disease%3A+regulation%2C+cell+biology%2C+function%2C+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">The β-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential</span></div><div class="casAuthors">Vassar, Robert; Kovacs, Dora M.; Yan, Riqiang; Wong, Philip C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">12787-12794</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A review.  The β-amyloid (Aβ) peptide is the major constituent of amyloid plaques in Alzheimer's disease (AD) brain and is likely to play a central role in the pathogenesis of this devastating neurodegenerative disorder.  The β-secretase, β-site amyloid precursor protein cleaving enzyme (BACE1; also called Asp2, memapsin 2), is the enzyme responsible for initiating Aβ generation.  Thus, BACE is a prime drug target for the therapeutic inhibition of Aβ prodn. in AD.  Since its discovery 10 years ago, much has been learned about BACE.  This review summarizes BACE properties, describes BACE translation dysregulation in AD, and discusses BACE physiol. functions in sodium current, synaptic transmission, myelination, and schizophrenia.  The therapeutic potential of BACE will also be considered.  This is a summary of topics covered at a symposium held at the 39th annual meeting of the Society for Neuroscience and is not meant to be a comprehensive review of BACE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGn8h_x-7_bVg90H21EOLACvtfcHk0ljIUpl-enlDgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP&md5=a462ad002cf3801570725719d71647c6</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3657-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3657-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DKovacs%26aufirst%3DD.%2BM.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DP.%2BC.%26atitle%3DThe%2520%25CE%25B2-secretase%2520enzyme%2520in%2520health%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520regulation%252C%2520cell%2520biology%252C%2520function%252C%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D12787%26epage%3D12794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: γ-secretase inhibitors</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=169-175&author=B.+P.+Imbimbo&title=Alzheimer%E2%80%99s+disease%3A+%CE%B3-secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520%25CE%25B3-secretase%2520inhibitors%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2008%26volume%3D5%26spage%3D169%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Wu, W.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">γ-Secretase inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2009&pages=94-100&author=W.-L.+Wuauthor=L.+Zhang&title=%CE%B3-Secretase+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.-L.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3D%25CE%25B3-Secretase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2009%26volume%3D70%26spage%3D94%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kha, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span> </span><span class="NLM_article-title">Mice deficient in BACE1, the Alzheimer’s beta-secretase, have normal phenotype and abolished beta-amyloid generation</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1038%2F85059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=11224535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=231-232&author=Y.+Luoauthor=B.+Bolonauthor=S.+Kahnauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=P.+Denisauthor=W.+Fanauthor=H.+Khaauthor=J.+Zhangauthor=Y.+Gongauthor=L.+Martinauthor=J.-C.+Louisauthor=Q.+Yanauthor=W.+G.+Richardsauthor=M.+Citronauthor=R.+Vassar&title=Mice+deficient+in+BACE1%2C+the+Alzheimer%E2%80%99s+beta-secretase%2C+have+normal+phenotype+and+abolished+beta-amyloid+generation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation</span></div><div class="casAuthors">Luo, Yi; Bolon, Brad; Kahn, Steve; Bennett, Brian D.; Babu-Khan, Safura; Denis, Paul; Fan, Wei; Kha, Hue; Zhang, Jianhua; Gong, Yunhua; Martin, Laura; Louis, Jean-Claude; Yan, Qiao; Richards, William G.; Citron, Martin; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">231-232</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Mice deficient in beta-site APP-cleaving enzyme 1 (BACE1) lack Aβ- and β-secretase-cleaved APP C-terminal fragments (CTFs) in the brain.  Moreover, BACE1-/- mice are normal in appearance and behavior and are healthy and fertile.  These results provide validation of BACE1 as the major β-secretase in vivo and indicated that BACE2 is not significant in β-secretase cleavage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx9Z5X-KkqkbVg90H21EOLACvtfcHk0ljIUpl-enlDgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbY%253D&md5=f733e8c48464c6521ce302be48c76b12</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1038%2F85059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F85059%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DBolon%26aufirst%3DB.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DFan%26aufirst%3DW.%26aulast%3DKha%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DLouis%26aufirst%3DJ.-C.%26aulast%3DYan%26aufirst%3DQ.%26aulast%3DRichards%26aufirst%3DW.%2BG.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DMice%2520deficient%2520in%2520BACE1%252C%2520the%2520Alzheimer%25E2%2580%2599s%2520beta-secretase%252C%2520have%2520normal%2520phenotype%2520and%2520abolished%2520beta-amyloid%2520generation%26jtitle%3DNat.%2520Neurosci.%26date%3D2001%26volume%3D4%26spage%3D231%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Roberds, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienkowski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branstetter, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigon, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Games, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson-Wood, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kappenman, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabe, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shopp, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuck, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tintrup, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijsman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConlogue, L.</span><span> </span><span class="NLM_article-title">BACE knockout mice are healthy despite lacking the primary beta secretase activity in brain: implications for Alzheimer’s disease therapeutics</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1317</span><span class="NLM_x">–</span> <span class="NLM_lpage">1324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1093%2Fhmg%2F10.12.1317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=11406613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkslSrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2001&pages=1317-1324&author=S.+L.+Roberdsauthor=J.+Andersonauthor=G.+Basiauthor=M.+J.+Bienkowskiauthor=D.+G.+Branstetterauthor=K.+S.+Chenauthor=S.+B.+Freedmanauthor=N.+L.+Frigonauthor=D.+Gamesauthor=K.+Huauthor=K.+Johnson-Woodauthor=K.+E.+Kappenmanauthor=T.+T.+Kawabeauthor=I.+Kolaauthor=R.+Kuehnauthor=M.+Leeauthor=W.+Liuauthor=R.+Motterauthor=N.+F.+Nicholsauthor=M.+Powerauthor=D.+W.+Robertsonauthor=D.+Schenkauthor=M.+Schoorauthor=G.+M.+Shoppauthor=M.+E.+Shuckauthor=S.+Sinhaauthor=K.+A.+Svenssonauthor=G.+Tatsunoauthor=H.+Tintrupauthor=J.+Wijsmanauthor=S.+Wrightauthor=L.+McConlogue&title=BACE+knockout+mice+are+healthy+despite+lacking+the+primary+beta+secretase+activity+in+brain%3A+implications+for+Alzheimer%E2%80%99s+disease+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">BACE knockout mice are healthy despite lacking the primary β-secretase activity in brain: implications for Alzheimer's disease therapeutics</span></div><div class="casAuthors">Roberds, Steven L.; Anderson, John; Basi, Guriqbal; Bienkowski, Michael J.; Branstetter, Daniel G.; Chen, Karen S.; Freedman, Stephen B.; Frigon, Normand L.; Games, Dora; Hu, Kang; Johnson-Wood, Kelly; Kappenman, Karl E.; Kawabe, Thomas T.; Kola, Ismail; Kuehn, Ralf; Lee, Michael; Liu, Weiqun; Motter, Ruth; Nichols, Nanette F.; Power, Michael; Robertson, David W.; Schenk, Dale; Schoor, Michael; Shopp, George M.; Shuck, Mary E.; Sinha, Sukanto; Svensson, Kjell A.; Tatsuno, Gwen; Tintrup, Hartmut; Wijsman, John; Wright, Sarah; McConlogue, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1317-1324</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disorder characterized by accumulation of amyloid plaques and neurofibrillary tangles in the brain.  The major components of plaque, β-amyloid peptides (Aβs), are produced from amyloid precursor protein (APP) by the activity of β- and γ-secretases.  β-Secretase activity cleaves APP to define the N-terminus of the Aβ1-x peptides and, therefore, has been a long-sought therapeutic target for treatment of AD.  The gene encoding a β-secretase for beta-site APP cleaving enzyme (BACE) was identified recently.  However, it was not known whether BACE was the primary β-secretase in mammalian brain nor whether inhibition of β-secretase might have effects in mammals that would preclude its utility as a therapeutic target.  In the work described herein, the authors generated two lines of BACE knockout mice and characterized them for pathol., β-secretase activity and Aβ prodn.  These mice appeared to develop normally and showed no consistent phenotypic differences from their wild-type littermates, including overall normal tissue morphol. and brain histochem., normal blood and urine chemistries, normal blood-cell compn., and no overt behavioral and neuromuscular effects.  Brain and primary cortical cultures from BACE knockout mice showed no detectable β-secretase activity, and primary cortical cultures from BACE knockout mice produced much less Aβ from APP.  The findings that BACE is the primary β-secretase activity in brain and that loss of β-secretase activity produces no profound phenotypic defects with a concomitant redn. in β-amyloid peptide clearly indicate that BACE is an excellent therapeutic target for treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ78rSt6xEe7Vg90H21EOLACvtfcHk0lgnZClyc7c9vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkslSrurs%253D&md5=c18a9ff9f800eebd994476badc6ec1bc</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F10.12.1317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F10.12.1317%26sid%3Dliteratum%253Aachs%26aulast%3DRoberds%26aufirst%3DS.%2BL.%26aulast%3DAnderson%26aufirst%3DJ.%26aulast%3DBasi%26aufirst%3DG.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DBranstetter%26aufirst%3DD.%2BG.%26aulast%3DChen%26aufirst%3DK.%2BS.%26aulast%3DFreedman%26aufirst%3DS.%2BB.%26aulast%3DFrigon%26aufirst%3DN.%2BL.%26aulast%3DGames%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DK.%26aulast%3DJohnson-Wood%26aufirst%3DK.%26aulast%3DKappenman%26aufirst%3DK.%2BE.%26aulast%3DKawabe%26aufirst%3DT.%2BT.%26aulast%3DKola%26aufirst%3DI.%26aulast%3DKuehn%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMotter%26aufirst%3DR.%26aulast%3DNichols%26aufirst%3DN.%2BF.%26aulast%3DPower%26aufirst%3DM.%26aulast%3DRobertson%26aufirst%3DD.%2BW.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DSchoor%26aufirst%3DM.%26aulast%3DShopp%26aufirst%3DG.%2BM.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DTatsuno%26aufirst%3DG.%26aulast%3DTintrup%26aufirst%3DH.%26aulast%3DWijsman%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DS.%26aulast%3DMcConlogue%26aufirst%3DL.%26atitle%3DBACE%2520knockout%2520mice%2520are%2520healthy%2520despite%2520lacking%2520the%2520primary%2520beta%2520secretase%2520activity%2520in%2520brain%253A%2520implications%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapeutics%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2001%26volume%3D10%26spage%3D1317%26epage%3D1324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ohno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sametsky, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younkin, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakley, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younkin, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Disterhoft, J. F.</span><span> </span><span class="NLM_article-title">BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2004&pages=27-33&author=M.+Ohnoauthor=E.+A.+Sametskyauthor=L.+H.+Younkinauthor=H.+Oakleyauthor=S.+G.+Younkinauthor=M.+Citronauthor=R.+Vassarauthor=J.+F.+Disterhoft&title=BACE1+deficiency+rescues+memory+deficits+and+cholinergic+dysfunction+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhno%26aufirst%3DM.%26aulast%3DSametsky%26aufirst%3DE.%2BA.%26aulast%3DYounkin%26aufirst%3DL.%2BH.%26aulast%3DOakley%26aufirst%3DH.%26aulast%3DYounkin%26aufirst%3DS.%2BG.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DDisterhoft%26aufirst%3DJ.%2BF.%26atitle%3DBACE1%2520deficiency%2520rescues%2520memory%2520deficits%2520and%2520cholinergic%2520dysfunction%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D2004%26volume%3D41%26spage%3D27%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">McConlogue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buttini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brigham, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Games, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson Wood, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, S.</span><span> </span><span class="NLM_article-title">Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">26326</span><span class="NLM_x">–</span> <span class="NLM_lpage">26334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=26326-26334&author=L.+McConlogueauthor=M.+Buttiniauthor=J.+P.+Andersonauthor=E.+F.+Brighamauthor=K.+S.+Chenauthor=S.+B.+Freedmanauthor=D.+Gamesauthor=K.+Johnson+Woodauthor=M.+Leeauthor=M.+Zellerauthor=W.+Liuauthor=R.+Motterauthor=S.+Sinha&title=Partial+reduction+of+BACE1+has+dramatic+effects+on+Alzheimer+plaque+and+synaptic+pathology+in+APP+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DButtini%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DJ.%2BP.%26aulast%3DBrigham%26aufirst%3DE.%2BF.%26aulast%3DChen%26aufirst%3DK.%2BS.%26aulast%3DFreedman%26aufirst%3DS.%2BB.%26aulast%3DGames%26aufirst%3DD.%26aulast%3DJohnson%2BWood%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DZeller%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMotter%26aufirst%3DR.%26aulast%3DSinha%26aufirst%3DS.%26atitle%3DPartial%2520reduction%2520of%2520BACE1%2520has%2520dramatic%2520effects%2520on%2520Alzheimer%2520plaque%2520and%2520synaptic%2520pathology%2520in%2520APP%2520transgenic%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D26326%26epage%3D26334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemere, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lannfelt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The Swedish mutation causes early-onset Alzheimer’s disease by β-secretase cleavage within the secretory pathway</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1291</span><span class="NLM_x">–</span> <span class="NLM_lpage">1296</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1038%2Fnm1295-1291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=7489411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADyaK2MXpslGhtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=1291-1296&author=C.+Haassauthor=C.+A.+Lemereauthor=A.+Capellauthor=M.+Citronauthor=P.+Seubertauthor=D.+Schenkauthor=L.+Lannfeltauthor=D.+J.+Selkoe&title=The+Swedish+mutation+causes+early-onset+Alzheimer%E2%80%99s+disease+by+%CE%B2-secretase+cleavage+within+the+secretory+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway</span></div><div class="casAuthors">Haass, Christian; Lemere, Cynthia A.; Capell, Anja; Citron, Martin; Seubert, Peter; Schenk, Dale; Lannfelt, Lars; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1291-6</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">Several missense mutations causing early-onset Alzheimer's disease (AD) have been described in the gene coding for the β-amyloid precursor protein (βAPP).  A double mutation found in a Swedish family is located before the amyloid β-peptide (Aβ) region of βAPP and results in the increased prodn. and secretion of Aβ.  Here the authors show that the increased prodn. of Aβ results from a cellular mechanism, which differs substantially from that responsible for the prodn. of Aβ from wild-type βAPP.  In the latter case, Aβ generation requires reinternalization and recycling of βAPP.  In the case of the Swedish mutation the N-terminal β-secretase cleavage of Aβ occurs in Golgi-derived vesicles, most likely within secretory vesicles.  Therefore, this cleavage occurs in the same compartment as the α-secretase cleavage, which normally prevents Aβ prodn., explaining the increased Aβ generation by a competition between α- and β-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwY2_Dmv4aPrVg90H21EOLACvtfcHk0lgnZClyc7c9vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpslGhtbk%253D&md5=af21095fbb11e8dfc6ffb0b9f9afb38b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnm1295-1291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1295-1291%26sid%3Dliteratum%253Aachs%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DLemere%26aufirst%3DC.%2BA.%26aulast%3DCapell%26aufirst%3DA.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520Swedish%2520mutation%2520causes%2520early-onset%2520Alzheimer%25E2%2580%2599s%2520disease%2520by%2520%25CE%25B2-secretase%2520cleavage%2520within%2520the%2520secretory%2520pathway%26jtitle%3DNat.%2520Med.%26date%3D1995%26volume%3D1%26spage%3D1291%26epage%3D1296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Jonsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snaedal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulem, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudbjartsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyte, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhangale, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huttenlocher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsdottir, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreassen, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jönsson, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palotie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsteinsdottir, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span> </span><span class="NLM_article-title">A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+J%C3%B6nssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+mutation+in+APP+protects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0lgU4sUX2IdAug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJ%25C3%25B6nsson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520mutation%2520in%2520APP%2520protects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith Labell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greg Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">16507</span><span class="NLM_x">–</span> <span class="NLM_lpage">16516</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+Smith+Labellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+Greg+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-%CE%B2+in+humans+with+an+orally+available%2C+non-peptidic+%CE%B2-secretase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0lgU4sUX2IdAug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DSmith%2BLabell%26aufirst%3DE.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DGreg%2BHall%26aufirst%3DD.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-%25CE%25B2%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520%25CE%25B2-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Stone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleijn, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dockendorf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palcza, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forman, M.</span><span> </span><span class="NLM_article-title">Consistency of Bace inhibitor-mediated brain amyloid production inhibition by MK-8931 in Alzheimer’s disease patients and healthy young adults</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">P690</span><span class="NLM_x">–</span> <span class="NLM_lpage">P691</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=P690-P691&issue=4&author=J.+Stoneauthor=H.+J.+Kleijnauthor=M.+Dockendorfauthor=L.+Maauthor=J.+Palczaauthor=J.+Tsengauthor=M.+Tanenauthor=M.+Forman&title=Consistency+of+Bace+inhibitor-mediated+brain+amyloid+production+inhibition+by+MK-8931+in+Alzheimer%E2%80%99s+disease+patients+and+healthy+young+adults"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DKleijn%26aufirst%3DH.%2BJ.%26aulast%3DDockendorf%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DPalcza%26aufirst%3DJ.%26aulast%3DTseng%26aufirst%3DJ.%26aulast%3DTanen%26aufirst%3DM.%26aulast%3DForman%26aufirst%3DM.%26atitle%3DConsistency%2520of%2520Bace%2520inhibitor-mediated%2520brain%2520amyloid%2520production%2520inhibition%2520by%2520MK-8931%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%2520and%2520healthy%2520young%2520adults%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2013%26volume%3D9%26issue%3D4%26spage%3DP690%26epage%3DP691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cheret, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wende, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulf-Goldenberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahirovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nave, K.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garratt, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span> </span><span class="NLM_article-title">Bace1 and Neuregulin-1 cooperate to control formation and maintenance of muscle spindles</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2015</span><span class="NLM_x">–</span> <span class="NLM_lpage">2028</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=2015-2028&author=C.+Cheretauthor=M.+Willemauthor=F.+R.+Frickerauthor=H.+Wendeauthor=A.+Wulf-Goldenbergauthor=S.+Tahirovicauthor=K.-A.+Naveauthor=P.+Saftigauthor=C.+Haassauthor=A.+N.+Garrattauthor=D.+L.+Bennettauthor=C.+Birchmeier&title=Bace1+and+Neuregulin-1+cooperate+to+control+formation+and+maintenance+of+muscle+spindles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheret%26aufirst%3DC.%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DFricker%26aufirst%3DF.%2BR.%26aulast%3DWende%26aufirst%3DH.%26aulast%3DWulf-Goldenberg%26aufirst%3DA.%26aulast%3DTahirovic%26aufirst%3DS.%26aulast%3DNave%26aufirst%3DK.-A.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DGarratt%26aufirst%3DA.%2BN.%26aulast%3DBennett%26aufirst%3DD.%2BL.%26aulast%3DBirchmeier%26aufirst%3DC.%26atitle%3DBace1%2520and%2520Neuregulin-1%2520cooperate%2520to%2520control%2520formation%2520and%2520maintenance%2520of%2520muscle%2520spindles%26jtitle%3DEMBO%2520J.%26date%3D2013%26volume%3D32%26spage%3D2015%26epage%3D2028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Willem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garratt, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeStrooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Control of peripheral nerve myelination by the beta-secretase BACE1</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">666</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=664-666&author=M.+Willemauthor=A.+N.+Garrattauthor=B.+Novakauthor=M.+Citronauthor=S.+Kaufmannauthor=A.+Rittgerauthor=B.+DeStrooperauthor=P.+Saftigauthor=C.+Birchmeierauthor=C.+Haass&title=Control+of+peripheral+nerve+myelination+by+the+beta-secretase+BACE1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DGarratt%26aufirst%3DA.%2BN.%26aulast%3DNovak%26aufirst%3DB.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DKaufmann%26aufirst%3DS.%26aulast%3DRittger%26aufirst%3DA.%26aulast%3DDeStrooper%26aufirst%3DB.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DControl%2520of%2520peripheral%2520nerve%2520myelination%2520by%2520the%2520beta-secretase%2520BACE1%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D664%26epage%3D666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kandalepas, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span> </span><span class="NLM_article-title">Identification and biology of β-secretase</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1111%2Fj.1471-4159.2011.07512.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=22122287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFynsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=55-61&issue=Suppl+1&author=P.+C.+Kandalepasauthor=R.+Vassar&title=Identification+and+biology+of+%CE%B2-secretase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and biology of β-secretase</span></div><div class="casAuthors">Kandalepas, Patty C.; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">55-61</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Our knowledge of the etiol. of Alzheimer's disease (AD) has advanced tremendously since the discovery of amyloid beta (Aβ) aggregation in diseased brains.  Accumulating evidence suggests that Aβ plays a causative role in AD.  The β-secretase enzyme, beta-site APP cleaving enzyme-1 (BACE1), is also implicated in AD pathogenesis, given that BACE1 cleavage of amyloid precursor protein is the initiating step in the formation of Aβ.  As a result, BACE1 inhibition has been branded as a potential AD therapy.  In this study, we review the identification and basic characteristics of BACE1, as well as the progress in our understanding of BACE1 cell biol., substrates, and phenotypes of BACE1 knockout mice that are informative about the physiol. functions of BACE1 beyond amyloid precursor protein cleavage.  These data are crucial for predicting potential mechanism-based toxicity that would arise from inhibiting BACE1 for the treatment or prevention of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa4bt1FCIVq7Vg90H21EOLACvtfcHk0lgA1QNSQ-omSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFynsrc%253D&md5=84dd150d53c2012280933f886cc4d1d6</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07512.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07512.x%26sid%3Dliteratum%253Aachs%26aulast%3DKandalepas%26aufirst%3DP.%2BC.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DIdentification%2520and%2520biology%2520of%2520%25CE%25B2-secretase%26jtitle%3DJ.%2520Neurochem.%26date%3D2012%26volume%3D120%26issue%3DSuppl%25201%26spage%3D55%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Kuhn, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koroniak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeitschel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volbracht, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schepers, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imhof, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmeister, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brase, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenthaler, S. F.</span><span> </span><span class="NLM_article-title">Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">3157</span><span class="NLM_x">–</span> <span class="NLM_lpage">3168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=3157-3168&author=P.+H.+Kuhnauthor=K.+Koroniakauthor=S.+Hoglauthor=A.+Colomboauthor=U.+Zeitschelauthor=M.+Willemauthor=C.+Volbrachtauthor=U.+Schepersauthor=A.+Imhofauthor=A.+Hoffmeisterauthor=C.+Haassauthor=S.+Rossnerauthor=S.+Braseauthor=S.+F.+Lichtenthaler&title=Secretome+protein+enrichment+identifies+physiological+BACE1+protease+substrates+in+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DP.%2BH.%26aulast%3DKoroniak%26aufirst%3DK.%26aulast%3DHogl%26aufirst%3DS.%26aulast%3DColombo%26aufirst%3DA.%26aulast%3DZeitschel%26aufirst%3DU.%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DVolbracht%26aufirst%3DC.%26aulast%3DSchepers%26aufirst%3DU.%26aulast%3DImhof%26aufirst%3DA.%26aulast%3DHoffmeister%26aufirst%3DA.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DRossner%26aufirst%3DS.%26aulast%3DBrase%26aufirst%3DS.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26atitle%3DSecretome%2520protein%2520enrichment%2520identifies%2520physiological%2520BACE1%2520protease%2520substrates%2520in%2520neurons%26jtitle%3DEMBO%2520J.%26date%3D2012%26volume%3D31%26spage%3D3157%26epage%3D3168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bockstael, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annaert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevaert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">25927</span><span class="NLM_x">–</span> <span class="NLM_lpage">25940</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=25927-25940&author=L.+Zhouauthor=S.+Baraoauthor=M.+Lagaauthor=K.+Bockstaelauthor=M.+Borgersauthor=H.+Gijsenauthor=W.+Annaertauthor=D.+Moecharsauthor=M.+Merckenauthor=K.+Gevaertauthor=B.+De+Strooper&title=The+neural+cell+adhesion+molecules+L1+and+CHL1+are+cleaved+by+BACE1+protease+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DBarao%26aufirst%3DS.%26aulast%3DLaga%26aufirst%3DM.%26aulast%3DBockstael%26aufirst%3DK.%26aulast%3DBorgers%26aufirst%3DM.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DAnnaert%26aufirst%3DW.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DGevaert%26aufirst%3DK.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520neural%2520cell%2520adhesion%2520molecules%2520L1%2520and%2520CHL1%2520are%2520cleaved%2520by%2520BACE1%2520protease%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D25927%26epage%3D25940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Tseng, J.; Dockendorf, M.; Krishna, G.; Ma, L.; Palcza, J.; Leempoels, J.; Ramael, S.; Han, D.; Jhee, S.; Ereshefsky, L.; Wagner, J.; Troyer, M.; Forman, M.</span><span> </span><span class="NLM_article-title">Safety and pharmacokinetics of the novel BACE inhibitor MK-8931 in healthy subjects following single- and multiple-dose administration</span>.  <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span>),   <span class="NLM_fpage">P184</span><span class="NLM_x">–</span> <span class="NLM_lpage">P185</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=P184-P185&issue=4&author=J.+Tseng&author=M.+Dockendorf&author=G.+Krishna&author=L.+Ma&author=J.+Palcza&author=J.+Leempoels&author=S.+Ramael&author=D.+Han&author=S.+Jhee&author=L.+Ereshefsky&author=J.+Wagner&author=M.+Troyer&author=M.+Forman&title=Safety+and+pharmacokinetics+of+the+novel+BACE+inhibitor+MK-8931+in+healthy+subjects+following+single-+and+multiple-dose+administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTseng%26aufirst%3DJ.%26atitle%3DSafety%2520and%2520pharmacokinetics%2520of%2520the%2520novel%2520BACE%2520inhibitor%2520MK-8931%2520in%2520healthy%2520subjects%2520following%2520single-%2520and%2520multiple-dose%2520administration%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2012%26volume%3D8%26issue%3D4%26spage%3DP184%26epage%3DP185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span>An Efficacy and Safety Trial of MK-8931 in Mild to Moderate Alzheimer's Disease (P07738) (EPOCH). <a href="http://clinicaltrials.gov/show/NCT01739348" class="extLink">http://clinicaltrials.gov/show/NCT01739348</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=An+Efficacy+and+Safety+Trial+of+MK-8931+in+Mild+to+Moderate+Alzheimer%27s+Disease+%28P07738%29+%28EPOCH%29.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01739348."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0ljbTJfomYa1iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Clark, D. E.</span><span> </span><span class="NLM_article-title">Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood–brain barrier penetration</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">815</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=815-821&author=D.+E.+Clark&title=Rapid+calculation+of+polar+molecular+surface+area+and+its+application+to+the+prediction+of+transport+phenomena.+2.+Prediction+of+blood%E2%80%93brain+barrier+penetration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%2BE.%26atitle%3DRapid%2520calculation%2520of%2520polar%2520molecular%2520surface%2520area%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520transport%2520phenomena.%25202.%2520Prediction%2520of%2520blood%25E2%2580%2593brain%2520barrier%2520penetration%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D815%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tang, T. P.; Thomas, A. A.; Metcalf, A. T.; Hunt, K. W.; Vigers, G.; Rizzi, J. P.; Watts, R. J.; Liu, X.; Smith, D.; Rhodes, S. P.; Brown, K. D.; Otten, J. N.; Burkard, M.; Cox, A. A.; Geck Do, M. K.; Dutcher, D.; Rana, S.; DeLisle, R. K.; Regal, K.; Wright, A. D.; Scearce-Levie, K.; Siu, M.; Purkey, H. E.; Lyssikatos, J. P.</span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Tang%2C+T.+P.%3B+Thomas%2C+A.+A.%3B+Metcalf%2C+A.+T.%3B+Hunt%2C+K.+W.%3B+Vigers%2C+G.%3B+Rizzi%2C+J.+P.%3B+Watts%2C+R.+J.%3B+Liu%2C+X.%3B+Smith%2C+D.%3B+Rhodes%2C+S.+P.%3B+Brown%2C+K.+D.%3B+Otten%2C+J.+N.%3B+Burkard%2C+M.%3B+Cox%2C+A.+A.%3B+Geck+Do%2C+M.+K.%3B+Dutcher%2C+D.%3B+Rana%2C+S.%3B+DeLisle%2C+R.+K.%3B+Regal%2C+K.%3B+Wright%2C+A.+D.%3B+Scearce-Levie%2C+K.%3B+Siu%2C+M.%3B+Purkey%2C+H.+E.%3B+Lyssikatos%2C+J.+P.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DT.%2BP." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hunt, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawardana, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geck Do, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutcher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLisle, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammond, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groneberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purkey, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marlow, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, T. P.</span><span> </span><span class="NLM_article-title">Spirocyclic β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: from hit to lowering of cerebrospinal fluid (CSF) amyloid β in a higher species</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3379</span><span class="NLM_x">–</span> <span class="NLM_lpage">3403</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4002154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3379-3403&author=K.+W.+Huntauthor=A.+W.+Cookauthor=R.+J.+Wattsauthor=C.+T.+Clarkauthor=G.+Vigersauthor=D.+Smithauthor=A.+T.+Metcalfauthor=I.+W.+Gunawardanaauthor=M.+Burkardauthor=A.+A.+Coxauthor=M.+K.+Geck+Doauthor=D.+Dutcherauthor=A.+A.+Thomasauthor=S.+Ranaauthor=N.+C.+Kallanauthor=R.+K.+DeLisleauthor=J.+P.+Rizziauthor=K.+Regalauthor=D.+Sammondauthor=R.+Gronebergauthor=M.+Siuauthor=H.+Purkeyauthor=J.+P.+Lyssikatosauthor=A.+Marlowauthor=X.+Liuauthor=T.+P.+Tang&title=Spirocyclic+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+from+hit+to+lowering+of+cerebrospinal+fluid+%28CSF%29+amyloid+%CE%B2+in+a+higher+species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Fjm4002154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4002154%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DCook%26aufirst%3DA.%2BW.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DClark%26aufirst%3DC.%2BT.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DMetcalf%26aufirst%3DA.%2BT.%26aulast%3DGunawardana%26aufirst%3DI.%2BW.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%2BA.%26aulast%3DGeck%2BDo%26aufirst%3DM.%2BK.%26aulast%3DDutcher%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DKallan%26aufirst%3DN.%2BC.%26aulast%3DDeLisle%26aufirst%3DR.%2BK.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DSammond%26aufirst%3DD.%26aulast%3DGroneberg%26aufirst%3DR.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPurkey%26aufirst%3DH.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMarlow%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DT.%2BP.%26atitle%3DSpirocyclic%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520from%2520hit%2520to%2520lowering%2520of%2520cerebrospinal%2520fluid%2520%2528CSF%2529%2520amyloid%2520%25CE%25B2%2520in%2520a%2520higher%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3379%26epage%3D3403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hunt, K. H.; Cook, A. W.; Watts, R. J.; Clark, C. T.; Vigers, G.; Smith, D.; Metcalf, A. T.; Gunawardana, I. W.; Burkard, M.; Cox, A. A.; Geck Do, M. K.; Dutcher, D.; Thomas, A. A.; Rana, S.; Kallan, N. C.; DeLisle, R. K.; Rizzi, J. P.; Regal, K.; Sammond, D.; Groneberg, R.; Siu, M.; Purkey, H.; Lyssikatos, J. P.; Marlow, A.; Liu, X.; Tang, T. P.</span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hunt%2C+K.+H.%3B+Cook%2C+A.+W.%3B+Watts%2C+R.+J.%3B+Clark%2C+C.+T.%3B+Vigers%2C+G.%3B+Smith%2C+D.%3B+Metcalf%2C+A.+T.%3B+Gunawardana%2C+I.+W.%3B+Burkard%2C+M.%3B+Cox%2C+A.+A.%3B+Geck+Do%2C+M.+K.%3B+Dutcher%2C+D.%3B+Thomas%2C+A.+A.%3B+Rana%2C+S.%3B+Kallan%2C+N.+C.%3B+DeLisle%2C+R.+K.%3B+Rizzi%2C+J.+P.%3B+Regal%2C+K.%3B+Sammond%2C+D.%3B+Groneberg%2C+R.%3B+Siu%2C+M.%3B+Purkey%2C+H.%3B+Lyssikatos%2C+J.+P.%3B+Marlow%2C+A.%3B+Liu%2C+X.%3B+Tang%2C+T.+P.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DK.%2BH." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Im, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazlauskas, A.</span><span> </span><span class="NLM_article-title">The role of cathepsins in ocular physiology and pathology</span> <span class="citation_source-journal">Exp. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1016%2Fj.exer.2006.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=16893541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhs1Cmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2007&pages=383-388&author=E.+Imauthor=A.+Kazlauskas&title=The+role+of+cathepsins+in+ocular+physiology+and+pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">The role of cathepsins in ocular physiology and pathology</span></div><div class="casAuthors">Im, Eunok; Kazlauskas, Andrius</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Eye Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">383-388</span>CODEN:
                <span class="NLM_cas:coden">EXERA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cathepsins are proteases that were originally identified in the lysosome, where they participate in house keeping tasks such as degrdn. of phagocytosed photoreceptors.  More recently, cathepsins have been detected outside of the lysosome, and assocd. with numerous diseases (keratoconus, retinal detachment, age related macular degeneration, and glaucoma).  The most likely mechanism by which cathepsins contribute to ocular pathologies is via degrdn. of the extracellular matrix, and/or regulation of angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjhnlC2VGrKrVg90H21EOLACvtfcHk0lgm8QBNECuzmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhs1Cmsrk%253D&md5=baec6bd7a6e1e1e894dd4b4ba7abe2a2</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1016%2Fj.exer.2006.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exer.2006.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DIm%26aufirst%3DE.%26aulast%3DKazlauskas%26aufirst%3DA.%26atitle%3DThe%2520role%2520of%2520cathepsins%2520in%2520ocular%2520physiology%2520and%2520pathology%26jtitle%3DExp.%2520Eye%2520Res.%26date%3D2007%26volume%3D84%26spage%3D383%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Benes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetvicka, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusek, M.</span><span> </span><span class="NLM_article-title">Cathepsin D--many functions of one aspartic protease</span> <span class="citation_source-journal">Crit. Rev. Oncol. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1016%2Fj.critrevonc.2008.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=18396408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A280%3ADC%252BD1crnsVehsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=12-28&author=P.+Benesauthor=V.+Vetvickaauthor=M.+Fusek&title=Cathepsin+D%2D%2Dmany+functions+of+one+aspartic+protease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin D--many functions of one aspartic protease</span></div><div class="casAuthors">Benes Petr; Vetvicka Vaclav; Fusek Martin</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-28</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">For years, it has been held that cathepsin D (CD) is involved in rather non-specific protein degradation in a strongly acidic milieu of lysosomes.  Studies with CD knock-out mice revealed that CD is not necessary for embryonal development, but it is indispensable for postnatal tissue homeostasis.  Mutation that abolishes CD enzymatic activity causes neuronal ceroid lipofuscinosis (NCL) characterized by severe neurodegeneration, developmental regression, visual loss and epilepsy in both animals and humans.  In the last decade, however, an increasing number of studies demonstrated that enzymatic function of CD is not restricted solely to acidic milieu of lysosomes with important consequences in regulation of apoptosis.  In addition to CD enzymatic activity, it has been shown that apoptosis is also regulated by catalytically inactive mutants of CD which suggests that CD interacts with other important molecules and influences cell signaling.  Moreover, procathepsin D (pCD), secreted from cancer cells, acts as a mitogen on both cancer and stromal cells and stimulates their pro-invasive and pro-metastatic properties.  Numerous studies found that pCD/CD level represents an independent prognostic factor in a variety of cancers and is therefore considered to be a potential target of anti-cancer therapy.  Studies dealing with functions of cathepsin D are complicated by the fact that there are several simultaneous forms of CD in a cell-pCD, intermediate enzymatically active CD and mature heavy and light chain CD.  It became evident that these forms may differently regulate the above-mentioned processes.  In this article, we review the possible functions of CD and its various forms in cells and organisms during physiological and pathological conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS9gz1Ed--NTiEJCPKhJPuqfW6udTcc2eYYLn17zdL_P7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1crnsVehsw%253D%253D&md5=eb34f9d185621ee4b845685ec1efa125</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1016%2Fj.critrevonc.2008.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.critrevonc.2008.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DBenes%26aufirst%3DP.%26aulast%3DVetvicka%26aufirst%3DV.%26aulast%3DFusek%26aufirst%3DM.%26atitle%3DCathepsin%2520D--many%2520functions%2520of%2520one%2520aspartic%2520protease%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D2008%26volume%3D68%26spage%3D12%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hassner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorber, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heathcock, C.</span><span> </span><span class="NLM_article-title">Addition of iodine isocyanate to olefins. Scope and synthetic utility</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">549</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01278a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1967&pages=540-549&author=A.+Hassnerauthor=M.+E.+Lorberauthor=C.+Heathcock&title=Addition+of+iodine+isocyanate+to+olefins.+Scope+and+synthetic+utility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Fjo01278a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01278a006%26sid%3Dliteratum%253Aachs%26aulast%3DHassner%26aufirst%3DA.%26aulast%3DLorber%26aufirst%3DM.%2BE.%26aulast%3DHeathcock%26aufirst%3DC.%26atitle%3DAddition%2520of%2520iodine%2520isocyanate%2520to%2520olefins.%2520Scope%2520and%2520synthetic%2520utility%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1967%26volume%3D32%26spage%3D540%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wittekind, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenau, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poos, G. I.</span><span> </span><span class="NLM_article-title">Ring cleavage reactions of <i>trans</i>-2-amino-3a,4,5,6,7,7a-hexahydrobenzoxazole</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">444</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01061a041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1961&pages=444-446&author=R.+R.+Wittekindauthor=J.+D.+Rosenauauthor=G.+I.+Poos&title=Ring+cleavage+reactions+of+trans-2-amino-3a%2C4%2C5%2C6%2C7%2C7a-hexahydrobenzoxazole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fjo01061a041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01061a041%26sid%3Dliteratum%253Aachs%26aulast%3DWittekind%26aufirst%3DR.%2BR.%26aulast%3DRosenau%26aufirst%3DJ.%2BD.%26aulast%3DPoos%26aufirst%3DG.%2BI.%26atitle%3DRing%2520cleavage%2520reactions%2520of%2520trans-2-amino-3a%252C4%252C5%252C6%252C7%252C7a-hexahydrobenzoxazole%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1961%26volume%3D26%26spage%3D444%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gebelein, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swern, D.</span><span> </span><span class="NLM_article-title">Observations on the mechanism of addition of iodine isocyanate to unsaturated compounds</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1677</span><span class="NLM_x">–</span> <span class="NLM_lpage">1679</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01258a031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1969&pages=1677-1679&author=C.+G.+Gebeleinauthor=S.+Rosenauthor=D.+Swern&title=Observations+on+the+mechanism+of+addition+of+iodine+isocyanate+to+unsaturated+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.1021%2Fjo01258a031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01258a031%26sid%3Dliteratum%253Aachs%26aulast%3DGebelein%26aufirst%3DC.%2BG.%26aulast%3DRosen%26aufirst%3DS.%26aulast%3DSwern%26aufirst%3DD.%26atitle%3DObservations%2520on%2520the%2520mechanism%2520of%2520addition%2520of%2520iodine%2520isocyanate%2520to%2520unsaturated%2520compounds%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1969%26volume%3D34%26spage%3D1677%26epage%3D1679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="note"><p class="first last">Final products <b>72</b>, <b>76</b>, <b>79</b>, <b>83</b>–<b>85</b>, <b>87</b>, and <b>89</b> were each cocrystallized with BACE1 using the same conditions as for compound <b>62</b>, in order to unambiguously assign relative stereochemistry.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Badawy, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandeel, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awad, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Rahman, A.-R. H.</span><span> </span><span class="NLM_article-title">Synthesis of some new naphthopyran, pyrazole, pyridine, and thienobenzochromene derivatives using 1-(1-hydroxy-2-naphthyl) ethanone as a versatile starting material</span> <span class="citation_source-journal">Phosphorus, Sulfur Silicon Relat. Elem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">184</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1080%2F10426500802083158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWktbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2009&pages=179-196&author=D.+S.+Badawyauthor=E.+M.+Kandeelauthor=N.+M.+Awadauthor=A.-R.+H.+Abdel-Rahman&title=Synthesis+of+some+new+naphthopyran%2C+pyrazole%2C+pyridine%2C+and+thienobenzochromene+derivatives+using+1-%281-hydroxy-2-naphthyl%29+ethanone+as+a+versatile+starting+material"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of some new naphthopyran, pyrazole, pyridine, and thienobenzochromene derivatives using 1-(1-hydroxy-2-naphthyl)ethanone as a versatile starting material</span></div><div class="casAuthors">Badawy, Doria S.; Kandeel, E. M.; Awad, Noha M.; Abdel-Rahman, Abdel-Rahman H.</div><div class="citationInfo"><span class="NLM_cas:title">Phosphorus, Sulfur and Silicon and the Related Elements</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">179-196</span>CODEN:
                <span class="NLM_cas:coden">PSSLEC</span>;
        ISSN:<span class="NLM_cas:issn">1042-6507</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Treatment of the enaminone (I) prepd. from 1-(1-hydroxy-2-naphthyl)ethanone (II) with N,N-dimethylformamide dimethylacetal with acetic acid, thionyl chloride, or bromine, gave the corresponding 4-oxo-4H-naphtho[1,2-b]pyran derivs.  Refluxing of p-toluidine or p-anisidine with I afforded the N-aryl analogs.  2-Methyl-4-oxo-4H-naphtho[1,2-b]pyran-3-carboxaldehyde (III) was prepd. via the acetylation of I.  Condensation of III with malononitrile or Et cyanoacetate gave 2-nicotinoylnaphthols.  Refluxing of III with hydrazine hydrate, phenylhydrazine, semicarbazide hydrochloride, or thiosemicarbazide afforded pyrazole derivs.  Reaction of I with malononitrile gave the chromenecarbonitrile deriv.  Treatment of this with malononitrile afforded the chromenemalononitrile.  This compd. was obtained directly by reaction of I with excess of malononitrile and catalytic piperidine.  Further reactions of the chromenecarbonitrile are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoly3AR0SA9ZbVg90H21EOLACvtfcHk0lgD3mx5T2_I7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWktbvK&md5=e8f2995a48e5445d1047f42f14964bd7</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1080%2F10426500802083158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10426500802083158%26sid%3Dliteratum%253Aachs%26aulast%3DBadawy%26aufirst%3DD.%2BS.%26aulast%3DKandeel%26aufirst%3DE.%2BM.%26aulast%3DAwad%26aufirst%3DN.%2BM.%26aulast%3DAbdel-Rahman%26aufirst%3DA.-R.%2BH.%26atitle%3DSynthesis%2520of%2520some%2520new%2520naphthopyran%252C%2520pyrazole%252C%2520pyridine%252C%2520and%2520thienobenzochromene%2520derivatives%2520using%25201-%25281-hydroxy-2-naphthyl%2529%2520ethanone%2520as%2520a%2520versatile%2520starting%2520material%26jtitle%3DPhosphorus%252C%2520Sulfur%2520Silicon%2520Relat.%2520Elem%26date%3D2009%26volume%3D184%26spage%3D179%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">Compound <b>40</b> has reportedly been synthesized by an alternative procedure:</p></div><span class="NLM_contrib-group">Shaw, G.</span><span> </span><span class="NLM_article-title">A novel high yield γ-chromone synthesis</span> <span class="citation_source-journal">J. Chem. Soc., Chem. Comm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_fpage">1735</span><span class="NLM_x">–</span> <span class="NLM_lpage">1736</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1039%2Fc39870001735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADyaL1cXhvVKmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1987&pages=1735-1736&author=G.+Shaw&title=A+novel+high+yield+%CE%B3-chromone+synthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">A novel high yield γ-chromone synthesis</span></div><div class="casAuthors">Shaw, Gordon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society, Chemical Communications</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1735-6</span>CODEN:
                <span class="NLM_cas:coden">JCCCAT</span>;
        ISSN:<span class="NLM_cas:issn">0022-4936</span>.
    </div><div class="casAbstract">Chromones I (R = H, Cl, Br, R1 = H, OMe, OEt, Br) were prepd. in > 90% yields by cyclocondensation of salicylaldehydes II with enamine III in hot EtOH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSpdiYNAppsLVg90H21EOLACvtfcHk0lgD3mx5T2_I7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhvVKmsrw%253D&md5=6141f715b670933fe215fb1710d02bfb</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1039%2Fc39870001735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc39870001735%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DG.%26atitle%3DA%2520novel%2520high%2520yield%2520%25CE%25B3-chromone%2520synthesis%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Comm.%26date%3D1987%26spage%3D1735%26epage%3D1736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="note"><p class="first last">Stereochemistry for compounds <b>41</b> and <b>50</b> assigned by analogy to related compounds from the literature.</p></div><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Saengchantara, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, T. W.</span><span> </span><span class="NLM_article-title">Heterodiene cycloadditions of 3-acylchromones with enol ethers</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. I</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">794</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1986&pages=789-794&author=S.+T.+Saengchantaraauthor=T.+W.+Wallace&title=Heterodiene+cycloadditions+of+3-acylchromones+with+enol+ethers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaengchantara%26aufirst%3DS.%2BT.%26aulast%3DWallace%26aufirst%3DT.%2BW.%26atitle%3DHeterodiene%2520cycloadditions%2520of%25203-acylchromones%2520with%2520enol%2520ethers%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%2520I%26date%3D1986%26spage%3D789%26epage%3D794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Coutts, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, T. W.</span><span> </span><span class="NLM_article-title">Heterodiene cycloadditions: Preparation and transformations of some substituted pyrano[4,3-b][1]benzopyrans</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">11755</span><span class="NLM_x">–</span> <span class="NLM_lpage">11780</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=11755-11780&author=S.+J.+Couttsauthor=T.+W.+Wallace&title=Heterodiene+cycloadditions%3A+Preparation+and+transformations+of+some+substituted+pyrano%5B4%2C3-b%5D%5B1%5Dbenzopyrans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoutts%26aufirst%3DS.%2BJ.%26aulast%3DWallace%26aufirst%3DT.%2BW.%26atitle%3DHeterodiene%2520cycloadditions%253A%2520Preparation%2520and%2520transformations%2520of%2520some%2520substituted%2520pyrano%255B4%252C3-b%255D%255B1%255Dbenzopyrans%26jtitle%3DTetrahedron%26date%3D1994%26volume%3D50%26spage%3D11755%26epage%3D11780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="note"><p class="first last">We found that using the 1 and 4 h time points for evaluating coverage ratio gave a comparable result to using an AUC-based coverage ratio for rank ordering compounds.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvester, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aharony, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andisik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folmer, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwindner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koether, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumrine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spear, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, G.</span><span> </span><span class="NLM_article-title">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5912</span><span class="NLM_x">–</span> <span class="NLM_lpage">5925</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070829p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5912-5925&author=P.+D.+Edwardsauthor=J.+S.+Albertauthor=M.+Sylvesterauthor=D.+Aharonyauthor=D.+Andisikauthor=O.+Callaghanauthor=J.+B.+Campbellauthor=R.+A.+Carrauthor=G.+Chessariauthor=M.+Congreveauthor=M.+Fredericksonauthor=R.+H.+Folmerauthor=S.+Geschwindnerauthor=G.+Koetherauthor=K.+Kolmodinauthor=J.+Krumrineauthor=R.+C.+Maugerauthor=C.+W.+Murrayauthor=L.+L.+Olssonauthor=S.+Patelauthor=N.+Spearauthor=G.+Tian&title=Application+of+fragment-based+lead+generation+to+the+discovery+of+novel%2C+cyclic+amidine+%CE%B2-secretase+inhibitors+with+nanomolar+potency%2C+cellular+activity%2C+and+high+ligand+efficiency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span></div><div class="casAuthors">Edwards, Philip D.; Albert, Jeffrey S.; Sylvester, Mark; Aharony, David; Andisik, Donald; Callaghan, Owen; Campbell, James B.; Carr, Robin A.; Chessari, Gianni; Congreve, Miles; Frederickson, Martyn; Folmer, Rutger H. A.; Geschwindner, Stefan; Koether, Gerard; Kolmodin, Karin; Krumrine, Jennifer; Mauger, Russell C.; Murray, Christopher W.; Olsson, Lise-Lotte; Patel, Sahil; Spear, Nate; Tian, Gaochao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5912-5925</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based lead generation has led to the discovery of a novel series of cyclic amidine-based inhibitors of β-secretase (BACE-1).  Initial fragment hits with an isocytosine core having millimolar potency were identified via NMR affinity screening.  Structure-guided evolution of these fragments using x-ray crystallog. together with potency detn. using surface plasmon resonance and functional enzyme inhibition assays afforded micromolar inhibitors.  Similarity searching around the isocytosine core led to the identification of a related series of inhibitors, the dihydroisocytosines.  By leveraging the knowledge of the ligand-BACE-1 recognition features generated from the isocytosines, the dihydroisocytosines were efficiently optimized to submicromolar potency.  Compd. (I), with an IC50 of 80 nM, a ligand efficiency of 0.37, and cellular activity of 470 nM, emerged as the lead structure for future optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmm71A2gRltrVg90H21EOLACvtfcHk0lgbc1rJ5bWPxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP&md5=140f3ade2b7754f62eb73589c5de4d7b</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fjm070829p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070829p%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26aulast%3DSylvester%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAndisik%26aufirst%3DD.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%2BB.%26aulast%3DCarr%26aufirst%3DR.%2BA.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DFolmer%26aufirst%3DR.%2BH.%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DKoether%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKrumrine%26aufirst%3DJ.%26aulast%3DMauger%26aufirst%3DR.%2BC.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DOlsson%26aufirst%3DL.%2BL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSpear%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DG.%26atitle%3DApplication%2520of%2520fragment-based%2520lead%2520generation%2520to%2520the%2520discovery%2520of%2520novel%252C%2520cyclic%2520amidine%2520%25CE%25B2-secretase%2520inhibitors%2520with%2520nanomolar%2520potency%252C%2520cellular%2520activity%252C%2520and%2520high%2520ligand%2520efficiency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5912%26epage%3D5925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6314</span><span class="NLM_x">–</span> <span class="NLM_lpage">6323</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9006752" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6314-6323&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=K.+Barnesauthor=M.+Johnsonauthor=Y.+Huiauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=A.+Ollandauthor=J.+Bardauthor=A.+J.+Robichaud&title=Aminoimidazoles+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Fjm9006752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9006752%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DBarnes%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DY.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DAminoimidazoles%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6314%26epage%3D6323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plobeck, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehgelmeble, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelissen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as BACE-1 inhibitors: the challenge to achieve in vivo brain efficacy</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1854</span><span class="NLM_x">–</span> <span class="NLM_lpage">1859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1854-1859&author=B.-M.+Swahnauthor=J.+Holenzauthor=J.+Kihlstr%C3%B6mauthor=K.+Kolmodinauthor=J.+Lindstr%C3%B6mauthor=N.+Plobeckauthor=D.+Rotticciauthor=F.+Sehgelmebleauthor=M.+Sundstr%C3%B6mauthor=S.+von+Bergauthor=J.+F%C3%A4ltingauthor=B.+Georgievskaauthor=S.+Gustavssonauthor=J.+Neelissenauthor=M.+Ekauthor=L.-L.+Olssonauthor=S.+Berg&title=Aminoimidazoles+as+BACE-1+inhibitors%3A+the+challenge+to+achieve+in+vivo+brain+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DPlobeck%26aufirst%3DN.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DSehgelmeble%26aufirst%3DF.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DNeelissen%26aufirst%3DJ.%26aulast%3DEk%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DBerg%26aufirst%3DS.%26atitle%3DAminoimidazoles%2520as%2520BACE-1%2520inhibitors%253A%2520the%2520challenge%2520to%2520achieve%2520in%2520vivo%2520brain%2520efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1854%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiang, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span> </span><span class="NLM_article-title">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9156</span><span class="NLM_x">–</span> <span class="NLM_lpage">9169</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300598e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9156-9169&author=H.+Huangauthor=D.+S.+Laauthor=A.+C.+Chengauthor=D.+A.+Whittingtonauthor=V.+F.+Patelauthor=K.+Chenauthor=T.+A.+Dineenauthor=O.+Epsteinauthor=R.+Graceffaauthor=D.+Hickmanauthor=Y.-H.+Kiangauthor=S.+Louieauthor=Y.+Luoauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=R.+T.+Fremeau&title=Structure-+and+property-based+design+of+aminooxazoline+xanthenes+as+selective%2C+orally+efficacious%2C+and+CNS+penetrable+BACE+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22d&amp;dbid=16384&amp;doi=10.1021%2Fjm300598e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300598e%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DKiang%26aufirst%3DY.-H.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DStructure-%2520and%2520property-based%2520design%2520of%2520aminooxazoline%2520xanthenes%2520as%2520selective%252C%2520orally%2520efficacious%252C%2520and%2520CNS%2520penetrable%2520BACE%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9156%26epage%3D9169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Jean, D. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span> </span><span class="NLM_article-title">From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5836</span><span class="NLM_x">–</span> <span class="NLM_lpage">5857</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200544q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22e&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5836-5857&author=Y.+Chengauthor=T.+C.+Juddauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=R.+T.+Fremeauauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=B.+Jordanauthor=V.+Liauthor=P.+Lopezauthor=S.+W.+Louieauthor=Y.+Luoauthor=K.+Michelsenauthor=T.+Nixeyauthor=T.+S.+Powersauthor=C.+Rattanauthor=E.+A.+Sickmierauthor=D.+J.+St.+Jeanauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Wood&title=From+fragment+screening+to+in+vivo+efficacy%3A+optimization+of+a+series+of+2-aminoquinolines+as+potent+inhibitors+of+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22eR"><div class="casContent"><span class="casTitleNuber">22e</span><div class="casTitle"><span class="NLM_cas:atitle">From Fragment Screening to In Vivo Efficacy: Optimization of a Series of 2-Aminoquinolines as Potent Inhibitors of Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)</span></div><div class="casAuthors">Cheng, Yuan; Judd, Ted C.; Bartberger, Michael D.; Brown, James; Chen, Kui; Fremeau, Robert T.; Hickman, Dean; Hitchcock, Stephen A.; Jordan, Brad; Li, Vivian; Lopez, Patricia; Louie, Steven W.; Luo, Yi; Michelsen, Klaus; Nixey, Thomas; Powers, Timothy S.; Rattan, Claire; Sickmier, E. Allen; St. Jean, David J.; Wahl, Robert C.; Wen, Paul H.; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5836-5857</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using fragment-based screening of a focused fragment library, 2-aminoquinoline 1 was identified as an initial hit for BACE1.  Further SAR development was supported by X-ray structures of BACE1 cocrystd. with various ligands and mol. modeling studies to expedite the discovery of potent compds.  These strategies enabled us to integrate the C-3 side chain on 2-aminoquinoline 1 extending deep into the P2' binding pocket of BACE1 and enhancing the ligand's potency.  We were able to improve the BACE1 potency to subnanomolar range, over 106-fold more potent than the initial hit (900 μM).  Further elaboration of the phys. properties of the lead compds. to those more consistent with good blood-brain barrier permeability led to inhibitors with greatly improved cellular activity and permeability.  Compd. 59 showed an IC50 value of 11 nM on BACE1 and cellular activity of 80 nM.  This compd. was advanced into rat pharmacokinetic and pharmacodynamic studies and demonstrated significant redn. of Aβ levels in cerebrospinal fluid (CSF).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLRGyUyxO1fLVg90H21EOLACvtfcHk0likqLKdDEPGQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D&md5=fa0f2b9b7524a1c3b75e162801f54d90</span></div><a href="/servlet/linkout?suffix=cit22e&amp;dbid=16384&amp;doi=10.1021%2Fjm200544q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200544q%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DJudd%26aufirst%3DT.%2BC.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DJordan%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%2BW.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DNixey%26aufirst%3DT.%26aulast%3DPowers%26aufirst%3DT.%2BS.%26aulast%3DRattan%26aufirst%3DC.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DFrom%2520fragment%2520screening%2520to%2520in%2520vivo%2520efficacy%253A%2520optimization%2520of%2520a%2520series%2520of%25202-aminoquinolines%2520as%2520potent%2520inhibitors%2520of%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5836%26epage%3D5857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Gravenfors, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viklund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kieseritzky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slivo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strömberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahm, F.</span><span> </span><span class="NLM_article-title">New aminoimidazoles as β-secretase (BACE-1) inhibitors showing amyloid-β (aβ) lowering in brain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9297</span><span class="NLM_x">–</span> <span class="NLM_lpage">9311</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300991n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9297-9311&author=Y.+Gravenforsauthor=J.+Viklundauthor=J.+Blidauthor=T.+Ginmanauthor=S.+Karlstr%C3%B6mauthor=J.+Kihlstr%C3%B6mauthor=K.+Kolmodinauthor=J.+Lindstr%C3%B6mauthor=S.+von+Bergauthor=F.+von+Kieseritzkyauthor=C.+Slivoauthor=B.-M.+Swahnauthor=L.-L.+Olssonauthor=P.+Johanssonauthor=S.+Eketj%C3%A4llauthor=J.+F%C3%A4ltingauthor=F.+Jeppssonauthor=K.+Str%C3%B6mbergauthor=J.+Jansonauthor=F.+Rahm&title=New+aminoimidazoles+as+%CE%B2-secretase+%28BACE-1%29+inhibitors+showing+amyloid-%CE%B2+%28a%CE%B2%29+lowering+in+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22f&amp;dbid=16384&amp;doi=10.1021%2Fjm300991n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300991n%26sid%3Dliteratum%253Aachs%26aulast%3DGravenfors%26aufirst%3DY.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DBlid%26aufirst%3DJ.%26aulast%3DGinman%26aufirst%3DT.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DStr%25C3%25B6mberg%26aufirst%3DK.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DRahm%26aufirst%3DF.%26atitle%3DNew%2520aminoimidazoles%2520as%2520%25CE%25B2-secretase%2520%2528BACE-1%2529%2520inhibitors%2520showing%2520amyloid-%25CE%25B2%2520%2528a%25CE%25B2%2529%2520lowering%2520in%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9297%26epage%3D9311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Mandal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzelak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buevich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9331</span><span class="NLM_x">–</span> <span class="NLM_lpage">9345</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301039c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22g&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9331-9345&author=M.+Mandalauthor=Z.+Zhuauthor=J.+N.+Cummingauthor=X.+Liuauthor=C.+Stricklandauthor=R.+D.+Mazzolaauthor=J.+P.+Caldwellauthor=P.+Leachauthor=M.+Grzelakauthor=L.+Hydeauthor=Q.+Zhangauthor=G.+Terracinaauthor=L.+Zhangauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=K.+Coxauthor=P.+Orthauthor=A.+Buevichauthor=J.+Voigtauthor=H.+Wangauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Design+and+validation+of+bicyclic+iminopyrimidinones+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors%3A+conformational+constraint+to+favor+a+bioactive+conformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22gR"><div class="casContent"><span class="casTitleNuber">22g</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation</span></div><div class="casAuthors">Mandal, Mihirbaran; Zhu, Zhaoning; Cumming, Jared N.; Liu, Xiaoxiang; Strickland, Corey; Mazzola, Robert D.; Caldwell, John P.; Leach, Prescott; Grzelak, Michael; Hyde, Lynn; Zhang, Qi; Terracina, Giuseppe; Zhang, Lili; Chen, Xia; Kuvelkar, Reshma; Kennedy, Matthew E.; Favreau, Leonard; Cox, Kathleen; Orth, Peter; Buevich, Alexei; Voigt, Johannes; Wang, Hongwu; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9331-9345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our observation that the biaryl substituent of iminopyrimidinone 7 must be in a pseudoaxial conformation to occupy the contiguous S1-S3 subsites of BACE1, we have designed a novel fused bicyclic iminopyrimidinone scaffold intended to favor this bioactive conformation.  Strategic incorporation of a nitrogen atom in the new constrained ring allowed us to develop SAR around the S2' binding pocket and ultimately resulted in analogs with low nanomolar potency for BACE1.  In particular, optimization of the prime side substituent led to major improvements in potency by displacement of two conserved water mols. from a region near S2'.  Further optimization of the pharmacokinetic properties of this fused pyrrolidine series, in conjunction with facile access to a rat pharmacodynamic model, led to identification of compd. 43, which is an orally active, brain penetrant inhibitor that reduces Aβ40 in the plasma, CSF, and cortex of rats in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlJsgY-3wuLVg90H21EOLACvtfcHk0likqLKdDEPGQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP&md5=6fd0bc5ac847ded7e235939594d4b20d</span></div><a href="/servlet/linkout?suffix=cit22g&amp;dbid=16384&amp;doi=10.1021%2Fjm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301039c%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLeach%26aufirst%3DP.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDesign%2520and%2520validation%2520of%2520bicyclic%2520iminopyrimidinones%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%253A%2520conformational%2520constraint%2520to%2520favor%2520a%2520bioactive%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9331%26epage%3D9345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Söderman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slivo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyring, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kieseritzky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors with in vivo brain reduction of β-amyloid peptides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9346</span><span class="NLM_x">–</span> <span class="NLM_lpage">9361</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3009025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22h&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9346-9361&author=B.-M.+Swahnauthor=K.+Kolmodinauthor=S.+Karlstr%C3%B6mauthor=S.+von+Bergauthor=P.+S%C3%B6dermanauthor=J.+Holenzauthor=S.+Bergauthor=J.+Lindstr%C3%B6mauthor=M.+Sundstr%C3%B6mauthor=D.+Turekauthor=J.+Kihlstr%C3%B6mauthor=C.+Slivoauthor=L.+Anderssonauthor=D.+Pyringauthor=D.+Rotticciauthor=L.+Ohbergauthor=A.+Kersauthor=K.+Bogarauthor=F.+von+Kieseritzkyauthor=M.+Berghauthor=L.-L.+Olssonauthor=J.+Jansonauthor=S.+Eketj%C3%A4llauthor=B.+Georgievskaauthor=F.+Jeppssonauthor=J.+F%C3%A4lting&title=Design+and+synthesis+of+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE1%29+inhibitors+with+in+vivo+brain+reduction+of+%CE%B2-amyloid+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22hR"><div class="casContent"><span class="casTitleNuber">22h</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides</span></div><div class="casAuthors">Swahn, Britt-Marie; Kolmodin, Karin; Karlstroem, Sofia; von Berg, Stefan; Soederman, Peter; Holenz, Joerg; Berg, Stefan; Lindstroem, Johan; Sundstroem, Marie; Turek, Dominika; Kihlstroem, Jacob; Slivo, Can; Andersson, Lars; Pyring, David; Rotticci, Didier; Oehberg, Liselotte; Kers, Annika; Bogar, Krisztian; Bergh, Margareta; Olsson, Lise-Lotte; Janson, Juliette; Eketjaell, Susanna; Georgievska, Biljana; Jeppsson, Fredrik; Faelting, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9346-9361</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The evaluation of a series of aminoisoindoles as β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors and the discovery of a clin. candidate drug for Alzheimer's disease, (S)-32 (I, AZD3839), are described.  The improvement in permeability properties by the introduction of fluorine adjacent to the amidine moiety, resulting in in vivo brain redn. of Aβ40, is discussed.  Due to the basic nature of these compds., they displayed affinity for the human ether-a-go-go related gene (hERG) ion channel.  Different ways to reduce hERG inhibition and increase hERG margins for this series are described, culminating in (S)-16 (II) and (R)-41 (III) showing large in vitro margins with BACE1 cell IC50 values of 8.6 and 0.16 nM, resp., and hERG IC50 values of 16 and 2.8 μM, resp.  Several compds. were advanced into pharmacodynamic studies and demonstrated significant redn. of β-amyloid peptides in mouse brain following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox062OT8a6ubVg90H21EOLACvtfcHk0ljcdzraPVcMPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM&md5=da7685d90f56449caa77b6e6393e0a7d</span></div><a href="/servlet/linkout?suffix=cit22h&amp;dbid=16384&amp;doi=10.1021%2Fjm3009025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009025%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DS%25C3%25B6derman%26aufirst%3DP.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DTurek%26aufirst%3DD.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DAndersson%26aufirst%3DL.%26aulast%3DPyring%26aufirst%3DD.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DOhberg%26aufirst%3DL.%26aulast%3DKers%26aufirst%3DA.%26aulast%3DBogar%26aufirst%3DK.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DBergh%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE1%2529%2520inhibitors%2520with%2520in%2520vivo%2520brain%2520reduction%2520of%2520%25CE%25B2-amyloid%2520peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9346%26epage%3D9361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2444</span><span class="NLM_x">–</span> <span class="NLM_lpage">2449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22i&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1016%2Fj.bmcl.2012.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22i&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=22390835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22i&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2444-2449&author=J.+N.+Cummingauthor=E.+M.+Smithauthor=L.+Wangauthor=J.+Misiaszekauthor=J.+Durkinauthor=J.+Panauthor=U.+Iserlohauthor=Y.+Wuauthor=Z.+Zhuauthor=C.+Stricklandauthor=J.+Voigtauthor=X.+Chenauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=M.+F.+Czarnieckiauthor=W.+J.+Greenleeauthor=B.+A.+McKittrickauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Structure+based+design+of+iminohydantoin+BACE1+inhibitors%3A+identification+of+an+orally+available%2C+centrally+active+BACE1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22iR"><div class="casContent"><span class="casTitleNuber">22i</span><div class="casTitle"><span class="NLM_cas:atitle">Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitor</span></div><div class="casAuthors">Cumming, Jared N.; Smith, Elizabeth M.; Wang, Lingyan; Misiaszek, Jeffrey; Durkin, James; Pan, Jianping; Iserloh, Ulrich; Wu, Yusheng; Zhu, Zhaoning; Strickland, Corey; Voigt, Johannes; Chen, Xia; Kennedy, Matthew E.; Kuvelkar, Reshma; Hyde, Lynn A.; Cox, Kathleen; Favreau, Leonard; Czarniecki, Michael F.; Greenlee, William J.; McKittrick, Brian A.; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2444-2449</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">From an initial lead 2-imino-1-methyl-4,4-diphenyl-5-imidazolidinone, a structure-based design approach led to identification of the novel, high-affinity iminohydantoin BACE1 inhibitor I that lowers CNS-derived Aβ following oral administration to rats.  SAR development in the S3 and F' subsites of BACE1 for this series, the synthetic approaches employed in this effort, and in vivo data for I are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3tWBE09QKNLVg90H21EOLACvtfcHk0ljcdzraPVcMPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D&md5=783b6cb9a6d9608ff5e9dc4f5d634397</span></div><a href="/servlet/linkout?suffix=cit22i&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCzarniecki%26aufirst%3DM.%2BF.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DStructure%2520based%2520design%2520of%2520iminohydantoin%2520BACE1%2520inhibitors%253A%2520identification%2520of%2520an%2520orally%2520available%252C%2520centrally%2520active%2520BACE1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2444%26epage%3D2449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of 5,5′-disubstituted aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1146</span><span class="NLM_x">–</span> <span class="NLM_lpage">1158</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901414e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22j&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1146-1158&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=R.+Chopraauthor=A.+Ollandauthor=J.+Bardauthor=S.+Jacobsenauthor=R.+L.+Magoldaauthor=M.+Pangalosauthor=A.+J.+Robichaud&title=Design+and+synthesis+of+5%2C5%E2%80%B2-disubstituted+aminohydantoins+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22jR"><div class="casContent"><span class="casTitleNuber">22j</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of 5,5'-Disubstituted Aminohydantoins as Potent and Selective Human β-Secretase (BACE1) Inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Erdei, Jim; Gunawan, Iwan; Turner, Jim; Hu, Yun; Wagner, Erik; Fan, Kristi; Chopra, Rajiv; Olland, Andrea; Bard, Jonathan; Jacobsen, Steve; Magolda, Ronald L.; Pangalos, Menelas; Robichaud, Albert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1146-1158</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of small mol. aminohydantoins as potent and selective human β-secretase inhibitors is reported.  These analogs exhibit low nanomolar potency for BACE1, show comparable activity in a cell-based (ELISA) assay, and demonstrate > 100 × selectivity for the other structurally related aspartyl proteases BACE2, cathepsinD, renin, and pepsin.  On the basis of the cocrystal structure of the HTS-hit I in the BACE1 active site and by use of a structure-based drug design approach, we methodically explored the comparatively large binding pocket of the BACE1 enzyme and identified key interactions between the ligand and the protein that contributed to the affinity.  One of the more potent compds., (S)-II, displayed an IC50 value for BACE1 of 10 nM and exhibited comparable cellular activity (EC50 = 20 nM) in the ELISA assay.  Acute oral administration of (S)-II at 100 mg/kg resulted in a 69% redn. of plasma Aβ40 at 8 h in a Tg2576 mouse (p < 0.001).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovSHqfBBe70bVg90H21EOLACvtfcHk0lhfGze_FdNX9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN&md5=a27e4fbd64ed167ca7baae773c178fbc</span></div><a href="/servlet/linkout?suffix=cit22j&amp;dbid=16384&amp;doi=10.1021%2Fjm901414e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901414e%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DPangalos%26aufirst%3DM.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25205%252C5%25E2%2580%25B2-disubstituted%2520aminohydantoins%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1146%26epage%3D1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Hilpert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woltering, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayweg, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers-Evans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krummenacher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnider, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergadano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochstrasser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David-Pierson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narquizian, R.</span><span> </span><span class="NLM_article-title">β-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3980</span><span class="NLM_x">–</span> <span class="NLM_lpage">3995</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400225m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3980-3995&author=H.+Hilpertauthor=W.+Gubaauthor=T.+J.+Wolteringauthor=W.+Wostlauthor=E.+Pinardauthor=H.+Mauserauthor=A.+V.+Maywegauthor=M.+Rogers-Evansauthor=R.+Hummauthor=D.+Krummenacherauthor=T.+Muserauthor=C.+Schniderauthor=H.+Jacobsenauthor=L.+Ozmenauthor=A.+Bergadanoauthor=D.+W.+Bannerauthor=R.+Hochstrasserauthor=A.+Kuglstatterauthor=P.+David-Piersonauthor=H.+Fischerauthor=A.+Polaraauthor=R.+Narquizian&title=%CE%B2-Secretase+%28BACE1%29+inhibitors+with+high+in+vivo+efficacy+suitable+for+clinical+evaluation+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm400225m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400225m%26sid%3Dliteratum%253Aachs%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DMayweg%26aufirst%3DA.%2BV.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DHumm%26aufirst%3DR.%26aulast%3DKrummenacher%26aufirst%3DD.%26aulast%3DMuser%26aufirst%3DT.%26aulast%3DSchnider%26aufirst%3DC.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DBergadano%26aufirst%3DA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHochstrasser%26aufirst%3DR.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DDavid-Pierson%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DPolara%26aufirst%3DA.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3D%25CE%25B2-Secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520high%2520in%2520vivo%2520efficacy%2520suitable%2520for%2520clinical%2520evaluation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3980%26epage%3D3995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="note"><p class="first last">The alternate trans diastereomers (not depicted), analogous to diastereomers B in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, were significantly less potent.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="note"><p class="first last">The alternate trans diastereomers (not depicted), analogous to diastereomers A in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, were significantly less potent.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="note"><p class="first last">The alternate trans diastereomer (not depicted), analogous to diastereomers A in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, was not accessible using the synthetic route described by Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0lhfGze_FdNX9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="note"><p class="first last"><i>F</i>% of 103% was within experimental error of 100%.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Du, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosner, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K. F.</span><span> </span><span class="NLM_article-title">Dominance of amyloid precursor protein sequence over host cell secretases in determining β-amyloid profiles studies of interspecies variation and drug action by internally standardized immunoprecipitation/mass spectrometry</span> <span class="citation_source-journal">J. Pharm. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">1144</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1124%2Fjpet.106.114561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=17202404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1Wgtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=1144-1152&author=P.+Duauthor=K.+M.+Woodauthor=M.+H.+Rosnerauthor=D.+Cunninghamauthor=B.+Tateauthor=K.+F.+Geoghegan&title=Dominance+of+amyloid+precursor+protein+sequence+over+host+cell+secretases+in+determining+%CE%B2-amyloid+profiles+studies+of+interspecies+variation+and+drug+action+by+internally+standardized+immunoprecipitation%2Fmass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Dominance of amyloid precursor protein sequence over host cell secretases in determining β-amyloid profiles studies of interspecies variation and drug action by internally standardized immunoprecipitation/mass spectrometry</span></div><div class="casAuthors">Du, Ping; Wood, Kathleen M.; Rosner, Michele H.; Cunningham, David; Tate, Barbara; Geoghegan, Kieran F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1144-1152</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">β-Amyloid peptides, tentatively regarded as the principal neurotoxins responsible for Alzheimer's Disease, make up a set of products that varies significantly among different biol. systems.  The full implications of this complexity and its variations have yet to be defined.  In this work, Aβ peptide populations were extd. from animal brain tissue or cell-conditioned media, immunopptd. with specific antibodies, and analyzed by matrix-assisted laser desorption time-of-flight mass spectrometry.  15N-Substituted Aβ internal stds. were added to gauge variations in the profile of captured peptides.  Results from a range of species, including guinea pig, dog, rabbit, and wild-type and transgenic mice, showed that the Aβ peptide population in each system was mainly detd. by the species of origin of the amyloid precursor protein (APP) and not by the host tissue or cell line.  The same method was used to gauge the effect on the Aβ peptide profile of an inhibitor of γ-secretase, one of the two proteinases that excises Aβ peptides from the precursor protein with different effects on specific peptides.  Overall, the results demonstrate that the species of origin of the APP substrate dictates the outcome of APP processing to a greater extent than the origin of the processing enzymes, an important consideration in rationalizing the properties of different model systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ4VzPbVJHdLVg90H21EOLACvtfcHk0lhfGze_FdNX9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1Wgtbs%253D&md5=954075f0f5b303e83eda3d571aaa81a7</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.114561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.114561%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DRosner%26aufirst%3DM.%2BH.%26aulast%3DCunningham%26aufirst%3DD.%26aulast%3DTate%26aufirst%3DB.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26atitle%3DDominance%2520of%2520amyloid%2520precursor%2520protein%2520sequence%2520over%2520host%2520cell%2520secretases%2520in%2520determining%2520%25CE%25B2-amyloid%2520profiles%2520studies%2520of%2520interspecies%2520variation%2520and%2520drug%2520action%2520by%2520internally%2520standardized%2520immunoprecipitation%252Fmass%2520spectrometry%26jtitle%3DJ.%2520Pharm.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D1144%26epage%3D1152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coraggio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wildsmith, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mango, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schauer, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hop, C. E. C. A.</span><span> </span><span class="NLM_article-title">Mechanistic pharmacokinetic–pharmacodynamic modeling of BACE1 inhibition in monkeys: development of a predictive model for amyloid precursor protein processing</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1319</span><span class="NLM_x">–</span> <span class="NLM_lpage">1328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=1319-1328&author=X.+Liuauthor=H.+Wongauthor=K.+Scearce-Levieauthor=R.+J.+Wattsauthor=M.+Coraggioauthor=Y.+G.+Shinauthor=K.+Pengauthor=K.+R.+Wildsmithauthor=J.+K.+Atwalauthor=J.+Mangoauthor=S.+P.+Schauerauthor=K.+Regalauthor=K.+W.+Huntauthor=A.+A.+Thomasauthor=M.+Siuauthor=J.+Lyssikatosauthor=G.+Deshmukhauthor=C.+E.+C.+A.+Hop&title=Mechanistic+pharmacokinetic%E2%80%93pharmacodynamic+modeling+of+BACE1+inhibition+in+monkeys%3A+development+of+a+predictive+model+for+amyloid+precursor+protein+processing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DCoraggio%26aufirst%3DM.%26aulast%3DShin%26aufirst%3DY.%2BG.%26aulast%3DPeng%26aufirst%3DK.%26aulast%3DWildsmith%26aufirst%3DK.%2BR.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DMango%26aufirst%3DJ.%26aulast%3DSchauer%26aufirst%3DS.%2BP.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DLyssikatos%26aufirst%3DJ.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DHop%26aufirst%3DC.%2BE.%2BC.%2BA.%26atitle%3DMechanistic%2520pharmacokinetic%25E2%2580%2593pharmacodynamic%2520modeling%2520of%2520BACE1%2520inhibition%2520in%2520monkeys%253A%2520development%2520of%2520a%2520predictive%2520model%2520for%2520amyloid%2520precursor%2520protein%2520processing%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26spage%3D1319%26epage%3D1328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paddock, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mildner, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lull, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cialdella, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prince, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span> </span><span class="NLM_article-title">High yield expression of human BACE constructs in <i>Eschericia coli</i> for refolding, purification, and high resolution diffracting crystal forms</span> <span class="citation_source-journal">Protein Pept. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.2174%2F092986608783489553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=18289105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVarurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=131-143&author=A.+G.+Tomasselliauthor=D.+J.+Paddockauthor=T.+L.+Emmonsauthor=A.+M.+Mildnerauthor=J.+W.+Leoneauthor=J.+M.+Lullauthor=J.+I.+Cialdellaauthor=D.+B.+Princeauthor=H.+D.+Fischerauthor=R.+L.+Heinriksonauthor=T.+E.+Benson&title=High+yield+expression+of+human+BACE+constructs+in+Eschericia+coli+for+refolding%2C+purification%2C+and+high+resolution+diffracting+crystal+forms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">High yield expression of human BACE constructs in Escherichia coli for refolding, purification, and high resolution diffracting crystal forms</span></div><div class="casAuthors">Tomasselli, A. G.; Paddock, D. J.; Emmons, T. L.; Mildner, A. M.; Leone, J. W.; Lull, J. M.; Cialdella, J. I.; Prince, D. B.; Fischer, H. D.; Heinrikson, R. L.; Benson, T. E.</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Peptide Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-143</span>CODEN:
                <span class="NLM_cas:coden">PPELEN</span>;
        ISSN:<span class="NLM_cas:issn">0929-8665</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">BACE (β-site APP cleaving enzyme) or β-secretase, the enzyme responsible for processing APP to give the N-terminal portion of the Aβ peptide, is a membrane bound aspartyl protease consisting of an ectodomain catalytic unit, a C-terminal transmembrane segment and a cytoplasmic domain.  Three BACE constructs, pET11a-BACE, pQE80L-BACE, and pQE70-BACE were designed to terminate at a position just before the transmembrane domain (Ser432) and are described schematically below.  (1) PET11a-T7.Tag-G-S-M-(A-8GV......QTDES432),.  (2) PQE80L-Met-R-G-S-(His)6-G-S-I-E-T-D-(T1QH...QTDES432), and.  (3) PQE70-Met-BACE (R36GSFVEMG....PQTDES432(His)6).  Each construct was over-expressed in Escherichia coli as inclusion bodies.  The inclusion body proteins were solubilized in urea and refolded by diln. in water to yield active enzyme.  Maximal activity for pET11a-BACE and pQE80L-BACE was usually reached at day 3 to 4, while construct pQE70-BACE required about 21 days.  Active BACE was purified to homogeneity by anion-exchange chromatog. and affinity chromatog. over a column of immobilized peptide inhibitor.  The process, easily scalable to 60 L of cell culture, yielded in excess of 400 mg of active enzyme for crystallog. anal.  Highly purified pET11a-BACE and pQE70-BACE formed complexes with various inhibitors, the latter protein giving crystals diffracting up to 1.45 Å resoln.  In addn., a crystal form that does not require the presence of an inhibitor has been obtained for pQE70-BACE.  This ligand-free crystal form has proven useful for the prepn. of BACE-inhibitor complexes in soaking expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEJA1PQtQJMrVg90H21EOLACvtfcHk0ljIsfr9IS3zoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVarurY%253D&md5=b4b34ea8ea98fe464c924be9e583238d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F092986608783489553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986608783489553%26sid%3Dliteratum%253Aachs%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DPaddock%26aufirst%3DD.%2BJ.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DMildner%26aufirst%3DA.%2BM.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DLull%26aufirst%3DJ.%2BM.%26aulast%3DCialdella%26aufirst%3DJ.%2BI.%26aulast%3DPrince%26aufirst%3DD.%2BB.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DHigh%2520yield%2520expression%2520of%2520human%2520BACE%2520constructs%2520in%2520Eschericia%2520coli%2520for%2520refolding%252C%2520purification%252C%2520and%2520high%2520resolution%2520diffracting%2520crystal%2520forms%26jtitle%3DProtein%2520Pept.%2520Lett.%26date%3D2008%26volume%3D15%26spage%3D131%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Leslie, A. G. W.; Powell, H. R.</span><span> </span><span class="NLM_article-title">Processing Diffraction Data with Mosfim</span>. In  <span class="citation_source-book">Evolving Methods for Macromolecular Crystallography</span>; <span class="NLM_contrib-group">Read, R. J.; Sussman, J. L.</span>, Eds.; NATO Science Series II: Mathematics, Physics, and Chemistry 245; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1007%2F978-1-4020-6316-9_4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=41-51&author=A.+G.+W.+Leslie&author=H.+R.+Powellauthor=R.+J.+Read&author=J.+L.+Sussman&title=Evolving+Methods+for+Macromolecular+Crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2F978-1-4020-6316-9_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4020-6316-9_4%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26atitle%3DProcessing%2520Diffraction%2520Data%2520with%2520Mosfim%26btitle%3DEvolving%2520Methods%2520for%2520Macromolecular%2520Crystallography%26aulast%3DRead%26aufirst%3DR.%2BJ.%26pub%3DSpringer%26date%3D2007%26spage%3D41%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krissinel, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. S.</span><span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">D67</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0lhtziBjakXqzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3DD67%26spage%3D235%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm401635n&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm401635n&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm401635n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lhtziBjakXqzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1LYA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1LYA','PDB','1LYA'); return false;">PDB: 1LYA</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FNK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FNK','PDB','1FNK'); return false;">PDB: 1FNK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4N00" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4N00','PDB','4N00'); return false;">PDB: 4N00</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i104"><a href="/doi/suppl/10.1021/jm401635n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_56258"></div></div></div></div></div><hr /></hr><p class="last">Figure S1 and experimental details for compound <b>94</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401635n/suppl_file/jm401635n_si_001.pdf">jm401635n_si_001.pdf (355.17 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB accession number for the coordinates of the cocrystal structure of BACE1 + compound <b>62</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4N00">4N00</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401635n&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-3%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm401635n%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401635n" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679978df0a87d187","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
